data_2nlu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nlu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 15.1 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.95 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 10.34 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' HG ' HD13 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 8.16 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 7.29 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 7.08 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.74 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.621 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 11.14 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 16.19 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.97 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.621 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.86 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 13.32 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.85 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 11.06 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 6.0 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 4.48 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 12.11 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 . . . . . 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.622 0.601 . . . . 8.99 112.622 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.72 109.823 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.38 109.975 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.564 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.83 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 6.19 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.37 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.22 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.638 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 7.24 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 6.16 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.79 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 8.3 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.36 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.87 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.36 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.98 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.911 ' HB3' HG22 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.37 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.95 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HA ' HG13 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.74 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.559 ' HE2' HD23 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.94 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.413 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.69 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.59 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.783 ' HZ3' ' HB2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.35 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 6.04 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.85 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 8.26 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 8.08 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.36 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 9.13 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 9.16 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 6.07 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.44 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.33 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.672 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.7 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.642 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.36 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.64 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 91' ' ' ASN . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.483 HG13 ' HB2' ' B' ' 127' ' ' PRO . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.5 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 88' ' ' GLU . 5.9 p30 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.16 109.817 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . 0.448 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.4 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.44 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 6.08 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 5.03 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.57 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.95 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 4.21 109.347 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.31 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 6.16 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.29 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 9.21 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.57 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.45 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.97 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 5.05 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.672 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.8 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.77 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 3.14 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.88 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.7 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.483 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.53 -0.545 . . . . 9.39 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 8.34 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 10.22 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 11.69 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.684 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.58 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 14.06 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.95 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.81 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.431 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 10.78 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.498 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 7.32 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.8 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 9.14 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 13.04 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.761 ' HB3' HG23 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 11.08 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.456 ' HG3' ' HH ' ' A' ' 10' ' ' TYR . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 11.64 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.433 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 12.53 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 13.11 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.82 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.47 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.9 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.586 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.99 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' B' ' 177' ' ' ASN . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.84 109.624 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 16.28 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 12.17 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 10.38 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.46 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 8.29 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 12.48 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.517 HD13 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.578 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 15.1 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.95 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 10.34 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.694 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 8.16 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 7.29 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 7.08 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.74 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.436 ' HG3' HD12 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 11.14 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 16.19 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.97 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.86 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 13.32 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.85 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 11.06 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 6.0 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 4.48 111.522 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 12.11 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.504 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.76 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 29' ' ' ARG . 17.2 mm-40 . . . . . 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.345 0.593 . . . . 8.99 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.72 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.38 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.83 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 6.19 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.515 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.37 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.411 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.22 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.81 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.522 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 7.24 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 6.16 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.79 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 8.3 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.36 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.87 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.36 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.98 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.413 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.37 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.95 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HA ' HG13 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.74 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.788 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.94 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.69 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.59 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.35 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 6.04 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.85 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 8.26 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 8.08 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.36 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 9.13 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 9.16 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 6.07 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.532 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.44 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.633 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.33 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.81 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.7 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.36 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.401 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.64 110.557 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.5 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' CD ' ' HZ3' ' A' ' 70' ' ' LYS . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.16 112.209 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.4 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.44 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 6.08 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 5.03 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.556 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.57 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.615 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.95 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 4.21 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . 0.489 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.31 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 6.16 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.29 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 9.21 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.57 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.45 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.97 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 5.05 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.532 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.8 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.77 111.686 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 3.14 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.88 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.548 HG21 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.7 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 109.324 -0.621 . . . . 9.39 109.324 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.76 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 8.34 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 32' ' ' GLU . 23.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 10.22 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 11.69 111.098 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.694 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.58 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 14.06 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.95 109.649 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.81 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 10.78 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 7.32 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.8 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 9.14 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 13.04 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.549 HD21 HG23 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 11.08 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.578 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 11.64 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 12.53 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 13.11 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.82 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.47 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' B' ' 176' ' ' PRO . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.9 106.594 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 175' ' ' LYS . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.99 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.84 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 16.28 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 12.17 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.416 ' CZ ' HD13 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 10.38 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.78 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.436 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.46 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.416 HD13 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 8.29 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 12.48 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.584 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . 0.584 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.048 -0.353 . . . . 10.33 110.048 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 15.1 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.649 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.95 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 10.34 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 8.16 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 7.29 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 7.08 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.74 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.444 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 11.14 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 16.19 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.97 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.86 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HB2' ' H ' ' A' ' 25' ' ' HIS . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 13.32 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.513 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 96.4 m-70 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.85 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 11.06 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 6.0 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 4.48 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 12.11 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.649 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 8.99 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.72 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.38 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.83 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 6.19 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.37 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.22 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 7.24 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 6.16 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.79 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 8.3 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.704 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.36 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.87 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.36 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.98 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.37 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.621 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.95 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 69' ' ' SER . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.74 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.94 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.69 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.59 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.35 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 6.04 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.85 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 8.26 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.598 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 8.08 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.36 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 9.13 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 9.16 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 6.07 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.44 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.598 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.33 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.647 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.7 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.36 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.64 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.477 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.5 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.16 110.304 176.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.507 -0.553 . . . . 8.32 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.4 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' B' ' 113' ' ' GLY . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.44 108.136 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.684 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 6.08 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 5.03 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.488 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' B' ' 114' ' ' ASP . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.57 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.95 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 4.21 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.31 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 6.16 111.123 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.29 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 9.21 109.322 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.57 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.45 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.97 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 5.05 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.733 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.8 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.77 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 3.14 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.88 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.7 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.555 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.218 -0.66 . . . . 9.39 109.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 8.34 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 10.22 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 11.69 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.58 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 14.06 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.95 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.81 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 10.78 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 18' ' ' ALA . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 7.32 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.8 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 9.14 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 13.04 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.485 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 11.08 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.629 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 11.64 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.474 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . 0.712 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 12.53 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.712 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 13.11 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . 0.507 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.82 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.47 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.753 ' HD3' HD12 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.9 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.623 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . 0.716 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.99 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.84 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 16.28 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 12.17 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.716 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 10.38 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.5 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.78 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.46 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.753 HD12 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 8.29 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 12.48 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.43 ' HA ' HD22 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.207 -0.664 . . . . 10.33 109.207 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 15.1 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.95 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 10.34 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 8.16 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.573 HG23 HD23 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 7.29 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 7.08 109.939 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.74 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.837 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 11.14 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 16.19 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.97 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.86 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 13.32 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.85 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 11.06 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 6.0 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' HD23 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 4.48 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 12.11 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.641 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.515 -0.389 0 N-CA-C 108.232 -1.025 . . . . 8.99 108.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.72 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.38 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.605 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.83 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 6.19 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.37 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.22 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.745 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 7.24 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 6.16 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.79 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 8.3 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.605 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.36 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.87 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.36 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.98 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.37 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.637 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.95 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HA ' HG12 ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.74 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.94 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.69 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.59 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.735 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.35 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 6.04 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.85 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 8.26 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 8.08 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.36 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.897 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 9.13 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 79' ' ' ARG . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 9.16 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 6.07 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.44 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.897 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.33 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.747 ' O ' HG21 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.7 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.781 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.36 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.64 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.5 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.16 110.338 -172.264 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.788 0.327 . . . . 8.32 110.432 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . 0.412 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.4 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.44 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 6.08 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 5.03 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.456 ' HB2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.69 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.57 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.95 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.41 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 4.21 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.31 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 6.16 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.464 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.29 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 9.21 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.57 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.464 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.45 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.97 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 5.05 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.745 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.8 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.781 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.77 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 3.14 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.88 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.7 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' B' ' 111' ' ' LYS . 43.1 tt0 . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.971 -0.751 . . . . 9.39 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 8.34 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 10.22 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.641 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 11.69 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.58 110.703 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 14.06 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.95 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.81 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 10.78 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 7.32 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.8 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 9.14 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 13.04 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.609 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 11.08 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 11.64 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.45 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . 0.45 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.6 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.539 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 12.53 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 13.11 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' B' ' 169' ' ' SER . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.82 110.339 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.47 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.9 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.99 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.618 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.84 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 16.28 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 12.17 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 10.38 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.78 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.46 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 8.29 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 12.48 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.489 HD13 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . 0.489 ' N ' HD13 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.74 0.305 . . . . 10.33 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 15.1 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 32' ' ' GLU . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.95 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 10.34 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 8.16 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 7.29 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 7.08 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.703 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.74 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.689 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 11.14 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 16.19 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.97 112.43 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.86 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 13.32 113.36 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.85 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 11.06 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 6.0 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 4.48 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 12.11 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' HB2' ' HD1' ' B' ' 145' ' ' TYR . 9.3 tp10 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 CA--C 1.521 -0.168 0 N-CA-C 109.568 -0.53 . . . . 8.99 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.72 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.38 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.83 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 6.19 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.37 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.521 ' HE2' ' HB3' ' A' ' 88' ' ' GLU . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.22 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 7.24 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 6.16 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.79 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 8.3 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.521 HD23 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.36 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.87 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.36 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.98 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.37 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.746 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.95 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.74 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.746 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.94 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.69 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.59 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.35 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 6.04 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.85 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 8.26 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 8.08 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.36 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 9.13 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 9.16 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 6.07 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.44 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.33 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.7 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.36 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.64 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' HD22 ' A' ' 91' ' ' ASN . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.695 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.5 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.54 HD22 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.16 111.739 -177.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.817 -0.438 . . . . 8.32 109.817 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.4 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.44 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 6.08 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 5.03 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.57 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.95 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 4.21 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.31 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.56 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 6.16 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.521 ' SD ' HD23 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.29 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 9.21 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.57 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.45 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.97 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 5.05 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.8 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.77 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 3.14 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.88 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.449 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.7 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.71 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.149 -0.315 . . . . 9.39 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.567 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 8.34 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 10.22 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 11.69 109.917 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.413 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.58 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 14.06 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.95 110.312 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.81 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 10.78 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.536 ' HB2' HG23 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 7.32 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.8 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.461 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 9.14 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 13.04 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.703 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.416 HD23 ' CG2' ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 11.08 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 11.64 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.949 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 12.53 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.585 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 13.11 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . 0.543 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . 0.543 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.82 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.47 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.9 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.99 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.84 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 16.28 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 12.17 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 10.38 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.78 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.46 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 8.29 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 12.48 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.629 ' HA ' HD22 ' B' ' 191' ' ' ASN . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.949 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.629 HD22 ' HA ' ' B' ' 188' ' ' GLU . 9.2 p30 . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.885 -0.413 . . . . 10.33 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 15.1 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.95 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.667 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 10.34 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.639 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 8.16 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.703 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 7.29 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 7.08 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.74 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 11.14 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 16.19 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.97 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.86 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 13.32 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.85 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.518 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 11.06 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 6.0 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 4.48 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 12.11 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.667 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.582 ' N ' HD12 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.102 0.477 . . . . 8.99 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.72 109.624 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 60' ' ' PRO . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.38 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.83 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 6.19 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.37 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.22 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 7.24 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 6.16 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.79 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 8.3 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 HD22 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.36 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.87 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.36 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.98 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.37 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.95 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.74 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.667 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.94 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.667 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.69 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.59 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.525 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.35 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 6.04 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.94 ' HB3' HD12 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.85 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 8.26 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 8.08 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.36 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 9.13 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 9.16 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 6.07 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.44 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.33 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.7 111.993 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.94 HD12 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.36 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.64 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.71 ' HA ' HD22 ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.464 HD12 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.5 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.71 HD22 ' HA ' ' A' ' 88' ' ' GLU . 4.2 p30 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.16 111.102 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.323 -0.621 . . . . 8.32 109.323 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . 0.576 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.4 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.44 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.443 ' HA ' HG21 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 6.08 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 5.03 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.57 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.596 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.95 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 4.21 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.31 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.805 ' HZ3' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 6.16 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.582 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.29 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 9.21 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.57 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.582 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.45 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.97 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 5.05 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.491 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.8 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.77 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 3.14 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.88 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.7 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.617 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.644 -0.502 . . . . 9.39 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 8.34 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 10.22 108.494 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD12 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 11.69 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.58 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.705 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 14.06 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.95 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.81 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.617 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 10.78 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 7.32 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.8 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 9.14 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' B' ' 162' ' ' ASP . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 13.04 112.052 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' B' ' 161' ' ' LYS . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.703 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.6 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 11.08 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 169' ' ' SER . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 11.64 114.302 -172.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 12.53 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.485 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 13.11 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.82 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.47 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.9 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.99 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.84 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 16.28 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 12.17 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 10.38 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.78 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.705 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.46 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 8.29 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 12.48 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD11 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 15.1 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.899 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.95 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 10.34 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 8.16 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 7.29 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 7.08 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.74 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.612 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 11.14 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 16.19 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.97 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.612 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.86 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 13.32 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.85 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.629 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 11.06 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 6.0 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 4.48 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 12.11 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.031 0.443 . . . . 8.99 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.72 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.535 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.38 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.83 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 6.19 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.37 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.22 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 7.24 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 6.16 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.79 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 8.3 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.36 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.87 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.36 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.98 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.37 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.95 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.74 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.569 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.94 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.529 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.69 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.59 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.35 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 6.04 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.85 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 8.26 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 8.08 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.36 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 9.13 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 9.16 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 6.07 113.107 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.44 110.738 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.33 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.577 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.7 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.36 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.64 110.033 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.774 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.5 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' HD11 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.16 110.459 -170.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.008 0.432 . . . . 8.32 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.4 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.44 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 6.08 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 5.03 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.774 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.57 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.95 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 4.21 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . 0.469 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.31 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 6.16 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.29 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 9.21 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.57 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.45 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.97 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 5.05 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.564 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.8 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.77 112.532 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.435 ' O ' HD21 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 3.14 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.596 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.88 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.7 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.166 0.508 . . . . 9.39 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 8.34 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 10.22 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 11.69 111.234 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.524 ' HE2' HD12 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.58 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 14.06 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.95 108.897 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.81 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 10.78 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 7.32 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.8 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 9.14 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 13.04 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.7 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 11.08 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.491 ' HA ' HG13 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 11.64 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.609 ' CD1' HG11 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 12.53 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 13.11 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.82 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.47 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.9 108.694 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.702 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.99 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.84 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 16.28 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 12.17 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.702 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 10.38 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.78 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.629 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.46 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 8.29 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 12.48 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 15.1 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.72 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.95 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 10.34 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 8.16 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.702 HG13 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 7.29 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 7.08 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.74 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 11.14 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 16.19 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.97 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.86 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 13.32 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.85 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 11.06 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 6.0 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 4.48 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 12.11 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.72 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.662 0.268 . . . . 8.99 110.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.72 110.892 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.38 108.745 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.83 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 6.19 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.601 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.37 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.22 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 7.24 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 6.16 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.79 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 8.3 110.521 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.36 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.87 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.36 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.98 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.37 110.356 -173.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.95 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.74 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.94 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.69 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.59 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.35 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 6.04 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.85 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.627 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 8.26 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 8.08 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.36 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 9.13 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 9.16 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 6.07 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.627 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.44 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.33 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.614 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.7 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.36 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.64 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.616 ' HA ' HD22 ' A' ' 91' ' ' ASN . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.5 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.616 HD22 ' HA ' ' A' ' 88' ' ' GLU . 3.6 p30 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.16 110.033 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.571 0.224 . . . . 8.32 111.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.4 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.44 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 6.08 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.426 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 5.03 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.57 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.95 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 4.21 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.31 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 6.16 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.463 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.29 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 9.21 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.57 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.463 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.45 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.97 113.42 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 5.05 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.614 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.8 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.432 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.77 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 3.14 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.88 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.638 HD11 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.7 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.638 ' N ' HD11 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 9.39 110.144 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 8.34 109.408 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 10.22 108.871 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 11.69 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.58 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 2.6 t60 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 14.06 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.95 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.81 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 10.78 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.609 ' HB2' HG23 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 7.32 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.8 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 9.14 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 13.04 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.623 HD22 HG22 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 11.08 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG13 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 11.64 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.466 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 12.53 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 13.11 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.82 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.467 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.47 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.9 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.57 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.99 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.84 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 16.28 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 12.17 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 10.38 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.78 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.46 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 8.29 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 12.48 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.408 HD13 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . 0.408 ' N ' HD13 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 10.33 110.089 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 15.1 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.95 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 10.34 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' N ' HG21 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 8.16 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 7.29 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 7.08 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.74 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.67 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 11.14 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 16.19 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.97 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.86 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 13.32 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.85 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 11.06 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 6.0 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 4.48 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 12.11 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.09 0.471 . . . . 8.99 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.72 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.38 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.83 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 6.19 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.37 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.597 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.22 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.747 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 7.24 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 6.16 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.79 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 8.3 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 HD23 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.36 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.87 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.487 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.36 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.98 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.831 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.37 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.595 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.95 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.74 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.94 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.69 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.59 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.35 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 6.04 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.85 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 8.26 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 77' ' ' ASN . 0.8 OUTLIER 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 8.08 109.748 -176.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.36 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 9.13 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 9.16 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 6.07 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.552 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.44 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.33 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.7 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.36 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.64 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.619 ' HA ' ' ND2' ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.519 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.5 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.16 110.58 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.456 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.4 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.44 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 6.08 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 5.03 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.658 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.57 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.831 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.95 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 4.21 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.31 110.877 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.478 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 6.16 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.588 ' HE3' ' HD2' ' B' ' 123' ' ' TYR . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.29 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 9.21 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.57 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.588 ' HD2' ' HE3' ' B' ' 120' ' ' MET . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.45 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.97 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 5.05 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.8 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.77 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.412 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 3.14 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.658 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.88 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.7 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.523 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.722 -0.473 . . . . 9.39 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 8.34 110.763 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 10.22 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 11.69 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.66 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.58 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 14.06 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.95 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.81 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 10.78 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.667 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 7.32 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.8 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 9.14 112.069 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 13.04 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.854 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.57 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 11.08 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.52 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 11.64 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 12.53 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 13.11 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.82 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.47 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.554 ' HB2' ' HZ2' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.9 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.99 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.84 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 16.28 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 12.17 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 10.38 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.78 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.467 ' O ' HD12 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.46 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.661 HD12 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 8.29 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 12.48 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.639 ' HA ' ' ND2' ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.499 HD13 HD23 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.639 ' ND2' ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 15.1 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.95 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 10.34 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD21 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 8.16 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 7.29 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 7.08 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.74 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 11.14 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 16.19 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.97 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.86 109.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 13.32 112.789 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.85 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 11.06 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 6.0 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 4.48 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 12.11 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.945 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t30 . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.744 -0.465 . . . . 8.99 109.744 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.72 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.38 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.83 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 6.19 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.37 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.22 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 7.24 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 6.16 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.79 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 8.3 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.36 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.87 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.36 111.181 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.98 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HG ' HG22 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.37 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.743 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.95 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.74 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.94 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.69 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.59 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.35 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 6.04 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.85 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 8.26 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 8.08 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.36 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 9.13 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 9.16 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 6.07 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE2' HD13 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.44 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.33 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.7 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.36 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.64 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.703 ' HA ' HD22 ' A' ' 91' ' ' ASN . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.567 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.5 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.703 HD22 ' HA ' ' A' ' 88' ' ' GLU . 2.7 p30 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.16 110.367 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.048 -0.353 . . . . 8.32 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.4 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.44 111.153 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 6.08 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 5.03 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.57 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.95 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 4.21 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.31 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 6.16 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.437 ' HE1' ' HD2' ' B' ' 123' ' ' TYR . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.29 108.237 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 9.21 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.57 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.437 ' HD2' ' HE1' ' B' ' 120' ' ' MET . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.45 110.514 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.481 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.97 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 5.05 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.8 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.77 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 3.14 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.634 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.88 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.424 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.7 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 9.39 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.643 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 8.34 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 10.22 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.462 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 11.69 109.865 -174.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.58 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 14.06 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' THR . . . . . 0.462 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.95 109.574 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.81 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 10.78 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 7.32 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.8 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.643 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 9.14 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 13.04 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 11.08 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.504 ' HA ' HG11 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 11.64 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 12.53 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 13.11 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.82 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.47 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.9 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.99 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.84 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 16.28 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 12.17 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 10.38 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.78 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.46 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 8.29 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 12.48 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.738 ' HA ' HD22 ' B' ' 191' ' ' ASN . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.738 HD22 ' HA ' ' B' ' 188' ' ' GLU . 5.6 p30 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.431 ' HB2' HG13 ' A' ' 30' ' ' ILE . 75.9 m-85 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.67 0.272 . . . . 10.33 110.616 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 15.1 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.95 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 10.34 112.749 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.659 HD21 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 8.16 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.571 ' CG2' ' HG ' ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 7.29 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 7.08 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.74 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.799 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 11.14 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 16.19 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.97 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.799 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.86 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 13.32 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.85 110.205 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.609 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 11.06 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 6.0 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 4.48 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 12.11 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' N ' HD12 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 11' ' ' LYS . 15.7 pt-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.235 0.541 . . . . 8.99 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.72 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.38 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 8.5 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.83 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 6.19 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.863 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.37 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.22 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 7.24 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 6.16 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.79 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 8.3 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.36 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.87 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.36 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.98 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.789 HD23 HG22 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.37 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.95 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.74 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.94 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 73' ' ' PHE . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.69 112.978 -168.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.59 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.675 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.675 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.35 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 6.04 110.807 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.85 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.601 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 8.26 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.409 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 8.08 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.36 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 9.13 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 9.16 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.699 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 6.07 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.44 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.33 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.7 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.36 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.64 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.581 HG21 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.5 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 88' ' ' GLU . 10.1 p30 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.16 110.491 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.012 0.434 . . . . 8.32 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.4 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' B' ' 111' ' ' LYS . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.44 111.315 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 6.08 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 5.03 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.57 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.95 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 4.21 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . 0.428 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.31 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 6.16 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.506 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.29 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 9.21 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.57 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.45 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.519 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.97 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 5.05 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.863 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.8 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.77 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 3.14 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.643 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.88 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.7 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.645 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.702 -0.481 . . . . 9.39 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 8.34 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 10.22 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.526 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 11.69 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.609 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.659 ' HE2' HD21 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.58 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.551 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 14.06 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.95 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.81 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 10.78 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.65 ' HB2' HG23 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 7.32 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.8 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 9.14 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 13.04 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 11.08 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.475 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 11.64 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.449 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 12.53 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.73 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 13.11 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.82 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.47 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.684 ' HA2' HD13 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.455 ' HA ' ' HD2' ' B' ' 176' ' ' PRO . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.9 108.23 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 175' ' ' LYS . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.99 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.84 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 16.28 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 12.17 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.419 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 10.38 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.78 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.46 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.684 HD13 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 8.29 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 12.48 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.517 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.545 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 15.1 110.868 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.95 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 10.34 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 8.16 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 7.29 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 7.08 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.554 ' HA ' HD21 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 19' ' ' LYS . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.74 110.892 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 11.14 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 16.19 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.97 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.86 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 13.32 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.85 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 11.06 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 6.0 112.698 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 4.48 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 12.11 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.751 0.31 . . . . 8.99 111.251 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.72 109.745 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.38 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.83 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 6.19 110.975 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.37 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.22 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.513 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 7.24 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 6.16 109.783 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.79 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 8.3 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.36 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.87 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.36 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.98 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD12 HG21 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.37 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.95 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.74 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.94 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.69 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.59 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.35 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 6.04 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.85 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 8.26 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 8.08 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.36 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 9.13 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 9.16 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 6.07 112.492 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.44 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.33 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.485 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.7 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.36 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.64 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.5 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.501 HD22 ' HA ' ' A' ' 88' ' ' GLU . 4.9 p30 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.16 109.96 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.588 0.233 . . . . 8.32 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.4 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.44 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 6.08 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 5.03 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.457 HD21 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.57 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.95 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 4.21 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.31 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 6.16 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.452 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.29 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 9.21 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.57 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.45 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.97 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 5.05 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.8 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.77 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.457 ' O ' HD21 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 3.14 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.608 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.88 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.7 112.004 -173.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.912 0.387 . . . . 9.39 110.49 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 8.34 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 10.22 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 11.69 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.58 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 14.06 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.95 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.81 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 10.78 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 7.32 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.8 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 9.14 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 13.04 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 11.08 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 11.64 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.632 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 12.53 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.632 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 13.11 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . 0.415 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.82 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.47 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.9 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.556 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.99 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.404 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.84 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 16.28 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 12.17 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 10.38 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.78 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.431 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.46 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 8.29 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 12.48 110.435 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.467 -0.197 . . . . 10.33 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 15.1 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.95 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 10.34 112.624 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 8.16 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 7.29 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.649 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 7.08 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.74 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 11.14 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 16.19 109.293 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.97 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.86 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 13.32 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.85 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 11.06 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 6.0 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 4.48 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 12.11 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.604 0.24 . . . . 8.99 111.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.72 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.38 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 24.4 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.83 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 6.19 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.37 110.091 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.22 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 7.24 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 6.16 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.79 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 8.3 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.36 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.87 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.36 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.98 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.411 HD23 HG22 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.37 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.538 ' HB3' ' HG ' ' A' ' 69' ' ' SER . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.95 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.74 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.94 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.684 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.69 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.59 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.35 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 6.04 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.85 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 8.26 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 8.08 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.36 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 9.13 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 9.16 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 6.07 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.44 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.33 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.7 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.473 HD23 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.36 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.64 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.5 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.16 110.642 -179.25 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.4 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.44 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 6.08 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 5.03 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.596 HD21 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.57 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.596 ' N ' HD21 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.95 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 4.21 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.31 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 6.16 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.29 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 9.21 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.57 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.478 ' HD1' ' CZ3' ' B' ' 126' ' ' TRP . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.45 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.97 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 5.05 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.485 ' CD1' ' HD2' ' B' ' 127' ' ' PRO . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.8 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.77 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 3.14 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.88 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.686 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.7 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.603 ' HZ1' ' HB3' ' B' ' 144' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.999 -0.371 . . . . 9.39 109.999 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 8.34 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 10.22 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 11.69 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.426 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.58 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.445 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 14.06 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.95 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.81 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 10.78 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.522 ' HB2' HG22 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 7.32 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.8 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 9.14 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' B' ' 161' ' ' LYS . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 13.04 111.061 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.473 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 11.08 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 11.64 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 12.53 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.649 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 13.11 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.82 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.47 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.9 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.529 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.99 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.84 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 16.28 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 12.17 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.529 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 10.38 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.78 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.46 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 8.29 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 12.48 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.67 ' HA ' HD22 ' B' ' 191' ' ' ASN . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.575 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.67 HD22 ' HA ' ' B' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 22.9 m-85 . . . . . 0 C--O 1.217 -0.64 0 N-CA-C 110.531 -0.174 . . . . 10.33 110.531 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 15.1 113.375 -171.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.95 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 10.34 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 8.16 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.54 ' N ' HD21 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 7.29 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.529 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 7.08 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.74 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.596 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 11.14 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 16.19 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.97 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.86 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 13.32 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.85 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 11.06 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 6.0 112.526 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 4.48 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 12.11 109.56 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 1.149 HD12 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.454 ' H ' HD11 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.667 0.746 . . . . 8.99 109.117 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.72 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.38 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.543 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.83 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.863 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 6.19 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.37 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.22 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.689 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 7.24 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 6.16 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.79 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 8.3 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.36 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.87 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.36 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.98 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 HD21 HG22 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.37 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.95 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.74 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.655 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.94 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.69 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.59 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.35 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 6.04 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.85 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HB3' HD11 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 8.26 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 8.08 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.36 112.01 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 9.13 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 9.16 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 6.07 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.44 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.33 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.7 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.36 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.64 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.59 HG12 HD23 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.5 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.16 111.704 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' B' ' 109' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.009 0.433 . . . . 8.32 110.732 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . 0.648 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.4 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.44 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 6.08 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 5.03 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' B' ' 129' ' ' ARG . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.57 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.547 HG22 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.95 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 4.21 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.31 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 6.16 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.29 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 9.21 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.57 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.536 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.45 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.97 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 5.05 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.689 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.8 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.77 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 3.14 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.863 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.88 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.7 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.809 -0.441 . . . . 9.39 109.809 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 1.149 ' HB3' HD12 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 8.34 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 10.22 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 11.69 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.431 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.58 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 14.06 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.95 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.81 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 10.78 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 7.32 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.8 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 9.14 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 13.04 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.501 HD12 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 11.08 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 11.64 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.529 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 12.53 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 13.11 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.82 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.47 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.9 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 3.0 t-20 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . 0.573 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.99 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.492 ' HA ' ' HB2' ' B' ' 183' ' ' SER . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.84 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' B' ' 181' ' ' GLY . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 16.28 109.499 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . 0.461 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 12.17 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 10.38 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.78 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.615 ' O ' HG21 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.46 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 8.29 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 12.48 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.615 HG21 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . 0.515 ' N ' HD11 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.118 -0.327 . . . . 10.33 110.118 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.702 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 15.1 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.95 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 10.34 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 8.16 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 7.29 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 7.08 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' B' ' 158' ' ' LEU . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.74 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 11.14 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 16.19 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.97 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.86 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 13.32 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.85 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 11.06 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 6.0 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 4.48 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 12.11 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.671 0.748 . . . . 8.99 110.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.72 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.38 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.83 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 6.19 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.37 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.22 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 7.24 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 6.16 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.79 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 8.3 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' B' ' 118' ' ' ALA . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.36 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.87 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.36 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.98 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.37 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.95 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.966 ' HA ' HG13 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.74 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.751 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.94 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.772 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.69 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.59 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 72' ' ' LYS . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.35 111.638 -168.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.772 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 6.04 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.879 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.85 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 8.26 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.557 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 8.08 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.36 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 9.13 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 9.16 111.947 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 6.07 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.44 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.33 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.7 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.879 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.36 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.64 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.475 HD11 HD23 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.5 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.16 109.507 175.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.205 0.526 . . . . 8.32 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.4 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.44 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 6.08 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 5.03 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.708 HD21 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.57 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.966 HG13 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.95 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 4.21 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.31 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 6.16 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.29 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 9.21 108.72 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.57 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.45 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.97 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 5.05 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.565 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.8 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . 0.406 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.77 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 3.14 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.708 ' HA ' HD21 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.88 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.7 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.171 0.51 . . . . 9.39 111.581 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 8.34 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 10.22 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 11.69 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.58 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 14.06 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.95 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.81 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.45 ' C ' HD13 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 10.78 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.693 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 7.32 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.8 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 9.14 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 13.04 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.504 ' HB3' HD21 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 11.08 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.518 ' HA ' HG11 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 11.64 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.535 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . 0.535 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 12.53 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 13.11 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.82 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.47 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.9 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.708 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . 0.484 ' N ' HD21 ' B' ' 177' ' ' ASN . 0.8 OUTLIER -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.99 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.84 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 16.28 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 12.17 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.708 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 10.38 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.78 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 188' ' ' GLU . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.6 ' O ' HG21 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.46 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 8.29 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 12.48 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 184' ' ' GLU . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.6 HG21 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.783 -0.451 . . . . 10.33 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 15.1 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.95 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 10.34 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 8.16 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.775 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 7.29 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 7.08 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.74 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.72 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 11.14 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 16.19 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.97 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.86 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 13.32 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.85 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.737 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 11.06 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 6.0 112.518 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 4.48 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 12.11 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.609 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.756 -0.461 . . . . 8.99 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.72 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.38 112.362 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.83 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 6.19 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.37 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CE2' HD12 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.22 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 7.24 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 6.16 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.79 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 8.3 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.36 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.87 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.36 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.98 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.37 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.609 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.95 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' B' ' 116' ' ' VAL . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.74 113.122 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.85 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.94 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.671 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.69 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.59 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.35 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 6.04 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.85 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 8.26 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 8.08 110.417 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.36 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 9.13 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 9.16 111.783 -168.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 6.07 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.44 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.33 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.7 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.36 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.64 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HA ' HD22 ' A' ' 91' ' ' ASN . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.5 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.63 HD22 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.16 111.364 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 120.943 0.401 . . . . 8.32 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.4 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.44 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 6.08 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 5.03 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.402 ' OD1' HG11 ' B' ' 116' ' ' VAL . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.57 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.85 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.95 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 4.21 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.31 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 6.16 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.682 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.29 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 9.21 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.57 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.45 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.97 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 5.05 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.712 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.8 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.77 112.563 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 3.14 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.88 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.499 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.7 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.499 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.772 0.32 . . . . 9.39 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 8.34 109.886 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' GLN . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 10.22 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 11.69 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.58 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 14.06 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.95 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.81 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 10.78 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 7.32 110.839 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.8 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 9.14 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 13.04 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' PHE . . . . . 0.675 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 11.08 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' PRO . . . . . 0.519 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 11.64 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' TYR . . . . . 0.775 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 12.53 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 13.11 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.82 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.47 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.9 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.99 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' ARG . . . . . 0.526 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.84 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 16.28 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 12.17 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 10.38 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.78 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.46 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' LEU . . . . . 0.405 HD23 ' O ' ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 8.29 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 12.48 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.461 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' ASN . . . . . 0.449 ' N ' HD21 ' B' ' 191' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.786 0.327 . . . . 29.65 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p -102.17 148.65 25.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.897 -0.409 . . . . 26.73 109.897 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 3' ' ' ARG . 40.9 ttp180 -106.88 137.84 44.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.318 . . . . 25.8 110.379 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -89.17 173.27 8.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.094 -0.503 . . . . 23.48 111.121 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -117.63 122.94 44.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.87 -0.605 . . . . 21.47 109.883 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -98.96 -16.98 18.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.613 0.244 . . . . 20.32 111.151 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -77.83 111.1 13.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 16.94 109.975 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -102.89 -17.6 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.789 -0.641 . . . . 16.4 110.639 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.36 134.41 51.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.435 0.636 . . . . 13.24 111.736 -173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 -80.2 148.64 30.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 168.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 15.1 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.95 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 10.34 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' HG ' HD13 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 8.16 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 7.29 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 7.08 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.74 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.621 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 11.14 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 16.19 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.97 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.621 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.86 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 13.32 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.85 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 11.06 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 6.0 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 4.48 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 12.11 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 75.02 172.48 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.9 tpt -166.41 94.8 0.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 13.04 109.517 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.74 87.01 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.084 2.523 . . . . 13.77 112.576 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -140.79 -21.61 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 14.04 111.733 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 94.45 3.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 111.527 0.195 . . . . 15.56 111.527 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.709 . . . . 15.1 111.188 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.26 141.45 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.684 -0.488 . . . . 12.84 109.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -102.84 -47.72 4.3 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.795 -0.817 . . . . 11.23 108.795 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 m -168.86 138.41 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.812 -1.085 . . . . 9.91 109.367 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 m -68.3 101.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.978 -0.378 . . . . 9.83 109.978 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -122.96 142.0 51.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.137 -0.483 . . . . 8.59 110.554 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.36 7.98 0.55 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.477 1.111 . . . . 8.99 112.622 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.72 109.823 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.38 109.975 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.564 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.83 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 6.19 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.37 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.22 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.638 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 7.24 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 6.16 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.79 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 8.3 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.36 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.87 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.36 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.98 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.911 ' HB3' HG22 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.37 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.95 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HA ' HG13 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.74 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.559 ' HE2' HD23 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.94 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.413 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.69 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.59 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' HG2' ' HD1' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.783 ' HZ3' ' HB2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.35 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 6.04 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' HD12 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.85 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 8.26 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 8.08 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.36 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 9.13 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 9.16 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 6.07 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.44 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.33 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.672 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.7 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.642 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.36 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.64 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 91' ' ' ASN . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 92' ' ' ASN . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.5 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 88' ' ' GLU . 5.9 p30 -108.2 28.77 7.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.16 109.817 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 4.7 p-10 -60.13 152.89 59.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.239 -0.891 . . . . 5.09 112.179 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.42 -45.57 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.34 2.693 . . . . 7.02 113.357 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -85.94 72.15 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.708 . . . . 7.48 110.589 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG23 ' HE2' ' A' ' 70' ' ' LYS . 3.8 p -111.75 111.81 37.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.54 0.686 . . . . 6.38 110.878 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -83.97 75.22 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 9.94 109.794 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.85 139.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.014 0.821 . . . . 8.62 112.403 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 t -72.72 -24.38 60.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.491 -0.559 . . . . 9.98 109.491 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.08 74.28 1.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.556 -0.747 . . . . 9.93 112.756 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HD1' ' HG2' ' A' ' 71' ' ' GLU . 85.6 m-85 . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 123.444 0.698 . . . . 13.17 111.978 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.475 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 63.1 mtt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.383 0.611 . . . . 14.01 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.8 t -81.42 98.66 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.301 -0.863 . . . . 12.42 111.254 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 69.59 -74.19 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.471 -0.786 . . . . 12.47 111.524 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -159.07 140.69 13.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.673 -0.492 . . . . 10.53 109.673 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -84.94 102.03 12.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.161 0.505 . . . . 8.15 110.501 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -118.19 -18.88 9.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.479 -0.782 . . . . 11.46 110.739 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.32 118.57 11.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 8.75 110.312 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' B' ' 108' ' ' LYS . 9.0 mmmm -137.55 18.06 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 9.35 110.972 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -76.17 167.9 21.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.448 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.4 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.44 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 6.08 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 5.03 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.57 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.911 HG22 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.95 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 4.21 109.347 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.31 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 6.16 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.29 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 9.21 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.57 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.453 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.45 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.97 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 5.05 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.672 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.8 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.77 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 3.14 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.88 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.7 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.483 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 -80.27 175.82 10.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.28 134.92 93.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.645 -0.707 . . . . 9.9 110.348 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.66 -40.53 55.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.325 2.683 . . . . 9.8 113.732 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 67.14 85.9 0.14 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.642 0.734 . . . . 12.27 110.443 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' B' ' 138' ' ' VAL . . . -167.13 74.47 0.14 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 11.9 108.963 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.21 -43.75 0.57 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.238 -0.892 . . . . 11.66 110.423 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' B' ' 136' ' ' ALA . 61.8 t -95.63 129.07 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.141 -0.481 . . . . 9.68 110.059 174.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -178.64 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.085 -1.45 . . . . 11.53 107.085 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -162.45 -172.56 3.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.493 -1.231 . . . . 8.79 108.729 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' B' ' 144' ' ' LYS . 3.2 m 65.32 98.13 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.661 0.6 . . . . 9.62 110.67 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.43 -72.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 8.95 111.319 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -92.25 95.08 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.245 0.545 . . . . 10.14 111.055 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.448 ' HD3' ' HB ' ' B' ' 141' ' ' THR . 23.7 pttm -131.07 137.08 48.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.369 -0.832 . . . . 9.39 109.53 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 8.34 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 10.22 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 11.69 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.684 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.58 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 14.06 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.95 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.81 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 10.78 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.498 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 7.32 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.8 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 9.14 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 13.04 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.761 ' HB3' HG23 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 11.08 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.456 ' HG3' ' HH ' ' A' ' 10' ' ' TYR . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 11.64 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.433 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 12.53 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 13.11 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.82 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.47 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.9 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.586 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.99 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' B' ' 177' ' ' ASN . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.84 109.624 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 16.28 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 12.17 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 10.38 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.46 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 8.29 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 12.48 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.517 HD13 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -3.61 58.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.631 ' ND2' ' HA ' ' B' ' 195' ' ' VAL . 7.9 t30 -164.42 71.18 1.6 Allowed Pre-proline 0 CA--C 1.531 0.224 0 O-C-N 122.253 -0.279 . . . . 14.02 111.068 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -87.43 -39.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.579 2.186 . . . . 14.9 112.878 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 11.7 t -97.78 2.34 49.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.079 -0.509 . . . . 18.01 109.77 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . 0.631 ' HA ' ' ND2' ' B' ' 192' ' ' ASN . 64.6 t 63.46 100.66 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 115.196 -0.911 . . . . 18.06 110.507 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.31 90.06 7.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.522 -0.763 . . . . 21.56 111.051 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.7 7.72 13.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 21.53 110.18 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 11.9 p -126.29 -56.42 1.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.405 -0.816 . . . . 23.03 111.286 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -104.63 59.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.658 -0.782 . . . . 24.72 113.087 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.414 -0.803 . . . . 27.31 109.873 176.008 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.003 -0.369 . . . . 29.65 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -134.76 123.97 24.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.444 -0.344 . . . . 26.73 110.573 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -82.7 74.89 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.173 0.511 . . . . 25.8 109.918 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -70.0 141.38 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.331 -0.849 . . . . 23.48 110.784 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -89.25 91.36 8.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 21.47 110.497 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -116.86 0.13 12.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.688 -0.687 . . . . 20.32 109.323 172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -109.5 119.44 39.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.6 -0.727 . . . . 16.94 109.437 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -85.26 175.9 8.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 16.4 110.315 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 71.84 -55.6 0.66 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.997 0.811 . . . . 13.24 112.096 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 -120.86 145.99 47.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 15.1 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.95 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 10.34 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.694 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 8.16 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 7.29 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 7.08 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.74 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.436 ' HG3' HD12 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 11.14 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 16.19 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.97 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.86 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 13.32 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.85 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 11.06 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 6.0 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 4.48 111.522 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 12.11 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.504 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.76 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 29' ' ' ARG . 17.2 mm-40 67.43 -71.42 0.1 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.6 mtt -142.2 142.73 25.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 13.04 111.438 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -95.65 148.7 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.325 2.683 . . . . 13.77 112.125 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 39' ' ' LYS . 11.1 tp10 -91.71 62.68 4.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.103 -0.703 . . . . 14.04 109.103 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.21 80.57 0.22 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.203 -0.908 . . . . 15.56 110.529 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.23 -73.86 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.233 -0.894 . . . . 15.1 111.527 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG21 ' H ' ' A' ' 40' ' ' SER . 8.5 p -79.07 163.11 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.256 -0.646 . . . . 12.84 109.256 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -118.67 21.76 12.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.684 -0.635 . . . . 11.23 110.541 175.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' H ' HG21 ' A' ' 38' ' ' VAL . 74.5 m -157.84 103.66 1.9 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.932 0.396 . . . . 9.91 110.928 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -95.9 59.32 2.0 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.739 0.781 . . . . 9.83 109.188 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.96 112.64 20.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 8.59 111.256 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.94 26.51 7.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 8.99 109.759 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.72 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.38 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.83 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 6.19 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.515 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.37 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.411 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.22 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.81 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.522 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 7.24 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 6.16 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.79 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 8.3 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.36 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.87 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.36 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.98 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.413 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.37 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.95 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HA ' HG13 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.74 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.788 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.94 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.69 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.59 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.35 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 6.04 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.85 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 8.26 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 8.08 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.36 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 9.13 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 9.16 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 6.07 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.532 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.44 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.633 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.33 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.81 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.7 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.36 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.401 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.64 110.557 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.5 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' CD ' ' HZ3' ' A' ' 70' ' ' LYS . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER -56.5 -26.08 53.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.16 112.209 -179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 58.83 97.46 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.184 0 CA-C-O 121.458 0.647 . . . . 5.09 111.078 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.07 -153.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.694 2.263 . . . . 7.02 110.9 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.3 m -79.14 72.74 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.274 0.559 . . . . 7.48 109.573 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.87 86.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 6.38 109.99 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -117.49 91.5 3.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.594 -0.73 . . . . 9.94 110.315 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.76 130.32 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.111 -0.495 . . . . 8.62 110.329 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 102.4 9.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.998 0.428 . . . . 9.98 110.077 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.89 63.45 4.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.875 -0.679 . . . . 9.93 112.701 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 13.17 110.284 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.471 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 26.2 ttt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.253 -0.647 . . . . 14.01 109.253 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -161.76 94.14 0.93 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.197 -0.91 . . . . 12.42 108.747 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -94.76 92.78 7.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 12.47 110.575 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 29.8 p -97.36 -42.01 7.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 10.53 111.088 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.04 155.59 18.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 8.15 111.18 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -123.34 106.45 10.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.762 -0.829 . . . . 11.46 108.762 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -70.44 104.84 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.165 -0.47 . . . . 8.75 112.205 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 52.03 87.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.108 -0.951 . . . . 9.35 111.938 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.88 -8.06 44.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.4 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.44 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 6.08 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 5.03 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.556 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.57 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.615 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.95 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 4.21 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . 0.489 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.31 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 6.16 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.29 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 9.21 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.57 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.45 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.97 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 5.05 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.532 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.8 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.77 111.686 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 3.14 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.88 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.548 HG21 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.7 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 -107.83 134.43 50.79 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 64.3 mtt -105.34 111.69 64.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.767 -0.651 . . . . 9.9 109.488 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 -30.47 66.19 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.704 2.269 . . . . 9.8 112.359 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -171.5 111.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 12.27 109.399 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.6 -114.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.618 -0.264 . . . . 11.9 110.966 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.39 -30.82 60.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.7 0.762 . . . . 11.66 109.648 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' B' ' 139' ' ' LYS . 13.1 p -80.45 140.84 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.63 -1.168 . . . . 9.68 109.01 173.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.585 ' HG2' HG22 ' B' ' 138' ' ' VAL . 31.6 mmmt 66.23 -69.48 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.722 0.639 . . . . 11.53 111.154 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m 63.88 39.73 7.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.426 0.69 . . . . 8.79 110.234 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 78.6 p 52.44 18.46 0.94 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.861 0.865 . . . . 9.62 111.993 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 38' ' ' VAL . . . 59.17 23.76 12.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.185 -0.461 . . . . 8.95 111.015 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.65 100.51 8.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.103 -0.498 . . . . 10.14 110.422 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.423 ' HD2' ' OG ' ' A' ' 40' ' ' SER . 17.2 ptpt -165.06 152.54 11.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.637 -0.711 . . . . 9.39 109.324 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.76 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 8.34 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 32' ' ' GLU . 23.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 10.22 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 11.69 111.098 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.694 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.58 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 14.06 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.95 109.649 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.81 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 10.78 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 7.32 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.8 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 9.14 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 13.04 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.549 HD21 HG23 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 11.08 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.578 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 11.64 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 12.53 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 13.11 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.82 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.47 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' B' ' 176' ' ' PRO . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.9 106.594 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 175' ' ' LYS . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.99 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.84 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 16.28 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 12.17 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.416 ' CZ ' HD13 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 10.38 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.78 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.436 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.46 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.416 HD13 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 8.29 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 12.48 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.584 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . 0.584 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -104.22 64.96 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -53.73 118.53 15.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.021 . . . . 14.02 111.808 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.24 -28.68 47.62 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.667 2.245 . . . . 14.9 111.064 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 8.2 p -89.89 86.35 6.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.659 -0.701 . . . . 18.01 110.446 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.57 -27.82 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.498 0.665 . . . . 18.06 109.248 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -76.69 85.04 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.938 -1.028 . . . . 21.56 109.852 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.57 104.5 7.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.831 -0.622 . . . . 21.53 109.521 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 21.9 t -84.1 75.95 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.133 0.492 . . . . 23.03 111.353 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.14 -31.13 61.96 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.938 -1.665 . . . . 24.72 108.938 167.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 58.9 t80 . . . . . 0 C--O 1.243 0.73 0 CA-C-N 113.928 -1.136 . . . . 27.31 108.625 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.826 0.346 . . . . 29.65 110.309 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -77.17 34.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.944 0.72 . . . . 26.73 112.944 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -109.67 -29.73 8.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.27 -0.641 . . . . 25.8 109.27 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -75.98 -50.09 15.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.26 -0.644 . . . . 23.48 109.26 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -109.01 132.06 54.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.236 -0.893 . . . . 21.47 109.711 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -86.79 -47.41 9.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.267 0.556 . . . . 20.32 109.737 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -95.46 178.61 5.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.409 -0.814 . . . . 16.94 110.359 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -124.39 132.39 53.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.613 -0.884 . . . . 16.4 108.613 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -100.34 123.33 44.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.13 -0.486 . . . . 13.24 111.579 -166.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 -122.31 150.3 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 10.33 110.048 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 15.1 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.649 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.95 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 10.34 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 8.16 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 7.29 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 7.08 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.74 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.444 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 11.14 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 16.19 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.97 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.86 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HB2' ' H ' ' A' ' 25' ' ' HIS . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 13.32 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.513 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 96.4 m-70 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.85 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 11.06 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 6.0 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 4.48 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 12.11 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.649 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 -158.94 129.87 6.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 61.0 mtt -137.23 137.2 22.0 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.555 -0.748 . . . . 13.04 109.744 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 34.1 Cg_exo -60.17 134.78 58.03 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.271 2.647 . . . . 13.77 112.937 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 73.95 -47.16 0.64 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.288 1.035 . . . . 14.04 112.134 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.82 74.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 15.56 110.91 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' B' ' 146' ' ' GLN . . . -126.22 -63.98 1.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.093 -0.503 . . . . 15.1 111.105 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' B' ' 142' ' ' ALA . 14.1 m -91.48 145.23 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.537 -0.301 . . . . 12.84 110.401 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -97.34 175.56 6.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.027 0.441 . . . . 11.23 110.513 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 t -129.82 80.99 1.99 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.712 -1.218 . . . . 9.91 107.712 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 157.12 45.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 9.83 110.935 -171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' B' ' 137' ' ' ALA . . . -120.92 -14.91 8.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.628 -0.715 . . . . 8.59 110.237 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 6.8 m-20 73.05 -53.17 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.071 0.857 . . . . 8.99 111.139 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.72 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.38 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.83 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 6.19 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.37 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.22 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 7.24 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 6.16 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.79 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 8.3 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.704 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.36 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.87 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.36 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.98 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.37 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.621 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.95 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 69' ' ' SER . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.74 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.94 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.69 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.59 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.35 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 6.04 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.85 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 8.26 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.598 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 8.08 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.36 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 9.13 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 9.16 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 6.07 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.44 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.598 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.33 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.647 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.7 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.36 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.64 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.477 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.5 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -54.0 -31.41 50.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.16 110.304 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' OD1' ' HB ' ' A' ' 95' ' ' VAL . 3.5 t-20 59.72 81.12 0.25 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.979 . . . . 5.09 112.412 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 -57.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.628 2.219 . . . . 7.02 111.452 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.4 m -101.17 112.19 24.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.854 -0.612 . . . . 7.48 110.368 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' HB ' ' OD1' ' A' ' 92' ' ' ASN . 5.2 p -122.89 118.8 56.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.131 -0.486 . . . . 6.38 110.925 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 70.97 10.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.539 0.685 . . . . 9.94 110.134 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -165.2 139.81 5.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.295 -0.866 . . . . 8.62 109.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -114.03 18.41 17.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.332 0.586 . . . . 9.98 110.317 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.25 141.06 3.02 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.426 -0.807 . . . . 9.93 111.662 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 13.17 110.641 179.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.439 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 14.1 tpt . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.377 0.608 . . . . 14.01 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 57.2 p -133.65 -44.6 0.82 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 12.42 110.34 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -135.02 73.66 1.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.32 0.581 . . . . 12.47 110.157 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.7 t -100.16 -12.53 19.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 10.53 108.593 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -80.41 109.94 15.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.931 . . . . 8.15 110.154 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.63 -39.27 24.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.764 -0.653 . . . . 11.46 111.02 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -87.37 113.84 23.45 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.909 -0.587 . . . . 8.75 111.395 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' B' ' 108' ' ' LYS . 20.9 ptmt -85.28 -17.47 36.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.413 -0.958 . . . . 9.35 108.413 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.83 172.42 8.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.522 -1.217 . . . . 8.32 109.507 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.4 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' B' ' 113' ' ' GLY . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.44 108.136 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.684 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 6.08 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 5.03 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.488 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' B' ' 114' ' ' ASP . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.57 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.95 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 4.21 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.31 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 6.16 111.123 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.29 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 9.21 109.322 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.57 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.45 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.97 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 5.05 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.733 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.8 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.77 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 3.14 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.88 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.7 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.555 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.67 88.79 2.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.483 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 23.6 mmt -111.84 147.49 36.96 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.165 -0.47 . . . . 9.9 110.469 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' B' ' 136' ' ' ALA . 18.3 Cg_endo -59.97 138.57 83.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.974 2.449 . . . . 9.8 111.659 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 71.11 -18.43 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.492 0.717 . . . . 12.27 112.342 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' B' ' 134' ' ' PRO . . . -95.28 -63.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.562 . . . . 11.9 110.149 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.473 ' O ' ' HB1' ' A' ' 42' ' ' ALA . . . -86.9 -62.19 1.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.783 -0.821 . . . . 11.66 108.783 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.31 103.09 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 9.68 110.115 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' B' ' 139' ' ' LYS . 9.1 ptpp? -125.31 13.48 8.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.442 0.639 . . . . 11.53 110.163 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 23.8 t -161.49 -174.3 4.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.275 -1.009 . . . . 8.79 108.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 48.6 m -154.58 -69.28 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 9.62 110.087 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -110.81 145.74 37.65 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.835 -0.62 . . . . 8.95 111.191 -175.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -105.73 -32.63 8.33 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.492 -0.929 . . . . 10.14 108.492 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -121.47 156.18 33.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.637 -1.165 . . . . 9.39 109.218 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 8.34 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 37' ' ' ALA . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 10.22 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 11.69 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.58 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 14.06 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.95 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.81 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 10.78 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 18' ' ' ALA . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 7.32 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.8 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 9.14 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 13.04 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.813 HD11 HG22 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.485 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 11.08 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.629 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 11.64 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.474 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.712 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 12.53 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.712 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 13.11 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . 0.507 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.82 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.47 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.753 ' HD3' HD12 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.9 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.623 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . 0.716 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.99 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.84 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 16.28 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 12.17 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.716 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 10.38 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.5 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.78 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.46 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.753 HD12 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 8.29 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 12.48 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.43 ' HA ' HD22 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 -79.2 -17.5 54.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -126.9 74.1 76.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.0 -0.741 . . . . 14.02 109.0 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.0 88.85 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.11 2.54 . . . . 14.9 112.965 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 3.5 m 60.79 27.61 17.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.59 -0.732 . . . . 18.01 110.935 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.95 111.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 18.06 109.87 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -74.05 102.2 4.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 21.56 109.952 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.4 115.92 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.029 -0.532 . . . . 21.53 110.99 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 56.6 m -156.09 -46.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.998 -0.546 . . . . 23.03 110.483 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.43 -96.72 0.35 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.04 -0.824 . . . . 24.72 111.04 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.409 -0.805 . . . . 27.31 109.072 173.296 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.669 0.271 . . . . 29.65 110.673 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -80.42 104.76 11.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.62 -0.511 . . . . 26.73 109.62 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -90.5 -48.92 6.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.714 -0.675 . . . . 25.8 110.312 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 t -109.47 116.37 31.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.871 -0.604 . . . . 23.48 110.013 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.37 169.18 13.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.922 -0.399 . . . . 21.47 109.922 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 57.27 -114.89 0.84 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.831 0.452 . . . . 20.32 111.517 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 4.0 pt20 -122.47 156.63 33.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.314 . . . . 16.94 110.909 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -103.57 -64.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.914 -0.772 . . . . 16.4 108.914 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 7' ' ' GLN . 7.5 mm-40 58.15 -160.89 0.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.952 -1.022 . . . . 13.24 112.35 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -119.93 112.06 18.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.675 -0.693 . . . . 10.33 109.207 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 15.1 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.95 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 10.34 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 8.16 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.573 HG23 HD23 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 7.29 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 7.08 109.939 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.74 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.837 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 11.14 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 16.19 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.97 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.86 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 13.32 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.85 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 11.06 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 6.0 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' HD23 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 4.48 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 12.11 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.641 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.03 147.94 9.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.402 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 55.7 ttp -140.83 107.65 6.4 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.379 -0.6 . . . . 13.04 109.379 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 19.6 Cg_endo -60.98 135.45 59.27 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.228 1.952 . . . . 13.77 110.776 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.56 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 11.9 mm-40 -53.12 -49.03 67.36 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.498 0.499 . . . . 14.04 110.503 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.76 92.29 0.94 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.571 -0.741 . . . . 15.56 109.593 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.72 -54.77 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.959 0.787 . . . . 15.1 110.606 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.24 155.59 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.261 -1.014 . . . . 12.84 108.261 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 43.6 tttp -84.34 79.32 9.59 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.275 -0.639 . . . . 11.23 109.275 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -89.15 115.66 26.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 9.91 111.483 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' B' ' 140' ' ' SER . 22.3 m -156.6 129.53 7.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.071 -0.513 . . . . 9.83 110.61 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' B' ' 139' ' ' LYS . . . -152.73 -85.64 0.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 8.59 109.722 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.55 94.18 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.232 -1.025 . . . . 8.99 108.232 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.72 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.38 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.605 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.83 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 6.19 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.37 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.22 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.745 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 7.24 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 6.16 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.79 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 8.3 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.605 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.36 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.87 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.36 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.98 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.37 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.95 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HA ' HG12 ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.74 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.94 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.69 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.59 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.735 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.35 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 6.04 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.85 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 8.26 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 8.08 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.36 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.897 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 9.13 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 79' ' ' ARG . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 9.16 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 6.07 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.44 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.897 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.33 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.747 ' O ' HG21 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.7 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.781 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.36 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.64 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.5 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -122.3 30.89 6.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.16 110.338 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.74 121.1 65.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 5.09 110.954 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 94' ' ' THR . 13.0 Cg_exo -69.71 110.44 2.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.844 2.363 . . . . 7.02 111.599 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 93' ' ' PRO . 98.2 m 71.56 91.72 0.09 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.742 0.651 . . . . 7.48 110.831 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.37 151.43 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 6.38 110.786 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.79 102.6 10.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 9.94 110.907 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.73 -70.74 0.67 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 8.62 109.527 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 m 70.18 -52.55 0.64 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.551 0.74 . . . . 9.98 112.381 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.6 -26.82 1.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.643 -0.583 . . . . 9.93 111.643 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 123.178 0.591 . . . . 13.17 111.333 176.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.472 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 50.0 ttm . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.935 0.397 . . . . 14.01 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -79.18 -9.4 59.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.056 0.455 . . . . 12.42 111.151 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -143.32 102.16 3.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 12.47 110.34 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -87.82 126.93 35.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.837 -0.62 . . . . 10.53 110.017 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -93.4 136.47 33.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 8.15 110.596 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -89.26 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 11.46 109.698 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -76.86 111.14 12.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.186 0.517 . . . . 8.75 111.949 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.53 -32.32 22.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.471 -0.786 . . . . 9.35 109.162 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.57 147.89 27.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.426 -0.806 . . . . 8.32 110.432 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.412 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.4 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.44 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 6.08 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 5.03 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.456 ' HB2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.69 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.57 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.95 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.41 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 4.21 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.31 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 6.16 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.464 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.29 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 9.21 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.57 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.464 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.45 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.97 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 5.05 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.745 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.8 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.781 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.77 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 3.14 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.88 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.7 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' B' ' 111' ' ' LYS . 43.1 tt0 -69.31 113.19 6.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.441 ' HE2' ' HE3' ' A' ' 44' ' ' LYS . 78.3 mtp -110.89 111.39 56.51 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.757 -0.656 . . . . 9.9 109.289 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 126.14 13.22 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.711 2.274 . . . . 9.8 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' B' ' 138' ' ' VAL . 32.1 mt-10 -89.26 12.53 15.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 12.27 109.41 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.32 101.34 6.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.956 -1.02 . . . . 11.9 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 79.28 -40.07 0.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.268 0.98 . . . . 11.66 110.606 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' B' ' 135' ' ' GLU . 92.5 t -97.3 101.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.363 0.602 . . . . 9.68 110.991 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 20.6 pttp -156.71 33.55 0.31 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.137 -1.06 . . . . 11.53 108.137 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 41' ' ' THR . 6.7 p -167.23 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.245 -1.343 . . . . 8.79 110.203 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m 60.2 58.58 2.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.717 0.77 . . . . 9.62 110.558 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' B' ' 143' ' ' ASN . . . -122.92 158.38 30.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.276 -0.875 . . . . 8.95 109.173 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' B' ' 142' ' ' ALA . 28.2 t-20 78.32 -38.82 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.085 0.554 . . . . 10.14 111.362 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -83.91 136.84 33.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.971 -0.751 . . . . 9.39 108.971 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 8.34 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 10.22 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.641 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 11.69 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.58 110.703 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 14.06 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.95 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.81 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 10.78 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 7.32 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.8 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 9.14 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 13.04 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.609 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 11.08 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 11.64 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.45 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.45 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.6 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.539 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 12.53 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 13.11 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' B' ' 169' ' ' SER . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.82 110.339 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.47 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.9 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.99 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.618 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.84 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 16.28 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 12.17 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 10.38 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.78 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.46 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 8.29 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 12.48 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.489 HD13 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . 0.489 ' N ' HD13 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -113.82 82.41 1.69 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -64.18 124.27 84.96 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.503 -0.771 . . . . 14.02 110.839 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.79 -28.59 59.41 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 14.9 112.178 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 18.4 m -100.55 98.03 8.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 18.01 110.085 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.24 135.88 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.003 -0.544 . . . . 18.06 110.471 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -100.8 107.97 19.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 21.56 110.497 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -153.92 133.49 12.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 21.53 109.743 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 12.8 t -111.93 91.68 3.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 23.03 110.144 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.46 62.39 0.65 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.269 -0.733 . . . . 24.72 111.269 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.677 -0.678 . . . . 27.31 110.317 -175.172 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.583 0.23 . . . . 29.65 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -68.84 -58.96 3.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.865 0.364 . . . . 26.73 110.737 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -108.18 104.0 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.558 -0.534 . . . . 25.8 109.558 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -98.83 173.16 7.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.036 -0.529 . . . . 23.48 110.039 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.43 123.44 25.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 21.47 109.803 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.64 -6.69 59.38 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.838 -0.619 . . . . 20.32 110.644 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -94.76 100.28 12.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.494 -0.775 . . . . 16.94 110.515 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 35.3 mtpt -110.88 107.75 17.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.569 . . . . 16.4 110.858 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -136.69 146.26 45.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.234 -0.654 . . . . 13.24 109.234 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.31 119.68 27.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.481 -0.327 . . . . 10.33 110.694 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 15.1 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 32' ' ' GLU . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.95 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 10.34 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 8.16 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 7.29 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 7.08 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.703 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.74 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.689 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 11.14 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 16.19 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.97 112.43 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.86 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 13.32 113.36 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.85 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 11.06 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 6.0 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 4.48 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 12.11 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' HB2' ' HD1' ' B' ' 145' ' ' TYR . 9.3 tp10 -90.0 125.26 35.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.506 ' SD ' ' HD2' ' A' ' 34' ' ' PRO . 48.9 tpp -150.22 128.05 5.74 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.109 -0.496 . . . . 13.04 110.094 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 29.3 Cg_endo -62.57 167.07 12.15 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.685 2.257 . . . . 13.77 111.973 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.6 -31.57 69.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.398 0.618 . . . . 14.04 109.441 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.89 -59.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.961 -1.018 . . . . 15.56 108.907 172.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.92 -33.83 2.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 15.1 109.69 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.655 HG22 HG23 ' B' ' 141' ' ' THR . 10.7 p -122.49 157.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.758 -0.656 . . . . 12.84 109.478 175.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 34' ' ' PRO . 28.1 ttmt -102.56 -51.57 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.928 0.394 . . . . 11.23 110.316 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 p -137.69 145.76 42.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 9.91 110.891 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.495 HG21 ' HE3' ' B' ' 139' ' ' LYS . 2.8 p -118.51 89.23 3.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.56 0.695 . . . . 9.83 110.198 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' B' ' 139' ' ' LYS . . . -95.09 121.6 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.564 -0.743 . . . . 8.59 111.643 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' B' ' 138' ' ' VAL . 43.4 t30 -177.42 -88.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.008 0.818 . . . . 8.99 109.568 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.72 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.38 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.83 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 6.19 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.37 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.521 ' HE2' ' HB3' ' A' ' 88' ' ' GLU . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.22 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 7.24 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 6.16 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.79 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 8.3 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.521 HD23 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.36 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.87 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.36 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.98 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.37 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.746 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.95 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.74 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.746 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.94 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.69 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.59 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.35 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 6.04 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.85 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 8.26 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 8.08 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.36 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 9.13 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 9.16 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 6.07 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.44 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.33 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.7 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.36 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.64 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' HD22 ' A' ' 91' ' ' ASN . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.695 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.5 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.54 HD22 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -87.77 10.3 18.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.16 111.739 -177.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.56 129.46 93.68 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 5.09 110.431 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.68 164.65 2.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.275 2.65 . . . . 7.02 112.855 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -65.4 105.72 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.861 0.838 . . . . 7.48 111.358 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.58 115.9 50.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.506 -0.77 . . . . 6.38 110.156 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.7 76.78 9.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.309 -0.405 . . . . 9.94 110.213 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 69.21 -59.1 0.49 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.713 0.805 . . . . 8.62 111.571 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 t -145.0 -40.78 0.24 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.537 -0.542 . . . . 9.98 109.537 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.82 -169.88 36.59 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.477 -0.649 . . . . 9.93 111.477 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.153 0.501 . . . . 13.17 110.123 -179.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.478 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 79.5 mtp . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.339 0.114 . . . . 14.01 110.715 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m 75.19 -59.24 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.453 0.701 . . . . 12.42 112.168 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.94 126.01 50.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.944 0.402 . . . . 12.47 111.02 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 40.5 m -145.71 111.88 5.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.828 -0.624 . . . . 10.53 110.119 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -76.75 109.77 10.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 8.15 110.255 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -90.74 -6.69 54.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.076 -0.511 . . . . 11.46 112.089 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -122.26 95.18 4.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.48 0.657 . . . . 8.75 111.387 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -100.35 78.17 2.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 9.35 109.988 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -169.29 129.1 1.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.929 -0.578 . . . . 8.32 109.817 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.4 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.44 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 6.08 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 5.03 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.57 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.95 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 4.21 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.31 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.56 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 6.16 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.521 ' SD ' HD23 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.29 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 9.21 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.57 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.45 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.97 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 5.05 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.8 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.77 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 3.14 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.88 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.449 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.7 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.71 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -96.69 127.44 42.67 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.552 ' HB2' HE21 ' A' ' 46' ' ' GLN . 23.5 ttt -123.51 90.28 50.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.73 0.3 . . . . 9.9 111.117 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -101.53 -173.68 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.422 2.748 . . . . 9.8 112.156 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . 0.462 ' OE2' ' HG2' ' B' ' 139' ' ' LYS . 24.2 mm-40 61.94 29.36 17.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 12.27 112.439 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.52 94.46 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.858 -0.337 . . . . 11.9 110.821 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 71.58 -58.81 0.57 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.93 0.769 . . . . 11.66 111.27 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 43' ' ' ASN . 32.6 t -107.86 146.77 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.519 -0.549 . . . . 9.68 109.519 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.495 ' HE3' HG21 ' A' ' 41' ' ' THR . 19.6 tptm 177.59 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.516 . . . . 11.53 109.987 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.408 ' H ' ' HB1' ' A' ' 42' ' ' ALA . 19.6 m -94.45 88.48 5.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.922 -0.581 . . . . 8.79 109.732 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 0.655 HG23 HG22 ' A' ' 38' ' ' VAL . 53.8 m -64.03 -32.73 74.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.84 -0.618 . . . . 9.62 110.789 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.13 165.57 12.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 8.95 109.475 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' B' ' 144' ' ' LYS . 28.8 t-20 -158.56 -68.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.83 0.348 . . . . 10.14 110.699 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' B' ' 143' ' ' ASN . 36.8 mtmm -123.1 130.35 52.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.291 -0.413 . . . . 9.39 110.149 177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.567 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 8.34 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 10.22 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 11.69 109.917 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.413 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.58 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 14.06 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.95 110.312 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.81 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 10.78 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.536 ' HB2' HG23 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 7.32 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.8 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.461 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 9.14 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 13.04 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.703 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.416 HD23 ' CG2' ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 11.08 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 11.64 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.949 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 12.53 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.585 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 13.11 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.543 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . 0.543 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.82 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.47 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.9 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.99 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.84 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 16.28 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 12.17 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 10.38 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.78 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.46 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 8.29 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 12.48 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.629 ' HA ' HD22 ' B' ' 191' ' ' ASN . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.949 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.629 HD22 ' HA ' ' B' ' 188' ' ' GLU . 9.2 p30 -73.65 -8.61 56.68 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.47 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 2.7 p-10 43.5 97.03 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.798 1.239 . . . . 14.02 114.066 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' B' ' 192' ' ' ASN . 42.0 Cg_endo -67.74 161.86 41.96 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.753 2.302 . . . . 14.9 111.674 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 41.9 m 70.66 -58.92 0.54 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.883 0.473 . . . . 18.01 111.633 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . 0.452 HG22 HD21 ' B' ' 192' ' ' ASN . 22.5 t 66.04 86.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.116 0.567 . . . . 18.06 110.577 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -96.36 114.45 26.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.772 -0.649 . . . . 21.56 109.71 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 64.57 73.66 0.42 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.606 0.717 . . . . 21.53 110.98 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 2.2 p -76.01 93.59 3.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.568 -0.742 . . . . 23.03 111.28 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -159.88 28.46 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.045 -0.597 . . . . 24.72 111.928 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.715 -0.659 . . . . 27.31 110.137 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.766 -0.457 . . . . 29.65 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -86.47 -44.74 11.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 26.73 109.44 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 61.23 -172.27 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.574 -0.739 . . . . 25.8 112.408 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m 59.58 22.06 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.04 -0.982 . . . . 23.48 112.157 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.03 96.34 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.019 -0.734 . . . . 21.47 109.019 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -100.4 -23.6 14.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.34 -0.391 . . . . 20.32 111.092 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -78.13 94.66 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.481 . . . . 16.94 109.848 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -143.56 -49.61 0.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.19 -0.914 . . . . 16.4 109.391 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -94.18 161.11 14.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.235 -0.893 . . . . 13.24 110.082 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -117.29 155.15 30.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 10.33 109.885 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 15.1 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.95 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.667 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 10.34 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.639 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 8.16 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.703 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 7.29 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 7.08 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.74 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 11.14 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 16.19 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.97 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.86 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 13.32 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.85 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.518 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 11.06 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 6.0 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 4.48 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 12.11 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.667 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.582 ' N ' HD12 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.99 123.34 37.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.5 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 47.1 tpp -140.87 101.03 6.47 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.929 -0.578 . . . . 13.04 110.28 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.791 ' CA ' ' HA ' ' B' ' 142' ' ' ALA . 47.8 Cg_exo -37.79 119.38 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 124.663 3.575 . . . . 13.77 115.161 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.842 ' HA ' ' HB ' ' B' ' 141' ' ' THR . 13.7 tt0 174.33 11.42 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.86 0.725 . . . . 14.04 112.166 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' B' ' 144' ' ' LYS . . . -86.84 -86.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.2 0.815 . . . . 15.56 113.2 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' B' ' 140' ' ' SER . . . -113.86 -53.18 2.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.295 0.48 . . . . 15.1 112.295 -171.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.657 ' O ' ' HB3' ' B' ' 142' ' ' ALA . 12.0 p -122.21 143.38 35.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 N-CA-C 109.405 -0.591 . . . . 12.84 109.405 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.776 ' HD2' ' HB2' ' B' ' 142' ' ' ALA . 21.5 tptp -117.12 -22.95 8.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 11.23 110.181 170.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.68 ' HA ' ' HG2' ' B' ' 135' ' ' GLU . 22.1 m 64.75 19.73 11.92 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.651 -0.704 . . . . 9.91 110.518 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.73 148.14 30.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 9.83 109.99 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.8 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.521 -0.309 . . . . 8.59 110.486 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.54 20.29 11.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.102 0.477 . . . . 8.99 110.923 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.72 109.624 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 60' ' ' PRO . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.38 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.83 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 6.19 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.37 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.22 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 7.24 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 6.16 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.79 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 8.3 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.543 HD22 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.36 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.87 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.36 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.98 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.37 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.95 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.74 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.667 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.94 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.667 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.69 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.59 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.525 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.35 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 6.04 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.94 ' HB3' HD12 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.85 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 8.26 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 8.08 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.36 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 9.13 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 9.16 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 6.07 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.44 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.33 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.7 111.993 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.94 HD12 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.36 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.64 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.71 ' HA ' HD22 ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.464 HD12 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.5 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.71 HD22 ' HA ' ' A' ' 88' ' ' GLU . 4.2 p30 -93.65 0.96 56.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.16 111.102 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.1 t30 -70.15 113.07 15.03 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.472 -0.331 . . . . 5.09 111.022 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -84.44 -30.22 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.988 2.459 . . . . 7.02 112.893 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 t -85.19 94.62 8.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.889 0.852 . . . . 7.48 111.326 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.97 94.94 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.315 -0.857 . . . . 6.38 108.947 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.09 88.28 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 9.94 111.02 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.02 175.12 6.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.809 -0.632 . . . . 8.62 110.304 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -60.45 -29.33 68.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.138 0.494 . . . . 9.98 111.146 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.98 85.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.815 -0.707 . . . . 9.93 111.976 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.845 0.355 . . . . 13.17 110.058 179.099 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.466 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 26.2 ptm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.686 0.279 . . . . 14.01 110.488 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -89.6 146.08 24.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.428 -0.582 . . . . 12.42 109.428 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 68.17 86.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.918 0.761 . . . . 12.47 110.284 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 69.8 p -93.86 120.58 34.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.634 -0.712 . . . . 10.53 110.203 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -74.38 91.42 2.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 8.15 110.215 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -121.63 -26.44 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.732 -0.667 . . . . 11.46 110.591 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.76 112.39 18.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 8.75 110.181 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -96.06 -71.91 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.334 0.588 . . . . 9.35 110.242 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -106.75 139.93 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 8.32 109.323 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.576 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.4 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.44 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.443 ' HA ' HG21 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 6.08 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 5.03 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.57 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.596 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.95 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 4.21 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.31 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.805 ' HZ3' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 6.16 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.582 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.29 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 9.21 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.57 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.582 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.45 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.97 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 5.05 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.491 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.8 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.77 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 3.14 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.88 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.7 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.75 147.93 25.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 91.7 mtp -133.27 134.69 24.35 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 9.9 109.586 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 4.4 Cg_exo -78.47 -70.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.729 2.286 . . . . 9.8 111.998 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -165.14 -149.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 12.27 109.991 177.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . 0.46 ' H ' ' HB2' ' B' ' 135' ' ' GLU . . . 71.53 13.15 6.45 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.731 0.644 . . . . 11.9 111.701 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -178.51 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 11.66 109.87 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.22 117.89 35.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.13 -0.941 . . . . 9.68 110.757 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 62.54 -78.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.575 -0.739 . . . . 11.53 111.211 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 54.2 m 54.8 47.59 22.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.215 0.531 . . . . 8.79 111.283 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 0.842 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 19.4 p -116.78 85.91 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.11 0.781 . . . . 9.62 113.11 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.791 ' HA ' ' CA ' ' A' ' 34' ' ' PRO . . . -148.1 166.68 27.1 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.144 -0.347 . . . . 8.95 111.262 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.481 ' N ' ' HA ' ' A' ' 34' ' ' PRO . 4.5 t30 63.95 37.4 9.44 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.825 0.85 . . . . 10.14 112.319 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.617 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt -89.61 147.08 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.383 -0.527 . . . . 9.39 109.644 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 8.34 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 33' ' ' MET . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 10.22 108.494 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD12 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 11.69 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.58 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.705 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 14.06 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.95 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.81 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.617 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 10.78 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 7.32 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.8 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 9.14 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' B' ' 162' ' ' ASP . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 13.04 112.052 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' B' ' 161' ' ' LYS . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.703 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.6 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 11.08 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 169' ' ' SER . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 11.64 114.302 -172.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 12.53 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.485 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 13.11 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.82 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.47 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.9 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.99 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.84 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 16.28 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 12.17 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 10.38 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.78 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.705 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.46 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.433 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 8.29 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 12.48 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD11 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -124.85 83.76 2.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -82.03 126.2 75.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.428 -0.582 . . . . 14.02 109.428 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 100.83 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.698 2.265 . . . . 14.9 112.385 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 60.2 m 63.75 97.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.72 . . . . 18.01 111.805 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.85 87.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.03 0.919 . . . . 18.06 110.692 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -79.14 77.46 5.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.665 -0.698 . . . . 21.56 110.216 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -162.28 -36.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 21.53 111.004 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 15.7 m -83.79 5.7 24.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.137 -0.483 . . . . 23.03 111.521 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 81.1 -96.77 1.73 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.872 -0.68 . . . . 24.72 111.887 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.575 -0.726 . . . . 27.31 110.424 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.442 -0.207 . . . . 29.65 110.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 m -87.85 -45.05 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.414 -0.587 . . . . 26.73 109.414 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -141.99 -163.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 25.8 109.228 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m 70.26 91.9 0.09 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.58 0.705 . . . . 23.48 110.241 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.91 175.09 10.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.209 -0.905 . . . . 21.47 110.907 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 71.0 mtt180 -127.22 79.22 1.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.007 -0.542 . . . . 20.32 109.789 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -108.34 95.93 6.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.792 -0.64 . . . . 16.94 110.895 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.715 ' HB3' HG23 ' A' ' 38' ' ' VAL . 65.4 tttp -175.83 126.62 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 16.4 110.894 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -154.73 -67.75 0.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.57 -0.9 . . . . 13.24 108.57 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.66 151.52 42.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 15.1 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.899 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.95 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 10.34 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 8.16 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 7.29 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 7.08 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.74 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.612 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 11.14 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 16.19 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.97 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.612 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.86 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 13.32 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.85 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.629 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 11.06 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 6.0 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 4.48 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 12.11 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 -129.87 160.02 34.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 61.0 mtt -97.77 151.79 37.78 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.473 -0.785 . . . . 13.04 109.189 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.35 162.23 15.04 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.64 2.227 . . . . 13.77 112.118 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.99 77.7 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 14.04 110.784 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.79 -48.2 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.19 -0.459 . . . . 15.56 110.658 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.11 -21.17 2.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.595 . . . . 15.1 110.793 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 39' ' ' LYS . 14.4 p -67.19 134.91 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 12.84 111.099 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.782 ' HG2' HG21 ' A' ' 38' ' ' VAL . 13.1 mmmm 70.2 -43.82 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.575 0.75 . . . . 11.23 111.224 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t 66.0 -154.83 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.524 0.73 . . . . 9.91 110.758 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -61.16 -20.76 63.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.672 0.389 . . . . 9.83 111.716 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 71.52 -53.36 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.465 0.706 . . . . 8.59 110.922 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -82.44 100.59 10.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 8.99 110.376 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.72 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.535 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.38 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.83 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 6.19 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.37 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.22 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 7.24 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 6.16 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.79 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 8.3 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.36 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.87 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.36 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.98 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.37 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.95 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.74 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.569 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.94 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.482 ' CD ' ' HZ2' ' B' ' 108' ' ' LYS . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.529 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.69 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.59 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.35 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 6.04 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.85 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 8.26 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 8.08 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.36 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 9.13 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 9.16 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 6.07 113.107 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.44 110.738 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.33 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.577 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.7 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.36 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.64 110.033 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.774 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.5 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' HD11 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.03 25.31 10.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.16 110.459 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 88' ' ' GLU . 6.7 t30 -64.0 115.96 23.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 5.09 111.087 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.48 -18.31 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.726 2.284 . . . . 7.02 113.057 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.7 t -151.84 97.66 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.469 0.652 . . . . 7.48 111.225 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' N ' HD22 ' A' ' 92' ' ' ASN . 7.6 p -93.0 123.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.731 -0.668 . . . . 6.38 110.35 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 48.2 tptt -87.48 80.96 7.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.387 0.613 . . . . 9.94 110.328 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.84 115.33 1.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.193 -0.912 . . . . 8.62 110.074 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 p -80.87 55.55 2.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.142 0.496 . . . . 9.98 110.656 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.97 -168.07 21.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.625 -0.716 . . . . 9.93 112.82 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.618 0.723 . . . . 13.17 110.714 -176.132 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.465 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 26.1 ptm . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 14.01 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m 56.36 -168.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.647 0.592 . . . . 12.42 111.619 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -93.44 127.77 39.22 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.659 -0.497 . . . . 12.47 109.659 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.5 t -78.96 -27.6 43.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 10.53 110.194 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -79.05 110.8 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.32 0.581 . . . . 8.15 109.953 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -79.94 90.96 5.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.638 -0.71 . . . . 11.46 109.909 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -81.5 107.58 14.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 8.75 110.614 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.482 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -96.91 -62.72 1.22 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.692 -0.485 . . . . 9.35 109.692 175.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 58.17 96.78 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.142 -0.935 . . . . 8.32 111.124 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.4 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.44 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 6.08 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 5.03 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.774 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.57 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.95 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 4.21 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . 0.469 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.31 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 6.16 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.29 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 9.21 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.57 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.45 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.97 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 5.05 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.564 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.8 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.77 112.532 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.435 ' O ' HD21 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 3.14 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.596 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.88 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.7 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.29 138.7 33.5 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 25.2 ptt? -105.3 139.94 20.64 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.703 -0.48 . . . . 9.9 109.703 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 2.9 Cg_exo -73.82 100.3 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.645 2.23 . . . . 9.8 111.787 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -86.39 29.55 0.76 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.258 -0.428 . . . . 12.27 111.298 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.56 -59.25 5.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 11.9 110.95 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.89 -45.22 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 11.66 110.296 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.414 HG23 ' HB1' ' B' ' 142' ' ' ALA . 5.5 p -96.08 163.06 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.914 -0.585 . . . . 9.68 109.903 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -112.83 -64.71 1.27 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.846 0.355 . . . . 11.53 110.399 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 32.9 p -103.85 -82.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 8.79 111.506 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.8 p -139.22 115.65 10.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.795 0.331 . . . . 9.62 110.979 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.414 ' HB1' HG23 ' B' ' 138' ' ' VAL . . . -168.52 81.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 8.95 109.895 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -114.78 -3.63 12.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.089 -0.505 . . . . 10.14 111.056 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.99 155.55 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.166 0.508 . . . . 9.39 111.506 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 8.34 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 10.22 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 11.69 111.234 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.524 ' HE2' HD12 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.58 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 14.06 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.95 108.897 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.81 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 10.78 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 7.32 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.8 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 9.14 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 13.04 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.7 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 11.08 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.491 ' HA ' HG13 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 11.64 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.609 ' CD1' HG11 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 12.53 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 13.11 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.82 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.47 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.9 108.694 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.702 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.99 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.84 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 16.28 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 12.17 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.702 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 10.38 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.78 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.629 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.46 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 8.29 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 12.48 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -90.04 -17.76 27.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 61.41 102.45 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.383 -0.826 . . . . 14.02 112.132 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.45 5.98 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.942 2.428 . . . . 14.9 113.666 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 27.4 m -139.41 108.35 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 18.01 110.917 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 14.2 m -110.69 132.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.19 0.519 . . . . 18.06 111.811 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -110.68 70.97 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.6 -0.727 . . . . 21.56 109.508 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -159.51 107.46 1.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 21.53 110.796 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m 71.05 163.93 0.27 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.043 0.839 . . . . 23.03 111.528 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.93 84.55 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.823 -0.626 . . . . 24.72 111.872 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.447 -0.787 . . . . 27.31 110.222 179.868 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' B' ' 168' ' ' GLU . 25.1 ptt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.851 0.358 . . . . 29.65 110.579 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -60.39 138.4 57.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.557 -0.747 . . . . 26.73 111.383 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -104.99 -43.24 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 25.8 110.492 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -116.93 111.17 19.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 23.48 110.145 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -83.83 90.92 7.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.34 0.591 . . . . 21.47 109.549 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -99.52 -8.35 24.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.284 -0.871 . . . . 20.32 110.837 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -88.98 104.75 17.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.806 -0.634 . . . . 16.94 110.625 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.37 15.94 23.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.508 . . . . 16.4 110.286 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' HA ' ' OH ' ' B' ' 145' ' ' TYR . 7.8 tp10 -143.21 104.01 4.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.396 -0.82 . . . . 13.24 109.406 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -96.93 119.39 35.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 15.1 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.72 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.95 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 10.34 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 8.16 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.702 HG13 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 7.29 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 7.08 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.74 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 11.14 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 16.19 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.97 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.86 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 13.32 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.85 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 11.06 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 6.0 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 4.48 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 12.11 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.72 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 -115.3 125.86 53.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.674 ' HE3' ' HG3' ' B' ' 146' ' ' GLN . 25.7 mmt -80.49 132.82 57.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.796 -0.638 . . . . 13.04 109.662 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -59.09 -36.14 96.72 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.415 2.076 . . . . 13.77 111.968 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 32.4 tt0 -154.33 -84.14 0.07 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.134 -0.485 . . . . 14.04 110.425 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.48 -87.65 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.495 0.497 . . . . 15.56 111.097 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.04 -1.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.364 . . . . 15.1 110.79 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 7.6 p -122.53 129.54 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 12.84 110.83 -175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 19.8 ptmt 64.17 -35.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.393 1.477 . . . . 11.23 113.497 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 23.0 p 49.21 47.38 22.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.469 0.708 . . . . 9.91 111.993 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 m 75.76 -59.18 0.53 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.631 -0.713 . . . . 9.83 110.331 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HA ' ' OG ' ' B' ' 140' ' ' SER . . . -164.74 90.78 0.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.783 -0.644 . . . . 8.59 109.795 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' B' ' 140' ' ' SER . 3.1 p-10 -81.94 5.09 20.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 8.99 110.909 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.72 110.892 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.554 ' HA ' ' HB3' ' B' ' 133' ' ' MET . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.38 108.745 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' HG2' ' HD3' ' B' ' 134' ' ' PRO . 15.5 mm100 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.83 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 6.19 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.601 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.37 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.22 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 7.24 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.601 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 6.16 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.79 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 8.3 110.521 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.36 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.87 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.36 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.98 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.37 110.356 -173.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.95 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.74 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.94 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.69 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.59 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.35 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 6.04 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.85 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.627 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 8.26 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 8.08 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.36 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 9.13 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 9.16 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 6.07 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.627 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.44 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.33 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.614 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.7 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.36 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.64 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.616 ' HA ' HD22 ' A' ' 91' ' ' ASN . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.5 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.616 HD22 ' HA ' ' A' ' 88' ' ' GLU . 3.6 p30 -78.5 -37.28 43.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.16 110.033 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 55.65 86.85 0.15 Allowed Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 115.412 -0.813 . . . . 5.09 112.184 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -92.27 7.3 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.953 2.435 . . . . 7.02 111.039 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -85.72 30.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.286 -0.87 . . . . 7.48 110.459 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -72.56 -26.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 6.38 109.884 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.3 80.12 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 9.94 110.809 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.77 -55.38 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.518 -0.765 . . . . 8.62 109.596 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -123.61 170.76 10.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.62 -0.718 . . . . 9.98 109.874 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.55 134.17 2.21 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.156 -0.778 . . . . 9.93 111.156 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 13.17 110.022 -179.3 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.468 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 16.2 tpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.896 0.379 . . . . 14.01 110.506 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.5 m -95.51 26.01 4.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 12.42 110.278 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -64.69 106.54 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.664 -0.698 . . . . 12.47 111.901 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 25.6 t -104.83 -8.29 18.83 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.28 -1.007 . . . . 10.53 108.28 169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -65.51 119.92 11.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.835 -1.075 . . . . 8.15 109.835 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 68.81 22.36 7.31 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.715 0.634 . . . . 11.46 111.094 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' B' ' 108' ' ' LYS . 16.1 mm100 -114.78 121.76 44.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.5 -0.556 . . . . 8.75 109.5 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' B' ' 107' ' ' GLN . 9.1 mtpm? 72.45 80.21 0.14 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.701 0.762 . . . . 9.35 109.62 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -58.92 142.0 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.358 -1.292 . . . . 8.32 111.554 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.4 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.44 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 6.08 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.426 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 5.03 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.57 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.95 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 4.21 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.31 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 6.16 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.463 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.29 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 9.21 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.57 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.463 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.45 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.97 113.42 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 5.05 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.614 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.8 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.432 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.77 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 3.14 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.88 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.638 HD11 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.7 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.638 ' N ' HD11 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -49.16 122.17 5.68 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.554 ' HB3' ' HA ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -67.26 156.04 89.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.788 -0.642 . . . . 9.9 111.083 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' B' ' 138' ' ' VAL . 24.2 Cg_exo -63.25 152.17 81.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.782 2.321 . . . . 9.8 112.515 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.57 -6.3 12.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 12.27 109.979 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.62 133.44 25.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.845 -0.616 . . . . 11.9 110.784 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.38 -42.87 0.55 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.442 1.089 . . . . 11.66 112.542 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' B' ' 134' ' ' PRO . 55.3 t -121.52 133.26 68.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.543 0.211 . . . . 9.68 111.514 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -149.93 -51.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.064 -0.517 . . . . 11.53 110.418 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.499 ' OG ' ' HA ' ' A' ' 42' ' ' ALA . 52.6 m -147.36 -156.11 0.69 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.036 -0.529 . . . . 8.79 110.819 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 m -137.58 92.88 2.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.545 -0.539 . . . . 9.62 109.545 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.484 ' HB1' ' CZ ' ' B' ' 145' ' ' TYR . . . -82.64 112.2 19.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 8.95 110.835 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -72.62 -20.48 61.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.779 -0.646 . . . . 10.14 110.941 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -150.14 139.69 21.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 9.39 110.144 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.484 ' CZ ' ' HB1' ' B' ' 142' ' ' ALA . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 8.34 109.408 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.674 ' HG3' ' HE3' ' A' ' 33' ' ' MET . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 10.22 108.871 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 11.69 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.58 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 2.6 t60 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 14.06 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.95 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.81 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 10.78 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.609 ' HB2' HG23 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 7.32 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.8 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 9.14 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 13.04 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.623 HD22 HG22 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 11.08 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG13 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 11.64 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.466 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 1' ' ' MET . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 12.53 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 13.11 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.82 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.467 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.47 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.9 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.57 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.99 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.84 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 16.28 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 12.17 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 10.38 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.78 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.46 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 8.29 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 12.48 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.408 HD13 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . 0.408 ' N ' HD13 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -113.5 40.3 2.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 4.7 p-10 -57.84 127.17 78.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.857 . . . . 14.02 111.224 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 23.1 Cg_exo -63.83 -45.5 10.65 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.049 2.499 . . . . 14.9 111.976 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 31.3 m -101.43 116.21 32.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.876 -0.602 . . . . 18.01 109.648 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . 0.451 ' HA ' ' ND2' ' B' ' 192' ' ' ASN . 7.2 p -71.83 129.31 35.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.025 -0.361 . . . . 18.06 110.025 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.77 79.0 4.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 21.56 110.706 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.7 14.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.849 -0.614 . . . . 21.53 110.649 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -119.07 -18.17 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.29 0.567 . . . . 23.03 109.874 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -121.23 44.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.653 -0.703 . . . . 24.72 111.685 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 79.4 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.612 -0.708 . . . . 27.31 109.451 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.815 -0.069 . . . . 29.65 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m 67.68 -76.94 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.706 0.628 . . . . 26.73 110.63 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 41.4 ttp180 63.29 30.33 15.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 25.8 111.082 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -78.99 83.53 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.719 -0.845 . . . . 23.48 108.719 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -62.86 143.1 57.93 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.226 -0.897 . . . . 21.47 110.303 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -77.03 -179.88 5.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 20.32 111.042 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -98.08 133.73 42.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.921 -0.581 . . . . 16.94 111.782 -173.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -101.71 99.64 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.764 -1.199 . . . . 16.4 107.764 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.31 131.11 35.56 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.007 -0.542 . . . . 13.24 110.6 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 -88.99 110.49 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.856 -0.611 . . . . 10.33 110.089 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 15.1 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.95 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 10.34 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' N ' HG21 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 8.16 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 7.29 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 7.08 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.74 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.67 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 11.14 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 16.19 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.97 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.86 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 13.32 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.85 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 11.06 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 6.0 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 4.48 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 12.11 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.08 89.24 3.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.3 ttt -101.56 133.03 21.07 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.646 -0.706 . . . . 13.04 110.681 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 1.035 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 46.0 Cg_exo -57.8 149.51 68.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.89 2.394 . . . . 13.77 111.695 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 74.17 -36.37 0.33 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.493 0.717 . . . . 14.04 111.381 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -84.91 -61.82 1.69 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 15.56 110.37 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' B' ' 145' ' ' TYR . . . -99.55 -39.62 8.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.63 -0.713 . . . . 15.1 109.941 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.035 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 89.7 t -80.09 102.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.418 -0.81 . . . . 12.84 110.258 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -131.69 121.49 24.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.934 -0.765 . . . . 11.23 108.934 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -103.36 94.35 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.452 0.538 . . . . 9.91 112.452 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.015 ' HB ' HG21 ' B' ' 141' ' ' THR . 19.7 m -134.21 86.11 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.677 . . . . 9.83 109.171 171.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.68 101.29 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.94 -0.573 . . . . 8.59 111.068 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.69 0.72 56.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.141 -0.481 . . . . 8.99 110.319 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.72 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.38 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.83 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 6.19 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.37 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.597 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.22 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.747 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 7.24 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 6.16 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.79 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 8.3 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 HD23 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.36 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.87 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.487 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.36 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.98 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.831 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.37 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.95 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.74 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.94 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.69 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.59 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.35 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 6.04 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.85 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 8.26 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 77' ' ' ASN . 0.8 OUTLIER 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 8.08 109.748 -176.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.36 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 9.13 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 9.16 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 6.07 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.552 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.44 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.33 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.7 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.36 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.64 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.619 ' HA ' ' ND2' ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.5 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 -109.98 22.3 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.16 110.58 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.607 HD22 HG23 ' A' ' 95' ' ' VAL . 24.3 p-10 -50.08 122.5 14.67 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.539 -0.755 . . . . 5.09 112.18 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.09 10.52 3.62 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.916 2.411 . . . . 7.02 112.134 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.9 m -145.94 112.1 5.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 7.48 110.591 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.607 HG23 HD22 ' A' ' 92' ' ' ASN . 29.7 t -112.96 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.803 . . . . 6.38 109.26 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -99.31 92.28 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.958 0.409 . . . . 9.94 111.25 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.66 -51.41 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.439 -0.578 . . . . 8.62 109.439 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -115.24 47.86 1.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.872 -0.788 . . . . 9.98 108.872 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.89 105.03 2.38 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.461 -0.79 . . . . 9.93 112.544 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.812 0.339 . . . . 13.17 110.163 176.708 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.462 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 85.5 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.029 0.442 . . . . 14.01 111.26 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -159.54 110.26 1.97 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 12.42 110.174 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 103' ' ' ARG . 9.1 ptp85 -86.42 -18.2 32.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 12.47 110.172 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m -67.52 -25.93 66.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 10.53 110.797 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -89.82 124.39 34.62 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.265 -0.643 . . . . 8.15 109.265 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.25 160.25 22.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.101 0.477 . . . . 11.46 111.771 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -82.33 96.03 7.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.606 -0.725 . . . . 8.75 109.314 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -152.22 -44.23 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 9.35 108.686 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.456 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 -82.81 129.89 35.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 168.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.4 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.44 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 6.08 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 5.03 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.658 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.57 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.831 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.95 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 4.21 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.31 110.877 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.478 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 6.16 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.588 ' HE3' ' HD2' ' B' ' 123' ' ' TYR . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.29 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 9.21 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.57 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.588 ' HD2' ' HE3' ' B' ' 120' ' ' MET . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.45 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.97 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 5.05 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.8 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.77 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.412 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 3.14 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.658 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.88 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.7 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 -96.83 91.23 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 92.5 mmm -119.91 97.37 49.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 9.9 110.854 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.39 158.75 36.66 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.326 2.018 . . . . 9.8 111.343 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.55 16.78 10.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.802 -0.635 . . . . 12.27 111.162 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.07 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 11.9 110.328 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -155.76 -79.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 11.66 110.784 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.99 147.02 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.68 110.727 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 139' ' ' LYS . 0.4 OUTLIER -114.48 -30.18 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.411 -0.358 . . . . 11.53 110.108 177.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m 74.64 -42.41 0.5 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.412 0.893 . . . . 8.79 113.412 173.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 1.015 HG21 ' HB ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -66.41 -20.18 66.0 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.0 0.741 . . . . 9.62 113.0 -175.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.92 110.64 10.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.36 . . . . 8.95 110.309 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.412 ' O ' ' HD3' ' B' ' 160' ' ' PRO . 26.8 t-20 -132.36 -58.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.511 . . . . 10.14 110.756 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.523 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp -90.4 140.49 29.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.722 -0.473 . . . . 9.39 109.722 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.539 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 8.34 110.763 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 10.22 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 11.69 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.66 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.58 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 14.06 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.95 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.81 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 10.78 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.667 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 7.32 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.8 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' B' ' 143' ' ' ASN . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 9.14 112.069 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 13.04 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.854 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.57 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 11.08 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.52 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 11.64 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 12.53 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' B' ' 198' ' ' SER . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 13.11 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.82 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.47 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.554 ' HB2' ' HZ2' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.9 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.99 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.84 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 16.28 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 12.17 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 10.38 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.78 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.467 ' O ' HD12 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.46 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.661 HD12 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 8.29 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 12.48 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.639 ' HA ' ' ND2' ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.499 HD13 HD23 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.639 ' ND2' ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 -84.51 27.19 0.73 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 0.3 OUTLIER -47.44 137.02 9.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 115.581 -0.736 . . . . 14.02 112.076 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 32.3 Cg_exo -58.03 120.15 7.86 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.945 2.43 . . . . 14.9 111.921 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 57.4 m 71.91 86.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.549 -0.75 . . . . 18.01 110.42 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.65 101.4 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.431 -0.804 . . . . 18.06 110.472 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -98.87 98.29 9.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.24 -0.436 . . . . 21.56 111.2 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 53.84 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 124.175 0.922 . . . . 21.53 112.761 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' B' ' 170' ' ' LYS . 35.1 m -137.08 104.24 5.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.221 -0.445 . . . . 23.03 110.513 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 172.15 -143.32 7.38 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.948 -0.644 . . . . 24.72 111.949 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.357 -0.83 . . . . 27.31 110.83 -178.009 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.0 mpt? . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.026 0.441 . . . . 29.65 110.389 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -77.62 -40.0 43.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.276 -0.42 . . . . 26.73 111.934 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 62.37 17.0 9.04 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.542 0.526 . . . . 25.8 111.093 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -84.59 -45.3 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 23.48 110.351 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.94 97.85 11.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 21.47 110.092 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -118.26 -14.61 9.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 20.32 110.53 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.44 132.57 34.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.124 -0.489 . . . . 16.94 110.836 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 8' ' ' LYS . 3.4 mppt? -109.65 5.78 23.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 16.4 109.798 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -97.68 107.64 20.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 13.24 109.974 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -81.65 143.1 32.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 15.1 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.95 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 10.34 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD21 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 8.16 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 7.29 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 7.08 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.74 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 11.14 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 16.19 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.97 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.86 109.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 13.32 112.789 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.85 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 11.06 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 6.0 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 4.48 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 12.11 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.945 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 -101.97 118.43 36.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.4 mmt -120.88 148.6 48.95 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.865 -0.42 . . . . 13.04 109.865 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 36' ' ' ALA . 50.8 Cg_exo -56.11 150.2 49.36 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.922 2.415 . . . . 13.77 112.092 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.87 35.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.87 -0.605 . . . . 14.04 111.846 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -82.8 -29.48 29.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 15.56 110.358 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.12 -5.68 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.801 -0.636 . . . . 15.1 111.12 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.2 p -121.29 116.43 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 12.84 110.502 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 58.1 27.54 15.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.066 -0.516 . . . . 11.23 110.773 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.0 t -61.65 106.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.745 . . . . 9.91 110.002 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -100.12 81.11 2.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 9.83 111.038 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.57 109.18 11.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.368 -0.833 . . . . 8.59 110.137 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -136.13 -54.23 0.75 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.924 -0.58 . . . . 8.99 109.744 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.72 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.38 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.83 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 6.19 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.37 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.22 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 7.24 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 6.16 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.79 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 8.3 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.36 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.87 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.36 111.181 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.98 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HG ' HG22 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.37 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.743 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.95 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.74 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.94 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.69 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.59 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.35 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 6.04 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.85 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 8.26 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 8.08 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.36 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 9.13 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 9.16 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 6.07 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE2' HD13 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.44 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.33 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.7 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.36 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.64 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.703 ' HA ' HD22 ' A' ' 91' ' ' ASN . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.567 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.5 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.703 HD22 ' HA ' ' A' ' 88' ' ' GLU . 2.7 p30 -99.45 4.81 46.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.16 110.367 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -64.48 120.95 69.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 5.09 111.247 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.5 -33.82 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.367 2.045 . . . . 7.02 112.112 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 m -88.19 70.49 9.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.352 0.596 . . . . 7.48 110.905 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.46 -36.94 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.666 -0.864 . . . . 6.38 108.666 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -87.13 87.1 7.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.162 -0.926 . . . . 9.94 109.687 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.09 -66.67 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.449 -0.796 . . . . 8.62 110.437 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m -103.49 -44.55 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.501 -0.555 . . . . 9.98 109.501 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.46 -75.5 1.39 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.826 -0.624 . . . . 9.93 112.962 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 13.17 112.247 -173.595 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.471 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 25.9 ttt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.192 0.52 . . . . 14.01 109.981 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.7 m -91.29 30.34 1.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.029 -0.532 . . . . 12.42 110.302 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -67.94 -62.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 12.47 110.266 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.6 p -109.99 -36.25 5.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 10.53 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.99 118.92 20.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.574 -0.528 . . . . 8.15 109.574 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.83 145.08 29.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 11.46 111.22 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.8 96.7 7.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.873 -0.603 . . . . 8.75 110.16 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -107.25 5.28 27.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.807 -0.633 . . . . 9.35 110.03 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -103.55 139.94 38.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.455 -0.793 . . . . 8.32 110.048 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.4 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.44 111.153 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 6.08 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 5.03 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.57 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.95 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 4.21 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.31 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 6.16 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.437 ' HE1' ' HD2' ' B' ' 123' ' ' TYR . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.29 108.237 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 9.21 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.57 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.437 ' HD2' ' HE1' ' B' ' 120' ' ' MET . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.45 110.514 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.481 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.97 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 5.05 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.8 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.77 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 3.14 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.634 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.88 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.424 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.7 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.79 45.65 2.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 45.5 ttp -62.42 130.2 93.1 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 116.339 -0.392 . . . . 9.9 110.557 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.26 141.15 95.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.351 2.701 . . . . 9.8 112.775 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 68.18 8.72 6.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.428 -0.806 . . . . 12.27 110.827 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.44 -57.65 1.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.013 -0.54 . . . . 11.9 109.871 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.6 -56.29 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.891 -0.595 . . . . 11.66 109.691 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 86.5 t -93.24 128.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.718 -0.674 . . . . 9.68 110.521 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.19 168.28 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.851 -0.425 . . . . 11.53 109.851 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 38.3 t -125.45 116.71 22.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.25 -0.432 . . . . 8.79 109.969 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.9 p -110.61 27.01 10.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.279 0.561 . . . . 9.62 110.78 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.11 25.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.723 -0.671 . . . . 8.95 110.939 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -134.02 9.05 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 10.14 110.632 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.51 156.17 46.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 9.39 110.783 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.643 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 8.34 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 10.22 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.462 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 11.69 109.865 -174.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.58 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 14.06 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.462 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.95 109.574 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.81 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 10.78 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 7.32 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.8 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.643 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 9.14 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 13.04 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 11.08 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.504 ' HA ' HG11 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 11.64 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 12.53 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 13.11 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.82 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.47 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.9 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.99 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.84 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 16.28 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 12.17 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 10.38 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.78 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.46 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 8.29 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 12.48 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.738 ' HA ' HD22 ' B' ' 191' ' ' ASN . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' B' ' 192' ' ' ASN . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.738 HD22 ' HA ' ' B' ' 188' ' ' GLU . 5.6 p30 -105.6 -14.38 15.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' B' ' 189' ' ' ILE . 25.6 t30 -151.15 109.07 3.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 14.02 110.016 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.06 -34.22 66.86 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.02 2.48 . . . . 14.9 113.206 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.4 t -170.2 -48.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.075 -0.511 . . . . 18.01 109.882 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 3.5 p -173.74 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.668 0.747 . . . . 18.06 111.051 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.89 80.32 1.68 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.654 -0.703 . . . . 21.56 109.357 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.06 -40.92 11.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.646 -0.706 . . . . 21.53 110.621 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 29.9 m -76.37 125.08 28.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.083 -0.508 . . . . 23.03 110.456 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.5 -166.83 22.74 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.789 -0.72 . . . . 24.72 112.563 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.662 -0.685 . . . . 27.31 110.385 -179.331 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.631 0.253 . . . . 29.65 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -90.62 -12.78 35.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.432 0.634 . . . . 26.73 109.959 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.3 158.41 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 25.8 109.593 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -88.03 145.77 25.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.986 0.422 . . . . 23.48 110.056 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 122.98 36.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.211 -0.449 . . . . 21.47 110.048 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -70.18 115.13 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 20.32 109.318 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.83 137.95 31.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 16.94 111.001 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 26.5 tptp -77.16 119.43 20.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.67 -0.695 . . . . 16.4 109.336 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 48.9 mt-10 73.36 169.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.047 0.842 . . . . 13.24 111.234 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.431 ' HB2' HG13 ' A' ' 30' ' ' ILE . 75.9 m-85 -121.67 168.82 11.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.204 -0.453 . . . . 10.33 110.616 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 15.1 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.95 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' B' ' 197' ' ' ALA . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 10.34 112.749 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.659 HD21 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 8.16 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.571 ' CG2' ' HG ' ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 7.29 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 7.08 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.74 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.799 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 11.14 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 16.19 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.97 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.799 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.86 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 13.32 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.85 110.205 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.609 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 11.06 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 6.0 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 4.48 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 12.11 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' N ' HD12 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 11' ' ' LYS . 15.7 pt-20 -111.64 154.07 25.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.419 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 2.0 mpt? -94.17 132.15 29.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.635 -0.711 . . . . 13.04 109.468 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 23.8 Cg_exo -65.56 -23.86 56.74 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.083 2.522 . . . . 13.77 112.594 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.932 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . 35.3 tt0 69.76 94.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.788 0.68 . . . . 14.04 111.337 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.82 -17.4 19.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.635 . . . . 15.56 109.284 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.57 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.59 -1.186 . . . . 15.1 109.773 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.58 150.9 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.794 -0.639 . . . . 12.84 110.577 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.932 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 12.4 mmtp -93.66 -92.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.332 -0.147 . . . . 11.23 110.959 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p -176.89 29.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.432 -0.349 . . . . 9.91 111.143 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.601 HG22 ' H ' ' B' ' 143' ' ' ASN . 15.2 t -151.5 149.21 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.1 -0.64 . . . . 9.83 112.408 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.64 80.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 8.59 113.682 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 11.98 11.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.235 0.541 . . . . 8.99 110.289 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.72 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.38 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 8.5 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.83 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 6.19 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.863 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.37 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.22 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 7.24 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 6.16 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.79 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 8.3 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.36 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.87 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.36 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.98 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.789 HD23 HG22 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.37 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.95 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.79 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.74 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.94 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 73' ' ' PHE . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.69 112.978 -168.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.59 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.675 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.675 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.35 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 6.04 110.807 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.85 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.601 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 8.26 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 8.08 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.36 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 9.13 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 9.16 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.699 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 6.07 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.44 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.33 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.7 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.36 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.64 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.581 HG21 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.5 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 88' ' ' GLU . 10.1 p30 -91.21 16.52 9.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.16 110.491 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -54.42 115.94 9.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.086 -0.506 . . . . 5.09 111.374 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.41 -15.11 8.96 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.732 2.288 . . . . 7.02 112.99 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.5 m -85.09 86.14 7.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 7.48 110.629 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.24 126.17 57.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.15 0.5 . . . . 6.38 110.141 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -84.75 70.4 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.468 0.651 . . . . 9.94 110.143 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.17 -7.68 9.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.157 -0.929 . . . . 8.62 109.769 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 p -87.23 139.6 30.39 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.163 -0.926 . . . . 9.98 110.503 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 151.15 125.84 1.26 Allowed Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.667 -0.777 . . . . 9.93 111.888 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 13.17 110.117 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.452 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.231 -0.285 . . . . 14.01 110.231 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.4 m -89.32 171.21 9.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 12.42 110.06 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' B' ' 103' ' ' ARG . 5.8 tpp180 -67.0 -49.85 64.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.836 0.35 . . . . 12.47 111.212 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -92.71 141.49 28.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.439 . . . . 10.53 111.467 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.36 126.97 31.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.805 -0.634 . . . . 8.15 109.31 172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -92.91 121.92 34.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.981 0.42 . . . . 11.46 111.31 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -81.89 155.41 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.783 -0.644 . . . . 8.75 109.893 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 81.03 4.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.935 -0.765 . . . . 9.35 108.935 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.05 -45.45 67.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.878 -1.056 . . . . 8.32 111.119 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.4 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' B' ' 111' ' ' LYS . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.44 111.315 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 6.08 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 5.03 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.57 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.95 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 4.21 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . 0.428 ' HB1' HD11 ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.31 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 6.16 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.506 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.29 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 9.21 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.57 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.45 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.519 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.97 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 5.05 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.863 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.8 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.77 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 3.14 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.643 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.88 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.7 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.645 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 -83.16 116.72 22.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 75.0 mtp -88.23 129.85 48.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 9.9 110.208 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.32 -55.61 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.747 2.298 . . . . 9.8 112.559 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.1 124.54 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 12.27 110.677 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -170.01 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.657 -0.701 . . . . 11.9 109.501 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -111.84 -13.6 13.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.01 -0.737 . . . . 11.66 109.01 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.529 HG23 ' HG2' ' B' ' 139' ' ' LYS . 12.3 p -79.96 149.88 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.739 -1.118 . . . . 9.68 109.776 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' B' ' 138' ' ' VAL . 67.3 mmtt 64.13 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.804 0.69 . . . . 11.53 110.012 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' B' ' 139' ' ' LYS . 59.4 m 61.62 -172.89 0.14 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.938 -1.028 . . . . 8.79 112.191 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 0.627 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.9 p -85.84 -61.17 1.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 9.62 110.368 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -167.29 125.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.379 -0.373 . . . . 8.95 110.437 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.601 ' H ' HG22 ' A' ' 41' ' ' THR . 13.0 m120 -118.42 -28.12 5.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.317 -0.401 . . . . 10.14 110.348 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -141.14 135.81 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 9.39 109.702 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 8.34 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 10.22 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.526 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 11.69 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.609 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.659 ' HE2' HD21 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.58 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.551 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 14.06 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.95 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.81 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 10.78 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.65 ' HB2' HG23 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 7.32 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.8 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 9.14 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 13.04 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 11.08 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.475 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 11.64 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.449 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 12.53 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.73 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 13.11 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.82 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.47 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.684 ' HA2' HD13 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.455 ' HA ' ' HD2' ' B' ' 176' ' ' PRO . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.9 108.23 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 175' ' ' LYS . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.99 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.84 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 16.28 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 12.17 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.419 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 10.38 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.78 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.46 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.684 HD13 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 8.29 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 12.48 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' B' ' 193' ' ' PRO . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.517 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -82.51 -29.12 30.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 59.13 90.73 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 123.551 0.532 . . . . 14.02 110.938 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' B' ' 188' ' ' GLU . 24.1 Cg_exo -64.84 -55.66 0.49 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.398 2.065 . . . . 14.9 110.931 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 62.5 m -157.03 -47.75 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 18.01 109.866 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 41.0 t 58.02 68.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.877 0.846 . . . . 18.06 109.911 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -84.38 97.05 9.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.346 -0.843 . . . . 21.56 111.115 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 13' ' ' GLY . . . -86.67 -49.93 7.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 21.53 109.916 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 23.2 m -135.99 99.02 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 23.03 110.09 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.4 -49.23 5.58 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.281 -1.128 . . . . 24.72 110.281 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.512 -0.756 . . . . 27.31 109.179 172.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.838 0.351 . . . . 29.65 110.652 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t -135.79 3.96 3.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.338 -0.392 . . . . 26.73 111.24 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 25.8 111.255 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 t -130.41 113.41 14.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.363 -0.606 . . . . 23.48 109.363 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.84 121.65 15.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 21.47 110.892 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -85.38 171.68 11.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 20.32 110.477 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.54 171.5 8.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.093 0.473 . . . . 16.94 111.201 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -100.01 98.09 8.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.657 -0.701 . . . . 16.4 109.907 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.25 146.52 26.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.594 -0.73 . . . . 13.24 110.212 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 -70.62 144.65 51.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.545 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 15.1 110.868 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.95 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 10.34 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 8.16 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 7.29 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 7.08 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.554 ' HA ' HD21 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 19' ' ' LYS . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.74 110.892 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 11.14 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 16.19 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.97 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.86 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 13.32 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.85 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 11.06 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 6.0 112.698 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 4.48 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 12.11 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.61 137.06 21.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.5 ttm -141.55 100.33 6.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.852 -0.613 . . . . 13.04 109.87 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.34 169.41 22.56 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.067 2.512 . . . . 13.77 111.8 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -80.76 -53.54 6.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.683 -0.488 . . . . 14.04 109.683 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.03 82.66 0.37 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.733 -0.667 . . . . 15.56 109.275 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.83 0.48 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.936 0.773 . . . . 15.1 110.116 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.43 158.36 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.81 -0.811 . . . . 12.84 108.81 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' B' ' 141' ' ' THR . 75.1 mttt -108.35 96.57 6.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.627 -0.508 . . . . 11.23 109.627 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -133.12 176.61 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.032 -0.531 . . . . 9.91 109.952 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.636 HG22 ' HE2' ' A' ' 44' ' ' LYS . 16.4 m 73.88 3.63 4.49 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.366 0.416 . . . . 9.83 111.298 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.834 ' HA ' ' HB3' ' B' ' 139' ' ' LYS . . . -56.37 -49.23 75.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.948 0.404 . . . . 8.59 111.773 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -94.87 20.04 9.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.19 -0.459 . . . . 8.99 111.251 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.636 ' HE2' HG22 ' A' ' 41' ' ' THR . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.72 109.745 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.38 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.83 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 6.19 110.975 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.37 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.644 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.22 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.513 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 7.24 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 6.16 109.783 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.79 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 8.3 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.36 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.87 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.36 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.98 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 HD12 HG21 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.37 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.95 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.74 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.94 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.69 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.59 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.35 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 6.04 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.85 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 8.26 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 8.08 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.36 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 9.13 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 9.16 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 6.07 112.492 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.44 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.33 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.485 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.7 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.36 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.64 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.5 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.501 HD22 ' HA ' ' A' ' 88' ' ' GLU . 4.9 p30 -94.47 -34.17 12.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.16 109.96 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 t30 68.39 113.34 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.406 -0.815 . . . . 5.09 112.513 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.38 -59.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.843 2.362 . . . . 7.02 112.922 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.3 m -92.74 110.03 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.794 0.33 . . . . 7.48 110.812 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.81 141.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.065 -0.516 . . . . 6.38 110.587 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -84.62 98.63 10.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.333 0.587 . . . . 9.94 110.469 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.87 -39.97 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.278 -0.874 . . . . 8.62 110.267 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.2 t 69.52 90.22 0.1 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.502 -0.772 . . . . 9.98 110.48 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.4 -141.39 9.59 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.413 -0.812 . . . . 9.93 112.634 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.506 0.67 . . . . 13.17 111.898 -175.203 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.441 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 41.3 tpp . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.344 0.592 . . . . 14.01 109.89 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -92.59 47.44 1.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 12.42 110.955 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -140.56 129.99 23.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.88 -0.785 . . . . 12.47 108.88 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.1 t -76.9 146.46 37.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.825 0.345 . . . . 10.53 111.114 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -96.97 122.88 40.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 8.15 109.963 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -97.24 145.53 25.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 11.46 110.882 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -115.1 135.24 54.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.052 -0.721 . . . . 8.75 109.052 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -89.24 -18.7 26.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 9.35 110.512 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.87 173.94 7.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.918 -0.583 . . . . 8.32 110.658 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.4 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.44 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 6.08 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 5.03 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.457 HD21 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.57 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.95 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 4.21 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.31 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 6.16 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.452 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.29 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 9.21 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.57 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.45 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.97 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 5.05 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.8 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.77 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.457 ' O ' HD21 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 3.14 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.608 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.88 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.7 112.004 -173.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 47.89 25.62 0.78 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 46.4 tpp -166.7 102.94 0.66 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 9.9 109.814 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.04 177.71 8.4 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.821 2.348 . . . . 9.8 113.154 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 29.25 5.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.737 -0.665 . . . . 12.27 110.109 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.44 85.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.538 -0.755 . . . . 11.9 112.159 -174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.54 10.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 11.66 111.641 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.61 136.97 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.966 -0.383 . . . . 9.68 109.966 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.834 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 13.3 mtmt 55.61 20.98 4.17 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.436 0.46 . . . . 11.53 110.703 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -74.88 -60.35 2.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 8.79 111.75 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' THR . . . . . 0.458 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 42.8 p -100.78 104.75 16.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.745 0.307 . . . . 9.62 111.589 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.68 -77.2 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 8.95 109.857 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.1 -45.05 20.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.192 0.52 . . . . 10.14 110.136 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -91.62 142.06 28.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.627 -0.715 . . . . 9.39 110.49 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 8.34 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 10.22 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 11.69 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.58 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 14.06 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.95 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.81 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 10.78 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 7.32 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.8 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 9.14 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 13.04 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 11.08 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 11.64 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.632 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 12.53 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.632 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 13.11 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.415 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.82 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.47 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.9 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.556 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.99 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.404 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.84 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 16.28 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 12.17 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 10.38 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.78 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.431 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.46 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 8.29 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 12.48 110.435 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.0 72.06 1.21 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -61.76 154.82 64.86 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.441 -0.799 . . . . 14.02 111.425 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.95 169.12 10.89 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.636 2.224 . . . . 14.9 111.386 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.8 p -58.26 105.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 18.01 111.179 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.99 94.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.792 -0.448 . . . . 18.06 109.792 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . 0.64 ' HE3' ' HA3' ' B' ' 199' ' ' GLY . 64.2 tttp -127.66 93.21 3.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 21.56 110.522 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -95.4 -15.34 23.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.532 -0.758 . . . . 21.53 109.536 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 35.4 p -63.43 -37.83 88.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.33 -0.85 . . . . 23.03 110.518 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . 0.64 ' HA3' ' HE3' ' B' ' 196' ' ' LYS . . . -123.06 72.88 0.4 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.376 -0.829 . . . . 24.72 111.29 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 26.4 t80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.594 -0.717 . . . . 27.31 109.38 -178.657 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.785 0.326 . . . . 29.65 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -98.44 -52.66 3.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.779 -0.191 . . . . 26.73 111.376 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 61.55 19.39 10.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.991 0.516 . . . . 25.8 111.866 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -126.48 150.81 48.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.509 -0.552 . . . . 23.48 109.509 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -79.34 148.83 31.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.807 0.337 . . . . 21.47 110.548 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -75.89 123.16 25.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.469 -0.937 . . . . 20.32 108.469 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -70.38 137.99 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.06 0.457 . . . . 16.94 111.069 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -80.31 95.24 6.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.522 0.677 . . . . 16.4 109.837 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.08 147.46 31.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.087 -0.96 . . . . 13.24 110.202 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -75.07 144.71 42.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 10.33 110.467 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 15.1 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.95 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 10.34 112.624 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 8.16 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 7.29 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.649 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 7.08 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.74 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 11.14 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 16.19 109.293 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.97 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.86 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 13.32 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.85 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 11.06 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 6.0 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 4.48 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 12.11 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 11.2 pt-20 -165.42 153.06 10.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.48 101.68 36.98 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 13.04 111.139 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 32' ' ' GLU . 2.0 Cg_endo -83.15 113.85 2.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.957 2.438 . . . . 13.77 110.986 175.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.81 -50.44 70.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.92 0.39 . . . . 14.04 110.814 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.69 83.41 1.93 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.969 -0.56 . . . . 15.56 110.235 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.63 -65.08 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.543 0.737 . . . . 15.1 111.394 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 40' ' ' SER . 8.9 p -121.54 147.57 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.633 -0.506 . . . . 12.84 109.633 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.21 8.8 10.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.33 0.586 . . . . 11.23 110.567 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 38' ' ' VAL . 22.4 m -104.85 120.31 41.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 9.91 110.442 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.3 m -152.3 102.05 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 9.83 110.734 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.66 133.61 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 8.59 110.068 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -168.88 20.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 8.99 111.51 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.72 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.38 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 24.4 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.83 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 6.19 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.37 110.091 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.22 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 7.24 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 6.16 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.79 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 8.3 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.36 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.87 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.36 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.98 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.411 HD23 HG22 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.37 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.538 ' HB3' ' HG ' ' A' ' 69' ' ' SER . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.95 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.74 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.94 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.684 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.69 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.59 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.35 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 6.04 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.85 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 8.26 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 8.08 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.36 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 9.13 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 9.16 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 6.07 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.44 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.33 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.7 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.473 HD23 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.36 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.64 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.5 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.31 -38.88 68.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.16 110.642 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -172.19 108.41 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 5.09 110.336 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.18 -25.71 72.58 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.234 2.622 . . . . 7.02 112.685 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -121.37 79.95 1.6 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.169 0.509 . . . . 7.48 110.701 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 p -78.3 125.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 6.38 109.84 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 22.6 ttmm -122.93 78.92 1.6 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.304 -0.407 . . . . 9.94 110.212 -177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 68.89 -85.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.963 -1.017 . . . . 8.62 111.574 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.5 m -143.01 140.92 31.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.493 -0.321 . . . . 9.98 110.199 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.08 55.61 5.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.663 -0.779 . . . . 9.93 113.147 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.2 p90 . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 110.245 -0.279 . . . . 13.17 110.245 176.399 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.458 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 2.1 mpt? . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.14 -0.319 . . . . 14.01 110.14 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 9.4 t -149.2 -170.92 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.732 -0.47 . . . . 12.42 109.732 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -128.59 120.23 26.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.963 0.411 . . . . 12.47 110.48 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -113.89 -26.97 7.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 10.53 111.347 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -113.98 168.92 9.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 8.15 111.364 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -148.91 168.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 11.46 109.619 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.47 123.01 47.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 8.75 110.404 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -94.37 -9.24 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.921 0.341 . . . . 9.35 111.921 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.77 141.32 28.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 -174.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.4 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.44 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 6.08 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 5.03 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.596 HD21 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.57 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.596 ' N ' HD21 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.95 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 4.21 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.31 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 6.16 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.29 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 9.21 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.57 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.478 ' HD1' ' CZ3' ' B' ' 126' ' ' TRP . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.45 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.97 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 5.05 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.485 ' CD1' ' HD2' ' B' ' 127' ' ' PRO . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.8 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.77 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 3.14 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.88 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.686 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.7 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 106.65 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 17.0 tpt -79.59 126.92 79.74 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 9.9 109.355 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 24.4 Cg_exo -65.27 -165.93 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.137 2.558 . . . . 9.8 112.202 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' B' ' 136' ' ' ALA . 5.6 pt-20 -102.86 -67.16 0.89 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.331 -0.395 . . . . 12.27 111.566 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . 0.413 ' H ' ' HG3' ' B' ' 135' ' ' GLU . . . 61.43 -67.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.029 0.532 . . . . 11.9 110.894 -172.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.21 -39.12 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 11.66 110.25 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.03 134.52 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.298 -0.41 . . . . 9.68 110.658 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 pttm 50.77 13.86 0.15 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.264 1.026 . . . . 11.53 113.153 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.608 ' O ' ' HE2' ' B' ' 144' ' ' LYS . 25.7 t -71.26 -42.66 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 8.79 110.714 -173.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 p -82.33 -1.77 50.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 9.62 111.759 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.11 -65.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 8.95 111.46 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 50.3 t-20 -90.82 84.21 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.659 -0.246 . . . . 10.14 110.98 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' B' ' 140' ' ' SER . 0.1 OUTLIER 172.16 166.5 0.11 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.454 -0.794 . . . . 9.39 109.999 170.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 8.34 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 10.22 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 11.69 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.426 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.58 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.445 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 14.06 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.95 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.81 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 10.78 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.522 ' HB2' HG22 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 7.32 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.8 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 9.14 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' B' ' 161' ' ' LYS . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 13.04 111.061 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.473 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 11.08 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 11.64 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 12.53 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.649 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 13.11 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.82 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.47 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.9 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.529 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.99 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.84 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 16.28 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 12.17 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.529 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 10.38 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.78 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.46 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 8.29 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 12.48 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.67 ' HA ' HD22 ' B' ' 191' ' ' ASN . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.575 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.67 HD22 ' HA ' ' B' ' 188' ' ' GLU . 0.1 OUTLIER -93.19 -99.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.544 ' H ' ' ND2' ' B' ' 191' ' ' ASN . 3.7 p-10 -173.49 148.13 1.48 Allowed Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 14.02 109.5 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.98 115.85 3.35 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.581 2.187 . . . . 14.9 111.662 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 88.8 m 67.94 95.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.581 . . . . 18.01 110.658 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.68 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 18.06 110.786 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -101.0 71.23 1.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.111 0.481 . . . . 21.56 110.412 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -94.5 -49.51 5.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.861 -0.609 . . . . 21.53 110.001 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 44.9 m -102.33 126.51 49.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.72 -0.673 . . . . 23.03 110.237 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -95.38 94.87 1.78 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.824 -0.703 . . . . 24.72 111.846 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.719 -0.658 . . . . 27.31 109.803 -179.701 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.189 -0.3 . . . . 29.65 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -60.6 134.33 56.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.292 0.567 . . . . 26.73 112.188 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -133.19 -29.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.807 -0.633 . . . . 25.8 110.851 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.4 p 56.86 -166.6 0.13 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.081 0.952 . . . . 23.48 111.114 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -76.67 131.98 39.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.467 -0.333 . . . . 21.47 110.555 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -78.86 102.66 8.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.189 -0.459 . . . . 20.32 110.69 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.513 ' HB2' ' OD2' ' A' ' 14' ' ' ASP . 3.6 pt20 -81.35 141.97 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.975 -0.557 . . . . 16.94 110.341 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.605 ' HG3' ' HG2' ' A' ' 9' ' ' GLU . 16.4 ptpt -158.61 0.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.253 -0.43 . . . . 16.4 111.231 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 7.9 pt-20 -166.04 18.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.115 0.483 . . . . 13.24 110.532 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 22.9 m-85 -122.24 175.76 6.21 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.042 -0.526 . . . . 10.33 110.531 -173.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 15.1 113.375 -171.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.95 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 10.34 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 8.16 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.54 ' N ' HD21 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 7.29 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.529 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 7.08 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.74 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.596 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 11.14 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 16.19 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.97 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.86 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 13.32 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.85 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.645 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 11.06 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 6.0 112.526 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 4.48 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 12.11 109.56 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 1.149 HD12 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.454 ' H ' HD11 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.86 156.88 27.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.625 ' HG3' ' HB ' ' A' ' 38' ' ' VAL . 83.9 mmm -86.76 135.94 35.13 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.32 -0.993 . . . . 13.04 108.32 168.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 13.0 Cg_exo -71.24 37.86 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.067 2.511 . . . . 13.77 112.865 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 33' ' ' MET . 37.6 tt0 59.86 95.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.84 0.856 . . . . 14.04 111.911 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.74 -77.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.158 -0.928 . . . . 15.56 109.405 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.42 -6.99 9.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.345 0.593 . . . . 15.1 109.505 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.625 ' HB ' ' HG3' ' A' ' 33' ' ' MET . 39.1 t -121.28 129.25 75.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.336 -0.847 . . . . 12.84 110.473 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' B' ' 143' ' ' ASN . 0.0 OUTLIER -139.13 -175.22 4.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.683 -0.858 . . . . 11.23 108.683 172.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 p -84.99 -168.29 2.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.673 -0.491 . . . . 9.91 109.673 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -82.5 127.22 33.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 9.83 111.0 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' B' ' 140' ' ' SER . . . -136.25 21.77 3.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.457 -0.792 . . . . 8.59 109.657 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -127.58 28.18 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.43 -0.804 . . . . 8.99 109.117 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.72 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.38 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.543 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.83 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.863 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 6.19 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.37 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.22 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.689 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 7.24 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 6.16 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.79 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 8.3 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.36 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.87 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.36 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.98 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 HD21 HG22 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.37 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.95 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.74 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.655 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.94 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.69 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.59 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.35 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 6.04 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.85 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HB3' HD11 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 8.26 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 8.08 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.36 112.01 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 9.13 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 9.16 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 6.07 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.44 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.33 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.7 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.36 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.64 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.59 HG12 HD23 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.5 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.36 -2.13 48.07 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.16 111.704 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -156.37 93.8 2.42 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 5.09 111.481 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.52 -30.62 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.792 2.328 . . . . 7.02 111.282 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.2 p -86.61 75.5 9.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.807 -0.633 . . . . 7.48 111.137 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.87 2.32 5.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.035 -0.53 . . . . 6.38 111.607 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.43 70.44 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.557 0.694 . . . . 9.94 110.685 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.82 -31.68 0.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.816 -1.084 . . . . 8.62 109.196 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 t -71.85 99.97 2.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.329 -0.85 . . . . 9.98 109.427 173.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.27 -159.51 28.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.647 -0.787 . . . . 9.93 111.794 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 109.847 -0.427 . . . . 13.17 109.847 -176.623 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.46 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 55.5 ttp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.527 -0.546 . . . . 14.01 109.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t 71.24 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.88 0.737 . . . . 12.42 110.729 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -64.88 107.35 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.699 . . . . 12.47 110.432 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -80.97 -9.58 59.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.186 0.517 . . . . 10.53 110.912 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -95.96 166.96 11.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.699 -0.682 . . . . 8.15 110.193 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -111.4 128.86 56.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.441 -0.345 . . . . 11.46 110.08 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.55 124.58 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.48 . . . . 8.75 110.359 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -114.2 -38.32 4.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 9.35 109.731 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' B' ' 109' ' ' GLU . 0.0 OUTLIER -86.25 165.03 16.8 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.08 -0.963 . . . . 8.32 110.732 -177.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.648 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.4 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.44 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 6.08 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 5.03 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' B' ' 129' ' ' ARG . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.57 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.547 HG22 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.95 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 4.21 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.31 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 6.16 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.29 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 9.21 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.57 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.536 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.45 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.97 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 5.05 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.689 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.8 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.77 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 3.14 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.863 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.88 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.7 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 69.91 124.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 13.3 ptm -133.22 99.09 14.96 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 9.9 111.278 -171.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.41 102.87 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.488 2.792 . . . . 9.8 112.207 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . 0.734 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 20.1 tp10 -140.21 -25.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 12.27 110.603 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.36 123.41 47.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.336 -0.393 . . . . 11.9 110.85 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 69.84 -45.91 0.58 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.993 0.808 . . . . 11.66 112.578 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 42' ' ' ALA . 96.9 t -90.8 129.2 41.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.79 0.329 . . . . 9.68 111.255 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.734 ' HE3' ' HA ' ' B' ' 135' ' ' GLU . 28.0 mmtp -163.09 120.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.573 -0.899 . . . . 11.53 108.573 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 42' ' ' ALA . 23.1 t -140.97 104.8 4.74 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.093 -0.643 . . . . 8.79 110.611 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -91.51 -29.73 16.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.088 -0.505 . . . . 9.62 110.528 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.65 82.86 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 8.95 110.513 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 5.1 p30 -103.68 96.69 6.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.736 0.779 . . . . 10.14 110.77 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -129.57 145.86 51.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.347 -0.842 . . . . 9.39 109.809 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 1.149 ' HB3' HD12 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 8.34 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 10.22 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 11.69 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.431 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.58 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 14.06 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.95 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.81 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 10.78 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 7.32 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.8 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 9.14 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 13.04 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.501 HD12 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 11.08 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.537 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 11.64 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.529 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 12.53 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 13.11 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.82 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.47 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.9 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 3.0 t-20 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . 0.573 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.99 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.492 ' HA ' ' HB2' ' B' ' 183' ' ' SER . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.84 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' B' ' 181' ' ' GLY . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 16.28 109.499 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . 0.461 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 12.17 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 10.38 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.78 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.615 ' O ' HG21 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.46 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 8.29 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 12.48 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.615 HG21 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . 0.515 ' N ' HD11 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -130.96 74.5 1.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.708 HD21 HG22 ' B' ' 195' ' ' VAL . 9.8 t30 -56.99 120.28 37.26 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.397 -0.819 . . . . 14.02 111.65 -173.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.67 167.07 23.01 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.959 2.44 . . . . 14.9 112.528 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 25.5 m 71.44 -73.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 18.01 111.192 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . 0.708 HG22 HD21 ' B' ' 192' ' ' ASN . 22.7 t 53.8 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.087 0.555 . . . . 18.06 111.277 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . 0.715 ' HB2' ' HZ2' ' B' ' 196' ' ' LYS . 10.3 mtmp? -85.37 99.13 10.96 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.041 -0.355 . . . . 21.56 110.041 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -97.32 -67.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 21.53 109.347 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 48.5 m -108.27 152.39 24.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.957 -0.565 . . . . 23.03 109.926 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 155.89 -62.17 0.34 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.454 -0.658 . . . . 24.72 111.454 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 52.9 t80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.111 -0.947 . . . . 27.31 109.712 176.546 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.883 -0.414 . . . . 29.65 109.883 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -145.88 132.99 20.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 26.73 110.53 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 109.96 22.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 25.8 109.471 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 m -66.28 -29.53 69.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.015 0.436 . . . . 23.48 110.801 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.91 158.28 20.62 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.504 -0.554 . . . . 21.47 109.504 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 5.1 mmp_? -104.44 116.43 32.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.96 0.41 . . . . 20.32 111.463 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -75.89 146.68 39.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.336 -0.616 . . . . 16.94 109.336 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -110.5 175.47 5.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.482 0.182 . . . . 16.4 110.555 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.19 157.81 35.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 13.24 110.486 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.77 122.7 48.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 10.33 110.118 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.702 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 15.1 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.95 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 10.34 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 8.16 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 7.29 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 7.08 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' B' ' 158' ' ' LEU . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.74 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 11.14 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 16.19 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.97 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.86 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 13.32 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.85 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 11.06 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 6.0 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 4.48 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 12.11 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -114.65 128.9 56.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.5 ' HE2' ' HB2' ' B' ' 146' ' ' GLN . 2.1 mpt? -82.22 153.57 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 13.04 109.874 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 3.0 Cg_exo -76.51 175.76 10.94 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.683 2.255 . . . . 13.77 110.879 172.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.92 83.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.249 0.547 . . . . 14.04 110.594 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.65 -48.02 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.864 . . . . 15.56 109.35 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.75 -28.69 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.715 -0.675 . . . . 15.1 110.14 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -121.99 145.77 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 12.84 109.677 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 38' ' ' VAL . 29.6 mmmt 54.65 25.47 6.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.174 0.511 . . . . 11.23 110.79 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -60.76 -38.76 86.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.21 -0.905 . . . . 9.91 111.784 -171.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -152.02 155.2 37.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.907 -0.405 . . . . 9.83 109.907 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.66 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.685 -0.234 . . . . 8.59 111.203 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -91.37 71.93 6.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 8.99 110.484 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.72 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.38 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.83 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 6.19 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.37 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.22 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 7.24 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 6.16 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.79 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 8.3 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' B' ' 118' ' ' ALA . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.36 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.87 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.36 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.98 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.37 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.95 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.966 ' HA ' HG13 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.74 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.751 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.94 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.772 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.69 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.59 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 72' ' ' LYS . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.35 111.638 -168.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.772 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 6.04 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.879 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.85 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 8.26 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.557 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 8.08 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.36 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 9.13 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 9.16 111.947 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 6.07 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.44 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.33 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.7 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.879 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.36 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.64 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD11 HD23 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.5 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -76.51 -24.25 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.16 109.507 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 t30 58.64 89.65 0.1 Allowed Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 114.797 -1.092 . . . . 5.09 111.467 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.79 -49.05 3.32 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.783 2.322 . . . . 7.02 112.578 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 m -96.88 102.58 14.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 7.48 111.246 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.2 m -98.09 129.37 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.173 -0.467 . . . . 6.38 110.732 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -146.98 71.11 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.283 0.563 . . . . 9.94 110.812 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.59 -55.96 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.62 110.208 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -101.45 -52.96 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 9.98 110.119 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.86 -81.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.821 -0.627 . . . . 9.93 112.393 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.746 0.308 . . . . 13.17 110.308 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.467 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 95.4 mmm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.934 0.397 . . . . 14.01 111.128 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 45.6 m -157.25 156.88 33.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.29 -0.868 . . . . 12.42 109.193 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -95.81 147.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.753 -0.379 . . . . 12.47 110.159 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -141.15 161.48 37.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.274 -0.421 . . . . 10.53 110.283 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -69.94 138.29 52.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.86 -0.609 . . . . 8.15 110.459 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.26 -39.2 33.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.106 0.479 . . . . 11.46 110.141 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 128.28 47.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 8.75 110.392 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -107.24 93.64 4.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.092 0.473 . . . . 9.35 110.736 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -89.58 -30.08 18.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 8.32 110.304 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.4 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.44 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 6.08 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 5.03 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.708 HD21 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.57 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.966 HG13 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.95 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 4.21 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.31 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 6.16 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.29 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 9.21 108.72 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.57 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.45 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.97 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 5.05 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.565 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.8 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . 0.406 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.77 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 3.14 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.708 ' HA ' HD21 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.88 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.7 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.38 110.83 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 74.1 mtm -124.4 104.64 31.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.725 -0.843 . . . . 9.9 108.725 170.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 10.5 Cg_exo -71.87 -18.99 27.66 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.153 2.569 . . . . 9.8 113.53 -173.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.37 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.536 0.208 . . . . 12.27 110.96 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . 73.07 -71.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.049 0.843 . . . . 11.9 111.85 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.26 -20.94 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.071 0.462 . . . . 11.66 110.909 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' B' ' 139' ' ' LYS . 7.3 p -121.95 162.77 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.634 . . . . 9.68 109.807 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.495 ' HG2' HG23 ' B' ' 138' ' ' VAL . 7.6 mmmm 51.77 -94.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.701 0.625 . . . . 11.53 111.91 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 33.4 m 60.57 -90.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.045 -0.98 . . . . 8.79 111.783 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -125.91 103.07 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.395 . . . . 9.62 110.306 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.04 7.53 46.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.002 -0.545 . . . . 8.95 110.972 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -87.63 97.6 10.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.085 -0.507 . . . . 10.14 109.83 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -163.04 125.93 2.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.171 0.51 . . . . 9.39 111.581 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 8.34 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 10.22 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 11.69 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.58 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 14.06 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.95 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.81 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.45 ' C ' HD13 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 10.78 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.693 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 7.32 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.8 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 9.14 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 13.04 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.504 ' HB3' HD21 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 11.08 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.518 ' HA ' HG11 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 11.64 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.535 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.535 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 12.53 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 13.11 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.82 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.47 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.9 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.708 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . 0.484 ' N ' HD21 ' B' ' 177' ' ' ASN . 0.8 OUTLIER -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.99 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.84 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 16.28 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 12.17 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.708 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 10.38 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.78 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 188' ' ' GLU . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.6 ' O ' HG21 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.46 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 8.29 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 12.48 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 184' ' ' GLU . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.6 HG21 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -137.16 42.04 2.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . 0.525 ' O ' HG12 ' B' ' 195' ' ' VAL . 0.3 OUTLIER -52.68 141.86 34.35 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.818 -0.628 . . . . 14.02 111.781 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -35.26 86.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.336 2.691 . . . . 14.9 113.226 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 9.5 m -82.97 88.7 6.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.079 0.466 . . . . 18.01 110.641 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . 0.525 HG12 ' O ' ' B' ' 192' ' ' ASN . 6.2 m -119.02 147.23 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.493 0.663 . . . . 18.06 112.004 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -102.51 97.29 7.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.027 -0.988 . . . . 21.56 108.766 171.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 59.57 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.883 -0.599 . . . . 21.53 110.927 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -131.67 14.59 4.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 23.03 109.998 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.46 -35.51 2.16 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.979 -0.849 . . . . 24.72 110.979 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.842 -0.599 . . . . 27.31 109.557 178.387 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.061 0.458 . . . . 29.65 110.303 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -71.77 -36.83 70.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 26.73 110.474 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 59.45 30.4 20.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.617 0.722 . . . . 25.8 109.998 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -63.99 126.02 26.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.231 -0.895 . . . . 23.48 110.673 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -75.73 92.42 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.156 0.503 . . . . 21.47 110.31 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -86.01 114.45 22.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.827 -0.624 . . . . 20.32 109.691 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -62.21 110.66 1.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 16.94 111.66 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -135.66 83.9 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.726 . . . . 16.4 109.737 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.52 -24.46 17.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 13.24 109.82 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -114.93 120.6 40.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.328 -0.851 . . . . 10.33 109.783 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 15.1 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.95 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.609 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 10.34 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 8.16 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.775 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 7.29 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 7.08 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.74 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.72 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 11.14 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 16.19 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.97 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.86 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 13.32 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.85 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.737 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 11.06 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 6.0 112.518 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 4.48 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 12.11 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.609 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.58 139.05 40.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.38 114.77 2.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.95 -1.023 . . . . 13.04 109.187 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 1.03 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 42.4 Cg_exo -57.93 151.49 56.94 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.436 2.09 . . . . 13.77 111.212 175.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 43.3 tt0 76.77 -33.61 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.388 0.675 . . . . 14.04 111.66 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.25 -64.85 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.74 0.305 . . . . 15.56 110.495 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' B' ' 145' ' ' TYR . . . -95.14 -42.76 8.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.179 0.514 . . . . 15.1 110.178 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.03 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 66.2 t -81.64 102.85 7.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 12.84 109.853 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.66 11.63 24.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 11.23 110.54 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 t -100.88 4.23 42.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 9.91 110.883 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.83 1.84 48.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.435 . . . . 9.83 111.74 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.11 106.77 18.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.187 0.518 . . . . 8.59 110.982 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.28 95.4 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 8.99 109.756 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.72 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HA ' ' HB1' ' B' ' 137' ' ' ALA . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.38 112.362 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.83 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 6.19 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.37 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CE2' HD12 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.22 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 7.24 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 6.16 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.79 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 8.3 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.36 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.87 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.36 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.98 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.37 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.609 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.95 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' B' ' 116' ' ' VAL . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.74 113.122 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.85 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.94 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.671 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.69 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.59 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.35 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 6.04 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.85 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 8.26 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 8.08 110.417 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.36 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 9.13 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 9.16 111.783 -168.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 6.07 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.44 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.33 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.7 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.36 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.64 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HA ' HD22 ' A' ' 91' ' ' ASN . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.5 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.63 HD22 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -86.71 5.55 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.16 111.364 -179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 88' ' ' GLU . 2.1 t-20 -157.71 82.7 2.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.252 -0.431 . . . . 5.09 110.704 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.83 -78.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.797 2.331 . . . . 7.02 111.354 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.9 m -126.09 76.23 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.478 0.656 . . . . 7.48 110.711 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.9 133.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.587 -0.894 . . . . 6.38 108.587 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -92.67 95.4 9.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.053 -0.351 . . . . 9.94 110.053 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.09 -77.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.026 0.829 . . . . 8.62 111.46 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 t -150.39 147.54 27.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.746 -0.835 . . . . 9.98 108.746 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.48 88.16 0.47 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.224 -0.988 . . . . 9.93 113.276 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.193 0.521 . . . . 13.17 109.967 174.174 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.472 ' N ' ' H2 ' ' B' ' 101' ' ' MET . 65.2 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.99 0.424 . . . . 14.01 110.528 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -116.53 95.34 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.451 . . . . 12.42 109.908 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.0 31.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.004 0.43 . . . . 12.47 110.984 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 41.3 m 68.39 86.25 0.13 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.202 -0.908 . . . . 10.53 112.494 175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -83.28 119.66 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.674 -0.861 . . . . 8.15 108.674 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -77.21 93.32 3.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.42 0.628 . . . . 11.46 111.164 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -86.47 110.08 19.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 8.75 110.263 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -96.75 0.13 49.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.916 -0.584 . . . . 9.35 110.473 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.86 156.88 16.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 8.32 110.981 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.4 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.44 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 6.08 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 5.03 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.402 ' OD1' HG11 ' B' ' 116' ' ' VAL . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.57 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.85 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.95 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 4.21 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.31 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 6.16 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.682 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.29 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 9.21 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.57 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.45 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.97 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 5.05 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.712 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.8 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.77 112.563 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 3.14 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.88 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.499 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.7 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.499 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.08 149.71 27.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' MET . . . . . 0.577 ' HB3' ' HB3' ' B' ' 136' ' ' ALA . 43.8 tpp -160.74 109.51 1.31 Allowed Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.324 -0.991 . . . . 9.9 108.324 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.35 -6.24 8.12 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.64 2.893 . . . . 9.8 113.892 -171.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -128.94 17.19 6.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.934 0.397 . . . . 12.27 110.635 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' B' ' 133' ' ' MET . . . -143.95 -54.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.41 . . . . 11.9 111.159 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.713 ' HB1' ' HA ' ' A' ' 45' ' ' TYR . . . -77.85 -75.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 11.66 109.417 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -78.7 111.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.163 -0.68 . . . . 9.68 109.163 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -79.67 116.74 20.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.063 0.458 . . . . 11.53 111.187 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 20.9 p -121.22 17.56 11.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.833 0.825 . . . . 8.79 109.066 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 11.9 m -77.0 102.51 6.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.734 -1.121 . . . . 9.62 111.23 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.82 110.32 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.014 -0.539 . . . . 8.95 109.556 174.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.55 -55.14 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.956 0.407 . . . . 10.14 110.996 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -136.88 158.58 44.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 9.39 110.762 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.495 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 8.34 109.886 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 10.22 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 11.69 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.58 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 14.06 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.95 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.81 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 10.78 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 7.32 110.839 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.8 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 9.14 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 13.04 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' PHE . . . . . 0.675 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 11.08 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' PRO . . . . . 0.519 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 11.64 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' TYR . . . . . 0.775 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 12.53 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 13.11 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.82 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.47 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.9 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.99 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' ARG . . . . . 0.526 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.84 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 16.28 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 12.17 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 10.38 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.78 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.46 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' LEU . . . . . 0.405 HD23 ' O ' ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 8.29 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 12.48 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.461 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' ASN . . . . . 0.449 ' N ' HD21 ' B' ' 191' ' ' ASN . 0.1 OUTLIER -70.36 -18.48 63.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.7 135.77 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.908 0.755 . . . . 14.02 110.813 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.66 147.08 18.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.723 2.282 . . . . 14.9 112.258 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 23.8 m -49.88 106.43 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.506 0.504 . . . . 18.01 111.509 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.67 111.22 19.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 18.06 110.781 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -149.61 88.56 1.56 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.62 -0.718 . . . . 21.56 109.25 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -83.76 -71.1 0.52 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.015 -0.539 . . . . 21.53 110.313 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 6.6 p -136.79 57.84 1.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.878 -0.601 . . . . 23.03 109.815 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.92 60.25 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.48 -1.048 . . . . 24.72 110.48 -171.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 108.709 -0.849 . . . . 27.31 108.709 -177.239 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 14.9 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.71 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 9.66 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 7.46 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 6.87 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 6.78 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.44 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.639 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 10.95 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 15.91 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.09 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.65 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 12.38 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.05 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 10.23 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 5.52 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 3.98 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 11.28 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 . . . . . 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.622 0.601 . . . . 8.55 112.622 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.5 109.823 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' HD11 ' B' ' 130' ' ' ILE . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.01 109.975 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.6 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 5.62 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.03 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.15 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 6.72 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 49' ' ' PHE . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 5.99 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.39 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 7.73 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.32 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.57 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.06 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.7 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.21 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.63 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.58 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.79 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.49 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.26 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' ' HZ2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.1 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 5.97 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.38 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 7.75 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 7.82 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.11 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 8.81 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 8.87 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 5.87 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.14 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.17 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.6 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.05 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.15 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' B' ' 127' ' ' PRO . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.46 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.04 109.817 179.152 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 110' ' ' TYR . . . . . 0.414 ' HB3' HG13 ' B' ' 130' ' ' ILE . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.28 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.12 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.513 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 5.93 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 4.62 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.32 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.43 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 66' ' ' TYR . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 3.93 109.347 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.3 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 5.76 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.08 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 8.78 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.27 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.06 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.68 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 4.71 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.676 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.03 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.669 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.48 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 2.83 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.622 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.33 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.414 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.34 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.498 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.53 -0.545 . . . . 8.97 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 7.97 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 9.5 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 10.78 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.24 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 13.51 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.75 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.03 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.444 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 9.95 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 20' ' ' MET . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 6.89 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.24 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 8.35 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 12.73 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.774 ' HB3' HG21 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.499 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 10.48 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 164' ' ' PHE . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 10.82 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 11.91 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 12.55 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.47 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.15 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.56 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.74 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.14 109.624 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 15.89 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 11.57 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 9.65 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.46 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.24 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 7.89 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 11.87 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.51 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 14.9 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.71 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 9.66 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.652 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 7.46 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.616 HG21 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 6.87 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 6.78 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.44 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG3' HD11 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 10.95 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 15.91 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.09 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.65 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 12.38 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 75.0 m80 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.05 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.631 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 10.23 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 5.52 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 3.98 111.522 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 11.28 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.783 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.52 ' OE2' ' HD3' ' A' ' 29' ' ' ARG . 17.2 mm-40 . . . . . 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.345 0.593 . . . . 8.55 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.5 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.01 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.6 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 5.62 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.03 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.15 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.846 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 6.72 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 5.99 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.39 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 7.73 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.634 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.32 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.57 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.06 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.7 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.21 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.63 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.58 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.79 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.49 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.26 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.1 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 5.97 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.38 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 7.75 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 7.82 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.11 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 8.81 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 8.87 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 5.87 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.14 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.17 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.846 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.6 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.05 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.15 110.557 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.46 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 . . . . . 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.04 112.209 -179.013 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.28 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.12 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 5.93 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 4.62 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.32 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.626 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.43 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 3.93 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.3 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 5.76 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.08 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 8.78 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.27 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.06 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.68 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 4.71 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.03 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.48 111.686 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 2.83 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.33 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.34 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 109.324 -0.621 . . . . 8.97 109.324 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.783 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 7.97 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 96.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 9.5 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.483 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 10.78 111.098 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.652 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.24 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 13.51 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.483 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.75 109.649 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.03 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.95 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.58 ' HB2' HG21 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 6.89 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.24 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 8.35 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 12.73 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 10.48 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.575 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 10.82 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 11.91 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 12.55 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.47 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.15 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.56 106.594 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.74 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.14 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 15.89 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 11.57 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 9.65 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.46 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.456 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.24 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 7.89 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 11.87 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.607 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 190' ' ' GLU . . . . . 0.607 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.048 -0.353 . . . . 10.33 110.048 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 14.9 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.659 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.71 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 9.66 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 7.46 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.796 HG21 HD13 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 6.87 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 6.78 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.44 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 10.95 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 15.91 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.09 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.65 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 12.38 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 72.4 m80 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.05 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 10.23 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 5.52 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 3.98 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 11.28 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 8.55 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.5 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.01 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.6 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 5.62 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.03 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.15 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 6.72 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 5.99 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.39 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 7.73 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.32 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.57 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.06 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.7 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.21 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.631 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.63 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.58 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.769 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.79 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.49 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.26 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.1 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 5.97 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.38 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.718 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 7.75 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 7.82 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.11 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 8.81 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 8.87 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 5.87 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.718 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.14 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.17 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.6 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.05 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.15 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.46 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.04 110.304 176.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.507 -0.553 . . . . 8.32 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.28 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.12 108.136 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.712 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 5.93 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.478 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 4.62 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.51 HD12 HG13 ' A' ' 89' ' ' ILE . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.32 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.43 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 3.93 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.3 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 5.76 111.123 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.08 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' B' ' 121' ' ' LYS . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 8.78 109.322 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.27 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.06 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.68 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 4.71 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.03 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.48 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 2.83 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.33 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.34 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.561 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.218 -0.66 . . . . 8.97 109.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 7.97 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.411 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 9.5 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 10.78 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.405 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.24 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 13.51 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.75 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.03 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 9.95 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 6.89 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.24 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 8.35 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 12.73 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.489 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 10.48 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.61 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 10.82 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.47 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.737 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 11.91 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 12.55 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.47 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.15 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.739 ' HD3' HD11 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.56 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.634 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ASN . . . . . 0.718 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.74 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.14 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 15.89 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 11.57 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.718 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 9.65 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.46 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.24 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.739 HD11 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 7.89 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 11.87 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.8 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' ASN . . . . . 0.483 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.207 -0.664 . . . . 10.33 109.207 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 14.9 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.71 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 9.66 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 7.46 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 HD21 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 6.87 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' B' ' 166' ' ' TYR . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 6.78 109.939 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.44 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.848 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 10.95 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 15.91 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.09 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.848 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.65 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 12.38 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.05 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 10.23 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 5.52 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 3.98 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 11.28 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 CA--C 1.515 -0.389 0 N-CA-C 108.232 -1.025 . . . . 8.55 108.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.5 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.01 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.593 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.6 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 5.62 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.03 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.15 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 6.72 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 5.99 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.39 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 7.73 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.32 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.57 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.06 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.7 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HG ' HG21 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.21 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.646 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.63 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.58 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.79 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.49 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.26 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.1 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 5.97 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.38 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 7.75 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 7.82 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.11 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 8.81 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 8.87 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 5.87 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.14 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.925 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.17 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.6 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.784 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.05 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.15 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.46 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.04 110.338 -172.264 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.788 0.327 . . . . 8.32 110.432 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 110' ' ' TYR . . . . . 0.431 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.28 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.43 ' HD3' ' OE1' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.12 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 5.93 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 4.62 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.72 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.32 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.43 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 3.93 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.3 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 5.76 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.48 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.08 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 8.78 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.27 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.48 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.06 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.68 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 4.71 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.761 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.03 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.784 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.48 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 2.83 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.33 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.34 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 111' ' ' LYS . 43.1 tt0 . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.971 -0.751 . . . . 8.97 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 7.97 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 9.5 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 10.78 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.416 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.24 110.703 -171.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 13.51 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.75 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.03 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 9.95 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 6.89 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.24 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 8.35 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 12.73 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.616 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 10.48 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.618 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 10.82 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.446 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.446 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 11.91 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 12.55 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 171' ' ' GLU . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.47 110.339 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.15 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.56 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.74 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.14 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 15.89 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 11.57 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 9.65 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.615 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.46 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.24 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 7.89 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 11.87 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.488 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 190' ' ' GLU . . . . . 0.488 ' N ' HD12 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.74 0.305 . . . . 10.33 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 14.9 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 30' ' ' ILE . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.71 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 9.66 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 7.46 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 6.87 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 6.78 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.44 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.706 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 10.95 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 15.91 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.09 112.43 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.65 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 12.38 113.36 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.05 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 10.23 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 5.52 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 3.98 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 11.28 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 9.3 tp10 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 CA--C 1.521 -0.168 0 N-CA-C 109.568 -0.53 . . . . 8.55 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.5 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.01 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.6 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 5.62 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.03 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.546 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.15 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 6.72 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 5.99 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.39 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 7.73 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.32 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.57 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.06 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.7 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.21 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.749 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.63 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.58 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.79 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.49 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.26 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.1 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 5.97 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.38 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 7.75 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 7.82 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.11 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 8.81 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 8.87 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 5.87 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.729 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.14 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.17 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.6 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.05 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.15 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 50' ' ' PHE . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.714 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.46 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.04 111.739 -177.132 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.817 -0.438 . . . . 8.32 109.817 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.28 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.12 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 5.93 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 4.62 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.32 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 66' ' ' TYR . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.43 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 3.93 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.3 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.579 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 5.76 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.08 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 8.78 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.27 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.06 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.68 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 4.71 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.03 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.48 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.546 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 2.83 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.33 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.46 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.34 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.149 -0.315 . . . . 8.97 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.573 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 7.97 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 9.5 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.474 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 10.78 109.917 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.662 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.24 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 13.51 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.474 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.75 110.312 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.03 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 9.95 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 6.89 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.24 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.476 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 8.35 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 12.73 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.735 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 10.48 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 10.82 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.973 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 11.91 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 12.55 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.47 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.15 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.56 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ASN . . . . . 0.409 HD22 ' HE2' ' B' ' 182' ' ' PHE . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.74 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.14 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 15.89 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 11.57 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 9.65 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.46 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.24 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 7.89 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 11.87 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.973 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.885 -0.413 . . . . 10.33 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 14.9 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.71 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.678 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 9.66 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 7.46 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 6.87 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 6.78 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.44 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.657 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 10.95 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 15.91 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.09 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.65 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 12.38 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.05 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 10.23 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 5.52 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 3.98 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 11.28 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.678 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.589 ' N ' HD13 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.102 0.477 . . . . 8.55 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.5 109.624 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CE2' ' HD2' ' B' ' 110' ' ' TYR . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.01 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.6 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 5.62 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.03 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.15 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 6.72 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 5.99 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.39 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 7.73 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.32 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.57 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.06 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.7 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.21 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.63 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HG11 ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.58 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.673 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.79 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.49 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.26 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.1 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 5.97 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.951 ' HB3' HD13 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.38 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 7.75 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 7.82 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.11 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 8.81 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 8.87 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 5.87 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.14 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.17 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' HD13 ' A' ' 89' ' ' ILE . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.6 111.993 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.05 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.15 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 HD11 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.46 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.544 ' OD1' ' HA ' ' A' ' 88' ' ' GLU . 1.4 p-10 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.04 111.102 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.323 -0.621 . . . . 8.32 109.323 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 110' ' ' TYR . . . . . 0.598 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.28 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.12 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.46 ' HA ' HG23 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 5.93 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 4.62 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.533 HD11 HD11 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.32 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.595 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.43 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 3.93 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.3 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 5.76 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.595 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.08 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 8.78 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.27 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.06 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.68 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 4.71 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.03 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.48 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.33 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.34 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.644 -0.502 . . . . 8.97 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 7.97 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 9.5 108.494 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD13 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 10.78 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.472 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.24 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.737 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 13.51 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.75 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.03 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.641 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 6.89 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.24 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 8.35 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 12.73 112.052 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.618 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 10.48 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 10.82 114.302 -172.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.526 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 11.91 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 12.55 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.47 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.15 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.56 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.74 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.14 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 15.89 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 11.57 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 9.65 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.46 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.737 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.24 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.43 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 7.89 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 11.87 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD12 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 14.9 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.909 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.71 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 9.66 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 7.46 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 6.87 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 6.78 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.44 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.603 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 10.95 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 15.91 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.09 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.603 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.65 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 12.38 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.05 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.646 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 10.23 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.866 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 5.52 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 3.98 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 11.28 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.031 0.443 . . . . 8.55 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.5 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.01 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.6 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 5.62 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.03 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.15 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 6.72 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 5.99 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.39 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 7.73 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.32 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.57 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.06 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.7 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.21 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.63 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.612 ' HA ' HG12 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.58 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.587 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.79 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.542 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.49 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.26 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.1 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 5.97 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.38 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 7.75 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 7.82 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.11 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 8.81 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 8.87 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 5.87 113.107 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.14 110.738 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.17 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.6 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.05 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.15 110.033 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.803 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.46 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' N ' HD13 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.04 110.459 -170.754 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.008 0.432 . . . . 8.32 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.28 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.12 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 5.93 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 4.62 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.803 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.32 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.43 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 3.93 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.3 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 5.76 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.504 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.08 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 8.78 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.27 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.06 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.68 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 4.71 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.03 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.48 112.532 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.453 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 2.83 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.604 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.33 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.34 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.166 0.508 . . . . 8.97 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 7.97 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 9.5 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.429 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 10.78 111.234 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.529 ' HE2' HD11 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.24 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 13.51 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.75 108.897 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.03 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 9.95 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 6.89 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.24 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 8.35 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 12.73 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.702 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 10.48 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.484 ' HA ' HG11 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 10.82 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 11.91 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 12.55 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.47 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.15 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' B' ' 175' ' ' LYS . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.56 108.694 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.657 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.74 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.14 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 15.89 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 11.57 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.657 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 9.65 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.46 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.646 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.24 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 7.89 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 11.87 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' N ' ' HH ' ' B' ' 145' ' ' TYR . 74.4 m-85 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 14.9 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.71 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 9.66 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 7.46 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 6.87 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 6.78 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.44 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 10.95 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 15.91 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.09 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.65 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 12.38 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.05 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.819 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 10.23 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 5.52 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 3.98 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 11.28 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.752 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.662 0.268 . . . . 8.55 110.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.01 108.745 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.6 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 5.62 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.03 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.15 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 6.72 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 5.99 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.39 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 7.73 110.521 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.729 ' HB2' HG21 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.32 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.57 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.06 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.7 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.21 110.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.63 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' HG11 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.58 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.79 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.49 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.26 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.1 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 5.97 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.38 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 7.75 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 7.82 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.11 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 8.81 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 8.87 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 5.87 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.624 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.14 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.17 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.619 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.6 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.05 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.15 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.46 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.04 110.033 178.567 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.571 0.224 . . . . 8.32 111.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.28 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.12 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 5.93 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.436 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 4.62 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.32 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.43 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 3.93 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.3 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 5.76 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.441 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.08 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 8.78 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.27 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.06 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.68 113.42 -173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 4.71 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.619 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.03 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.463 ' HB2' HG13 ' A' ' 89' ' ' ILE . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.48 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 2.83 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.33 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.641 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.34 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.641 ' N ' HD13 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 8.97 110.144 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.579 ' HH ' ' N ' ' A' ' 10' ' ' TYR . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 7.97 109.408 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 9.5 108.871 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 10.78 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.24 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.819 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 13.51 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.75 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.03 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 9.95 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.62 ' HB2' HG21 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 6.89 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.24 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 8.35 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 12.73 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.65 HD21 HG21 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 10.48 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG12 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 10.82 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.476 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 11.91 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 12.55 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.47 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.464 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.15 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.56 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.613 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.74 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.14 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 180' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 15.89 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 11.57 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 9.65 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.46 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.24 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 7.89 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 11.87 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 190' ' ' GLU . . . . . 0.412 ' N ' HD12 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.661 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 10.33 110.089 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 14.9 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.71 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 9.66 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 HD11 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 7.46 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 6.87 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 6.78 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.44 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.672 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 10.95 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 15.91 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.09 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.672 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.65 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 12.38 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.05 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 10.23 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 5.52 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 3.98 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 11.28 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' HD13 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.09 0.471 . . . . 8.55 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.5 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.475 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.01 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.6 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 5.62 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.03 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.612 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.15 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 6.72 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 5.99 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.39 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 7.73 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.32 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.57 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.06 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.7 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.21 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.63 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.58 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.79 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.49 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.26 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.1 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 5.97 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.38 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 7.75 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 3.9 m-20 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 7.82 109.748 -176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.11 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 8.81 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 8.87 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 5.87 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.14 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.17 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.6 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.05 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.15 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.46 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.04 110.58 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.477 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.28 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.12 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 5.93 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 4.62 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.32 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.832 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.43 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.558 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 3.93 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 63' ' ' LEU . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.3 110.877 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 5.76 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.589 ' HG3' HD21 ' A' ' 58' ' ' LEU . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.08 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 8.78 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.27 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.433 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.06 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.68 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' HIS . . . . . 0.558 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 4.71 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.03 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.48 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.83 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.668 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.33 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.34 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.722 -0.473 . . . . 8.97 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 7.97 110.763 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 9.5 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 10.78 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.671 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.473 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.24 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 13.51 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.75 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.03 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 9.95 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.674 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 6.89 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.24 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 8.35 112.069 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 12.73 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.891 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.58 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 10.48 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.515 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 10.82 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 11.91 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 12.55 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.47 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.15 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.667 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.45 ' HB2' ' NZ ' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.56 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.74 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.14 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 15.89 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 11.57 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 9.65 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.46 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.492 ' O ' HD13 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.24 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.667 HD11 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 7.89 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 11.87 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.673 ' HA ' HD21 ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' ASN . . . . . 0.673 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 14.9 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.71 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 9.66 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 7.46 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 6.87 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 6.78 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.44 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 10.95 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 15.91 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.09 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.65 109.783 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 12.38 112.789 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.05 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 10.23 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 5.52 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 3.98 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.738 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 11.28 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.964 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 30.8 t30 . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.744 -0.465 . . . . 8.55 109.744 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.01 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.6 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 5.62 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.03 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.15 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 6.72 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 5.99 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.39 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 7.73 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.32 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.57 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.06 111.181 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.7 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.525 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.21 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.75 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.63 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.58 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.79 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.49 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.26 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.1 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 5.97 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.38 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 7.75 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 7.82 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.11 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 8.81 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 8.87 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 5.87 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.14 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.17 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.6 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.05 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.15 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.46 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.04 110.367 -178.275 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.048 -0.353 . . . . 8.32 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.28 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.409 ' HG3' ' OD2' ' B' ' 114' ' ' ASP . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.12 111.153 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 5.93 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 4.62 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' B' ' 111' ' ' LYS . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.32 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.75 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.43 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 3.93 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.3 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 5.76 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.08 108.237 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 8.78 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.27 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.06 110.514 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.68 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 4.71 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.03 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.48 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 2.83 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.64 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.33 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.441 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.34 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 8.97 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.689 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 7.97 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 9.5 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 10.78 109.865 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.24 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 13.51 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.75 109.574 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.03 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 9.95 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 6.89 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.24 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.689 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 8.35 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 12.73 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 10.48 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 10.82 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 11.91 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 12.55 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.47 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.15 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.56 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.74 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.14 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 15.89 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 11.57 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 9.65 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.46 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.24 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 7.89 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 11.87 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.538 ' HA ' ' OE1' ' B' ' 188' ' ' GLU . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 188' ' ' GLU . 2.9 p-10 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 75.9 m-85 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.67 0.272 . . . . 10.33 110.616 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 14.9 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.71 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 9.66 112.749 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.671 HD23 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 7.46 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.591 HG11 HD21 ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 6.87 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.747 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 6.78 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.44 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.811 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 10.95 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 15.91 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.09 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.65 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 12.38 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 70.8 m80 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.05 110.205 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.622 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 10.23 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 5.52 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 3.98 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 11.28 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD13 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 15.7 pt-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.235 0.541 . . . . 8.55 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.5 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.01 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 53.1 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.6 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 5.62 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.896 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.03 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.15 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 6.72 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 5.99 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.39 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 7.73 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.32 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.57 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.06 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.7 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD21 HG21 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.21 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.63 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.824 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.58 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.79 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.49 112.978 -168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.794 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.26 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.698 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.1 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 5.97 110.807 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.38 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.615 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 7.75 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 7.82 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.11 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 8.81 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 8.87 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 5.87 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.14 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.17 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.6 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.05 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.15 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.593 HG22 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.46 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.04 110.491 178.14 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.012 0.434 . . . . 8.32 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.28 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.12 111.315 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 5.93 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 4.62 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.32 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.43 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 3.93 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.3 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 5.76 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.521 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.08 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 8.78 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.27 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.06 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.68 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 4.71 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.896 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.03 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.48 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 2.83 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.33 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.536 HG12 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.34 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.648 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.702 -0.481 . . . . 8.97 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 7.97 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 9.5 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 10.78 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.671 ' HE2' HD23 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.24 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 13.51 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.75 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.03 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 9.95 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.66 ' HB2' HG21 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 6.89 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.24 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 8.35 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 12.73 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 10.48 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 10.82 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.472 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 11.91 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 12.55 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.47 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.15 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.56 108.23 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.74 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.14 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 15.89 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 11.57 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.416 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 9.65 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.46 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.24 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 7.89 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 11.87 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.533 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 14.9 110.868 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.71 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 9.66 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 7.46 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 6.87 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 6.78 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HA ' HD23 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.44 110.892 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 10.95 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 15.91 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.09 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.65 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 12.38 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.05 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 10.23 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 26' ' ' TRP . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 5.52 112.698 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 3.98 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 11.28 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.751 0.31 . . . . 8.55 111.251 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.5 109.745 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.01 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.6 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 5.62 110.975 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.03 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.655 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.15 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.535 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 6.72 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 48' ' ' PHE . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 5.99 109.783 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.39 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 7.73 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.32 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.57 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.06 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.7 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.512 HD11 HG23 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.21 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.63 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.58 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.79 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.49 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.26 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.1 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 5.97 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.38 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 7.75 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 7.82 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.11 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 8.81 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 8.87 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' HG22 ' A' ' 52' ' ' THR . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 5.87 112.492 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.14 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.17 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.6 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.05 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.15 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.46 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.04 109.96 177.326 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.588 0.233 . . . . 8.32 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.28 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.12 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 5.93 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 4.62 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.462 HD22 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.32 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.43 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 3.93 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.3 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 5.76 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.459 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.08 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 8.78 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.27 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.535 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.06 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.432 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.68 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 4.71 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.786 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.03 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.48 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.462 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 2.83 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.649 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.33 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.414 HD13 ' H ' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.34 112.004 -173.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.718 ' HA ' ' HB3' ' A' ' 45' ' ' TYR . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.912 0.387 . . . . 8.97 110.49 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 7.97 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 10.78 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.24 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 13.51 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.75 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.03 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 9.95 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG21 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 6.89 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.24 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 8.35 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 12.73 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.822 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 10.48 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 10.82 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 167' ' ' GLU . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 11.91 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 12.55 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.47 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.15 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.56 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.557 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.74 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.14 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 15.89 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 11.57 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.557 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 9.65 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.46 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.441 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.24 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 7.89 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 11.87 110.435 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.467 -0.197 . . . . 10.33 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 14.9 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.71 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 30' ' ' ILE . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 9.66 112.624 -173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 7.46 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 6.87 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.651 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 6.78 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.44 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 10.95 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 15.91 109.293 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.09 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.65 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 12.38 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.05 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.51 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 10.23 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 5.52 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 3.98 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 11.28 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 30' ' ' ILE . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.604 0.24 . . . . 8.55 111.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.5 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.01 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 91.7 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.6 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 5.62 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.03 110.091 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.15 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 6.72 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 5.99 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.39 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 7.73 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.32 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.57 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.06 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.7 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 HG21 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.21 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.63 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.58 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.79 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.712 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.49 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.26 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.712 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.1 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 5.97 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.38 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 7.75 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.703 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 7.82 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.11 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 8.81 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 8.87 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 5.87 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.14 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.17 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.6 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.05 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.15 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.46 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.04 110.642 -179.25 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.28 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.706 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.12 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 5.93 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 4.62 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.617 HD23 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.32 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.617 ' N ' HD23 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.43 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 3.93 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.3 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 5.76 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.08 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 8.78 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.27 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.06 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.68 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 4.71 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.481 ' CZ3' ' HD1' ' B' ' 123' ' ' TYR . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.03 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.48 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 2.83 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.33 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.706 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.34 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 132' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.577 ' NZ ' ' HB3' ' B' ' 144' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.999 -0.371 . . . . 8.97 109.999 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.464 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 7.97 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 9.5 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 10.78 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.24 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.487 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 13.51 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.75 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.03 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 9.95 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 6.89 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.24 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.464 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 8.35 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 12.73 111.061 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 10.48 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 10.82 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.661 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.537 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 11.91 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 12.55 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.47 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.15 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.56 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.74 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.14 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 15.89 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 11.57 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 9.65 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.46 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.24 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 7.89 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 11.87 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' B' ' 150' ' ' PHE . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 11.8 p30 . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.624 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.9 m-85 . . . . . 0 C--O 1.217 -0.64 0 N-CA-C 110.531 -0.174 . . . . 10.33 110.531 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 14.9 113.375 -171.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.71 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 9.66 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 7.46 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 6.87 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 6.78 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.44 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.614 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 10.95 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 15.91 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.09 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.65 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 12.38 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.05 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 10.23 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 5.52 112.526 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 3.98 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 11.28 109.56 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.141 HD11 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' H ' HD13 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.667 0.746 . . . . 8.55 109.117 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.5 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.01 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.6 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.89 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 5.62 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.03 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.15 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 6.72 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 5.99 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.39 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 7.73 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.32 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.57 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.06 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.7 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD21 HG21 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.21 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.63 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.58 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.667 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.79 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.49 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.26 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.1 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 5.97 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.38 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 7.75 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 7.82 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.11 112.01 -176.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 8.81 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 8.87 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 5.87 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.14 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.17 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.541 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.6 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.05 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.15 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 HD21 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.46 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.04 111.704 -179.756 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.009 0.433 . . . . 8.32 110.732 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.28 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.12 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 5.93 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 4.62 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.32 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.884 HG21 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.43 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 3.93 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.3 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 5.76 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.544 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.08 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 8.78 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.27 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.06 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.68 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 4.71 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.705 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.03 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.48 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 2.83 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.33 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.34 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.809 -0.441 . . . . 8.97 109.809 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 1.141 ' HB3' HD11 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 7.97 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 9.5 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 10.78 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.484 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.24 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 13.51 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.75 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.03 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 9.95 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 6.89 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.24 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 8.35 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 12.73 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.497 HD11 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.513 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 10.48 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.555 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 10.82 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.541 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 11.91 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 12.55 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.47 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.15 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.56 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 50.5 t30 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.74 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' B' ' 182' ' ' PHE . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.14 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 15.89 109.499 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 11.57 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 9.65 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.46 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.623 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.24 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 7.89 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 11.87 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 190' ' ' GLU . . . . . 0.496 ' N ' HD13 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.118 -0.327 . . . . 10.33 110.118 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.7 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 14.9 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.71 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 9.66 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.591 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 7.46 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 6.87 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 6.78 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.44 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 10.95 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 15.91 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.09 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.65 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 12.38 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.05 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 10.23 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 5.52 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 3.98 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 11.28 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.7 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.671 0.748 . . . . 8.55 110.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.5 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.01 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.6 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 5.62 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.03 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.15 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 6.72 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 5.99 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.39 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 7.73 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.668 ' HB2' HG21 ' A' ' 47' ' ' VAL . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.32 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.57 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.06 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.7 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD21 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.21 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.63 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 1.032 ' HA ' HG12 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.58 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.752 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.79 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.781 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.49 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.26 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.1 111.638 -168.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.781 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 5.97 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.866 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.38 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 7.75 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.579 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 7.82 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.11 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 8.81 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 8.87 111.947 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 5.87 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.14 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.17 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.585 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.6 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.866 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.05 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.15 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.46 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.04 109.507 175.923 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.205 0.526 . . . . 8.32 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.28 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.12 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 5.93 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 4.62 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.32 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 1.032 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.43 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 3.93 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.3 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 5.76 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.08 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' B' ' 121' ' ' LYS . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 8.78 108.72 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.27 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.06 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.68 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 4.71 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.585 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.03 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.48 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 2.83 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.771 ' HA ' HD23 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.33 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.34 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.171 0.51 . . . . 8.97 111.581 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 7.97 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 9.5 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 10.78 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.442 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.24 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 153' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 13.51 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.75 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.03 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.453 ' C ' HD12 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 9.95 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 6.89 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.24 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 8.35 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 12.73 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.537 ' HB3' HD23 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 10.48 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.564 ' HA ' HG12 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 10.82 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.533 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 167' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' SER . . . . . 0.67 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 11.91 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 12.55 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.47 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.15 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.56 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.734 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.74 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.14 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 15.89 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 11.57 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.734 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 9.65 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.46 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.24 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 7.89 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 11.87 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.622 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.783 -0.451 . . . . 10.33 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 14.9 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.71 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.626 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 9.66 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 7.46 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 6.87 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 6.78 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.44 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.728 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 10.95 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 15.91 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.09 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.65 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 12.38 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.05 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.751 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 10.23 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 5.52 112.518 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 3.98 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 11.28 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.756 -0.461 . . . . 8.55 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.5 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.01 112.362 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.6 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 5.62 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.03 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.15 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 6.72 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 5.99 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.39 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 7.73 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.32 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.57 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.06 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.7 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.21 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.63 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.58 113.122 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.847 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.79 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.49 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.26 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.1 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 5.97 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.38 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 7.75 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 7.82 110.417 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.11 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 8.81 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 8.87 111.783 -168.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 5.87 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.14 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.17 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.6 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.05 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.15 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.74 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.46 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.04 111.364 -179.434 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 120.943 0.401 . . . . 8.32 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.28 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.12 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 5.93 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 4.62 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.74 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.32 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.847 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.43 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 3.93 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.3 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 5.76 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.691 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.08 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 8.78 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.27 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.06 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.68 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 4.71 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.73 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.03 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 126' ' ' TRP . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.48 112.563 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 2.83 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.33 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.509 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.34 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.772 0.32 . . . . 8.97 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 7.97 109.886 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 9.5 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' B' ' 158' ' ' LEU . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 10.78 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.751 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 150' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.24 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' GLY . . . . . 0.434 ' H ' ' HH2' ' A' ' 26' ' ' TRP . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 13.51 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.75 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.03 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 9.95 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 6.89 110.839 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.24 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 8.35 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 12.73 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 164' ' ' PHE . . . . . 0.684 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 10.48 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 165' ' ' PRO . . . . . 0.542 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 10.82 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 166' ' ' TYR . . . . . 0.792 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 11.91 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 12.55 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.47 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.15 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.56 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.74 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.14 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 15.89 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 11.57 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 9.65 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.46 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' GLY . . . . . 0.54 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.24 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 186' ' ' LEU . . . . . 0.424 ' O ' HD23 ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 7.89 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 11.87 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.786 0.327 . . . . 29.42 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p -102.17 148.65 25.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.897 -0.409 . . . . 26.59 109.897 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 3' ' ' ARG . 40.9 ttp180 -106.88 137.84 44.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.318 . . . . 25.53 110.379 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -89.17 173.27 8.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.094 -0.503 . . . . 23.29 111.121 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -117.63 122.94 44.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.87 -0.605 . . . . 21.2 109.883 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -98.96 -16.98 18.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.613 0.244 . . . . 20.05 111.151 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -77.83 111.1 13.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 16.73 109.975 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -102.89 -17.6 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.789 -0.641 . . . . 16.22 110.639 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.36 134.41 51.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.435 0.636 . . . . 13.24 111.736 -173.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 -80.2 148.64 30.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 168.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 14.9 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.71 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 9.66 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 7.46 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 6.87 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 6.78 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.44 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.639 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 10.95 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 15.91 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.09 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.65 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 12.38 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.05 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 10.23 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 5.52 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 3.98 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 11.28 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 75.02 172.48 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.9 tpt -166.41 94.8 0.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 12.85 109.517 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.74 87.01 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.084 2.523 . . . . 13.07 112.576 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -140.79 -21.61 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 14.04 111.733 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 94.45 3.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 111.527 0.195 . . . . 15.24 111.527 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.709 . . . . 14.64 111.188 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.26 141.45 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.684 -0.488 . . . . 12.42 109.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -102.84 -47.72 4.3 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.795 -0.817 . . . . 10.84 108.795 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 m -168.86 138.41 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.812 -1.085 . . . . 9.63 109.367 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 m -68.3 101.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.978 -0.378 . . . . 9.56 109.978 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -122.96 142.0 51.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.137 -0.483 . . . . 8.3 110.554 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.36 7.98 0.55 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.477 1.111 . . . . 8.55 112.622 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.5 109.823 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' HD11 ' B' ' 130' ' ' ILE . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.01 109.975 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.6 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 5.62 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.03 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.15 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 6.72 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 49' ' ' PHE . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 5.99 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.39 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 7.73 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.32 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.57 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.06 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.7 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.21 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.63 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.58 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.79 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.49 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.26 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HG2' ' HD1' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' ' HZ2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.1 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 5.97 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.38 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 7.75 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 7.82 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.11 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 8.81 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 8.87 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 5.87 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.14 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.17 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.6 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.05 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.15 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' B' ' 127' ' ' PRO . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.46 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -108.2 28.77 7.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.04 109.817 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 4.6 p30 -60.13 152.89 59.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.239 -0.891 . . . . 5.09 112.179 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 9.3 Cg_exo -72.42 -45.57 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.34 2.693 . . . . 6.48 113.357 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -85.94 72.15 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.708 . . . . 7.32 110.589 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG23 ' HE2' ' A' ' 70' ' ' LYS . 3.8 p -111.75 111.81 37.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.54 0.686 . . . . 6.13 110.878 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -83.97 75.22 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 9.68 109.794 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.85 139.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.014 0.821 . . . . 8.54 112.403 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 t -72.72 -24.38 60.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.491 -0.559 . . . . 9.88 109.491 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.08 74.28 1.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.556 -0.747 . . . . 9.93 112.756 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.539 ' HD1' ' HG2' ' A' ' 71' ' ' GLU . 85.6 m-85 . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 123.444 0.698 . . . . 12.88 111.978 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.383 0.611 . . . . 13.85 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.8 t -81.42 98.66 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.301 -0.863 . . . . 12.37 111.254 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 69.59 -74.19 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.471 -0.786 . . . . 12.02 111.524 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -159.07 140.69 13.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.673 -0.492 . . . . 10.42 109.673 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -84.94 102.03 12.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.161 0.505 . . . . 8.13 110.501 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -118.19 -18.88 9.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.479 -0.782 . . . . 10.78 110.739 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.32 118.57 11.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 8.36 110.312 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -137.55 18.06 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 8.99 110.972 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -76.17 167.9 21.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.414 ' HB3' HG13 ' B' ' 130' ' ' ILE . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.28 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.12 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.513 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 5.93 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 4.62 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.32 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.43 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 66' ' ' TYR . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 3.93 109.347 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.3 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 5.76 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.08 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 8.78 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.27 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.06 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.68 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 4.71 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.676 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.03 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.669 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.48 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 2.83 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.622 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.33 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.414 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.34 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.498 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 -80.27 175.82 10.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 43.3 mtt -67.28 134.92 93.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.645 -0.707 . . . . 9.64 110.348 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 76.5 Cg_exo -50.66 -40.53 55.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.325 2.683 . . . . 9.8 113.732 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 67.14 85.9 0.14 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.642 0.734 . . . . 12.27 110.443 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.13 74.47 0.14 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 11.49 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.21 -43.75 0.57 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.238 -0.892 . . . . 11.38 110.423 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.63 129.07 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.141 -0.481 . . . . 9.65 110.059 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -178.64 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.085 -1.45 . . . . 11.11 107.085 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -162.45 -172.56 3.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.493 -1.231 . . . . 8.66 108.729 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' THR . . . . . 0.444 ' HB ' ' HD3' ' B' ' 144' ' ' LYS . 3.2 m 65.32 98.13 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.661 0.6 . . . . 9.44 110.67 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.43 -72.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 8.63 111.319 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -92.25 95.08 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.245 0.545 . . . . 9.61 111.055 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' B' ' 141' ' ' THR . 23.7 pttm -131.07 137.08 48.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.369 -0.832 . . . . 8.97 109.53 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 7.97 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 9.5 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 10.78 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.24 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 13.51 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.75 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.03 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.444 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 9.95 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 20' ' ' MET . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 6.89 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.24 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 8.35 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 12.73 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.774 ' HB3' HG21 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.499 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 10.48 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 164' ' ' PHE . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 10.82 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 11.91 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 12.55 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.47 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.15 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.56 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.74 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.14 109.624 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 15.89 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 11.57 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 9.65 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.46 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.24 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 7.89 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 11.87 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.51 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.11 -3.61 58.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 195' ' ' VAL . 7.9 t30 -164.42 71.18 1.6 Allowed Pre-proline 0 CA--C 1.531 0.224 0 O-C-N 122.253 -0.279 . . . . 13.52 111.068 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -87.43 -39.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.579 2.186 . . . . 14.9 112.878 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 11.7 t -97.78 2.34 49.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.079 -0.509 . . . . 17.54 109.77 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' VAL . . . . . 0.648 ' HA ' ' ND2' ' B' ' 192' ' ' ASN . 64.6 t 63.46 100.66 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 115.196 -0.911 . . . . 18.06 110.507 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.31 90.06 7.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.522 -0.763 . . . . 21.28 111.051 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.7 7.72 13.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 21.53 110.18 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 11.9 p -126.29 -56.42 1.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.405 -0.816 . . . . 23.03 111.286 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -104.63 59.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.658 -0.782 . . . . 24.72 113.087 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.414 -0.803 . . . . 27.31 109.873 176.008 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.003 -0.369 . . . . 29.42 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -134.76 123.97 24.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.444 -0.344 . . . . 26.59 110.573 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -82.7 74.89 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.173 0.511 . . . . 25.53 109.918 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -70.0 141.38 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.331 -0.849 . . . . 23.29 110.784 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -89.25 91.36 8.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 21.2 110.497 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 6' ' ' ARG . 1.4 ptm85 -116.86 0.13 12.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.688 -0.687 . . . . 20.05 109.323 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -109.5 119.44 39.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.6 -0.727 . . . . 16.73 109.437 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -85.26 175.9 8.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 16.22 110.315 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 71.84 -55.6 0.66 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.997 0.811 . . . . 13.24 112.096 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 -120.86 145.99 47.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 14.9 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.71 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 9.66 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.652 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 7.46 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.616 HG21 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 6.87 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 6.78 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.44 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG3' HD11 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 10.95 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 15.91 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.09 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.65 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 12.38 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 75.0 m80 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.05 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.631 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 10.23 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 5.52 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 3.98 111.522 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 11.28 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.783 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' OE2' ' HD3' ' A' ' 29' ' ' ARG . 17.2 mm-40 67.43 -71.42 0.1 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 66.6 mtt -142.2 142.73 25.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 12.85 111.438 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 74.5 Cg_endo -95.65 148.7 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.325 2.683 . . . . 13.07 112.125 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 39' ' ' LYS . 11.1 tp10 -91.71 62.68 4.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.103 -0.703 . . . . 14.04 109.103 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.21 80.57 0.22 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.203 -0.908 . . . . 15.24 110.529 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.23 -73.86 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.233 -0.894 . . . . 14.64 111.527 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 ' H ' ' A' ' 40' ' ' SER . 8.5 p -79.07 163.11 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.256 -0.646 . . . . 12.42 109.256 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -118.67 21.76 12.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.684 -0.635 . . . . 10.84 110.541 175.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.5 m -157.84 103.66 1.9 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.932 0.396 . . . . 9.63 110.928 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -95.9 59.32 2.0 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.739 0.781 . . . . 9.56 109.188 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.96 112.64 20.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 8.3 111.256 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.94 26.51 7.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 8.55 109.759 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.5 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.01 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.6 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 5.62 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.03 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.15 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.846 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 6.72 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 5.99 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.39 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 7.73 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.634 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.32 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.57 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.06 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.7 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.21 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.63 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.58 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.79 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.49 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.26 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.1 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 5.97 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.38 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 7.75 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 7.82 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.11 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 8.81 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 8.87 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 5.87 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.14 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.17 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.846 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.6 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.05 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.15 110.557 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.46 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -56.5 -26.08 53.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.04 112.209 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 58.83 97.46 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.184 0 CA-C-O 121.458 0.647 . . . . 5.09 111.078 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.07 -153.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.694 2.263 . . . . 6.48 110.9 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.3 m -79.14 72.74 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.274 0.559 . . . . 7.32 109.573 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.87 86.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 6.13 109.99 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -117.49 91.5 3.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.594 -0.73 . . . . 9.68 110.315 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.76 130.32 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.111 -0.495 . . . . 8.54 110.329 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 102.4 9.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.998 0.428 . . . . 9.88 110.077 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.89 63.45 4.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.875 -0.679 . . . . 9.93 112.701 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 12.88 110.284 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.253 -0.647 . . . . 13.85 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -161.76 94.14 0.93 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.197 -0.91 . . . . 12.37 108.747 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -94.76 92.78 7.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 12.02 110.575 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 29.8 p -97.36 -42.01 7.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 10.42 111.088 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.04 155.59 18.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 8.13 111.18 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -123.34 106.45 10.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.762 -0.829 . . . . 10.78 108.762 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -70.44 104.84 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.165 -0.47 . . . . 8.36 112.205 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 52.03 87.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.108 -0.951 . . . . 8.99 111.938 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.88 -8.06 44.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.28 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.12 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 5.93 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 4.62 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.32 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.626 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.43 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 3.93 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.3 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 5.76 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.08 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 8.78 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.27 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.06 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.68 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 4.71 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.03 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.48 111.686 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 2.83 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.33 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.34 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 -107.83 134.43 50.79 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 64.3 mtt -105.34 111.69 64.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.767 -0.651 . . . . 9.64 109.488 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 -30.47 66.19 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.704 2.269 . . . . 9.8 112.359 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -171.5 111.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 12.27 109.399 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.6 -114.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.618 -0.264 . . . . 11.49 110.966 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.39 -30.82 60.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.7 0.762 . . . . 11.38 109.648 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' B' ' 139' ' ' LYS . 13.1 p -80.45 140.84 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.63 -1.168 . . . . 9.65 109.01 173.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.611 ' HG2' HG22 ' B' ' 138' ' ' VAL . 31.6 mmmt 66.23 -69.48 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.722 0.639 . . . . 11.11 111.154 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m 63.88 39.73 7.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.426 0.69 . . . . 8.66 110.234 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 78.6 p 52.44 18.46 0.94 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.861 0.865 . . . . 9.44 111.993 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 38' ' ' VAL . . . 59.17 23.76 12.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.185 -0.461 . . . . 8.63 111.015 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.65 100.51 8.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.103 -0.498 . . . . 9.61 110.422 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.424 ' HD2' ' OG ' ' A' ' 40' ' ' SER . 17.2 ptpt -165.06 152.54 11.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.637 -0.711 . . . . 8.97 109.324 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.783 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 7.97 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 96.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 9.5 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.483 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 10.78 111.098 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.652 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.24 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 13.51 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.483 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.75 109.649 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.03 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.95 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.58 ' HB2' HG21 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 6.89 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.24 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 8.35 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 12.73 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 10.48 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.575 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 10.82 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 11.91 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 12.55 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.47 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.15 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.56 106.594 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.74 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.14 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 15.89 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 11.57 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 9.65 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.46 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.456 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.24 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 7.89 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 11.87 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.607 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLU . . . . . 0.607 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -104.22 64.96 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 4.1 p-10 -53.73 118.53 15.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.021 . . . . 13.52 111.808 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' ' 192' ' ' ASN . 30.2 Cg_endo -66.24 -28.68 47.62 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.667 2.245 . . . . 14.9 111.064 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 8.2 p -89.89 86.35 6.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.659 -0.701 . . . . 17.54 110.446 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.57 -27.82 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.498 0.665 . . . . 18.06 109.248 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -76.69 85.04 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.938 -1.028 . . . . 21.28 109.852 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.57 104.5 7.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.831 -0.622 . . . . 21.53 109.521 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 21.9 t -84.1 75.95 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.133 0.492 . . . . 23.03 111.353 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.14 -31.13 61.96 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.938 -1.665 . . . . 24.72 108.938 167.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 58.9 t80 . . . . . 0 C--O 1.243 0.73 0 CA-C-N 113.928 -1.136 . . . . 27.31 108.625 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.826 0.346 . . . . 29.42 110.309 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -77.17 34.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.944 0.72 . . . . 26.59 112.944 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -109.67 -29.73 8.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.27 -0.641 . . . . 25.53 109.27 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -75.98 -50.09 15.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.26 -0.644 . . . . 23.29 109.26 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -109.01 132.06 54.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.236 -0.893 . . . . 21.2 109.711 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -86.79 -47.41 9.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.267 0.556 . . . . 20.05 109.737 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -95.46 178.61 5.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.409 -0.814 . . . . 16.73 110.359 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -124.39 132.39 53.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.613 -0.884 . . . . 16.22 108.613 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -100.34 123.33 44.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.13 -0.486 . . . . 13.24 111.579 -166.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 -122.31 150.3 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 10.33 110.048 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 14.9 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.659 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.71 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 9.66 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 7.46 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.796 HG21 HD13 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 6.87 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 6.78 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.44 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 10.95 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 15.91 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.09 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.65 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 12.38 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 72.4 m80 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.05 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 10.23 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 5.52 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 3.98 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 11.28 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 -158.94 129.87 6.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.464 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 61.0 mtt -137.23 137.2 22.0 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.555 -0.748 . . . . 12.85 109.744 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 34.1 Cg_exo -60.17 134.78 58.03 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.271 2.647 . . . . 13.07 112.937 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 73.95 -47.16 0.64 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.288 1.035 . . . . 14.04 112.134 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.82 74.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 15.24 110.91 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 146' ' ' GLN . . . -126.22 -63.98 1.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.093 -0.503 . . . . 14.64 111.105 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' B' ' 142' ' ' ALA . 14.1 m -91.48 145.23 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.537 -0.301 . . . . 12.42 110.401 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -97.34 175.56 6.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.027 0.441 . . . . 10.84 110.513 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 t -129.82 80.99 1.99 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.712 -1.218 . . . . 9.63 107.712 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 157.12 45.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 9.56 110.935 -171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' B' ' 137' ' ' ALA . . . -120.92 -14.91 8.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.628 -0.715 . . . . 8.3 110.237 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 6.8 m-20 73.05 -53.17 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.071 0.857 . . . . 8.55 111.139 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.5 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.01 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.6 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 5.62 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.03 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.15 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 6.72 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 5.99 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.39 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 7.73 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.32 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.57 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.06 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.7 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.21 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.631 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.63 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.58 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.769 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.79 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.49 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.26 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.1 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 5.97 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.38 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.718 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 7.75 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 7.82 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.11 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 8.81 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 8.87 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 5.87 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.718 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.14 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.17 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.6 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.05 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.15 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.46 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.0 -31.41 50.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.04 110.304 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' OD1' ' HB ' ' A' ' 95' ' ' VAL . 3.5 t-20 59.72 81.12 0.25 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.979 . . . . 5.09 112.412 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 -57.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.628 2.219 . . . . 6.48 111.452 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.4 m -101.17 112.19 24.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.854 -0.612 . . . . 7.32 110.368 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' HB ' ' OD1' ' A' ' 92' ' ' ASN . 5.2 p -122.89 118.8 56.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.131 -0.486 . . . . 6.13 110.925 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 70.97 10.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.539 0.685 . . . . 9.68 110.134 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -165.2 139.81 5.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.295 -0.866 . . . . 8.54 109.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -114.03 18.41 17.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.332 0.586 . . . . 9.88 110.317 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.25 141.06 3.02 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.426 -0.807 . . . . 9.93 111.662 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 12.88 110.641 179.37 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.377 0.608 . . . . 13.85 110.797 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 57.2 p -133.65 -44.6 0.82 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 12.37 110.34 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -135.02 73.66 1.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.32 0.581 . . . . 12.02 110.157 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.7 t -100.16 -12.53 19.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 10.42 108.593 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -80.41 109.94 15.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.931 . . . . 8.13 110.154 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.63 -39.27 24.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.764 -0.653 . . . . 10.78 111.02 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -87.37 113.84 23.45 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.909 -0.587 . . . . 8.36 111.395 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' B' ' 108' ' ' LYS . 20.9 ptmt -85.28 -17.47 36.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.413 -0.958 . . . . 8.99 108.413 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.83 172.42 8.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.522 -1.217 . . . . 8.32 109.507 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.28 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.12 108.136 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.712 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 5.93 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.478 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 4.62 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.51 HD12 HG13 ' A' ' 89' ' ' ILE . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.32 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.43 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 3.93 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.3 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 5.76 111.123 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.08 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' B' ' 121' ' ' LYS . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 8.78 109.322 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.27 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.06 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.68 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 4.71 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.03 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.48 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 2.83 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.33 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.34 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.561 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.67 88.79 2.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.5 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 23.6 mmt -111.84 147.49 36.96 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.165 -0.47 . . . . 9.64 110.469 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.97 138.57 83.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.974 2.449 . . . . 9.8 111.659 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 71.11 -18.43 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.492 0.717 . . . . 12.27 112.342 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.28 -63.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.562 . . . . 11.49 110.149 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.445 ' O ' ' HB1' ' A' ' 42' ' ' ALA . . . -86.9 -62.19 1.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.783 -0.821 . . . . 11.38 108.783 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.31 103.09 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 9.65 110.115 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -125.31 13.48 8.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.442 0.639 . . . . 11.11 110.163 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 23.8 t -161.49 -174.3 4.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.275 -1.009 . . . . 8.66 108.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 48.6 m -154.58 -69.28 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 9.44 110.087 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . . . -110.81 145.74 37.65 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.835 -0.62 . . . . 8.63 111.191 -175.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.73 -32.63 8.33 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.492 -0.929 . . . . 9.61 108.492 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -121.47 156.18 33.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.637 -1.165 . . . . 8.97 109.218 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 7.97 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.419 ' HB2' ' CB ' ' A' ' 37' ' ' ALA . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 9.5 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 10.78 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.405 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.24 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 13.51 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.75 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.03 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 9.95 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 6.89 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.24 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 8.35 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 12.73 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.489 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 10.48 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.61 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 10.82 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.47 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.737 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 11.91 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 12.55 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.47 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.15 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.739 ' HD3' HD11 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.56 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.634 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ASN . . . . . 0.718 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.74 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.14 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 15.89 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 11.57 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.718 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 9.65 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.46 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.24 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.739 HD11 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 7.89 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 11.87 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.8 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' ASN . . . . . 0.483 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 -79.2 -17.5 54.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -126.9 74.1 76.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.0 -0.741 . . . . 13.52 109.0 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.0 88.85 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.11 2.54 . . . . 14.9 112.965 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.403 HG22 ' HE2' ' B' ' 196' ' ' LYS . 3.5 m 60.79 27.61 17.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.59 -0.732 . . . . 17.54 110.935 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.95 111.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 18.06 109.87 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 196' ' ' LYS . . . . . 0.403 ' HE2' HG22 ' B' ' 194' ' ' THR . 72.5 mmtt -74.05 102.2 4.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 21.28 109.952 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.4 115.92 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.029 -0.532 . . . . 21.53 110.99 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 56.6 m -156.09 -46.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.998 -0.546 . . . . 23.03 110.483 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.43 -96.72 0.35 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.04 -0.824 . . . . 24.72 111.04 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.409 -0.805 . . . . 27.31 109.072 173.296 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.669 0.271 . . . . 29.42 110.673 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -80.42 104.76 11.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.62 -0.511 . . . . 26.59 109.62 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -90.5 -48.92 6.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.714 -0.675 . . . . 25.53 110.312 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 t -109.47 116.37 31.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.871 -0.604 . . . . 23.29 110.013 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.37 169.18 13.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.922 -0.399 . . . . 21.2 109.922 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 57.27 -114.89 0.84 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.831 0.452 . . . . 20.05 111.517 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 13.1 pt20 -122.47 156.63 33.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.314 . . . . 16.73 110.909 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -103.57 -64.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.914 -0.772 . . . . 16.22 108.914 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 7' ' ' GLN . 7.5 mm-40 58.15 -160.89 0.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.952 -1.022 . . . . 13.24 112.35 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -119.93 112.06 18.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.675 -0.693 . . . . 10.33 109.207 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 14.9 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.71 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 9.66 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 7.46 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 HD21 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 6.87 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' B' ' 166' ' ' TYR . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 6.78 109.939 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.44 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.848 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 10.95 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 15.91 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.09 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.848 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.65 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 12.38 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.05 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 10.23 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 5.52 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 3.98 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 11.28 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.03 147.94 9.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.421 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 55.7 ttp -140.83 107.65 6.4 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.379 -0.6 . . . . 12.85 109.379 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 19.6 Cg_endo -60.98 135.45 59.27 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.228 1.952 . . . . 13.07 110.776 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 11.9 mm-40 -53.12 -49.03 67.36 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.498 0.499 . . . . 14.04 110.503 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.76 92.29 0.94 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.571 -0.741 . . . . 15.24 109.593 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.72 -54.77 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.959 0.787 . . . . 14.64 110.606 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.24 155.59 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.261 -1.014 . . . . 12.42 108.261 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 43.6 tttp -84.34 79.32 9.59 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.275 -0.639 . . . . 10.84 109.275 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -89.15 115.66 26.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 9.63 111.483 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' B' ' 140' ' ' SER . 22.3 m -156.6 129.53 7.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.071 -0.513 . . . . 9.56 110.61 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' B' ' 139' ' ' LYS . . . -152.73 -85.64 0.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 8.3 109.722 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -82.55 94.18 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.232 -1.025 . . . . 8.55 108.232 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.5 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.01 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.593 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.6 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 5.62 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.03 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.15 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 6.72 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 5.99 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.39 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 7.73 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.32 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.57 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.06 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.7 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HG ' HG21 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.21 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.646 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.63 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.58 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.79 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.49 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.26 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.1 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 5.97 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.38 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 7.75 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 7.82 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.11 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 8.81 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 8.87 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 5.87 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.14 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.925 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.17 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.6 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.784 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.05 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.15 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.46 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -122.3 30.89 6.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.04 110.338 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.74 121.1 65.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 5.09 110.954 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 94' ' ' THR . 13.0 Cg_exo -69.71 110.44 2.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.844 2.363 . . . . 6.48 111.599 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 93' ' ' PRO . 98.2 m 71.56 91.72 0.09 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.742 0.651 . . . . 7.32 110.831 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.37 151.43 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 6.13 110.786 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.79 102.6 10.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 9.68 110.907 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.73 -70.74 0.67 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 8.54 109.527 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 m 70.18 -52.55 0.64 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.551 0.74 . . . . 9.88 112.381 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.6 -26.82 1.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.643 -0.583 . . . . 9.93 111.643 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 123.178 0.591 . . . . 12.88 111.333 176.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.935 0.397 . . . . 13.85 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -79.18 -9.4 59.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.056 0.455 . . . . 12.37 111.151 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 103' ' ' ARG . 25.7 ttp180 -143.32 102.16 3.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 12.02 110.34 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -87.82 126.93 35.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.837 -0.62 . . . . 10.42 110.017 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -93.4 136.47 33.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 8.13 110.596 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -89.26 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 10.78 109.698 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -76.86 111.14 12.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.186 0.517 . . . . 8.36 111.949 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.53 -32.32 22.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.471 -0.786 . . . . 8.99 109.162 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.57 147.89 27.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.426 -0.806 . . . . 8.32 110.432 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.431 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.28 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.43 ' HD3' ' OE1' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.12 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 5.93 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 4.62 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.72 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.32 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.43 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 3.93 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.3 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 5.76 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.48 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.08 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 8.78 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.27 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.48 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.06 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.68 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 4.71 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.761 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.03 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.784 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.48 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 2.83 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.33 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.34 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 111' ' ' LYS . 43.1 tt0 -69.31 113.19 6.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 78.3 mtp -110.89 111.39 56.51 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.757 -0.656 . . . . 9.64 109.289 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 126.14 13.22 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.711 2.274 . . . . 9.8 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' B' ' 138' ' ' VAL . 32.1 mt-10 -89.26 12.53 15.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 12.27 109.41 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' B' ' 137' ' ' ALA . . . -77.32 101.34 6.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.956 -1.02 . . . . 11.49 109.485 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' ' 136' ' ' ALA . . . 79.28 -40.07 0.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.268 0.98 . . . . 11.38 110.606 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' B' ' 135' ' ' GLU . 92.5 t -97.3 101.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.363 0.602 . . . . 9.65 110.991 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 20.6 pttp -156.71 33.55 0.31 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.137 -1.06 . . . . 11.11 108.137 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 41' ' ' THR . 6.7 p -167.23 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.245 -1.343 . . . . 8.66 110.203 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m 60.2 58.58 2.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.717 0.77 . . . . 9.44 110.558 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 143' ' ' ASN . . . -122.92 158.38 30.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.276 -0.875 . . . . 8.63 109.173 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 142' ' ' ALA . 28.2 t-20 78.32 -38.82 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.085 0.554 . . . . 9.61 111.362 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' B' ' 142' ' ' ALA . 2.7 mptp? -83.91 136.84 33.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.971 -0.751 . . . . 8.97 108.971 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 7.97 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 9.5 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 10.78 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.416 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.24 110.703 -171.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 13.51 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.75 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.03 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 9.95 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 6.89 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.24 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 8.35 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 12.73 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.616 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 10.48 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.618 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 10.82 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.446 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.446 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 11.91 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 12.55 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 171' ' ' GLU . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.47 110.339 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.15 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.56 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.74 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.14 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 15.89 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 11.57 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 9.65 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.615 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.46 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.24 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 7.89 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 11.87 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.488 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLU . . . . . 0.488 ' N ' HD12 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -113.82 82.41 1.69 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -64.18 124.27 84.96 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.503 -0.771 . . . . 13.52 110.839 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.79 -28.59 59.41 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 14.9 112.178 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 18.4 m -100.55 98.03 8.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 17.54 110.085 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.24 135.88 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.003 -0.544 . . . . 18.06 110.471 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -100.8 107.97 19.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 21.28 110.497 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -153.92 133.49 12.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 21.53 109.743 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 12.8 t -111.93 91.68 3.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 23.03 110.144 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.46 62.39 0.65 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.269 -0.733 . . . . 24.72 111.269 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.677 -0.678 . . . . 27.31 110.317 -175.172 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.583 0.23 . . . . 29.42 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -68.84 -58.96 3.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.865 0.364 . . . . 26.59 110.737 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -108.18 104.0 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.558 -0.534 . . . . 25.53 109.558 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -98.83 173.16 7.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.036 -0.529 . . . . 23.29 110.039 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.43 123.44 25.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 21.2 109.803 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.64 -6.69 59.38 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.838 -0.619 . . . . 20.05 110.644 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -94.76 100.28 12.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.494 -0.775 . . . . 16.73 110.515 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 35.3 mtpt -110.88 107.75 17.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.569 . . . . 16.22 110.858 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -136.69 146.26 45.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.234 -0.654 . . . . 13.24 109.234 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.31 119.68 27.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.481 -0.327 . . . . 10.33 110.694 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 14.9 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 30' ' ' ILE . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.71 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 9.66 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 7.46 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 6.87 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 6.78 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.44 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.706 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 10.95 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 15.91 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.09 112.43 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.65 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 12.38 113.36 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.05 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 10.23 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 5.52 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 3.98 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 11.28 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 9.3 tp10 -90.0 125.26 35.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.499 ' SD ' ' HD2' ' A' ' 34' ' ' PRO . 48.9 tpp -150.22 128.05 5.74 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.109 -0.496 . . . . 12.85 110.094 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 29.3 Cg_endo -62.57 167.07 12.15 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.685 2.257 . . . . 13.07 111.973 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.6 -31.57 69.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.398 0.618 . . . . 14.04 109.441 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.89 -59.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.961 -1.018 . . . . 15.24 108.907 172.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.92 -33.83 2.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 14.64 109.69 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.663 HG23 HG23 ' B' ' 141' ' ' THR . 10.7 p -122.49 157.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.758 -0.656 . . . . 12.42 109.478 175.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 34' ' ' PRO . 28.1 ttmt -102.56 -51.57 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.928 0.394 . . . . 10.84 110.316 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 p -137.69 145.76 42.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 9.63 110.891 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.515 HG22 ' HE3' ' B' ' 139' ' ' LYS . 2.8 p -118.51 89.23 3.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.56 0.695 . . . . 9.56 110.198 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' B' ' 140' ' ' SER . . . -95.09 121.6 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.564 -0.743 . . . . 8.3 111.643 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' B' ' 138' ' ' VAL . 43.4 t30 -177.42 -88.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.008 0.818 . . . . 8.55 109.568 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.5 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.01 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.6 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 5.62 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.03 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.546 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.15 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 6.72 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 5.99 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.39 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 7.73 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.32 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.57 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.06 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.7 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.21 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.749 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.63 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.58 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.79 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.49 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.26 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.1 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 5.97 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.38 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 7.75 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 7.82 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.11 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 8.81 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 8.87 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 5.87 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.729 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.14 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.17 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.6 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.05 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.15 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 50' ' ' PHE . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.714 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.46 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -87.77 10.3 18.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.04 111.739 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.56 129.46 93.68 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 5.09 110.431 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.68 164.65 2.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.275 2.65 . . . . 6.48 112.855 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 94' ' ' THR . 9.3 t -65.4 105.72 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.861 0.838 . . . . 7.32 111.358 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.58 115.9 50.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.506 -0.77 . . . . 6.13 110.156 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.7 76.78 9.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.309 -0.405 . . . . 9.68 110.213 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 69.21 -59.1 0.49 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.713 0.805 . . . . 8.54 111.571 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 t -145.0 -40.78 0.24 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.537 -0.542 . . . . 9.88 109.537 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.82 -169.88 36.59 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.477 -0.649 . . . . 9.93 111.477 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.153 0.501 . . . . 12.88 110.123 -179.663 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.339 0.114 . . . . 13.85 110.715 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m 75.19 -59.24 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.453 0.701 . . . . 12.37 112.168 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.94 126.01 50.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.944 0.402 . . . . 12.02 111.02 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 40.5 m -145.71 111.88 5.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.828 -0.624 . . . . 10.42 110.119 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -76.75 109.77 10.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 8.13 110.255 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -90.74 -6.69 54.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.076 -0.511 . . . . 10.78 112.089 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -122.26 95.18 4.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.48 0.657 . . . . 8.36 111.387 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -100.35 78.17 2.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 8.99 109.988 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -169.29 129.1 1.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.929 -0.578 . . . . 8.32 109.817 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.28 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.12 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 5.93 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 4.62 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.32 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 66' ' ' TYR . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.43 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 3.93 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.3 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.579 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 5.76 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.08 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 8.78 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.27 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.06 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.68 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 4.71 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.03 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.48 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.546 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 2.83 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.33 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.46 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.34 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -96.69 127.44 42.67 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.598 ' HB2' HE21 ' A' ' 46' ' ' GLN . 23.5 ttt -123.51 90.28 50.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.73 0.3 . . . . 9.64 111.117 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -101.53 -173.68 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.422 2.748 . . . . 9.8 112.156 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.47 ' OE2' ' HG2' ' B' ' 139' ' ' LYS . 24.2 mm-40 61.94 29.36 17.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 12.27 112.439 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.52 94.46 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.858 -0.337 . . . . 11.49 110.821 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 71.58 -58.81 0.57 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.93 0.769 . . . . 11.38 111.27 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 43' ' ' ASN . 32.6 t -107.86 146.77 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.519 -0.549 . . . . 9.65 109.519 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HE3' HG22 ' A' ' 41' ' ' THR . 19.6 tptm 177.59 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.516 . . . . 11.11 109.987 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.498 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 19.6 m -94.45 88.48 5.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.922 -0.581 . . . . 8.66 109.732 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' THR . . . . . 0.663 HG23 HG23 ' A' ' 38' ' ' VAL . 53.8 m -64.03 -32.73 74.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.84 -0.618 . . . . 9.44 110.789 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.13 165.57 12.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 8.63 109.475 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.481 ' OD1' ' HG3' ' B' ' 144' ' ' LYS . 28.8 t-20 -158.56 -68.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.83 0.348 . . . . 9.61 110.699 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' B' ' 143' ' ' ASN . 36.8 mtmm -123.1 130.35 52.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.291 -0.413 . . . . 8.97 110.149 177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.573 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 7.97 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 9.5 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.474 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 10.78 109.917 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.662 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.24 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 13.51 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.474 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.75 110.312 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.03 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 9.95 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 6.89 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.24 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.476 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 8.35 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 12.73 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.735 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 10.48 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 10.82 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.973 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 11.91 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 12.55 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.47 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.15 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.56 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ASN . . . . . 0.409 HD22 ' HE2' ' B' ' 182' ' ' PHE . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.74 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.14 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 15.89 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 11.57 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 9.65 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.46 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.24 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 7.89 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 11.87 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.973 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -73.65 -8.61 56.68 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.52 HD22 HG22 ' B' ' 195' ' ' VAL . 2.7 p-10 43.5 97.03 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.798 1.239 . . . . 13.52 114.066 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' B' ' 192' ' ' ASN . 42.0 Cg_endo -67.74 161.86 41.96 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.753 2.302 . . . . 14.9 111.674 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 41.9 m 70.66 -58.92 0.54 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.883 0.473 . . . . 17.54 111.633 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' VAL . . . . . 0.52 HG22 HD22 ' B' ' 192' ' ' ASN . 22.5 t 66.04 86.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.116 0.567 . . . . 18.06 110.577 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -96.36 114.45 26.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.772 -0.649 . . . . 21.28 109.71 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 64.57 73.66 0.42 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.606 0.717 . . . . 21.53 110.98 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 2.2 p -76.01 93.59 3.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.568 -0.742 . . . . 23.03 111.28 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -159.88 28.46 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.045 -0.597 . . . . 24.72 111.928 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.715 -0.659 . . . . 27.31 110.137 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.766 -0.457 . . . . 29.42 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -86.47 -44.74 11.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 26.59 109.44 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 61.23 -172.27 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.574 -0.739 . . . . 25.53 112.408 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m 59.58 22.06 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.04 -0.982 . . . . 23.29 112.157 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -86.03 96.34 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.019 -0.734 . . . . 21.2 109.019 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -100.4 -23.6 14.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.34 -0.391 . . . . 20.05 111.092 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -78.13 94.66 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.481 . . . . 16.73 109.848 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -143.56 -49.61 0.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.19 -0.914 . . . . 16.22 109.391 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -94.18 161.11 14.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.235 -0.893 . . . . 13.24 110.082 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -117.29 155.15 30.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 10.33 109.885 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 14.9 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.71 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.678 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 9.66 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 7.46 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 6.87 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 6.78 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.44 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.657 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 10.95 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 15.91 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.09 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.65 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 12.38 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.05 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 10.23 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 5.52 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 3.98 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 11.28 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.678 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.589 ' N ' HD13 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.99 123.34 37.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 47.1 tpp -140.87 101.03 6.47 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.929 -0.578 . . . . 12.85 110.28 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.802 ' CA ' ' HA ' ' B' ' 142' ' ' ALA . 47.8 Cg_exo -37.79 119.38 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 124.663 3.575 . . . . 13.07 115.161 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.858 ' HA ' ' HB ' ' B' ' 141' ' ' THR . 13.7 tt0 174.33 11.42 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.86 0.725 . . . . 14.04 112.166 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' B' ' 144' ' ' LYS . . . -86.84 -86.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.2 0.815 . . . . 15.24 113.2 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' B' ' 140' ' ' SER . . . -113.86 -53.18 2.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.295 0.48 . . . . 14.64 112.295 -171.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' B' ' 142' ' ' ALA . 12.0 p -122.21 143.38 35.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 N-CA-C 109.405 -0.591 . . . . 12.42 109.405 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.812 ' HD2' ' HB2' ' B' ' 142' ' ' ALA . 21.5 tptp -117.12 -22.95 8.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 10.84 110.181 170.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.703 ' HA ' ' HG2' ' B' ' 135' ' ' GLU . 22.1 m 64.75 19.73 11.92 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.651 -0.704 . . . . 9.63 110.518 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.73 148.14 30.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 9.56 109.99 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.8 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.521 -0.309 . . . . 8.3 110.486 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.54 20.29 11.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.102 0.477 . . . . 8.55 110.923 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.5 109.624 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CE2' ' HD2' ' B' ' 110' ' ' TYR . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.01 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.6 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 5.62 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.03 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.15 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 6.72 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 5.99 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.39 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 7.73 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.32 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.57 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.06 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.7 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.21 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.63 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HG11 ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.58 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.673 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.79 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.49 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.26 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.1 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 5.97 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.951 ' HB3' HD13 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.38 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 7.75 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 7.82 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.11 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 8.81 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 8.87 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 5.87 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.14 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.17 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' HD13 ' A' ' 89' ' ' ILE . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.6 111.993 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.05 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.15 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 HD11 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.46 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.544 ' OD1' ' HA ' ' A' ' 88' ' ' GLU . 1.4 p-10 -93.65 0.96 56.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.04 111.102 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.1 t30 -70.15 113.07 15.03 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.472 -0.331 . . . . 5.09 111.022 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -84.44 -30.22 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.988 2.459 . . . . 6.48 112.893 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 t -85.19 94.62 8.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.889 0.852 . . . . 7.32 111.326 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.97 94.94 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.315 -0.857 . . . . 6.13 108.947 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.09 88.28 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 9.68 111.02 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.02 175.12 6.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.809 -0.632 . . . . 8.54 110.304 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -60.45 -29.33 68.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.138 0.494 . . . . 9.88 111.146 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.98 85.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.815 -0.707 . . . . 9.93 111.976 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.845 0.355 . . . . 12.88 110.058 179.099 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.686 0.279 . . . . 13.85 110.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -89.6 146.08 24.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.428 -0.582 . . . . 12.37 109.428 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 68.17 86.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.918 0.761 . . . . 12.02 110.284 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 69.8 p -93.86 120.58 34.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.634 -0.712 . . . . 10.42 110.203 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -74.38 91.42 2.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 8.13 110.215 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -121.63 -26.44 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.732 -0.667 . . . . 10.78 110.591 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.76 112.39 18.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 8.36 110.181 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -96.06 -71.91 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.334 0.588 . . . . 8.99 110.242 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -106.75 139.93 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 8.32 109.323 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.598 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.28 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.12 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.46 ' HA ' HG23 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 5.93 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 4.62 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.533 HD11 HD11 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.32 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.595 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.43 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 3.93 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.3 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 5.76 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.595 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.08 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 8.78 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.27 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.06 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.68 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 4.71 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.03 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.48 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.33 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.34 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.75 147.93 25.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 91.7 mtp -133.27 134.69 24.35 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 9.64 109.586 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 4.4 Cg_exo -78.47 -70.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.729 2.286 . . . . 9.8 111.998 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -165.14 -149.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 12.27 109.991 177.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' B' ' 135' ' ' GLU . . . 71.53 13.15 6.45 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.731 0.644 . . . . 11.49 111.701 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -178.51 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 11.38 109.87 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 139' ' ' LYS . 4.3 p -91.22 117.89 35.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.13 -0.941 . . . . 9.65 110.757 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.42 ' HG2' HG22 ' B' ' 138' ' ' VAL . 31.8 mmmt 62.54 -78.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.575 -0.739 . . . . 11.11 111.211 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 54.2 m 54.8 47.59 22.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.215 0.531 . . . . 8.66 111.283 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' THR . . . . . 0.858 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 19.4 p -116.78 85.91 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.11 0.781 . . . . 9.44 113.11 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.812 ' HB2' ' HD2' ' A' ' 39' ' ' LYS . . . -148.1 166.68 27.1 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.144 -0.347 . . . . 8.63 111.262 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.466 ' N ' ' HA ' ' A' ' 34' ' ' PRO . 4.5 t30 63.95 37.4 9.44 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.825 0.85 . . . . 9.61 112.319 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt -89.61 147.08 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.383 -0.527 . . . . 8.97 109.644 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 7.97 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 33' ' ' MET . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 9.5 108.494 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD13 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 10.78 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.472 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.24 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.737 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 13.51 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.75 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.03 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.641 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 6.89 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.24 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 8.35 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 12.73 112.052 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.618 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 10.48 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 10.82 114.302 -172.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.526 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 11.91 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 12.55 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.47 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.15 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.56 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.74 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.14 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 15.89 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 11.57 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 9.65 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.46 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.737 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.24 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.43 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 7.89 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 11.87 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD12 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -124.85 83.76 2.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -82.03 126.2 75.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.428 -0.582 . . . . 13.52 109.428 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 100.83 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.698 2.265 . . . . 14.9 112.385 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 60.2 m 63.75 97.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.72 . . . . 17.54 111.805 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.85 87.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.03 0.919 . . . . 18.06 110.692 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -79.14 77.46 5.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.665 -0.698 . . . . 21.28 110.216 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -162.28 -36.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 21.53 111.004 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 15.7 m -83.79 5.7 24.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.137 -0.483 . . . . 23.03 111.521 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 81.1 -96.77 1.73 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.872 -0.68 . . . . 24.72 111.887 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.575 -0.726 . . . . 27.31 110.424 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.442 -0.207 . . . . 29.42 110.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 m -87.85 -45.05 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.414 -0.587 . . . . 26.59 109.414 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -141.99 -163.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 25.53 109.228 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m 70.26 91.9 0.09 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.58 0.705 . . . . 23.29 110.241 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.91 175.09 10.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.209 -0.905 . . . . 21.2 110.907 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 71.0 mtt180 -127.22 79.22 1.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.007 -0.542 . . . . 20.05 109.789 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -108.34 95.93 6.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.792 -0.64 . . . . 16.73 110.895 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.744 ' HB3' HG21 ' A' ' 38' ' ' VAL . 65.4 tttp -175.83 126.62 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 16.22 110.894 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -154.73 -67.75 0.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.57 -0.9 . . . . 13.24 108.57 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.66 151.52 42.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 14.9 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.909 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.71 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 9.66 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 7.46 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 6.87 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 6.78 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.44 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.603 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 10.95 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 15.91 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.09 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.603 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.65 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 12.38 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.05 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.646 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 10.23 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.866 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 5.52 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 3.98 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 11.28 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 -129.87 160.02 34.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 61.0 mtt -97.77 151.79 37.78 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.473 -0.785 . . . . 12.85 109.189 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.35 162.23 15.04 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.64 2.227 . . . . 13.07 112.118 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.99 77.7 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 14.04 110.784 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.79 -48.2 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.19 -0.459 . . . . 15.24 110.658 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.11 -21.17 2.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.595 . . . . 14.64 110.793 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.781 HG22 ' HG2' ' A' ' 39' ' ' LYS . 14.4 p -67.19 134.91 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 12.42 111.099 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 38' ' ' VAL . 13.1 mmmm 70.2 -43.82 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.575 0.75 . . . . 10.84 111.224 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t 66.0 -154.83 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.524 0.73 . . . . 9.63 110.758 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -61.16 -20.76 63.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.672 0.389 . . . . 9.56 111.716 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 71.52 -53.36 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.465 0.706 . . . . 8.3 110.922 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -82.44 100.59 10.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 8.55 110.376 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.5 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.01 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.6 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 5.62 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.03 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.15 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 6.72 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 5.99 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.39 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 7.73 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.32 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.57 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.06 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.7 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.21 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.63 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.612 ' HA ' HG12 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.58 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.587 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.79 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' B' ' 108' ' ' LYS . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.542 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.49 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.26 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.1 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 5.97 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.38 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 7.75 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 7.82 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.11 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 8.81 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 8.87 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 5.87 113.107 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.14 110.738 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.17 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.6 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.05 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.15 110.033 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.803 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.46 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' N ' HD13 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -105.03 25.31 10.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.04 110.459 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 88' ' ' GLU . 18.8 t-20 -64.0 115.96 23.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 5.09 111.087 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.48 -18.31 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.726 2.284 . . . . 6.48 113.057 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.7 t -151.84 97.66 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.469 0.652 . . . . 7.32 111.225 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.0 123.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.731 -0.668 . . . . 6.13 110.35 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 48.2 tptt -87.48 80.96 7.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.387 0.613 . . . . 9.68 110.328 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.84 115.33 1.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.193 -0.912 . . . . 8.54 110.074 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 p -80.87 55.55 2.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.142 0.496 . . . . 9.88 110.656 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.97 -168.07 21.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.625 -0.716 . . . . 9.93 112.82 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.618 0.723 . . . . 12.88 110.714 -176.132 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 13.85 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m 56.36 -168.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.647 0.592 . . . . 12.37 111.619 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -93.44 127.77 39.22 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.659 -0.497 . . . . 12.02 109.659 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.5 t -78.96 -27.6 43.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 10.42 110.194 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -79.05 110.8 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.32 0.581 . . . . 8.13 109.953 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -79.94 90.96 5.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.638 -0.71 . . . . 10.78 109.909 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -81.5 107.58 14.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 8.36 110.614 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.414 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -96.91 -62.72 1.22 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.692 -0.485 . . . . 8.99 109.692 175.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 58.17 96.78 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.142 -0.935 . . . . 8.32 111.124 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.28 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.12 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 5.93 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 4.62 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.803 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.32 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.43 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 3.93 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.3 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 5.76 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.504 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.08 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 8.78 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.27 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.06 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.68 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 4.71 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.03 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.48 112.532 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.453 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 2.83 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.604 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.33 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.34 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.29 138.7 33.5 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 25.2 ptt? -105.3 139.94 20.64 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.703 -0.48 . . . . 9.64 109.703 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 2.9 Cg_exo -73.82 100.3 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.645 2.23 . . . . 9.8 111.787 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -86.39 29.55 0.76 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.258 -0.428 . . . . 12.27 111.298 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.56 -59.25 5.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 11.49 110.95 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.89 -45.22 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 11.38 110.296 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' B' ' 142' ' ' ALA . 5.5 p -96.08 163.06 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.914 -0.585 . . . . 9.65 109.903 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -112.83 -64.71 1.27 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.846 0.355 . . . . 11.11 110.399 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 32.9 p -103.85 -82.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 8.66 111.506 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.8 p -139.22 115.65 10.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.795 0.331 . . . . 9.44 110.979 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' B' ' 138' ' ' VAL . . . -168.52 81.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 8.63 109.895 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -114.78 -3.63 12.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.089 -0.505 . . . . 9.61 111.056 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.99 155.55 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.166 0.508 . . . . 8.97 111.506 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 7.97 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 9.5 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.429 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 10.78 111.234 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.529 ' HE2' HD11 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.24 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 13.51 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.75 108.897 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.03 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 9.95 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 6.89 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.24 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 8.35 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 12.73 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.702 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 10.48 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.484 ' HA ' HG11 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 10.82 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 11.91 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 12.55 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.47 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.15 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' B' ' 175' ' ' LYS . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.56 108.694 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.657 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.74 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.14 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 15.89 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 11.57 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.657 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 9.65 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.46 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.646 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.24 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 7.89 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 11.87 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.04 -17.76 27.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 61.41 102.45 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.383 -0.826 . . . . 13.52 112.132 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.45 5.98 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.942 2.428 . . . . 14.9 113.666 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 27.4 m -139.41 108.35 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 17.54 110.917 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 14.2 m -110.69 132.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.19 0.519 . . . . 18.06 111.811 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -110.68 70.97 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.6 -0.727 . . . . 21.28 109.508 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -159.51 107.46 1.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 21.53 110.796 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m 71.05 163.93 0.27 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.043 0.839 . . . . 23.03 111.528 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.93 84.55 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.823 -0.626 . . . . 24.72 111.872 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.447 -0.787 . . . . 27.31 110.222 179.868 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' B' ' 168' ' ' GLU . 25.1 ptt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.851 0.358 . . . . 29.42 110.579 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -60.39 138.4 57.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.557 -0.747 . . . . 26.59 111.383 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -104.99 -43.24 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 25.53 110.492 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -116.93 111.17 19.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 23.29 110.145 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -83.83 90.92 7.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.34 0.591 . . . . 21.2 109.549 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -99.52 -8.35 24.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.284 -0.871 . . . . 20.05 110.837 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -88.98 104.75 17.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.806 -0.634 . . . . 16.73 110.625 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.37 15.94 23.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.508 . . . . 16.22 110.286 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' OH ' ' B' ' 145' ' ' TYR . 7.8 tp10 -143.21 104.01 4.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.396 -0.82 . . . . 13.24 109.406 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -96.93 119.39 35.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 14.9 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.71 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 9.66 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 7.46 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 6.87 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 6.78 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.44 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 10.95 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 15.91 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.09 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.65 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 12.38 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.05 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.819 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 10.23 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 5.52 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 3.98 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 11.28 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.752 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 -115.3 125.86 53.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.49 132.82 57.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.796 -0.638 . . . . 12.85 109.662 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -59.09 -36.14 96.72 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.415 2.076 . . . . 13.07 111.968 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 32.4 tt0 -154.33 -84.14 0.07 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.134 -0.485 . . . . 14.04 110.425 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.48 -87.65 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.495 0.497 . . . . 15.24 111.097 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.04 -1.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.364 . . . . 14.64 110.79 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 7.6 p -122.53 129.54 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 12.42 110.83 -175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 19.8 ptmt 64.17 -35.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.393 1.477 . . . . 10.84 113.497 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.758 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 23.0 p 49.21 47.38 22.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.469 0.708 . . . . 9.63 111.993 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 m 75.76 -59.18 0.53 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.631 -0.713 . . . . 9.56 110.331 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' OG ' ' B' ' 140' ' ' SER . . . -164.74 90.78 0.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.783 -0.644 . . . . 8.3 109.795 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' A' ' 44' ' ' LYS . 3.1 p-10 -81.94 5.09 20.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 8.55 110.909 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.578 ' HA ' ' HB3' ' B' ' 133' ' ' MET . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.01 108.745 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' HG2' ' HD3' ' B' ' 134' ' ' PRO . 15.5 mm100 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.6 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 5.62 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.03 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.15 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 6.72 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 5.99 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.39 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 7.73 110.521 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.729 ' HB2' HG21 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.32 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.57 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.06 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.7 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.21 110.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.63 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' HG11 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.58 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.79 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.49 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.26 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.1 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 5.97 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.38 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 7.75 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 7.82 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.11 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 8.81 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 8.87 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 5.87 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.624 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.14 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.17 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.619 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.6 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.05 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.15 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.46 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -78.5 -37.28 43.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.04 110.033 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 55.65 86.85 0.15 Allowed Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 115.412 -0.813 . . . . 5.09 112.184 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -92.27 7.3 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.953 2.435 . . . . 6.48 111.039 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -85.72 30.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.286 -0.87 . . . . 7.32 110.459 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -72.56 -26.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 6.13 109.884 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.3 80.12 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 9.68 110.809 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.77 -55.38 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.518 -0.765 . . . . 8.54 109.596 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -123.61 170.76 10.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.62 -0.718 . . . . 9.88 109.874 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.55 134.17 2.21 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.156 -0.778 . . . . 9.93 111.156 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 12.88 110.022 -179.3 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.896 0.379 . . . . 13.85 110.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.5 m -95.51 26.01 4.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 12.37 110.278 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -64.69 106.54 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.664 -0.698 . . . . 12.02 111.901 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 25.6 t -104.83 -8.29 18.83 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.28 -1.007 . . . . 10.42 108.28 169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -65.51 119.92 11.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.835 -1.075 . . . . 8.13 109.835 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 68.81 22.36 7.31 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.715 0.634 . . . . 10.78 111.094 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' B' ' 108' ' ' LYS . 16.1 mm100 -114.78 121.76 44.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.5 -0.556 . . . . 8.36 109.5 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' B' ' 107' ' ' GLN . 9.1 mtpm? 72.45 80.21 0.14 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.701 0.762 . . . . 8.99 109.62 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -58.92 142.0 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.358 -1.292 . . . . 8.32 111.554 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.28 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.12 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 5.93 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.436 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 4.62 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.32 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.43 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 3.93 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.3 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 5.76 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.441 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.08 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 8.78 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.27 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.06 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.68 113.42 -173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 4.71 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.619 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.03 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.463 ' HB2' HG13 ' A' ' 89' ' ' ILE . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.48 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 2.83 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.33 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.641 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.34 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.641 ' N ' HD13 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -49.16 122.17 5.68 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.578 ' HB3' ' HA ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -67.26 156.04 89.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.788 -0.642 . . . . 9.64 111.083 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.577 ' HB2' ' O ' ' B' ' 138' ' ' VAL . 24.2 Cg_exo -63.25 152.17 81.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.782 2.321 . . . . 9.8 112.515 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.57 -6.3 12.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 12.27 109.979 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.62 133.44 25.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.845 -0.616 . . . . 11.49 110.784 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.38 -42.87 0.55 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.442 1.089 . . . . 11.38 112.542 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' B' ' 134' ' ' PRO . 55.3 t -121.52 133.26 68.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.543 0.211 . . . . 9.65 111.514 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -149.93 -51.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.064 -0.517 . . . . 11.11 110.418 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 42' ' ' ALA . 52.6 m -147.36 -156.11 0.69 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.036 -0.529 . . . . 8.66 110.819 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 m -137.58 92.88 2.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.545 -0.539 . . . . 9.44 109.545 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' B' ' 145' ' ' TYR . . . -82.64 112.2 19.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 8.63 110.835 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -72.62 -20.48 61.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.779 -0.646 . . . . 9.61 110.941 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -150.14 139.69 21.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 8.97 110.144 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 142' ' ' ALA . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 7.97 109.408 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 9.5 108.871 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 10.78 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.24 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.819 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 13.51 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.75 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.03 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 9.95 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.62 ' HB2' HG21 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 6.89 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.24 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 8.35 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 12.73 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.65 HD21 HG21 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 10.48 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG12 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 10.82 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.476 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 1' ' ' MET . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 11.91 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 12.55 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.47 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.464 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.15 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.56 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.613 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.74 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.14 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 180' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 15.89 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 11.57 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 9.65 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.46 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.24 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 7.89 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 11.87 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLU . . . . . 0.412 ' N ' HD12 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -113.5 40.3 2.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 4.0 p30 -57.84 127.17 78.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.857 . . . . 13.52 111.224 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 23.1 Cg_exo -63.83 -45.5 10.65 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.049 2.499 . . . . 14.9 111.976 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 31.3 m -101.43 116.21 32.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.876 -0.602 . . . . 17.54 109.648 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.83 129.31 35.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.025 -0.361 . . . . 18.06 110.025 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.77 79.0 4.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 21.28 110.706 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.7 14.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.849 -0.614 . . . . 21.53 110.649 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -119.07 -18.17 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.29 0.567 . . . . 23.03 109.874 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -121.23 44.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.653 -0.703 . . . . 24.72 111.685 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 79.4 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.612 -0.708 . . . . 27.31 109.451 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.815 -0.069 . . . . 29.42 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m 67.68 -76.94 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.706 0.628 . . . . 26.59 110.63 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 41.4 ttp180 63.29 30.33 15.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 25.53 111.082 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -78.99 83.53 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.719 -0.845 . . . . 23.29 108.719 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -62.86 143.1 57.93 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.226 -0.897 . . . . 21.2 110.303 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -77.03 -179.88 5.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 20.05 111.042 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.08 133.73 42.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.921 -0.581 . . . . 16.73 111.782 -173.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -101.71 99.64 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.764 -1.199 . . . . 16.22 107.764 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.31 131.11 35.56 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.007 -0.542 . . . . 13.24 110.6 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.661 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 -88.99 110.49 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.856 -0.611 . . . . 10.33 110.089 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 14.9 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.71 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 9.66 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 HD11 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 7.46 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 6.87 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 6.78 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.44 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.672 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 10.95 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 15.91 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.09 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.672 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.65 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 12.38 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.05 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 10.23 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 5.52 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 3.98 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 11.28 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' HD13 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.08 89.24 3.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.3 ttt -101.56 133.03 21.07 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.646 -0.706 . . . . 12.85 110.681 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 1.008 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 46.0 Cg_exo -57.8 149.51 68.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.89 2.394 . . . . 13.07 111.695 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 74.17 -36.37 0.33 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.493 0.717 . . . . 14.04 111.381 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.91 -61.82 1.69 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 15.24 110.37 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' B' ' 145' ' ' TYR . . . -99.55 -39.62 8.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.63 -0.713 . . . . 14.64 109.941 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.008 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 89.7 t -80.09 102.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.418 -0.81 . . . . 12.42 110.258 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -131.69 121.49 24.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.934 -0.765 . . . . 10.84 108.934 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -103.36 94.35 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.452 0.538 . . . . 9.63 112.452 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.038 ' HB ' HG21 ' B' ' 141' ' ' THR . 19.7 m -134.21 86.11 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.677 . . . . 9.56 109.171 171.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.68 101.29 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.94 -0.573 . . . . 8.3 111.068 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.69 0.72 56.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.141 -0.481 . . . . 8.55 110.319 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.5 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.475 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.01 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.6 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 5.62 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.03 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.15 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 6.72 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 5.99 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.39 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 7.73 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.32 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.57 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.06 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.7 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.21 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.63 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.58 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.79 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.49 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.26 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.1 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 5.97 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.38 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 7.75 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 3.9 m-20 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 7.82 109.748 -176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.11 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 8.81 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 8.87 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 5.87 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.14 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.17 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.6 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.05 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.15 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.46 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 -109.98 22.3 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.04 110.58 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.666 HD21 HG22 ' A' ' 95' ' ' VAL . 24.3 p-10 -50.08 122.5 14.67 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.539 -0.755 . . . . 5.09 112.18 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.09 10.52 3.62 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.916 2.411 . . . . 6.48 112.134 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.9 m -145.94 112.1 5.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 7.32 110.591 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 92' ' ' ASN . 29.7 t -112.96 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.803 . . . . 6.13 109.26 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -99.31 92.28 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.958 0.409 . . . . 9.68 111.25 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.66 -51.41 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.439 -0.578 . . . . 8.54 109.439 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -115.24 47.86 1.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.872 -0.788 . . . . 9.88 108.872 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.89 105.03 2.38 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.461 -0.79 . . . . 9.93 112.544 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.812 0.339 . . . . 12.88 110.163 176.708 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.029 0.442 . . . . 13.85 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -159.54 110.26 1.97 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 12.37 110.174 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' B' ' 103' ' ' ARG . 9.1 ptp85 -86.42 -18.2 32.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 12.02 110.172 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m -67.52 -25.93 66.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 10.42 110.797 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -89.82 124.39 34.62 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.265 -0.643 . . . . 8.13 109.265 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.25 160.25 22.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.101 0.477 . . . . 10.78 111.771 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -82.33 96.03 7.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.606 -0.725 . . . . 8.36 109.314 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -152.22 -44.23 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 8.99 108.686 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.477 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 -82.81 129.89 35.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 168.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.28 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.12 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 5.93 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 4.62 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.32 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.832 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.43 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.558 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 3.93 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 63' ' ' LEU . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.3 110.877 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 5.76 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.589 ' HG3' HD21 ' A' ' 58' ' ' LEU . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.08 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 8.78 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.27 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.433 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.06 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.68 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' HIS . . . . . 0.558 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 4.71 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.03 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.48 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.83 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.668 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.33 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.34 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 -96.83 91.23 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 92.5 mmm -119.91 97.37 49.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 9.64 110.854 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.39 158.75 36.66 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.326 2.018 . . . . 9.8 111.343 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.55 16.78 10.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.802 -0.635 . . . . 12.27 111.162 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.07 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 11.49 110.328 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -155.76 -79.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 11.38 110.784 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.99 147.02 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.65 110.727 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 139' ' ' LYS . 0.4 OUTLIER -114.48 -30.18 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.411 -0.358 . . . . 11.11 110.108 177.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m 74.64 -42.41 0.5 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.412 0.893 . . . . 8.66 113.412 173.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' THR . . . . . 1.038 HG21 ' HB ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -66.41 -20.18 66.0 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.0 0.741 . . . . 9.44 113.0 -175.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.92 110.64 10.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.36 . . . . 8.63 110.309 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' B' ' 160' ' ' PRO . 26.8 t-20 -132.36 -58.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.511 . . . . 9.61 110.756 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp -90.4 140.49 29.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.722 -0.473 . . . . 8.97 109.722 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 7.97 110.763 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 9.5 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 10.78 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.671 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.473 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.24 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 13.51 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.75 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.03 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 9.95 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.674 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 6.89 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.24 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' B' ' 143' ' ' ASN . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 8.35 112.069 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 12.73 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.891 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.58 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 10.48 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.515 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 10.82 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 11.91 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' B' ' 198' ' ' SER . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 12.55 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.47 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.15 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.667 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.45 ' HB2' ' NZ ' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.56 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.74 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.14 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 15.89 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 11.57 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 9.65 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.46 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.492 ' O ' HD13 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.24 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.667 HD11 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 7.89 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 11.87 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.673 ' HA ' HD21 ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' ASN . . . . . 0.673 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 -84.51 27.19 0.73 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 0.3 OUTLIER -47.44 137.02 9.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 115.581 -0.736 . . . . 13.52 112.076 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 32.3 Cg_exo -58.03 120.15 7.86 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.945 2.43 . . . . 14.9 111.921 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.405 HG22 ' HG3' ' B' ' 196' ' ' LYS . 57.4 m 71.91 86.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.549 -0.75 . . . . 17.54 110.42 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.65 101.4 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.431 -0.804 . . . . 18.06 110.472 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' LYS . . . . . 0.405 ' HG3' HG22 ' B' ' 194' ' ' THR . 63.2 mttm -98.87 98.29 9.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.24 -0.436 . . . . 21.28 111.2 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 53.84 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 124.175 0.922 . . . . 21.53 112.761 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' B' ' 170' ' ' LYS . 35.1 m -137.08 104.24 5.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.221 -0.445 . . . . 23.03 110.513 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 172.15 -143.32 7.38 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.948 -0.644 . . . . 24.72 111.949 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.357 -0.83 . . . . 27.31 110.83 -178.009 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.026 0.441 . . . . 29.42 110.389 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -77.62 -40.0 43.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.276 -0.42 . . . . 26.59 111.934 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 62.37 17.0 9.04 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.542 0.526 . . . . 25.53 111.093 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -84.59 -45.3 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 23.29 110.351 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.94 97.85 11.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 21.2 110.092 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -118.26 -14.61 9.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 20.05 110.53 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.44 132.57 34.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.124 -0.489 . . . . 16.73 110.836 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 8' ' ' LYS . 3.4 mppt? -109.65 5.78 23.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 16.22 109.798 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -97.68 107.64 20.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 13.24 109.974 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -81.65 143.1 32.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 14.9 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.71 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 9.66 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 7.46 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 6.87 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 6.78 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.44 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 10.95 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 15.91 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.09 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.65 109.783 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 12.38 112.789 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.05 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 10.23 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 5.52 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 3.98 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.738 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 11.28 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.964 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 -101.97 118.43 36.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.4 mmt -120.88 148.6 48.95 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.865 -0.42 . . . . 12.85 109.865 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' ALA . 50.8 Cg_exo -56.11 150.2 49.36 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.922 2.415 . . . . 13.07 112.092 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.87 35.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.87 -0.605 . . . . 14.04 111.846 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -82.8 -29.48 29.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 15.24 110.358 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.12 -5.68 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.801 -0.636 . . . . 14.64 111.12 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.29 116.43 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 12.42 110.502 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 58.1 27.54 15.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.066 -0.516 . . . . 10.84 110.773 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.0 t -61.65 106.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.745 . . . . 9.63 110.002 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -100.12 81.11 2.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 9.56 111.038 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.57 109.18 11.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.368 -0.833 . . . . 8.3 110.137 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 30.8 t30 -136.13 -54.23 0.75 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.924 -0.58 . . . . 8.55 109.744 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.01 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.6 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 5.62 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.03 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.15 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 6.72 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 5.99 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.39 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 7.73 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.32 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.57 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.06 111.181 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.7 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.525 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.21 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.75 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.63 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.58 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.79 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.49 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.26 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.1 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 5.97 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.38 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 7.75 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 7.82 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.11 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 8.81 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 8.87 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 5.87 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.14 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.17 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.6 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.05 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.15 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.46 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.45 4.81 46.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.04 110.367 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -64.48 120.95 69.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 5.09 111.247 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.5 -33.82 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.367 2.045 . . . . 6.48 112.112 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 m -88.19 70.49 9.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.352 0.596 . . . . 7.32 110.905 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.46 -36.94 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.666 -0.864 . . . . 6.13 108.666 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -87.13 87.1 7.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.162 -0.926 . . . . 9.68 109.687 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.09 -66.67 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.449 -0.796 . . . . 8.54 110.437 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m -103.49 -44.55 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.501 -0.555 . . . . 9.88 109.501 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.46 -75.5 1.39 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.826 -0.624 . . . . 9.93 112.962 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 12.88 112.247 -173.595 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.192 0.52 . . . . 13.85 109.981 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.7 m -91.29 30.34 1.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.029 -0.532 . . . . 12.37 110.302 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -67.94 -62.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 12.02 110.266 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.6 p -109.99 -36.25 5.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 10.42 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.99 118.92 20.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.574 -0.528 . . . . 8.13 109.574 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.83 145.08 29.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 10.78 111.22 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.8 96.7 7.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.873 -0.603 . . . . 8.36 110.16 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -107.25 5.28 27.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.807 -0.633 . . . . 8.99 110.03 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -103.55 139.94 38.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.455 -0.793 . . . . 8.32 110.048 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.28 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.409 ' HG3' ' OD2' ' B' ' 114' ' ' ASP . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.12 111.153 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 5.93 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 4.62 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' B' ' 111' ' ' LYS . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.32 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.75 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.43 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 3.93 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.3 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 5.76 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.08 108.237 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 8.78 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.27 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.06 110.514 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.68 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 4.71 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.03 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.48 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 2.83 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.64 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.33 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.441 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.34 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.79 45.65 2.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 45.5 ttp -62.42 130.2 93.1 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 116.339 -0.392 . . . . 9.64 110.557 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.26 141.15 95.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.351 2.701 . . . . 9.8 112.775 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 68.18 8.72 6.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.428 -0.806 . . . . 12.27 110.827 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.44 -57.65 1.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.013 -0.54 . . . . 11.49 109.871 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.6 -56.29 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.891 -0.595 . . . . 11.38 109.691 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 86.5 t -93.24 128.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.718 -0.674 . . . . 9.65 110.521 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.19 168.28 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.851 -0.425 . . . . 11.11 109.851 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 38.3 t -125.45 116.71 22.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.25 -0.432 . . . . 8.66 109.969 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.9 p -110.61 27.01 10.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.279 0.561 . . . . 9.44 110.78 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.11 25.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.723 -0.671 . . . . 8.63 110.939 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -134.02 9.05 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 9.61 110.632 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.51 156.17 46.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 8.97 110.783 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.689 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 7.97 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 9.5 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 10.78 109.865 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.24 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 13.51 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.75 109.574 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.03 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 9.95 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 6.89 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.24 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.689 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 8.35 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 12.73 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 10.48 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 10.82 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 11.91 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 12.55 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.47 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.15 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.56 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.74 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.14 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 15.89 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 11.57 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 9.65 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.46 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.24 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 7.89 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 11.87 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.538 ' HA ' ' OE1' ' B' ' 188' ' ' GLU . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' B' ' 192' ' ' ASN . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 188' ' ' GLU . 2.9 p-10 -105.6 -14.38 15.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 189' ' ' ILE . 25.6 t30 -151.15 109.07 3.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 13.52 110.016 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.06 -34.22 66.86 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.02 2.48 . . . . 14.9 113.206 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.4 t -170.2 -48.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.075 -0.511 . . . . 17.54 109.882 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 3.5 p -173.74 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.668 0.747 . . . . 18.06 111.051 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.89 80.32 1.68 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.654 -0.703 . . . . 21.28 109.357 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.06 -40.92 11.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.646 -0.706 . . . . 21.53 110.621 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 29.9 m -76.37 125.08 28.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.083 -0.508 . . . . 23.03 110.456 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.5 -166.83 22.74 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.789 -0.72 . . . . 24.72 112.563 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.662 -0.685 . . . . 27.31 110.385 -179.331 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.631 0.253 . . . . 29.42 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -90.62 -12.78 35.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.432 0.634 . . . . 26.59 109.959 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.3 158.41 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 25.53 109.593 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -88.03 145.77 25.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.986 0.422 . . . . 23.29 110.056 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 122.98 36.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.211 -0.449 . . . . 21.2 110.048 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -70.18 115.13 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 20.05 109.318 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.83 137.95 31.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 16.73 111.001 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 26.5 tptp -77.16 119.43 20.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.67 -0.695 . . . . 16.22 109.336 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 48.9 mt-10 73.36 169.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.047 0.842 . . . . 13.24 111.234 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 75.9 m-85 -121.67 168.82 11.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.204 -0.453 . . . . 10.33 110.616 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 14.9 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.71 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 197' ' ' ALA . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 9.66 112.749 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.671 HD23 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 7.46 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.591 HG11 HD21 ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 6.87 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.747 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 6.78 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.44 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.811 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 10.95 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 15.91 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.09 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.65 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 12.38 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 70.8 m80 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.05 110.205 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.622 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 10.23 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 5.52 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 3.98 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 11.28 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD13 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 15.7 pt-20 -111.64 154.07 25.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.454 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 2.0 mpt? -94.17 132.15 29.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.635 -0.711 . . . . 12.85 109.468 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 23.8 Cg_exo -65.56 -23.86 56.74 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.083 2.522 . . . . 13.07 112.594 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.944 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . 35.3 tt0 69.76 94.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.788 0.68 . . . . 14.04 111.337 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.82 -17.4 19.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.635 . . . . 15.24 109.284 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.57 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.59 -1.186 . . . . 14.64 109.773 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.58 150.9 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.794 -0.639 . . . . 12.42 110.577 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 12.4 mmtp -93.66 -92.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.332 -0.147 . . . . 10.84 110.959 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p -176.89 29.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.432 -0.349 . . . . 9.63 111.143 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.641 HG21 ' H ' ' B' ' 143' ' ' ASN . 15.2 t -151.5 149.21 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.1 -0.64 . . . . 9.56 112.408 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.64 80.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 8.3 113.682 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -119.98 11.98 11.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.235 0.541 . . . . 8.55 110.289 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.5 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.01 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 53.1 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.6 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 5.62 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.896 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.03 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.15 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 6.72 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 5.99 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.39 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 7.73 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.32 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.57 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.06 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.7 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD21 HG21 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.21 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.63 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.824 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.58 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.79 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.49 112.978 -168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.794 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.26 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.698 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.1 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 5.97 110.807 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.38 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.615 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 7.75 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 7.82 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.11 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 8.81 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 8.87 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 5.87 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.14 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.17 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.6 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.05 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.15 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.593 HG22 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.46 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -91.21 16.52 9.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.04 110.491 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -54.42 115.94 9.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.086 -0.506 . . . . 5.09 111.374 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.41 -15.11 8.96 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.732 2.288 . . . . 6.48 112.99 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.5 m -85.09 86.14 7.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 7.32 110.629 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.24 126.17 57.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.15 0.5 . . . . 6.13 110.141 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -84.75 70.4 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.468 0.651 . . . . 9.68 110.143 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.17 -7.68 9.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.157 -0.929 . . . . 8.54 109.769 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 p -87.23 139.6 30.39 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.163 -0.926 . . . . 9.88 110.503 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 151.15 125.84 1.26 Allowed Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.667 -0.777 . . . . 9.93 111.888 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 12.88 110.117 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.231 -0.285 . . . . 13.85 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.4 m -89.32 171.21 9.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 12.37 110.06 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' B' ' 103' ' ' ARG . 5.8 tpp180 -67.0 -49.85 64.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.836 0.35 . . . . 12.02 111.212 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -92.71 141.49 28.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.439 . . . . 10.42 111.467 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.36 126.97 31.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.805 -0.634 . . . . 8.13 109.31 172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -92.91 121.92 34.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.981 0.42 . . . . 10.78 111.31 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -81.89 155.41 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.783 -0.644 . . . . 8.36 109.893 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 81.03 4.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.935 -0.765 . . . . 8.99 108.935 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.05 -45.45 67.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.878 -1.056 . . . . 8.32 111.119 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.28 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.12 111.315 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 5.93 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 4.62 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.32 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.43 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 3.93 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.3 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 5.76 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.521 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.08 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 8.78 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.27 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.06 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.68 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 4.71 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.896 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.03 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.48 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 2.83 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.33 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.536 HG12 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.34 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.648 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 -83.16 116.72 22.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 75.0 mtp -88.23 129.85 48.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 9.64 110.208 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.32 -55.61 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.747 2.298 . . . . 9.8 112.559 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.1 124.54 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 12.27 110.677 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -170.01 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.657 -0.701 . . . . 11.49 109.501 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -111.84 -13.6 13.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.01 -0.737 . . . . 11.38 109.01 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 139' ' ' LYS . 12.3 p -79.96 149.88 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.739 -1.118 . . . . 9.65 109.776 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.542 ' HG2' HG22 ' B' ' 138' ' ' VAL . 67.3 mmtt 64.13 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.804 0.69 . . . . 11.11 110.012 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 59.4 m 61.62 -172.89 0.14 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.938 -1.028 . . . . 8.66 112.191 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' THR . . . . . 0.632 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.9 p -85.84 -61.17 1.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 9.44 110.368 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -167.29 125.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.379 -0.373 . . . . 8.63 110.437 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.641 ' H ' HG21 ' A' ' 41' ' ' THR . 89.4 m-20 -118.42 -28.12 5.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.317 -0.401 . . . . 9.61 110.348 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -141.14 135.81 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 8.97 109.702 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 7.97 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 9.5 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 10.78 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.671 ' HE2' HD23 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.24 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 13.51 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.75 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.03 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 9.95 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.66 ' HB2' HG21 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 6.89 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.24 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 8.35 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 12.73 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 10.48 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 10.82 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.472 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 11.91 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 12.55 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.47 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.15 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.56 108.23 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.74 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.14 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 15.89 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 11.57 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.416 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 9.65 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.46 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.24 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 7.89 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 11.87 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' B' ' 193' ' ' PRO . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.533 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -82.51 -29.12 30.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 59.13 90.73 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 123.551 0.532 . . . . 13.52 110.938 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' B' ' 188' ' ' GLU . 24.1 Cg_exo -64.84 -55.66 0.49 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.398 2.065 . . . . 14.9 110.931 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 62.5 m -157.03 -47.75 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 17.54 109.866 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 41.0 t 58.02 68.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.877 0.846 . . . . 18.06 109.911 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -84.38 97.05 9.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.346 -0.843 . . . . 21.28 111.115 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 197' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 13' ' ' GLY . . . -86.67 -49.93 7.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 21.53 109.916 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 23.2 m -135.99 99.02 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 23.03 110.09 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.4 -49.23 5.58 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.281 -1.128 . . . . 24.72 110.281 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.512 -0.756 . . . . 27.31 109.179 172.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.838 0.351 . . . . 29.42 110.652 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t -135.79 3.96 3.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.338 -0.392 . . . . 26.59 111.24 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 25.53 111.255 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 t -130.41 113.41 14.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.363 -0.606 . . . . 23.29 109.363 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.84 121.65 15.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 21.2 110.892 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -85.38 171.68 11.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 20.05 110.477 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -121.54 171.5 8.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.093 0.473 . . . . 16.73 111.201 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -100.01 98.09 8.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.657 -0.701 . . . . 16.22 109.907 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.25 146.52 26.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.594 -0.73 . . . . 13.24 110.212 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 -70.62 144.65 51.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 14.9 110.868 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.71 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 9.66 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 7.46 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 6.87 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 6.78 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HA ' HD23 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.44 110.892 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 10.95 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 15.91 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.09 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.65 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 12.38 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.05 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 10.23 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 26' ' ' TRP . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 5.52 112.698 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 3.98 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 11.28 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.61 137.06 21.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.5 ttm -141.55 100.33 6.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.852 -0.613 . . . . 12.85 109.87 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.34 169.41 22.56 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.067 2.512 . . . . 13.07 111.8 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -80.76 -53.54 6.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.683 -0.488 . . . . 14.04 109.683 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.03 82.66 0.37 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.733 -0.667 . . . . 15.24 109.275 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.83 0.48 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.936 0.773 . . . . 14.64 110.116 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.43 158.36 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.81 -0.811 . . . . 12.42 108.81 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' B' ' 141' ' ' THR . 75.1 mttt -108.35 96.57 6.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.627 -0.508 . . . . 10.84 109.627 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -133.12 176.61 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.032 -0.531 . . . . 9.63 109.952 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.667 HG23 ' HE2' ' A' ' 44' ' ' LYS . 16.4 m 73.88 3.63 4.49 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.366 0.416 . . . . 9.56 111.298 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' B' ' 139' ' ' LYS . . . -56.37 -49.23 75.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.948 0.404 . . . . 8.3 111.773 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -94.87 20.04 9.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.19 -0.459 . . . . 8.55 111.251 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.667 ' HE2' HG23 ' A' ' 41' ' ' THR . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.5 109.745 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.01 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.6 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 5.62 110.975 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.03 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.655 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.15 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.535 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 6.72 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 48' ' ' PHE . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 5.99 109.783 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.39 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 7.73 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.32 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.57 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.06 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.7 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.512 HD11 HG23 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.21 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.63 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.58 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.79 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.49 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.26 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.1 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 5.97 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.38 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 7.75 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 7.82 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.11 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 8.81 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 8.87 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' HG22 ' A' ' 52' ' ' THR . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 5.87 112.492 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.14 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.17 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.6 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.05 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.15 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.46 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.47 -34.17 12.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.04 109.96 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 t30 68.39 113.34 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.406 -0.815 . . . . 5.09 112.513 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.38 -59.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.843 2.362 . . . . 6.48 112.922 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.3 m -92.74 110.03 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.794 0.33 . . . . 7.32 110.812 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.81 141.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.065 -0.516 . . . . 6.13 110.587 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -84.62 98.63 10.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.333 0.587 . . . . 9.68 110.469 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.87 -39.97 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.278 -0.874 . . . . 8.54 110.267 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.2 t 69.52 90.22 0.1 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.502 -0.772 . . . . 9.88 110.48 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.4 -141.39 9.59 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.413 -0.812 . . . . 9.93 112.634 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.506 0.67 . . . . 12.88 111.898 -175.203 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 41.3 tpp . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.344 0.592 . . . . 13.85 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -92.59 47.44 1.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 12.37 110.955 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -140.56 129.99 23.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.88 -0.785 . . . . 12.02 108.88 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.1 t -76.9 146.46 37.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.825 0.345 . . . . 10.42 111.114 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -96.97 122.88 40.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 8.13 109.963 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -97.24 145.53 25.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 10.78 110.882 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -115.1 135.24 54.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.052 -0.721 . . . . 8.36 109.052 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -89.24 -18.7 26.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 8.99 110.512 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.87 173.94 7.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.918 -0.583 . . . . 8.32 110.658 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.28 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.12 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 5.93 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 4.62 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.462 HD22 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.32 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.43 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 3.93 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.3 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 5.76 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.459 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.08 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 8.78 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.27 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.535 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.06 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.432 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.68 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 4.71 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.786 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.03 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.48 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.462 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 2.83 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.649 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.33 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.414 HD13 ' H ' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.34 112.004 -173.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.718 ' HA ' ' HB3' ' A' ' 45' ' ' TYR . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 47.89 25.62 0.78 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 46.4 tpp -166.7 102.94 0.66 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 9.64 109.814 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.04 177.71 8.4 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.821 2.348 . . . . 9.8 113.154 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' B' ' 135' ' ' GLU . 0.0 OUTLIER -101.97 29.25 5.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.737 -0.665 . . . . 12.27 110.109 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.44 85.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.538 -0.755 . . . . 11.49 112.159 -174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.54 10.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 11.38 111.641 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.434 HG23 ' HE2' ' B' ' 139' ' ' LYS . 34.4 m -120.61 136.97 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.966 -0.383 . . . . 9.65 109.966 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 13.3 mtmt 55.61 20.98 4.17 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.436 0.46 . . . . 11.11 110.703 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -74.88 -60.35 2.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 8.66 111.75 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 42.8 p -100.78 104.75 16.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.745 0.307 . . . . 9.44 111.589 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.68 -77.2 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 8.63 109.857 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.1 -45.05 20.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.192 0.52 . . . . 9.61 110.136 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -91.62 142.06 28.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.627 -0.715 . . . . 8.97 110.49 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 7.97 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 10.78 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.24 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 13.51 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.75 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.03 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 9.95 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG21 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 6.89 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.24 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 8.35 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 12.73 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.822 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 10.48 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 10.82 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 167' ' ' GLU . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 11.91 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 12.55 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.47 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.15 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.56 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.557 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.74 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.14 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 15.89 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 11.57 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.557 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 9.65 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.46 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.441 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.24 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 7.89 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 11.87 110.435 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -125.0 72.06 1.21 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -61.76 154.82 64.86 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.441 -0.799 . . . . 13.52 111.425 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.95 169.12 10.89 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.636 2.224 . . . . 14.9 111.386 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.8 p -58.26 105.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 17.54 111.179 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.99 94.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.792 -0.448 . . . . 18.06 109.792 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 196' ' ' LYS . . . . . 0.646 ' HE3' ' HA3' ' B' ' 199' ' ' GLY . 64.2 tttp -127.66 93.21 3.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 21.28 110.522 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -95.4 -15.34 23.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.532 -0.758 . . . . 21.53 109.536 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 35.4 p -63.43 -37.83 88.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.33 -0.85 . . . . 23.03 110.518 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 199' ' ' GLY . . . . . 0.646 ' HA3' ' HE3' ' B' ' 196' ' ' LYS . . . -123.06 72.88 0.4 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.376 -0.829 . . . . 24.72 111.29 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 26.4 t80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.594 -0.717 . . . . 27.31 109.38 -178.657 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.785 0.326 . . . . 29.42 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -98.44 -52.66 3.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.779 -0.191 . . . . 26.59 111.376 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 61.55 19.39 10.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.991 0.516 . . . . 25.53 111.866 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -126.48 150.81 48.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.509 -0.552 . . . . 23.29 109.509 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -79.34 148.83 31.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.807 0.337 . . . . 21.2 110.548 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -75.89 123.16 25.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.469 -0.937 . . . . 20.05 108.469 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -70.38 137.99 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.06 0.457 . . . . 16.73 111.069 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -80.31 95.24 6.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.522 0.677 . . . . 16.22 109.837 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.08 147.46 31.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.087 -0.96 . . . . 13.24 110.202 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -75.07 144.71 42.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 10.33 110.467 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 14.9 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.71 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 30' ' ' ILE . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 9.66 112.624 -173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 7.46 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 6.87 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.651 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 6.78 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.44 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 10.95 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 15.91 109.293 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.09 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.65 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 12.38 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.05 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.51 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 10.23 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 5.52 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 3.98 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 11.28 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 30' ' ' ILE . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 11.2 pt-20 -165.42 153.06 10.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.48 101.68 36.98 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 12.85 111.139 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 32' ' ' GLU . 2.0 Cg_endo -83.15 113.85 2.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.957 2.438 . . . . 13.07 110.986 175.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.81 -50.44 70.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.92 0.39 . . . . 14.04 110.814 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.69 83.41 1.93 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.969 -0.56 . . . . 15.24 110.235 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.63 -65.08 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.543 0.737 . . . . 14.64 111.394 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 40' ' ' SER . 8.9 p -121.54 147.57 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.633 -0.506 . . . . 12.42 109.633 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.21 8.8 10.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.33 0.586 . . . . 10.84 110.567 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.71 ' H ' HG22 ' A' ' 38' ' ' VAL . 22.4 m -104.85 120.31 41.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 9.63 110.442 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.3 m -152.3 102.05 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 9.56 110.734 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.66 133.61 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 8.3 110.068 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -168.88 20.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 8.55 111.51 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.5 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.01 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 91.7 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.6 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 5.62 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.03 110.091 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.15 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 6.72 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 5.99 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.39 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 7.73 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.32 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.57 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.06 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.7 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 HG21 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.21 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.63 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.58 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.79 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.712 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.49 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.26 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.712 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.1 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 5.97 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.38 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 7.75 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.703 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 7.82 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.11 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 8.81 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 8.87 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 5.87 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.14 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.17 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.6 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.05 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.15 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.46 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.31 -38.88 68.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.04 110.642 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -172.19 108.41 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 5.09 110.336 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.18 -25.71 72.58 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.234 2.622 . . . . 6.48 112.685 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -121.37 79.95 1.6 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.169 0.509 . . . . 7.32 110.701 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 p -78.3 125.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 6.13 109.84 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 22.6 ttmm -122.93 78.92 1.6 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.304 -0.407 . . . . 9.68 110.212 -177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 68.89 -85.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.963 -1.017 . . . . 8.54 111.574 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 73.5 m -143.01 140.92 31.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.493 -0.321 . . . . 9.88 110.199 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.08 55.61 5.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.663 -0.779 . . . . 9.93 113.147 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' SER . 52.2 p90 . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 110.245 -0.279 . . . . 12.88 110.245 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.14 -0.319 . . . . 13.85 110.14 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 9.4 t -149.2 -170.92 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.732 -0.47 . . . . 12.37 109.732 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -128.59 120.23 26.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.963 0.411 . . . . 12.02 110.48 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -113.89 -26.97 7.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 10.42 111.347 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -113.98 168.92 9.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 8.13 111.364 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -148.91 168.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 10.78 109.619 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.47 123.01 47.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 8.36 110.404 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -94.37 -9.24 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.921 0.341 . . . . 8.99 111.921 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.77 141.32 28.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 -174.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.28 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.706 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.12 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 5.93 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 4.62 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.617 HD23 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.32 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.617 ' N ' HD23 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.43 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 3.93 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.3 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 5.76 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.08 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 8.78 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.27 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.06 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.68 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 4.71 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.481 ' CZ3' ' HD1' ' B' ' 123' ' ' TYR . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.03 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.48 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 2.83 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.33 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.706 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.34 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 132' ' ' GLU . 0.0 OUTLIER -90.24 106.65 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 17.0 tpt -79.59 126.92 79.74 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 9.64 109.355 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 24.4 Cg_exo -65.27 -165.93 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.137 2.558 . . . . 9.8 112.202 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.454 ' O ' HG12 ' B' ' 138' ' ' VAL . 5.6 pt-20 -102.86 -67.16 0.89 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.331 -0.395 . . . . 12.27 111.566 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' B' ' 135' ' ' GLU . . . 61.43 -67.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.029 0.532 . . . . 11.49 110.894 -172.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.21 -39.12 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 11.38 110.25 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 135' ' ' GLU . 12.5 p -69.03 134.52 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.298 -0.41 . . . . 9.65 110.658 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 pttm 50.77 13.86 0.15 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.264 1.026 . . . . 11.11 113.153 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' B' ' 144' ' ' LYS . 25.7 t -71.26 -42.66 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 8.66 110.714 -173.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 p -82.33 -1.77 50.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 9.44 111.759 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.11 -65.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 8.63 111.46 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 50.3 t-20 -90.82 84.21 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.659 -0.246 . . . . 9.61 110.98 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' B' ' 140' ' ' SER . 0.1 OUTLIER 172.16 166.5 0.11 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.454 -0.794 . . . . 8.97 109.999 170.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.464 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 7.97 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 9.5 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 10.78 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.24 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.487 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 13.51 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.75 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.03 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 9.95 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 6.89 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.24 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.464 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 8.35 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 12.73 111.061 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 10.48 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 10.82 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.661 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.537 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 11.91 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 12.55 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.47 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.15 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.56 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.74 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.14 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 15.89 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 11.57 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 9.65 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.46 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.24 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 7.89 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 11.87 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' B' ' 150' ' ' PHE . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -93.19 -99.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -173.49 148.13 1.48 Allowed Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 13.52 109.5 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.98 115.85 3.35 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.581 2.187 . . . . 14.9 111.662 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 88.8 m 67.94 95.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.581 . . . . 17.54 110.658 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 34.7 m -92.68 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 18.06 110.786 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -101.0 71.23 1.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.111 0.481 . . . . 21.28 110.412 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -94.5 -49.51 5.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.861 -0.609 . . . . 21.53 110.001 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 44.9 m -102.33 126.51 49.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.72 -0.673 . . . . 23.03 110.237 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -95.38 94.87 1.78 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.824 -0.703 . . . . 24.72 111.846 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.719 -0.658 . . . . 27.31 109.803 -179.701 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.189 -0.3 . . . . 29.42 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -60.6 134.33 56.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.292 0.567 . . . . 26.59 112.188 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -133.19 -29.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.807 -0.633 . . . . 25.53 110.851 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.4 p 56.86 -166.6 0.13 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.081 0.952 . . . . 23.29 111.114 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -76.67 131.98 39.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.467 -0.333 . . . . 21.2 110.555 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -78.86 102.66 8.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.189 -0.459 . . . . 20.05 110.69 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.518 ' HB2' ' OD2' ' A' ' 14' ' ' ASP . 21.3 pt20 -81.35 141.97 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.975 -0.557 . . . . 16.73 110.341 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' HG3' ' HG2' ' A' ' 9' ' ' GLU . 16.4 ptpt -158.61 0.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.253 -0.43 . . . . 16.22 111.231 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 7.9 pt-20 -166.04 18.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.115 0.483 . . . . 13.24 110.532 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.624 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.9 m-85 -122.24 175.76 6.21 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.042 -0.526 . . . . 10.33 110.531 -173.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 14.9 113.375 -171.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.71 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 9.66 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 7.46 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 6.87 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 6.78 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.44 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.614 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 10.95 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 15.91 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.09 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.65 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 12.38 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.05 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 10.23 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 5.52 112.526 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 3.98 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 11.28 109.56 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.141 HD11 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' H ' HD13 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.86 156.88 27.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.639 ' HG3' ' HB ' ' A' ' 38' ' ' VAL . 83.9 mmm -86.76 135.94 35.13 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.32 -0.993 . . . . 12.85 108.32 168.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 13.0 Cg_exo -71.24 37.86 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.067 2.511 . . . . 13.07 112.865 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 59.86 95.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.84 0.856 . . . . 14.04 111.911 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.74 -77.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.158 -0.928 . . . . 15.24 109.405 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.42 -6.99 9.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.345 0.593 . . . . 14.64 109.505 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 33' ' ' MET . 39.1 t -121.28 129.25 75.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.336 -0.847 . . . . 12.42 110.473 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 143' ' ' ASN . 0.0 OUTLIER -139.13 -175.22 4.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.683 -0.858 . . . . 10.84 108.683 172.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 p -84.99 -168.29 2.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.673 -0.491 . . . . 9.63 109.673 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -82.5 127.22 33.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 9.56 111.0 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' B' ' 140' ' ' SER . . . -136.25 21.77 3.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.457 -0.792 . . . . 8.3 109.657 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -127.58 28.18 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.43 -0.804 . . . . 8.55 109.117 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.5 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.01 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.6 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.89 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 5.62 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.03 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.15 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 6.72 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 5.99 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.39 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 7.73 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.32 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.57 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.06 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.7 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD21 HG21 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.21 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.63 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.58 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.667 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.79 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.49 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.26 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.1 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 5.97 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.38 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 7.75 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 7.82 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.11 112.01 -176.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 8.81 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 8.87 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 5.87 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.14 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.17 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.541 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.6 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.05 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.15 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 HD21 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.46 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -81.36 -2.13 48.07 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.04 111.704 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -156.37 93.8 2.42 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 5.09 111.481 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.52 -30.62 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.792 2.328 . . . . 6.48 111.282 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.2 p -86.61 75.5 9.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.807 -0.633 . . . . 7.32 111.137 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.87 2.32 5.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.035 -0.53 . . . . 6.13 111.607 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.43 70.44 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.557 0.694 . . . . 9.68 110.685 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.82 -31.68 0.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.816 -1.084 . . . . 8.54 109.196 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 t -71.85 99.97 2.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.329 -0.85 . . . . 9.88 109.427 173.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.27 -159.51 28.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.647 -0.787 . . . . 9.93 111.794 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 109.847 -0.427 . . . . 12.88 109.847 -176.623 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' B' ' 102' ' ' SER . 55.5 ttp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.527 -0.546 . . . . 13.85 109.527 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 101' ' ' MET . 45.8 t 71.24 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.88 0.737 . . . . 12.37 110.729 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -64.88 107.35 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.699 . . . . 12.02 110.432 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -80.97 -9.58 59.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.186 0.517 . . . . 10.42 110.912 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -95.96 166.96 11.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.699 -0.682 . . . . 8.13 110.193 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -111.4 128.86 56.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.441 -0.345 . . . . 10.78 110.08 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.55 124.58 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.48 . . . . 8.36 110.359 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -114.2 -38.32 4.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 8.99 109.731 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' B' ' 109' ' ' GLU . 0.0 OUTLIER -86.25 165.03 16.8 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.08 -0.963 . . . . 8.32 110.732 -177.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.28 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.12 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 5.93 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 4.62 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.32 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.884 HG21 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.43 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 3.93 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.3 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 5.76 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.544 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.08 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 8.78 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.27 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.06 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.68 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 4.71 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.705 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.03 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.48 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 2.83 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.33 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.34 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 69.91 124.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 13.3 ptm -133.22 99.09 14.96 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 9.64 111.278 -171.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.41 102.87 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.488 2.792 . . . . 9.8 112.207 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.773 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 20.1 tp10 -140.21 -25.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 12.27 110.603 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.36 123.41 47.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.336 -0.393 . . . . 11.49 110.85 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 69.84 -45.91 0.58 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.993 0.808 . . . . 11.38 112.578 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.498 ' CG1' ' HB1' ' A' ' 42' ' ' ALA . 96.9 t -90.8 129.2 41.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.79 0.329 . . . . 9.65 111.255 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' B' ' 135' ' ' GLU . 28.0 mmtp -163.09 120.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.573 -0.899 . . . . 11.11 108.573 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 140' ' ' SER . . . . . 0.555 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 23.1 t -140.97 104.8 4.74 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.093 -0.643 . . . . 8.66 110.611 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -91.51 -29.73 16.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.088 -0.505 . . . . 9.44 110.528 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.65 82.86 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 8.63 110.513 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 5.1 p30 -103.68 96.69 6.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.736 0.779 . . . . 9.61 110.77 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -129.57 145.86 51.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.347 -0.842 . . . . 8.97 109.809 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 1.141 ' HB3' HD11 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 7.97 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 9.5 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 10.78 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.484 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.24 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 13.51 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.75 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.03 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 9.95 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 6.89 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.24 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 8.35 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 12.73 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.497 HD11 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.513 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 10.48 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.555 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 10.82 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.541 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 11.91 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 12.55 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.47 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.15 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.56 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 50.5 t30 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.74 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' B' ' 182' ' ' PHE . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.14 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 15.89 109.499 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 11.57 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 9.65 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.46 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.623 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.24 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 7.89 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 11.87 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 190' ' ' GLU . . . . . 0.496 ' N ' HD13 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -130.96 74.5 1.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -56.99 120.28 37.26 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.397 -0.819 . . . . 13.52 111.65 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.67 167.07 23.01 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.959 2.44 . . . . 14.9 112.528 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 25.5 m 71.44 -73.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 17.54 111.192 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 22.7 t 53.8 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.087 0.555 . . . . 18.06 111.277 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -85.37 99.13 10.96 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.041 -0.355 . . . . 21.28 110.041 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -97.32 -67.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 21.53 109.347 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 48.5 m -108.27 152.39 24.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.957 -0.565 . . . . 23.03 109.926 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 155.89 -62.17 0.34 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.454 -0.658 . . . . 24.72 111.454 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 52.9 t80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.111 -0.947 . . . . 27.31 109.712 176.546 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.883 -0.414 . . . . 29.42 109.883 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -145.88 132.99 20.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 26.59 110.53 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 109.96 22.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 25.53 109.471 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 m -66.28 -29.53 69.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.015 0.436 . . . . 23.29 110.801 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.91 158.28 20.62 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.504 -0.554 . . . . 21.2 109.504 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 5.1 mmp_? -104.44 116.43 32.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.96 0.41 . . . . 20.05 111.463 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -75.89 146.68 39.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.336 -0.616 . . . . 16.73 109.336 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -110.5 175.47 5.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.482 0.182 . . . . 16.22 110.555 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.19 157.81 35.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 13.24 110.486 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.77 122.7 48.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 10.33 110.118 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.7 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 14.9 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.71 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 9.66 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.591 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 7.46 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 6.87 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 6.78 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.44 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 10.95 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 15.91 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.09 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.65 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 12.38 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.05 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 10.23 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 5.52 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 3.98 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 11.28 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.7 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -114.65 128.9 56.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.473 ' CE ' ' HB2' ' B' ' 146' ' ' GLN . 2.1 mpt? -82.22 153.57 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 12.85 109.874 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 3.0 Cg_exo -76.51 175.76 10.94 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.683 2.255 . . . . 13.07 110.879 172.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.92 83.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.249 0.547 . . . . 14.04 110.594 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.65 -48.02 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.864 . . . . 15.24 109.35 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.75 -28.69 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.715 -0.675 . . . . 14.64 110.14 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -121.99 145.77 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 12.42 109.677 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' HG2' HG22 ' A' ' 38' ' ' VAL . 29.6 mmmt 54.65 25.47 6.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.174 0.511 . . . . 10.84 110.79 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -60.76 -38.76 86.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.21 -0.905 . . . . 9.63 111.784 -171.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -152.02 155.2 37.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.907 -0.405 . . . . 9.56 109.907 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.66 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.685 -0.234 . . . . 8.3 111.203 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -91.37 71.93 6.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 8.55 110.484 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.5 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.01 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.6 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 5.62 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.03 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.15 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 6.72 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 5.99 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.39 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 7.73 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.668 ' HB2' HG21 ' A' ' 47' ' ' VAL . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.32 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.57 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.06 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.7 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD21 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.21 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.63 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 1.032 ' HA ' HG12 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.58 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.752 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.79 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.781 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.49 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.26 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.1 111.638 -168.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.781 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 5.97 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.866 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.38 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 7.75 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.579 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 7.82 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.11 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 8.81 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 8.87 111.947 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 5.87 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.14 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.17 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.585 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.6 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.866 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.05 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.15 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.46 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -76.51 -24.25 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.04 109.507 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 t30 58.64 89.65 0.1 Allowed Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 114.797 -1.092 . . . . 5.09 111.467 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.79 -49.05 3.32 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.783 2.322 . . . . 6.48 112.578 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 m -96.88 102.58 14.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 7.32 111.246 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.2 m -98.09 129.37 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.173 -0.467 . . . . 6.13 110.732 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -146.98 71.11 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.283 0.563 . . . . 9.68 110.812 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.59 -55.96 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.54 110.208 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -101.45 -52.96 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 9.88 110.119 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.86 -81.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.821 -0.627 . . . . 9.93 112.393 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.746 0.308 . . . . 12.88 110.308 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.934 0.397 . . . . 13.85 111.128 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 45.6 m -157.25 156.88 33.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.29 -0.868 . . . . 12.37 109.193 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -95.81 147.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.753 -0.379 . . . . 12.02 110.159 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -141.15 161.48 37.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.274 -0.421 . . . . 10.42 110.283 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -69.94 138.29 52.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.86 -0.609 . . . . 8.13 110.459 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 106' ' ' ARG . 18.5 mtm180 -79.26 -39.2 33.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.106 0.479 . . . . 10.78 110.141 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 128.28 47.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 8.36 110.392 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -107.24 93.64 4.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.092 0.473 . . . . 8.99 110.736 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -89.58 -30.08 18.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 8.32 110.304 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.28 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.12 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 5.93 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 4.62 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.32 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 1.032 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.43 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 3.93 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.3 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 5.76 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.08 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' B' ' 121' ' ' LYS . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 8.78 108.72 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.27 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.06 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.68 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 4.71 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.585 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.03 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.48 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 2.83 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.771 ' HA ' HD23 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.33 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.34 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.38 110.83 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 74.1 mtm -124.4 104.64 31.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.725 -0.843 . . . . 9.64 108.725 170.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 10.5 Cg_exo -71.87 -18.99 27.66 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.153 2.569 . . . . 9.8 113.53 -173.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 136' ' ' ALA . 46.2 mt-10 -140.37 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.536 0.208 . . . . 12.27 110.96 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' B' ' 135' ' ' GLU . . . 73.07 -71.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.049 0.843 . . . . 11.49 111.85 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.26 -20.94 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.071 0.462 . . . . 11.38 110.909 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' B' ' 139' ' ' LYS . 7.3 p -121.95 162.77 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.634 . . . . 9.65 109.807 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' B' ' 138' ' ' VAL . 7.6 mmmm 51.77 -94.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.701 0.625 . . . . 11.11 111.91 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 33.4 m 60.57 -90.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.045 -0.98 . . . . 8.66 111.783 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -125.91 103.07 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.395 . . . . 9.44 110.306 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.04 7.53 46.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.002 -0.545 . . . . 8.63 110.972 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -87.63 97.6 10.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.085 -0.507 . . . . 9.61 109.83 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -163.04 125.93 2.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.171 0.51 . . . . 8.97 111.581 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 7.97 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 9.5 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 10.78 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.442 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.24 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 13.51 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.75 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.03 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.453 ' C ' HD12 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 9.95 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 6.89 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.24 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 8.35 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 12.73 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.537 ' HB3' HD23 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 10.48 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.564 ' HA ' HG12 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 10.82 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.533 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.67 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 11.91 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 12.55 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.47 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.15 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.56 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.734 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.74 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.14 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 15.89 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 11.57 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.734 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 9.65 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.46 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.24 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 7.89 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 11.87 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.622 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -137.16 42.04 2.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' ASN . . . . . 0.531 ' O ' HG13 ' B' ' 195' ' ' VAL . 0.3 OUTLIER -52.68 141.86 34.35 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.818 -0.628 . . . . 13.52 111.781 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -35.26 86.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.336 2.691 . . . . 14.9 113.226 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 9.5 m -82.97 88.7 6.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.079 0.466 . . . . 17.54 110.641 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 195' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 192' ' ' ASN . 6.2 m -119.02 147.23 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.493 0.663 . . . . 18.06 112.004 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -102.51 97.29 7.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.027 -0.988 . . . . 21.28 108.766 171.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 59.57 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.883 -0.599 . . . . 21.53 110.927 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -131.67 14.59 4.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 23.03 109.998 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.46 -35.51 2.16 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.979 -0.849 . . . . 24.72 110.979 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.842 -0.599 . . . . 27.31 109.557 178.387 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.061 0.458 . . . . 29.42 110.303 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -71.77 -36.83 70.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 26.59 110.474 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 59.45 30.4 20.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.617 0.722 . . . . 25.53 109.998 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -63.99 126.02 26.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.231 -0.895 . . . . 23.29 110.673 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -75.73 92.42 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.156 0.503 . . . . 21.2 110.31 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -86.01 114.45 22.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.827 -0.624 . . . . 20.05 109.691 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.21 110.66 1.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 16.73 111.66 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -135.66 83.9 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.726 . . . . 16.22 109.737 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.52 -24.46 17.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 13.24 109.82 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -114.93 120.6 40.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.328 -0.851 . . . . 10.33 109.783 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 14.9 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.71 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.626 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 9.66 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 7.46 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 6.87 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 6.78 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.44 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.728 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 10.95 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 15.91 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.09 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.65 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 12.38 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.05 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.751 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 10.23 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 5.52 112.518 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 3.98 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 11.28 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.58 139.05 40.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.38 114.77 2.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.95 -1.023 . . . . 12.85 109.187 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 1.04 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 42.4 Cg_exo -57.93 151.49 56.94 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.436 2.09 . . . . 13.07 111.212 175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 43.3 tt0 76.77 -33.61 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.388 0.675 . . . . 14.04 111.66 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.25 -64.85 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.74 0.305 . . . . 15.24 110.495 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' B' ' 145' ' ' TYR . . . -95.14 -42.76 8.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.179 0.514 . . . . 14.64 110.178 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.04 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 66.2 t -81.64 102.85 7.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 12.42 109.853 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.66 11.63 24.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 10.84 110.54 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 t -100.88 4.23 42.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 9.63 110.883 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.83 1.84 48.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.435 . . . . 9.56 111.74 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.11 106.77 18.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.187 0.518 . . . . 8.3 110.982 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.28 95.4 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 8.55 109.756 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.5 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HA ' ' HB1' ' B' ' 137' ' ' ALA . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.01 112.362 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.6 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 5.62 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.03 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.15 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 6.72 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 5.99 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.39 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 7.73 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.32 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.57 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.06 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.7 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.21 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.63 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.58 113.122 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.847 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.79 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.49 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.26 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.1 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 5.97 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.38 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 7.75 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 7.82 110.417 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.11 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 8.81 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 8.87 111.783 -168.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 5.87 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.14 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.17 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.6 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.05 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.15 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.622 ' O ' ' HB3' ' A' ' 92' ' ' ASN . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.74 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.46 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -86.71 5.55 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.04 111.364 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 88' ' ' GLU . 29.0 t30 -157.71 82.7 2.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.252 -0.431 . . . . 5.09 110.704 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.83 -78.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.797 2.331 . . . . 6.48 111.354 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.9 m -126.09 76.23 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.478 0.656 . . . . 7.32 110.711 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.9 133.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.587 -0.894 . . . . 6.13 108.587 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -92.67 95.4 9.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.053 -0.351 . . . . 9.68 110.053 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.09 -77.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.026 0.829 . . . . 8.54 111.46 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 t -150.39 147.54 27.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.746 -0.835 . . . . 9.88 108.746 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.48 88.16 0.47 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.224 -0.988 . . . . 9.93 113.276 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.193 0.521 . . . . 12.88 109.967 174.174 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.99 0.424 . . . . 13.85 110.528 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -116.53 95.34 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.451 . . . . 12.37 109.908 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.0 31.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.004 0.43 . . . . 12.02 110.984 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 41.3 m 68.39 86.25 0.13 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.202 -0.908 . . . . 10.42 112.494 175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -83.28 119.66 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.674 -0.861 . . . . 8.13 108.674 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -77.21 93.32 3.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.42 0.628 . . . . 10.78 111.164 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -86.47 110.08 19.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 8.36 110.263 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -96.75 0.13 49.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.916 -0.584 . . . . 8.99 110.473 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.86 156.88 16.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 8.32 110.981 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.28 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.12 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 5.93 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 4.62 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.74 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.32 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.847 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.43 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 3.93 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.3 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 5.76 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.691 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.08 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 8.78 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.27 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.06 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.68 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 4.71 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.73 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.03 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 126' ' ' TRP . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.48 112.563 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 2.83 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.33 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.509 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.34 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.08 149.71 27.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' MET . . . . . 0.588 ' HB3' ' HB3' ' B' ' 136' ' ' ALA . 43.8 tpp -160.74 109.51 1.31 Allowed Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.324 -0.991 . . . . 9.64 108.324 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.35 -6.24 8.12 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.64 2.893 . . . . 9.8 113.892 -171.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -128.94 17.19 6.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.934 0.397 . . . . 12.27 110.635 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' B' ' 133' ' ' MET . . . -143.95 -54.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.41 . . . . 11.49 111.159 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 45' ' ' TYR . . . -77.85 -75.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 11.38 109.417 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -78.7 111.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.163 -0.68 . . . . 9.65 109.163 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -79.67 116.74 20.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.063 0.458 . . . . 11.11 111.187 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 20.9 p -121.22 17.56 11.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.833 0.825 . . . . 8.66 109.066 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 11.9 m -77.0 102.51 6.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.734 -1.121 . . . . 9.44 111.23 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.82 110.32 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.014 -0.539 . . . . 8.63 109.556 174.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.55 -55.14 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.956 0.407 . . . . 9.61 110.996 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -136.88 158.58 44.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 8.97 110.762 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 7.97 109.886 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 9.5 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' B' ' 158' ' ' LEU . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 10.78 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.751 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.24 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLY . . . . . 0.434 ' H ' ' HH2' ' A' ' 26' ' ' TRP . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 13.51 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.75 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.03 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 9.95 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 6.89 110.839 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.24 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 8.35 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 12.73 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' PHE . . . . . 0.684 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 10.48 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' PRO . . . . . 0.542 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 10.82 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' TYR . . . . . 0.792 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 11.91 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 12.55 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.47 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.15 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.56 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.74 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.14 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 15.89 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 11.57 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 9.65 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.46 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.54 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.24 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 186' ' ' LEU . . . . . 0.424 ' O ' HD23 ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 7.89 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 11.87 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -70.36 -18.48 63.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.7 135.77 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.908 0.755 . . . . 13.52 110.813 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.66 147.08 18.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.723 2.282 . . . . 14.9 112.258 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 23.8 m -49.88 106.43 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.506 0.504 . . . . 17.54 111.509 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.67 111.22 19.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 18.06 110.781 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -149.61 88.56 1.56 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.62 -0.718 . . . . 21.28 109.25 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -83.76 -71.1 0.52 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.015 -0.539 . . . . 21.53 110.313 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 6.6 p -136.79 57.84 1.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.878 -0.601 . . . . 23.03 109.815 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.92 60.25 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.48 -1.048 . . . . 24.72 110.48 -171.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 108.709 -0.849 . . . . 27.31 108.709 -177.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 14.9 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.71 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 9.66 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 7.46 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 6.87 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 6.78 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.44 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.639 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 10.95 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 15.91 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.09 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.65 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 12.38 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.05 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 10.23 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 5.52 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 3.98 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 11.28 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 . . . . . 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.622 0.601 . . . . 8.55 112.622 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.5 109.823 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' HD11 ' B' ' 130' ' ' ILE . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.01 109.975 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.6 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 5.62 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.03 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.15 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 6.72 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 49' ' ' PHE . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 5.99 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.39 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 7.73 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.32 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.57 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.06 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.7 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.21 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.63 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.58 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.79 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.49 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.26 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' ' HZ2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.1 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 5.97 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.38 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 7.75 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 7.82 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.11 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 8.81 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 8.87 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 5.87 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.14 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.17 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.6 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.05 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.15 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 91' ' ' ASN . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' B' ' 127' ' ' PRO . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.46 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 88' ' ' GLU . 5.9 p30 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.04 109.817 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . 0.414 ' HB3' HG13 ' B' ' 130' ' ' ILE . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.28 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.12 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.513 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 5.93 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 4.62 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.32 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.43 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 66' ' ' TYR . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 3.93 109.347 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.3 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 5.76 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.08 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 8.78 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.27 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.06 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.68 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 4.71 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.676 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.03 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.669 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.48 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 2.83 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.622 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.33 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.414 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.34 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.498 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.53 -0.545 . . . . 8.97 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 7.97 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 9.5 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 10.78 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.24 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 13.51 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.75 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.03 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.444 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 9.95 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 20' ' ' MET . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 6.89 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.24 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 8.35 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 12.73 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.774 ' HB3' HG21 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.499 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 10.48 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 164' ' ' PHE . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 10.82 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 11.91 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 12.55 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.47 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.15 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.56 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.74 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.14 109.624 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 15.89 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 11.57 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 9.65 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.46 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.24 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 7.89 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 11.87 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.51 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 14.9 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.71 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 9.66 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.652 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 7.46 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.616 HG21 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 6.87 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 6.78 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.44 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG3' HD11 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 10.95 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 15.91 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.09 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.65 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 12.38 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.05 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.631 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 10.23 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 5.52 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 3.98 111.522 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 11.28 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.783 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' HE21 ' B' ' 146' ' ' GLN . 17.2 mm-40 . . . . . 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.345 0.593 . . . . 8.55 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.5 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.01 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.6 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 5.62 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.03 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.15 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.846 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 6.72 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 5.99 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.39 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 7.73 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.634 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.32 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.57 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.06 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.7 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.21 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.63 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.58 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.79 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.49 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.26 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.1 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 5.97 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.38 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 7.75 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 7.82 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.11 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 8.81 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 8.87 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 5.87 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.14 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.17 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.846 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.6 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.05 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.401 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.15 110.557 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.46 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.04 112.209 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.28 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.12 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 5.93 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 4.62 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.32 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.626 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.43 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 3.93 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.3 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 5.76 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.08 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 8.78 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.27 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.06 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.68 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 4.71 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.03 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.48 111.686 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 2.83 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.33 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.34 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 109.324 -0.621 . . . . 8.97 109.324 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.783 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 7.97 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.579 HE21 ' HB2' ' A' ' 32' ' ' GLU . 23.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 9.5 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.483 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 10.78 111.098 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.652 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.24 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 13.51 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.483 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.75 109.649 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.03 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.95 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.58 ' HB2' HG21 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 6.89 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.24 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 8.35 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 12.73 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 10.48 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.575 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 10.82 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 11.91 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 12.55 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.47 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.15 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.56 106.594 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.74 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.14 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 15.89 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 11.57 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 9.65 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.46 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.456 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.24 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 7.89 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 11.87 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.607 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . 0.607 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.048 -0.353 . . . . 10.33 110.048 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 14.9 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.659 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.71 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 9.66 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 7.46 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.796 HG21 HD13 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 6.87 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 6.78 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.44 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 10.95 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 15.91 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.09 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.65 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 12.38 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 96.4 m-70 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.05 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 10.23 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 5.52 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 3.98 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 11.28 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 8.55 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.5 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.01 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.6 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 5.62 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.03 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.15 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 6.72 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 5.99 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.39 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 7.73 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.32 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.57 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.06 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.7 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.21 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.631 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.63 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.58 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.769 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.79 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.49 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.26 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.1 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 5.97 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.38 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.718 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 7.75 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 7.82 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.11 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 8.81 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 8.87 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 5.87 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.718 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.14 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.17 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.6 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.05 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.15 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.46 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.04 110.304 176.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.507 -0.553 . . . . 8.32 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.28 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.12 108.136 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.712 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 5.93 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.478 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 4.62 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.51 HD12 HG13 ' A' ' 89' ' ' ILE . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.32 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.43 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 3.93 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.3 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 5.76 111.123 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.08 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' B' ' 121' ' ' LYS . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 8.78 109.322 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.27 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.06 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.68 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 4.71 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.03 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.48 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 2.83 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.33 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.34 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.561 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.218 -0.66 . . . . 8.97 109.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 7.97 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.411 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 9.5 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 10.78 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.405 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.24 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 13.51 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.75 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.03 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 9.95 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 6.89 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.24 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 8.35 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 12.73 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.489 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 10.48 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.61 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 10.82 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.47 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.737 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 11.91 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 12.55 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.47 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.15 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.739 ' HD3' HD11 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.56 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.634 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.718 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.74 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.14 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 15.89 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 11.57 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.718 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 9.65 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.46 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.24 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.739 HD11 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 7.89 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 11.87 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.8 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.483 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.207 -0.664 . . . . 10.33 109.207 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 14.9 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.71 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 9.66 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 7.46 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 HD21 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 6.87 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' B' ' 166' ' ' TYR . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 6.78 109.939 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.44 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.848 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 10.95 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 15.91 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.09 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.848 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.65 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 12.38 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.05 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 10.23 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 5.52 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 3.98 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 11.28 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.515 -0.389 0 N-CA-C 108.232 -1.025 . . . . 8.55 108.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.5 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.01 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.593 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.6 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 5.62 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.03 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.15 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 6.72 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 5.99 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.39 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 7.73 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.32 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.57 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.06 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.7 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HG ' HG21 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.21 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.646 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.63 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.58 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.79 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.49 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.26 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.1 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 5.97 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.38 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 7.75 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 7.82 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.11 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 8.81 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 8.87 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 5.87 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.14 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.925 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.17 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.6 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.784 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.05 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.15 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.46 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.04 110.338 -172.264 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.788 0.327 . . . . 8.32 110.432 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . 0.431 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.28 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.43 ' HD3' ' OE1' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.12 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 5.93 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 4.62 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.72 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.32 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.43 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 3.93 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.3 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 5.76 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.48 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.08 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 8.78 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.27 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.48 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.06 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.68 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 4.71 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.761 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.03 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.784 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.48 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 2.83 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.33 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.34 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 111' ' ' LYS . 43.1 tt0 . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.971 -0.751 . . . . 8.97 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 7.97 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 9.5 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 10.78 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.416 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.24 110.703 -171.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 13.51 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.75 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.03 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 9.95 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 6.89 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.24 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 8.35 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 12.73 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.616 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 10.48 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.618 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 10.82 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.446 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.446 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 11.91 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 12.55 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 171' ' ' GLU . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.47 110.339 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.15 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.56 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.74 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.14 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 15.89 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 11.57 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 9.65 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.615 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.46 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.24 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 7.89 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 11.87 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.488 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . 0.488 ' N ' HD12 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.74 0.305 . . . . 10.33 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 14.9 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 30' ' ' ILE . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.71 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 9.66 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 7.46 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 6.87 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 6.78 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.44 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.706 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 10.95 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 15.91 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.09 112.43 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.65 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 12.38 113.36 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.05 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 10.23 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 5.52 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 3.98 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 11.28 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 9.3 tp10 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 CA--C 1.521 -0.168 0 N-CA-C 109.568 -0.53 . . . . 8.55 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.5 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.01 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.6 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 5.62 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.03 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.546 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.15 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 6.72 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 5.99 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.39 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 7.73 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.32 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.57 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.06 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.7 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.21 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.749 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.63 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.58 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.79 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.49 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.26 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.1 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 5.97 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.38 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 7.75 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 7.82 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.11 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 8.81 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 8.87 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 5.87 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.729 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.14 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.17 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.6 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.05 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.15 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.585 ' HA ' HD21 ' A' ' 91' ' ' ASN . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.714 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.46 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.585 HD21 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.04 111.739 -177.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.817 -0.438 . . . . 8.32 109.817 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.28 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.12 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 5.93 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 4.62 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.32 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 66' ' ' TYR . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.43 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 3.93 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.3 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.579 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 5.76 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.08 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 8.78 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.27 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.06 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.68 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 4.71 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.03 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.48 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.546 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 2.83 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.33 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.46 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.34 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.149 -0.315 . . . . 8.97 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.573 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 7.97 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 9.5 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.474 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 10.78 109.917 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.662 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.24 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 13.51 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.474 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.75 110.312 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.03 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 9.95 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 6.89 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.24 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.476 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 8.35 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 12.73 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.735 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 10.48 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 10.82 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.973 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 11.91 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 12.55 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.47 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.15 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.56 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.409 HD22 ' HE2' ' B' ' 182' ' ' PHE . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.74 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.14 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 15.89 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 11.57 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 9.65 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.46 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.24 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 7.89 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 11.87 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.678 ' HA ' HD21 ' B' ' 191' ' ' ASN . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.973 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.678 HD21 ' HA ' ' B' ' 188' ' ' GLU . 9.2 p30 . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.885 -0.413 . . . . 10.33 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 14.9 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.71 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.678 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 9.66 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 7.46 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 6.87 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 6.78 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.44 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.657 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 10.95 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 15.91 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.09 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.65 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 12.38 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.05 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 10.23 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 5.52 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 3.98 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 11.28 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.678 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.589 ' N ' HD13 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.102 0.477 . . . . 8.55 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.5 109.624 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CE2' ' HD2' ' B' ' 110' ' ' TYR . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.01 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.6 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 5.62 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.03 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.15 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 6.72 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 5.99 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.39 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 7.73 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.32 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.57 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.06 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.7 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.21 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.63 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HG11 ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.58 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.673 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.79 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.49 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.26 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.1 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 5.97 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.951 ' HB3' HD13 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.38 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 7.75 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 7.82 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.11 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 8.81 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 8.87 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 5.87 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.14 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.17 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' HD13 ' A' ' 89' ' ' ILE . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.6 111.993 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.05 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.15 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HA ' HD21 ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 HD11 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.46 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.753 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.2 p30 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.04 111.102 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.323 -0.621 . . . . 8.32 109.323 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . 0.598 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.28 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.12 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.46 ' HA ' HG23 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 5.93 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 4.62 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.533 HD11 HD11 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.32 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.595 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.43 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 3.93 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.3 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 5.76 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.595 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.08 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 8.78 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.27 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.06 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.68 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 4.71 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.03 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.48 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.33 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.34 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.644 -0.502 . . . . 8.97 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 7.97 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 9.5 108.494 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD13 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 10.78 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.472 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.24 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.737 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 13.51 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.75 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.03 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.641 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 6.89 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.24 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 8.35 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 12.73 112.052 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.618 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 10.48 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 10.82 114.302 -172.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.526 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 11.91 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 12.55 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.47 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.15 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.56 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.74 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.14 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 15.89 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 11.57 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 9.65 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.46 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.737 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.24 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.43 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 7.89 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 11.87 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD12 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 14.9 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.909 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.71 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 9.66 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 7.46 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 6.87 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 6.78 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.44 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.603 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 10.95 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 15.91 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.09 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.603 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.65 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 12.38 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.05 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.646 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 10.23 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.866 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 5.52 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 3.98 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 11.28 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.031 0.443 . . . . 8.55 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.5 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.01 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.6 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 5.62 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.03 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.15 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 6.72 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 5.99 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.39 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 7.73 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.32 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.57 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.06 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.7 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.21 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.63 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.612 ' HA ' HG12 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.58 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.587 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.79 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.542 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.49 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.26 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.1 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 5.97 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.38 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 7.75 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 7.82 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.11 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 8.81 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 8.87 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 5.87 113.107 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.14 110.738 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.17 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.6 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.05 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.402 ' HA ' HD22 ' A' ' 91' ' ' ASN . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.15 110.033 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.803 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.46 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' N ' HD13 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 87' ' ' TRP . 10.6 m-80 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.04 110.459 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.008 0.432 . . . . 8.32 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.28 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.12 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 5.93 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 4.62 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.803 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.32 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.43 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 3.93 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.3 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 5.76 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.504 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.08 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 8.78 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.27 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.06 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.68 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 4.71 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.03 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.48 112.532 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.453 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 2.83 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.604 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.33 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.34 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 121.166 0.508 . . . . 8.97 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 7.97 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 9.5 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.429 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 10.78 111.234 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.529 ' HE2' HD11 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.24 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 13.51 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.75 108.897 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.03 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 9.95 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 6.89 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.24 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 8.35 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 12.73 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.702 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 10.48 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.484 ' HA ' HG11 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 10.82 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 11.91 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 12.55 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.47 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.15 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' B' ' 175' ' ' LYS . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.56 108.694 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.657 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.74 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.14 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 15.89 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 11.57 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.657 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 9.65 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.46 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.646 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.24 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 7.89 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 11.87 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' N ' ' HH ' ' B' ' 145' ' ' TYR . 74.4 m-85 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 14.9 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.71 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 9.66 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 7.46 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 6.87 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 6.78 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.44 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 10.95 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 15.91 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.09 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.65 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 12.38 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.05 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.819 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 10.23 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 5.52 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 3.98 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 11.28 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.752 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' A' ' 44' ' ' LYS . 3.1 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.662 0.268 . . . . 8.55 110.909 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.01 108.745 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.6 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 5.62 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.03 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.15 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 6.72 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 5.99 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.39 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 7.73 110.521 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.729 ' HB2' HG21 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.32 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.57 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.06 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.7 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.21 110.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.63 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' HG11 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.58 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.79 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.49 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.26 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.1 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 5.97 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.38 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 7.75 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 7.82 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.11 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 8.81 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 8.87 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 5.87 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.624 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.14 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.17 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.619 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.6 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.05 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.15 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.676 ' HA ' HD21 ' A' ' 91' ' ' ASN . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.46 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.676 HD21 ' HA ' ' A' ' 88' ' ' GLU . 3.6 p30 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.04 110.033 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.571 0.224 . . . . 8.32 111.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.28 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.12 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 5.93 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.436 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 4.62 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.32 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.43 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 3.93 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.3 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 5.76 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.441 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.08 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 8.78 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.27 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.06 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.68 113.42 -173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 4.71 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.619 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.03 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.463 ' HB2' HG13 ' A' ' 89' ' ' ILE . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.48 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 2.83 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.33 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.641 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.34 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.641 ' N ' HD13 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 8.97 110.144 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.579 ' HH ' ' N ' ' A' ' 10' ' ' TYR . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 7.97 109.408 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 9.5 108.871 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 10.78 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.24 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.819 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 2.6 t60 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 13.51 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.75 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.03 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 9.95 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.62 ' HB2' HG21 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 6.89 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.24 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 8.35 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 12.73 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.65 HD21 HG21 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 10.48 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG12 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 10.82 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.476 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 11.91 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 12.55 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.47 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.464 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.15 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.56 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.613 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.405 HD22 ' C ' ' B' ' 176' ' ' PRO . 1.0 OUTLIER -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.74 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.14 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 15.89 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 11.57 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 9.65 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.46 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.24 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 7.89 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 11.87 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . 0.412 ' N ' HD12 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.661 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 10.33 110.089 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 14.9 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.71 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 9.66 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 HD11 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 7.46 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 6.87 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 6.78 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.44 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.672 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 10.95 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 15.91 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.09 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.672 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.65 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 12.38 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.05 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 10.23 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 5.52 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 3.98 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 11.28 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' HD13 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.09 0.471 . . . . 8.55 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.5 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.475 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.01 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.6 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 5.62 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.03 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.612 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.15 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 6.72 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 5.99 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.39 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 7.73 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.32 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.57 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.06 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.7 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.21 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.63 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.58 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.79 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.49 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.26 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.1 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 5.97 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.38 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 7.75 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 7.82 109.748 -176.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.11 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 8.81 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 8.87 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 5.87 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.14 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.17 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.6 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.05 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.15 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.46 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.04 110.58 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.477 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.28 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.12 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 5.93 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 4.62 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.32 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.832 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.43 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.558 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 3.93 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 63' ' ' LEU . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.3 110.877 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 5.76 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.589 ' HG3' HD21 ' A' ' 58' ' ' LEU . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.08 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 8.78 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.27 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.433 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.06 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.68 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . 0.558 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 4.71 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.03 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.48 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.83 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.668 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.33 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.34 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.722 -0.473 . . . . 8.97 109.722 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 7.97 110.763 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 9.5 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 10.78 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.671 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.473 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.24 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 13.51 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.75 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.03 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 9.95 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.674 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 6.89 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.24 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 8.35 112.069 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 12.73 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.891 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.58 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 10.48 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.515 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 10.82 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 11.91 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 12.55 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.47 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.15 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.667 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.45 ' HB2' ' NZ ' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.56 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.74 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.14 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 15.89 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 11.57 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 9.65 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.46 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.492 ' O ' HD13 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.24 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.667 HD11 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 7.89 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 11.87 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.673 ' HA ' HD21 ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.673 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 14.9 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.71 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 9.66 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 7.46 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 6.87 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 6.78 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.44 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 10.95 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 15.91 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.09 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.65 109.783 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 12.38 112.789 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.05 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 10.23 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 5.52 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 3.98 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.738 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 11.28 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.964 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 30.8 t30 . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.744 -0.465 . . . . 8.55 109.744 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.01 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.6 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 5.62 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.03 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.15 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 6.72 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 5.99 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.39 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 7.73 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.32 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.57 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.06 111.181 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.7 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.525 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.21 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.75 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.63 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.58 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.79 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.49 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.26 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.1 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 5.97 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.38 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 7.75 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 7.82 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.11 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 8.81 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 8.87 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 5.87 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.14 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.17 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.6 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.05 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.15 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.764 ' HA ' HD21 ' A' ' 91' ' ' ASN . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.46 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.764 HD21 ' HA ' ' A' ' 88' ' ' GLU . 2.7 p30 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.04 110.367 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.048 -0.353 . . . . 8.32 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.28 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.409 ' HG3' ' OD2' ' B' ' 114' ' ' ASP . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.12 111.153 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 5.93 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 4.62 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' B' ' 111' ' ' LYS . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.32 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.75 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.43 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 3.93 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.3 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 5.76 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.08 108.237 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 8.78 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.27 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.06 110.514 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.68 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 4.71 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.03 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.48 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 2.83 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.64 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.33 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.441 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.34 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 8.97 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.689 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 7.97 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 9.5 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 10.78 109.865 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.24 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 13.51 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.75 109.574 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.03 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 9.95 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 6.89 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.24 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.689 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 8.35 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 12.73 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 10.48 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 10.82 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 11.91 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 12.55 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.47 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.15 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.56 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.74 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.14 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 15.89 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 11.57 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 9.65 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.46 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.24 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 7.89 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 11.87 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.791 ' HA ' HD21 ' B' ' 191' ' ' ASN . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.791 HD21 ' HA ' ' B' ' 188' ' ' GLU . 5.6 p30 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 75.9 m-85 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.67 0.272 . . . . 10.33 110.616 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 14.9 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.71 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 9.66 112.749 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.671 HD23 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 7.46 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.591 HG11 HD21 ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 6.87 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.747 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 6.78 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.44 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.811 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 10.95 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 15.91 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.09 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.65 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 12.38 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 94.9 m-70 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.05 110.205 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.622 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 10.23 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 5.52 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 3.98 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 11.28 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD13 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 15.7 pt-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.235 0.541 . . . . 8.55 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.5 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.01 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 8.5 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.6 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 5.62 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.896 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.03 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.15 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 6.72 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 5.99 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.39 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 7.73 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.32 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.57 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.06 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.7 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD21 HG21 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.21 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.63 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.824 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.58 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.79 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.49 112.978 -168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.794 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.26 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.698 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.1 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 5.97 110.807 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.38 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.615 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 7.75 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 7.82 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.11 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 8.81 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 8.87 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 5.87 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.14 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.17 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.6 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.05 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.15 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.593 HG22 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.46 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 88' ' ' GLU . 10.1 p30 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.04 110.491 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.012 0.434 . . . . 8.32 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.28 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.12 111.315 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 5.93 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 4.62 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.32 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.43 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 3.93 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.3 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 5.76 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.521 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.08 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 8.78 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.27 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.06 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.68 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 4.71 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.896 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.03 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.48 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 2.83 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.33 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.536 HG12 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.34 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.648 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.702 -0.481 . . . . 8.97 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 7.97 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 9.5 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 10.78 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.671 ' HE2' HD23 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.24 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 13.51 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.75 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.03 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 9.95 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.66 ' HB2' HG21 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 6.89 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.24 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 8.35 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 12.73 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 10.48 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 10.82 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.472 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 11.91 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 12.55 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.47 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.15 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.56 108.23 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.74 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.14 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 15.89 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 11.57 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.416 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 9.65 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.46 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.24 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 7.89 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 11.87 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.533 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 14.9 110.868 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.71 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 9.66 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 7.46 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 6.87 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 6.78 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HA ' HD23 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.44 110.892 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 10.95 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 15.91 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.09 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.65 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 12.38 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.05 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 10.23 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 26' ' ' TRP . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 5.52 112.698 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 3.98 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 11.28 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.751 0.31 . . . . 8.55 111.251 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.5 109.745 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.01 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.6 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 5.62 110.975 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.03 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.655 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.15 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.535 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 6.72 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 48' ' ' PHE . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 5.99 109.783 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.39 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 7.73 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.32 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.57 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.06 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.7 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.512 HD11 HG23 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.21 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.63 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.58 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.79 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.49 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.26 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.1 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 5.97 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.38 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 7.75 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 7.82 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.11 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 8.81 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 8.87 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' HG22 ' A' ' 52' ' ' THR . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 5.87 112.492 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.14 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.17 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.6 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.05 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.15 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.46 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.9 p30 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.04 109.96 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.588 0.233 . . . . 8.32 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.28 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.12 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 5.93 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 4.62 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.462 HD22 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.32 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.43 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 3.93 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.3 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 5.76 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.459 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.08 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 8.78 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.27 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.535 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.06 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.432 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.68 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 4.71 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.786 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.03 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.48 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.462 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 2.83 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.649 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.33 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.414 HD13 ' H ' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.34 112.004 -173.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.718 ' HA ' ' HB3' ' A' ' 45' ' ' TYR . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.912 0.387 . . . . 8.97 110.49 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 7.97 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 10.78 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.24 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 13.51 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.75 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.03 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 9.95 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG21 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 6.89 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.24 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 8.35 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 12.73 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.822 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 10.48 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 10.82 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 167' ' ' GLU . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 11.91 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 12.55 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.47 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.15 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.56 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.557 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.74 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.14 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 15.89 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 11.57 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.557 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 9.65 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.46 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.441 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.24 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 7.89 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . 0.434 ' HA ' HD22 ' B' ' 191' ' ' ASN . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 11.87 110.435 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' B' ' 187' ' ' TRP . 15.7 m-80 . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.467 -0.197 . . . . 10.33 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 14.9 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.71 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 30' ' ' ILE . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 9.66 112.624 -173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 7.46 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 6.87 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.651 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 6.78 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.44 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 10.95 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 15.91 109.293 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.09 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.65 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 12.38 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.05 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.51 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 10.23 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 5.52 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 3.98 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 11.28 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 30' ' ' ILE . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.604 0.24 . . . . 8.55 111.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.5 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.01 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 24.4 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.6 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 5.62 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.03 110.091 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.15 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 6.72 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 5.99 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.39 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 7.73 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.32 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.57 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.06 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.7 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 HG21 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.21 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.63 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.58 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.79 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.712 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.49 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.26 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.712 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.1 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 5.97 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.38 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 7.75 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.703 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 7.82 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.11 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 8.81 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 8.87 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 5.87 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.14 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.17 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.6 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.05 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.15 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.46 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.04 110.642 -179.25 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.28 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.706 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.12 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 5.93 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 4.62 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.617 HD23 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.32 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.617 ' N ' HD23 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.43 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 3.93 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.3 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 5.76 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.08 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 8.78 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.27 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.06 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.68 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 4.71 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.481 ' CZ3' ' HD1' ' B' ' 123' ' ' TYR . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.03 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.48 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 2.83 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.33 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.706 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.34 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 132' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.577 ' NZ ' ' HB3' ' B' ' 144' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.999 -0.371 . . . . 8.97 109.999 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.464 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 7.97 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 9.5 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 10.78 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.24 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.487 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 13.51 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.75 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.03 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 9.95 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 6.89 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.24 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.464 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 8.35 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 12.73 111.061 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 10.48 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 10.82 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.661 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.537 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 11.91 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 12.55 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.47 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.15 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.56 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.74 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.14 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 15.89 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 11.57 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 9.65 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.46 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.24 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 7.89 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 11.87 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.736 ' HA ' HD21 ' B' ' 191' ' ' ASN . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.736 HD21 ' HA ' ' B' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.624 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.9 m-85 . . . . . 0 C--O 1.217 -0.64 0 N-CA-C 110.531 -0.174 . . . . 10.33 110.531 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 14.9 113.375 -171.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.71 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 9.66 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 7.46 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 6.87 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 6.78 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.44 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.614 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 10.95 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 15.91 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.09 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.65 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 12.38 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.05 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 10.23 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 5.52 112.526 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 3.98 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 11.28 109.56 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.141 HD11 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' H ' HD13 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.667 0.746 . . . . 8.55 109.117 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.5 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.01 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.6 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.89 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 5.62 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.03 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.15 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 6.72 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 5.99 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.39 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 7.73 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.32 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.57 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.06 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.7 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD21 HG21 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.21 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.63 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.58 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.667 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.79 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.49 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.26 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.1 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 5.97 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.38 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 7.75 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 7.82 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.11 112.01 -176.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 8.81 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 8.87 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 5.87 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.14 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.17 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.541 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.6 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.05 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.15 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 HD21 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.46 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.04 111.704 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.009 0.433 . . . . 8.32 110.732 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.28 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.12 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 5.93 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 4.62 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.32 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.884 HG21 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.43 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 3.93 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.3 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 5.76 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.544 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.08 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 8.78 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.27 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.06 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.68 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 4.71 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.705 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.03 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.48 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 2.83 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.33 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.34 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.809 -0.441 . . . . 8.97 109.809 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 1.141 ' HB3' HD11 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 7.97 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 9.5 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 10.78 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.484 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.24 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 13.51 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.75 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.03 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 9.95 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 6.89 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.24 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 8.35 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 12.73 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.497 HD11 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.513 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 10.48 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.555 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 10.82 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.541 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 11.91 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 12.55 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.47 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.15 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.56 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 3.0 t-20 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.74 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' B' ' 182' ' ' PHE . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.14 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 15.89 109.499 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 11.57 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 9.65 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.46 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.623 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.24 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 7.89 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 11.87 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . 0.496 ' N ' HD13 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.118 -0.327 . . . . 10.33 110.118 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.7 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 14.9 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.71 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 9.66 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.591 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 7.46 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 6.87 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 6.78 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.44 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 10.95 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 15.91 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.09 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.65 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 12.38 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.05 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 10.23 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 5.52 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 3.98 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 11.28 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.7 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.671 0.748 . . . . 8.55 110.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.5 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.01 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.6 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 5.62 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.03 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.15 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 6.72 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 5.99 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.39 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 7.73 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.668 ' HB2' HG21 ' A' ' 47' ' ' VAL . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.32 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.57 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.06 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.7 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD21 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.21 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.63 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 1.032 ' HA ' HG12 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.58 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.752 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.79 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.781 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.49 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.26 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.1 111.638 -168.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.781 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 5.97 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.866 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.38 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 7.75 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.579 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 7.82 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.11 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 8.81 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 8.87 111.947 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 5.87 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.14 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.17 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.585 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.6 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.866 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.05 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.15 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.46 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.04 109.507 175.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.205 0.526 . . . . 8.32 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.28 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.12 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 5.93 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 4.62 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.32 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 1.032 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.43 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 3.93 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.3 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 5.76 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.08 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' B' ' 121' ' ' LYS . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 8.78 108.72 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.27 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.06 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.68 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 4.71 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.585 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.03 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.48 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 2.83 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.771 ' HA ' HD23 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.33 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.34 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.171 0.51 . . . . 8.97 111.581 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 7.97 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 9.5 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 10.78 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.442 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.24 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 13.51 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.75 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.03 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.453 ' C ' HD12 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 9.95 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 6.89 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.24 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 8.35 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 12.73 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.537 ' HB3' HD23 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 10.48 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.564 ' HA ' HG12 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 10.82 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.533 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . 0.67 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 11.91 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 12.55 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.47 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.15 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.56 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.734 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . 0.489 ' N ' HD22 ' B' ' 177' ' ' ASN . 0.8 OUTLIER -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.74 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.14 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 15.89 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 11.57 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.734 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 9.65 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.46 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.24 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 7.89 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 11.87 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.622 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.783 -0.451 . . . . 10.33 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 14.9 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.71 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.626 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 9.66 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 7.46 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 6.87 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 6.78 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.44 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.728 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 10.95 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 15.91 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.09 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.65 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 12.38 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.05 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.751 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 10.23 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 5.52 112.518 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 3.98 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 11.28 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.756 -0.461 . . . . 8.55 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.5 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.01 112.362 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.6 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 5.62 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.03 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.15 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 6.72 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 5.99 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.39 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 7.73 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.32 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.57 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.06 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.7 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.21 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.63 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.58 113.122 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.847 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.79 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.49 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.26 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.1 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 5.97 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.38 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 7.75 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 7.82 110.417 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.11 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 8.81 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 8.87 111.783 -168.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 5.87 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.14 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.17 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.6 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.05 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.15 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.643 ' HA ' HD21 ' A' ' 91' ' ' ASN . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.74 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.46 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.04 111.364 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 120.943 0.401 . . . . 8.32 110.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.28 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.12 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 5.93 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 4.62 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.74 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.32 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.847 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.43 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 3.93 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.3 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 5.76 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.691 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.08 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 8.78 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.27 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.06 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.68 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 4.71 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.73 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.03 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 126' ' ' TRP . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.48 112.563 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 2.83 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.33 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.509 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.34 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.772 0.32 . . . . 8.97 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 7.97 109.886 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 9.5 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' B' ' 158' ' ' LEU . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 10.78 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.751 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.24 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' GLY . . . . . 0.434 ' H ' ' HH2' ' A' ' 26' ' ' TRP . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 13.51 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.75 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.03 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 9.95 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 6.89 110.839 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.24 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 8.35 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 12.73 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' PHE . . . . . 0.684 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 10.48 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' PRO . . . . . 0.542 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 10.82 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' TYR . . . . . 0.792 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 11.91 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 12.55 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.47 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.15 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.56 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.74 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.14 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 15.89 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 11.57 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 9.65 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.46 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' GLY . . . . . 0.54 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.24 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' LEU . . . . . 0.424 ' O ' HD23 ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 7.89 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 11.87 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' ASN . . . . . 0.459 HD22 ' N ' ' B' ' 191' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.786 0.327 . . . . 29.42 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p -102.17 148.65 25.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.897 -0.409 . . . . 26.59 109.897 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 3' ' ' ARG . 40.9 ttp180 -106.88 137.84 44.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.318 . . . . 25.53 110.379 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -89.17 173.27 8.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.094 -0.503 . . . . 23.29 111.121 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -117.63 122.94 44.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.87 -0.605 . . . . 21.2 109.883 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -98.96 -16.98 18.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.613 0.244 . . . . 20.05 111.151 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -77.83 111.1 13.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 16.73 109.975 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -102.89 -17.6 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.789 -0.641 . . . . 16.22 110.639 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.36 134.41 51.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.435 0.636 . . . . 13.24 111.736 -173.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB3' ' OD2' ' A' ' 14' ' ' ASP . 70.6 m-85 -80.2 148.64 30.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.79 -1.189 . . . . 10.33 107.79 168.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 13' ' ' GLY . 97.8 mttt -66.92 115.23 6.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 14.9 109.25 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.6 m 66.3 -46.55 0.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.979 0.799 . . . . 11.71 110.663 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 158.03 -16.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.123 -0.791 . . . . 9.66 111.123 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 10' ' ' TYR . 6.1 m-20 58.02 -149.76 0.45 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 10.47 112.101 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' B' ' 189' ' ' ILE . 3.2 tm? -113.75 129.14 56.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 7.46 109.333 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' B' ' 163' ' ' LEU . 2.8 m -154.31 -174.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 6.87 111.139 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.12 113.46 25.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.154 -0.684 . . . . 6.78 109.154 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' B' ' 158' ' ' LEU . . . -93.65 140.14 29.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.871 -0.604 . . . . 6.21 111.121 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HE2' ' B' ' 164' ' ' PHE . 46.5 tttt -105.73 103.93 13.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.002 -0.544 . . . . 12.44 109.756 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.639 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.5 tmm? -110.64 173.07 6.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.447 -0.575 . . . . 10.95 109.447 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -65.64 116.69 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.498 -0.556 . . . . 15.91 109.498 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.38 -0.64 87.18 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.804 -0.713 . . . . 14.09 112.604 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 59.1 m-85 -126.18 95.41 39.09 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 122.63 -0.335 . . . . 13.65 110.474 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.2 88.52 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.901 2.401 . . . . 12.38 112.87 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.4 m80 69.49 81.32 0.17 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.665 -0.698 . . . . 11.05 110.385 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 2.0 t-105 -121.44 131.18 24.51 Favored Pre-proline 0 N--CA 1.44 -0.946 0 CA-C-N 115.524 -0.762 . . . . 10.23 109.357 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.87 113.55 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.844 2.363 . . . . 5.52 112.172 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.9 152.36 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.605 . . . . 3.98 110.984 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.2 ttt180 -115.27 152.62 32.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 11.28 110.867 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -82.21 154.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 7.51 110.89 -178.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 30' ' ' ILE . 38.7 t70 -145.17 138.15 26.36 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.213 -0.662 . . . . 10.28 109.213 174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 58.8 mm-40 75.02 172.48 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.972 0.795 . . . . 10.44 111.647 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.9 tpt -166.41 94.8 0.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 12.85 109.517 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.74 87.01 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.084 2.523 . . . . 13.07 112.576 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -140.79 -21.61 0.8 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 14.04 111.733 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 94.45 3.71 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 111.527 0.195 . . . . 15.24 111.527 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.709 . . . . 14.64 111.188 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.26 141.45 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.684 -0.488 . . . . 12.42 109.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -102.84 -47.72 4.3 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.795 -0.817 . . . . 10.84 108.795 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 m -168.86 138.41 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.812 -1.085 . . . . 9.63 109.367 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 m -68.3 101.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.978 -0.378 . . . . 9.56 109.978 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -122.96 142.0 51.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.137 -0.483 . . . . 8.3 110.554 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.36 7.98 0.55 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.477 1.111 . . . . 8.55 112.622 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 43.2 mmtm -96.78 138.56 34.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.823 -0.436 . . . . 7.5 109.823 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' HD11 ' B' ' 130' ' ' ILE . 98.3 m-85 -93.29 139.43 30.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.214 -0.448 . . . . 6.01 109.975 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.06 97.53 6.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.478 0.656 . . . . 6.99 109.429 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 58' ' ' LEU . 89.6 t -93.83 104.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.506 -0.77 . . . . 4.6 109.971 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -92.84 109.14 20.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.307 -0.406 . . . . 5.62 110.095 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.2 m-85 -61.0 116.6 4.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.888 -0.596 . . . . 4.03 110.584 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -62.54 -52.79 62.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.536 -1.211 . . . . 4.15 112.223 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -79.65 -52.7 4.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.912 -0.661 . . . . 5.0 113.396 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 p -76.58 3.38 11.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.148 0.474 . . . . 5.56 111.42 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.3 p80 42.23 49.83 4.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.422 1.089 . . . . 6.72 112.292 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 49' ' ' PHE . 12.9 pt-20 -124.7 134.97 52.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 6.33 111.377 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 m -86.19 126.46 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.042 -0.526 . . . . 5.99 110.562 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.53 31.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.044 -0.526 . . . . 5.39 110.111 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.69 117.81 31.87 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.812 -0.44 . . . . 7.73 109.812 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -132.81 175.71 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.101 -0.5 . . . . 5.32 110.644 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.88 -178.94 19.19 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.335 -0.706 . . . . 5.57 111.335 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 32.1 Cg_exo -58.49 -39.67 81.31 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 6.06 112.64 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.87 -14.27 59.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 7.7 110.747 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -89.79 -0.52 57.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.444 . . . . 5.82 110.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' B' ' 116' ' ' VAL . 25.8 mt -123.72 121.35 35.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.861 -0.608 . . . . 4.21 110.866 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 93.5 m-85 -115.46 119.21 38.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 4.63 111.738 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' B' ' 116' ' ' VAL . 18.1 Cg_exo -66.65 118.49 5.58 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.345 2.697 . . . . 4.58 113.522 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' B' ' 115' ' ' LEU . 23.6 p90 -81.79 -13.63 57.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.34 -0.391 . . . . 4.79 110.669 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -51.84 -34.33 40.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.212 0.53 . . . . 6.1 110.2 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.27 -43.94 3.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 6.71 111.142 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 64.0 m -91.82 17.84 8.54 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.099 0.778 . . . . 5.49 113.099 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 10.7 ptpp? -49.21 -35.97 18.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.046 0.451 . . . . 6.26 111.367 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HG2' ' HD1' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -78.2 -19.13 54.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.983 -0.553 . . . . 7.73 111.796 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' ' HZ2' ' A' ' 72' ' ' LYS . 3.5 ttmp? -84.01 -34.56 24.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 8.1 111.196 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -110.25 -31.91 7.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.931 0.345 . . . . 5.97 111.931 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.85 -115.39 1.93 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.474 -0.393 . . . . 6.74 112.578 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 86' ' ' LEU . 37.5 mtmm -136.32 92.73 15.34 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.826 -1.176 . . . . 8.38 107.826 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 36.5 Cg_endo -75.36 -19.66 16.9 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.802 2.335 . . . . 7.75 113.655 -172.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.57 144.51 48.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.813 0.34 . . . . 7.82 110.372 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.25 88.9 2.9 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.36 0.6 . . . . 10.11 109.728 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.505 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 96.7 mtt180 -130.14 152.72 49.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.367 -0.975 . . . . 8.81 108.367 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.21 -45.34 93.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.231 -0.188 . . . . 8.87 111.243 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -35.79 32.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.469 -0.872 . . . . 5.87 111.923 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 79' ' ' ARG . 30.6 t80 -63.43 -56.46 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.578 0.228 . . . . 5.14 110.823 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.4 m -65.72 -38.57 89.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.389 . . . . 6.17 110.937 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.41 -46.05 81.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.095 -0.242 . . . . 6.87 110.598 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -69.52 -41.54 76.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.101 -1.047 . . . . 4.6 111.934 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 2.2 tt -69.64 -28.92 66.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.729 -0.471 . . . . 5.05 109.729 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -69.29 -42.6 75.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 110.421 -0.215 . . . . 7.15 110.421 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 91' ' ' ASN . 8.0 mm-40 -57.88 -26.7 62.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.43 0.633 . . . . 5.21 109.966 173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' B' ' 127' ' ' PRO . 2.0 mm -87.89 -25.58 5.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.298 -0.865 . . . . 4.46 112.394 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -67.94 -18.75 64.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.162 0.506 . . . . 6.86 110.939 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 88' ' ' GLU . 5.9 p30 -108.2 28.77 7.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 6.04 109.817 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 4.7 p-10 -60.13 152.89 59.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.239 -0.891 . . . . 5.09 112.179 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 9.3 Cg_exo -72.42 -45.57 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.34 2.693 . . . . 6.48 113.357 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -85.94 72.15 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.708 . . . . 7.32 110.589 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG23 ' HE2' ' A' ' 70' ' ' LYS . 3.8 p -111.75 111.81 37.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.54 0.686 . . . . 6.13 110.878 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -83.97 75.22 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.906 -0.588 . . . . 9.68 109.794 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.85 139.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.014 0.821 . . . . 8.54 112.403 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 t -72.72 -24.38 60.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.491 -0.559 . . . . 9.88 109.491 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.08 74.28 1.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.556 -0.747 . . . . 9.93 112.756 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.539 ' HD1' ' HG2' ' A' ' 71' ' ' GLU . 85.6 m-85 . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 123.444 0.698 . . . . 12.88 111.978 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.383 0.611 . . . . 13.85 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 25.8 t -81.42 98.66 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.301 -0.863 . . . . 12.37 111.254 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 69.59 -74.19 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.471 -0.786 . . . . 12.02 111.524 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -159.07 140.69 13.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.673 -0.492 . . . . 10.42 109.673 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -84.94 102.03 12.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.161 0.505 . . . . 8.13 110.501 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -118.19 -18.88 9.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.479 -0.782 . . . . 10.78 110.739 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -68.32 118.57 11.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 8.36 110.312 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -137.55 18.06 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 8.99 110.972 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -76.17 167.9 21.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.769 0.319 . . . . 8.32 110.795 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.414 ' HB3' HG13 ' B' ' 130' ' ' ILE . 80.5 m-85 -67.58 121.94 16.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 5.28 109.188 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -93.92 130.7 39.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.218 -0.29 . . . . 8.12 110.218 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.513 ' HB2' ' HG3' ' B' ' 132' ' ' GLU . 36.5 t -48.79 115.91 1.44 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.828 -0.624 . . . . 5.93 111.262 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.17 -21.94 3.84 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.642 -0.708 . . . . 4.62 111.338 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -79.28 165.26 23.39 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 4.66 110.069 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' B' ' 129' ' ' ARG . 3.1 tt -145.12 138.1 26.38 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.155 -0.684 . . . . 3.32 109.155 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 63' ' ' LEU . 31.4 m -146.3 173.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.497 -0.32 . . . . 3.43 110.626 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 66' ' ' TYR . 43.3 m-85 -77.77 118.95 20.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.347 -0.612 . . . . 3.93 109.347 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.78 139.08 33.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.954 0.406 . . . . 3.3 111.005 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -103.53 100.53 10.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.819 -0.628 . . . . 5.76 110.152 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . 1.4 tmm? -119.62 177.6 4.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.855 0.36 . . . . 6.08 110.599 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.26 117.13 10.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.063 -0.517 . . . . 8.78 110.044 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.01 -0.99 76.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.928 -0.653 . . . . 6.27 112.404 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 47.1 m-85 -133.92 103.45 11.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.805 -0.443 . . . . 7.06 109.805 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 -59.17 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.473 2.115 . . . . 5.68 111.564 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -150.3 94.95 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.734 -0.469 . . . . 4.71 109.734 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.676 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -113.16 119.07 43.12 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.961 -0.755 . . . . 6.03 108.961 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.669 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 16.3 Cg_endo -57.23 113.93 1.71 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.989 2.459 . . . . 3.48 113.295 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.49 152.39 45.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.049 -0.523 . . . . 2.83 110.678 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.622 ' HA ' ' HG ' ' B' ' 115' ' ' LEU . 55.8 ttp180 -80.75 145.32 31.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 5.33 109.93 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.414 HG13 ' HB3' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -94.15 121.95 45.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 121.777 0.799 . . . . 4.34 110.025 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.498 ' HA ' ' SG ' ' B' ' 112' ' ' CYS . 1.0 OUTLIER -119.78 143.3 47.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.228 -0.896 . . . . 5.66 109.114 174.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' B' ' 112' ' ' CYS . 45.7 mt-10 -80.27 175.82 10.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.098 0.475 . . . . 7.05 110.601 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 43.3 mtt -67.28 134.92 93.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.645 -0.707 . . . . 9.64 110.348 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 76.5 Cg_exo -50.66 -40.53 55.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.325 2.683 . . . . 9.8 113.732 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 67.14 85.9 0.14 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.642 0.734 . . . . 12.27 110.443 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.13 74.47 0.14 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 11.49 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.21 -43.75 0.57 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.238 -0.892 . . . . 11.38 110.423 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.63 129.07 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.141 -0.481 . . . . 9.65 110.059 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -178.64 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.085 -1.45 . . . . 11.11 107.085 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -162.45 -172.56 3.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.493 -1.231 . . . . 8.66 108.729 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 0.444 ' HB ' ' HD3' ' B' ' 144' ' ' LYS . 3.2 m 65.32 98.13 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.661 0.6 . . . . 9.44 110.67 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.43 -72.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 8.63 111.319 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -92.25 95.08 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.245 0.545 . . . . 9.61 111.055 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' B' ' 141' ' ' THR . 23.7 pttm -131.07 137.08 48.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.369 -0.832 . . . . 8.97 109.53 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 30' ' ' ILE . 21.0 m-85 -95.92 145.48 25.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 7.97 109.974 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.42 141.09 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.257 -1.016 . . . . 9.5 108.257 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' B' ' 158' ' ' LEU . 76.4 t -129.4 125.62 62.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.177 0.513 . . . . 6.03 111.222 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.3 113.82 26.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.537 -0.756 . . . . 10.78 110.295 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 7.1 m-85 -87.79 115.29 25.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.729 -0.669 . . . . 8.4 110.338 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.1 -26.09 65.64 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.369 0.418 . . . . 9.24 109.901 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' B' ' 181' ' ' GLY . . . -61.78 -76.06 0.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.403 -0.817 . . . . 10.64 112.89 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.1 p -84.66 1.22 47.27 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 120.632 0.253 . . . . 12.27 111.346 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 m80 59.44 46.39 12.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.947 -0.57 . . . . 13.51 110.049 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -116.23 176.59 5.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.756 -0.657 . . . . 12.96 111.167 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 32.9 m -132.59 120.21 21.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 10.75 109.295 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.79 -178.6 4.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.298 -0.41 . . . . 8.03 111.326 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.444 ' C ' HD12 ' B' ' 158' ' ' LEU . 29.3 p90 -120.45 121.95 39.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 9.95 110.196 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 20' ' ' MET . 6.9 mp -133.5 175.88 9.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.904 -0.589 . . . . 6.89 110.444 -177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.43 176.75 17.48 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.926 -0.87 . . . . 6.24 110.926 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.55 -34.49 98.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.483 2.122 . . . . 8.35 111.984 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.41 -17.46 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.651 -0.704 . . . . 12.73 111.344 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -104.37 1.43 30.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.873 0.368 . . . . 9.49 110.584 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.774 ' HB3' HG21 ' A' ' 16' ' ' VAL . 33.3 mt -109.36 117.05 33.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 7.88 109.814 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.499 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 77.9 m-85 -111.59 134.53 21.22 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 10.48 111.246 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 164' ' ' PHE . 78.0 Cg_exo -50.38 119.86 5.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.715 2.943 . . . . 10.82 112.849 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 16' ' ' VAL . 2.7 p90 -78.96 -28.24 43.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.087 -0.506 . . . . 10.52 111.995 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.79 -34.18 74.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 13.98 110.326 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.43 -38.81 10.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 15.72 111.016 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 57.7 m -70.45 -35.69 73.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.971 0.359 . . . . 11.91 111.971 -175.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.14 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.13 0.49 . . . . 12.55 110.421 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.68 -19.79 44.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.986 -0.552 . . . . 15.86 111.114 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -89.16 -43.66 10.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 16.47 111.257 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 23.2 m-85 -104.21 32.12 4.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.487 -0.324 . . . . 11.15 111.044 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.39 63.31 2.98 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.252 -0.499 . . . . 11.12 112.964 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.56 93.79 37.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.895 -0.409 . . . . 14.56 109.895 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' B' ' 182' ' ' PHE . 68.9 Cg_endo -95.66 -159.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.298 2.665 . . . . 11.81 113.072 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' B' ' 176' ' ' PRO . 34.7 m-80 76.36 153.92 0.15 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.006 0.816 . . . . 13.38 111.91 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 73.72 -40.23 0.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.988 -1.005 . . . . 16.74 111.28 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -97.47 103.57 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.624 -0.51 . . . . 16.14 109.624 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -50.8 -60.49 3.01 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.794 0.684 . . . . 15.89 112.116 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -63.02 -24.2 66.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.963 -0.636 . . . . 11.57 113.138 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' B' ' 176' ' ' PRO . 67.1 t80 -72.12 -49.65 34.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.73 -0.47 . . . . 9.65 109.73 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.4 m -65.08 -45.34 85.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 10.46 110.524 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -62.01 -47.76 83.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 12.15 110.425 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.52 -41.78 99.12 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.863 -0.608 . . . . 8.24 112.624 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.0 -39.34 91.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 7.89 110.81 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -75.52 -47.09 28.43 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 110.3 -0.259 . . . . 11.87 110.3 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.93 -26.76 60.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.53 0.681 . . . . 11.62 109.515 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.51 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.1 mm -86.96 -42.9 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.88 -1.055 . . . . 9.26 111.547 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.99 -41.38 97.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.687 0.279 . . . . 11.04 111.22 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -3.61 58.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.925 0.342 . . . . 12.59 111.925 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 195' ' ' VAL . 7.9 t30 -164.42 71.18 1.6 Allowed Pre-proline 0 CA--C 1.531 0.224 0 O-C-N 122.253 -0.279 . . . . 13.52 111.068 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -87.43 -39.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.579 2.186 . . . . 14.9 112.878 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 11.7 t -97.78 2.34 49.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.079 -0.509 . . . . 17.54 109.77 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.648 ' HA ' ' ND2' ' B' ' 192' ' ' ASN . 64.6 t 63.46 100.66 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 115.196 -0.911 . . . . 18.06 110.507 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.31 90.06 7.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.522 -0.763 . . . . 21.28 111.051 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.7 7.72 13.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 21.53 110.18 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 11.9 p -126.29 -56.42 1.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.405 -0.816 . . . . 23.03 111.286 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -104.63 59.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.658 -0.782 . . . . 24.72 113.087 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.414 -0.803 . . . . 27.31 109.873 176.008 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.003 -0.369 . . . . 29.42 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -134.76 123.97 24.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.444 -0.344 . . . . 26.59 110.573 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -82.7 74.89 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.173 0.511 . . . . 25.53 109.918 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -70.0 141.38 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.331 -0.849 . . . . 23.29 110.784 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -89.25 91.36 8.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 21.2 110.497 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 6' ' ' ARG . 1.4 ptm85 -116.86 0.13 12.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.688 -0.687 . . . . 20.05 109.323 172.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -109.5 119.44 39.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.6 -0.727 . . . . 16.73 109.437 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -85.26 175.9 8.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 16.22 110.315 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 71.84 -55.6 0.66 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.997 0.811 . . . . 13.24 112.096 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' B' ' 165' ' ' PRO . 7.8 m-85 -120.86 145.99 47.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.134 -0.321 . . . . 10.33 110.134 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -82.02 119.09 23.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 14.9 110.677 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.5 p -60.07 116.88 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 11.71 111.16 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 30' ' ' ILE . . . 93.77 17.3 41.9 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.114 -0.565 . . . . 9.66 112.376 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.45 -164.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.61 0.243 . . . . 10.47 111.459 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.652 HD23 ' HE2' ' B' ' 150' ' ' PHE . 2.9 tm? -113.25 141.83 46.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.111 0.481 . . . . 7.46 110.685 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.616 HG21 HD21 ' B' ' 163' ' ' LEU . 1.1 m -144.96 165.82 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.831 -0.622 . . . . 6.87 110.785 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -97.77 114.99 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.901 -0.407 . . . . 6.78 109.901 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.94 136.78 38.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.935 -0.575 . . . . 6.21 111.401 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' B' ' 162' ' ' ASP . 27.6 tttm -104.39 102.71 12.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.422 -0.354 . . . . 12.44 110.793 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG3' HD11 ' B' ' 158' ' ' LEU . 69.1 mtp -112.52 174.45 5.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 10.95 110.627 174.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.44 116.76 7.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 15.91 109.209 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.72 2.44 75.65 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.599 -0.81 . . . . 14.09 112.03 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -133.82 92.03 23.65 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-O 120.763 0.315 . . . . 13.65 110.183 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.48 67.97 6.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.085 2.523 . . . . 12.38 112.422 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 72.37 85.46 0.12 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.354 -0.839 . . . . 11.05 109.996 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.631 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 2.6 t-105 -111.94 135.99 21.23 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.453 -1.249 . . . . 10.23 108.594 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.23 112.08 1.01 Allowed 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.298 . . . . 5.52 112.864 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -138.62 147.63 43.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.51 . . . . 3.98 111.522 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 32' ' ' GLU . 36.0 ttt180 -77.2 157.4 30.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.387 -0.37 . . . . 11.28 110.63 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG12 HD21 ' B' ' 163' ' ' LEU . 0.3 OUTLIER -104.75 137.37 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.071 -0.513 . . . . 7.51 112.029 -171.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.783 ' HA ' ' HB3' ' B' ' 145' ' ' TYR . 37.2 t70 75.29 -69.88 0.16 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.064 0.946 . . . . 10.28 113.109 166.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' HE21 ' B' ' 146' ' ' GLN . 17.2 mm-40 67.43 -71.42 0.1 Allowed 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.814 0.697 . . . . 10.44 112.219 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 66.6 mtt -142.2 142.73 25.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 12.85 111.438 -174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 74.5 Cg_endo -95.65 148.7 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.325 2.683 . . . . 13.07 112.125 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 39' ' ' LYS . 11.1 tp10 -91.71 62.68 4.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.103 -0.703 . . . . 14.04 109.103 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.21 80.57 0.22 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.203 -0.908 . . . . 15.24 110.529 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.23 -73.86 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.233 -0.894 . . . . 14.64 111.527 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 ' H ' ' A' ' 40' ' ' SER . 8.5 p -79.07 163.11 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.256 -0.646 . . . . 12.42 109.256 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -118.67 21.76 12.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.684 -0.635 . . . . 10.84 110.541 175.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.5 m -157.84 103.66 1.9 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.932 0.396 . . . . 9.63 110.928 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -95.9 59.32 2.0 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.739 0.781 . . . . 9.56 109.188 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.96 112.64 20.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 8.3 111.256 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.94 26.51 7.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 8.55 109.759 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.42 132.6 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.395 -0.82 . . . . 7.5 110.957 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -109.31 160.59 16.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.012 -0.736 . . . . 6.01 109.012 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -88.57 107.78 19.08 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.765 -0.828 . . . . 6.99 108.765 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.9 t -105.04 115.55 47.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.382 -0.826 . . . . 4.6 110.852 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.26 99.24 12.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 5.62 110.053 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' B' ' 120' ' ' MET . 6.6 m-85 -50.69 115.85 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.475 0.485 . . . . 4.03 110.118 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 51.7 t80 -84.9 -35.26 22.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.912 -0.586 . . . . 4.15 109.582 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.846 ' HA2' ' HA3' ' A' ' 85' ' ' GLY . . . -71.48 -50.74 19.43 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.768 -0.729 . . . . 5.0 112.355 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -82.45 -11.49 58.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 5.56 110.99 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 60.89 38.88 17.43 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.989 -0.55 . . . . 6.72 111.531 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 11.2 pt-20 -128.72 179.77 5.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.354 -0.385 . . . . 6.33 110.613 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -122.06 133.32 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.651 -0.25 . . . . 5.99 111.093 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.72 179.14 8.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.656 -0.247 . . . . 5.39 110.502 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.47 113.79 21.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.55 0.215 . . . . 7.73 110.544 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.634 ' HB2' HG21 ' A' ' 47' ' ' VAL . 7.3 mp -121.44 174.57 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.43 -0.35 . . . . 5.32 110.814 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.25 158.98 14.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.597 -0.601 . . . . 5.57 111.597 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 -18.04 61.87 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.855 2.37 . . . . 6.06 112.844 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -74.78 -23.9 58.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 7.7 111.469 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.67 17.18 22.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.463 -0.569 . . . . 5.82 109.463 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 116' ' ' VAL . 15.6 tp -112.84 124.97 53.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 4.21 110.056 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 29.9 m-85 -122.13 140.84 33.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 4.63 111.584 -172.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' B' ' 116' ' ' VAL . 56.2 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.849 2.366 . . . . 4.58 111.931 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 15.4 p90 -68.18 -28.74 67.54 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 112.214 0.45 . . . . 4.79 112.214 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -46.93 -41.25 15.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.015 0.376 . . . . 6.1 112.015 -172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.96 -25.4 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.839 0.311 . . . . 6.71 111.839 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.9 m -101.43 -15.77 17.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.342 0.867 . . . . 5.49 113.342 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.7 pttp -64.44 -22.1 66.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.36 0.527 . . . . 6.26 110.888 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.513 -0.312 . . . . 7.73 110.568 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.61 -39.03 22.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.189 0.518 . . . . 8.1 109.986 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -98.12 7.42 46.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 5.97 110.53 -174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.91 73.6 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.651 -0.704 . . . . 6.74 112.83 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.68 94.59 3.83 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.257 -0.645 . . . . 8.38 109.257 175.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 83' ' ' SER . 4.2 Cg_exo -79.97 54.15 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.225 2.617 . . . . 7.75 112.33 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -88.88 -12.35 42.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 7.82 111.462 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 69.1 mmtt -85.46 52.49 2.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 10.11 111.886 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 67.85 -177.2 0.21 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.005 -0.998 . . . . 8.81 112.724 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -51.46 -42.57 61.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.391 -0.822 . . . . 8.87 112.416 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.15 -56.6 24.29 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.538 -0.839 . . . . 5.87 112.992 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 7.9 t80 -69.41 -39.28 78.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.762 0.281 . . . . 5.14 110.546 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 38.6 t -60.75 -51.78 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 6.17 111.018 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 45.4 tt0 -68.35 -46.74 69.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.403 -0.362 . . . . 6.87 110.14 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.846 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -58.66 -40.6 94.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.62 . . . . 4.6 112.553 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.76 -40.35 88.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.104 -0.702 . . . . 5.05 109.104 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.401 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 73.3 t-105 -66.26 -47.01 75.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 119.489 -0.291 . . . . 7.15 110.557 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 48.1 mt-10 -56.74 -31.8 64.92 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.648 0.593 . . . . 5.21 111.282 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -86.9 -45.28 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 120.666 -0.414 . . . . 4.46 110.491 175.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.46 -57.28 12.53 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.799 0.44 . . . . 6.86 112.058 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -56.5 -26.08 53.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.182 -0.463 . . . . 6.04 112.209 -179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 58.83 97.46 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.184 0 CA-C-O 121.458 0.647 . . . . 5.09 111.078 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.07 -153.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.694 2.263 . . . . 6.48 110.9 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.3 m -79.14 72.74 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.274 0.559 . . . . 7.32 109.573 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.87 86.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 6.13 109.99 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -117.49 91.5 3.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.594 -0.73 . . . . 9.68 110.315 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.76 130.32 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.111 -0.495 . . . . 8.54 110.329 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 102.4 9.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.998 0.428 . . . . 9.88 110.077 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.89 63.45 4.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.875 -0.679 . . . . 9.93 112.701 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 47.0 p90 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 12.88 110.284 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.253 -0.647 . . . . 13.85 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -161.76 94.14 0.93 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.197 -0.91 . . . . 12.37 108.747 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -94.76 92.78 7.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 12.02 110.575 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 29.8 p -97.36 -42.01 7.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 10.42 111.088 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.04 155.59 18.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 8.13 111.18 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -123.34 106.45 10.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.762 -0.829 . . . . 10.78 108.762 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -70.44 104.84 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.165 -0.47 . . . . 8.36 112.205 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 52.03 87.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.108 -0.951 . . . . 8.99 111.938 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.88 -8.06 44.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.145 0.498 . . . . 8.32 110.538 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -79.52 151.98 30.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.727 -0.842 . . . . 5.28 108.727 171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -143.85 146.33 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 8.12 111.281 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.721 ' HB2' ' HB3' ' B' ' 132' ' ' GLU . 16.8 t -46.88 122.4 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.835 -0.62 . . . . 5.93 111.108 170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.25 60.02 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.74 . . . . 4.62 112.416 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -83.97 172.78 11.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.867 -0.42 . . . . 4.66 109.867 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 116' ' ' VAL . 2.3 tt -139.92 135.41 32.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.132 -0.692 . . . . 3.32 109.132 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.626 ' HA ' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -152.74 -172.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 3.43 110.343 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 66' ' ' TYR . 3.5 m-85 -97.4 123.88 41.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.812 0.339 . . . . 3.93 110.273 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -102.38 160.08 14.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.045 -0.525 . . . . 3.3 111.109 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 5.76 109.862 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 49' ' ' PHE . 2.8 tmm? -114.96 164.42 14.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.182 -0.673 . . . . 6.08 109.182 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -67.12 117.39 9.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.668 -0.493 . . . . 8.78 109.668 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.02 49.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.865 -0.683 . . . . 6.27 111.568 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -119.14 93.11 46.52 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.493 -0.558 . . . . 7.06 109.493 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.62 -62.99 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.207 2.605 . . . . 5.68 112.897 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -146.12 123.86 11.9 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.785 -0.82 . . . . 4.71 108.785 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -148.33 125.47 5.58 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-N 116.403 -0.362 . . . . 6.03 110.536 -173.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 19.3 Cg_endo -58.16 131.99 46.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.807 2.338 . . . . 3.48 111.686 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -145.23 153.58 41.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.099 0.476 . . . . 2.83 112.171 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -97.01 151.27 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.386 -0.825 . . . . 5.33 110.781 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' B' ' 112' ' ' CYS . 3.0 mm -96.57 120.65 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.92 -0.582 . . . . 4.34 111.737 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -108.95 100.14 9.38 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.024 -1.102 . . . . 5.66 108.024 163.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' B' ' 112' ' ' CYS . 31.8 tt0 -107.83 134.43 50.79 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.892 -1.049 . . . . 7.05 111.168 -171.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 64.3 mtt -105.34 111.69 64.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.767 -0.651 . . . . 9.64 109.488 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 -30.47 66.19 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.704 2.269 . . . . 9.8 112.359 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -171.5 111.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.775 -0.648 . . . . 12.27 109.399 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.6 -114.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.618 -0.264 . . . . 11.49 110.966 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.39 -30.82 60.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.7 0.762 . . . . 11.38 109.648 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' B' ' 139' ' ' LYS . 13.1 p -80.45 140.84 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.63 -1.168 . . . . 9.65 109.01 173.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.611 ' HG2' HG22 ' B' ' 138' ' ' VAL . 31.6 mmmt 66.23 -69.48 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.722 0.639 . . . . 11.11 111.154 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m 63.88 39.73 7.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.426 0.69 . . . . 8.66 110.234 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 78.6 p 52.44 18.46 0.94 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.861 0.865 . . . . 9.44 111.993 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 38' ' ' VAL . . . 59.17 23.76 12.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.185 -0.461 . . . . 8.63 111.015 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -115.65 100.51 8.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.103 -0.498 . . . . 9.61 110.422 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.424 ' HD2' ' OG ' ' A' ' 40' ' ' SER . 17.2 ptpt -165.06 152.54 11.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.637 -0.711 . . . . 8.97 109.324 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.783 ' HB3' ' HA ' ' A' ' 31' ' ' ASP . 35.7 m-85 -133.07 156.05 48.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.661 -0.245 . . . . 7.97 110.487 -174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.579 HE21 ' HB2' ' A' ' 32' ' ' GLU . 23.1 mt-30 -82.07 121.56 26.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.577 -0.897 . . . . 9.5 108.577 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' B' ' 158' ' ' LEU . 95.3 t -106.17 105.17 18.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.797 -0.638 . . . . 6.03 109.615 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.483 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 47.8 t80 -94.85 101.26 13.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.213 -0.449 . . . . 10.78 111.098 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 11.5 m-85 -61.85 121.26 12.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.159 -0.473 . . . . 8.4 110.204 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.652 ' HE2' HD23 ' A' ' 15' ' ' LEU . 50.9 m-85 -74.1 -47.76 34.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.431 . . . . 9.24 110.255 176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.08 -53.5 44.42 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.552 -0.749 . . . . 10.64 112.967 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -10.46 57.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 12.27 111.017 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 57.92 44.28 20.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.59 -0.732 . . . . 13.51 110.337 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -111.77 123.56 50.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.485 -0.78 . . . . 12.96 111.496 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.483 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 33.4 m -90.24 98.95 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.649 -0.5 . . . . 10.75 109.649 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.76 -178.4 3.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.966 -0.561 . . . . 8.03 111.2 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -131.01 124.49 31.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.95 110.062 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.58 ' HB2' HG21 ' B' ' 147' ' ' VAL . 87.7 mt -142.48 175.01 10.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 6.89 110.534 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.52 -179.79 16.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.024 -0.83 . . . . 6.24 111.024 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 10' ' ' TYR . 24.3 Cg_endo -62.62 -23.88 74.84 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.669 2.246 . . . . 8.35 112.655 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -50.03 -50.97 45.7 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.781 0.675 . . . . 12.73 112.416 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 21.2 m-20 -113.25 25.44 11.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.927 0.394 . . . . 9.49 111.14 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 16' ' ' VAL . 13.8 tp -118.55 125.39 49.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 7.88 109.927 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -127.38 142.21 43.26 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.086 0.402 . . . . 10.48 112.086 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.575 ' HG3' ' HD1' ' A' ' 10' ' ' TYR . 16.7 Cg_exo -67.55 127.93 17.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.256 2.637 . . . . 10.82 112.214 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -70.94 -28.61 64.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.505 -0.316 . . . . 10.52 111.632 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.69 -33.36 47.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.898 0.38 . . . . 13.98 111.572 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 42.9 mt-10 -109.02 -41.29 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.928 0.394 . . . . 15.72 111.038 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 t -83.72 -16.73 43.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.132 0.79 . . . . 11.91 113.132 -168.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -63.28 -16.48 60.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.316 0.507 . . . . 12.55 112.241 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 11.2 pt-20 -74.76 -19.82 60.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.626 -0.429 . . . . 15.86 110.872 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -93.84 -24.86 17.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.595 -0.275 . . . . 16.47 111.651 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -123.95 -29.44 3.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 11.15 111.183 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -80.73 80.69 1.65 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 116.055 -0.521 . . . . 11.12 112.349 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -143.43 96.59 5.72 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 106.594 -1.632 . . . . 14.56 106.594 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -62.04 118.29 5.17 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.098 2.532 . . . . 11.81 113.892 -163.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -104.26 -173.11 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.646 -1.161 . . . . 13.38 109.207 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -77.27 69.99 3.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.178 0.514 . . . . 16.74 111.447 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.37 125.39 15.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.321 -0.854 . . . . 16.14 108.761 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 48.1 tptt -63.99 -59.82 4.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 15.89 111.847 -170.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -59.81 -35.42 86.49 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.851 -0.69 . . . . 11.57 112.358 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' B' ' 186' ' ' LEU . 41.0 t80 -63.61 -48.77 75.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.684 0.278 . . . . 9.65 110.524 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.2 t -64.45 -44.69 90.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 10.46 110.579 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 30.4 mm-40 -59.98 -51.96 67.45 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.908 0.385 . . . . 12.15 110.264 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.456 ' O ' HG13 ' B' ' 189' ' ' ILE . . . -56.55 -47.16 86.16 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.576 -0.738 . . . . 8.24 112.511 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' B' ' 182' ' ' PHE . 65.7 mt -64.27 -44.55 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 7.89 111.448 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -70.0 -37.2 75.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.127 -0.488 . . . . 11.87 110.293 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.5 -32.83 66.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 11.62 111.228 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.607 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.8 pp -86.38 -31.78 6.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 112.222 0.453 . . . . 9.26 112.222 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . 0.607 ' N ' HD12 ' B' ' 189' ' ' ILE . 41.5 tt0 -89.46 -47.62 7.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 11.04 109.931 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -104.22 64.96 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.978 -0.749 . . . . 12.59 108.978 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 4.1 p-10 -53.73 118.53 15.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.021 . . . . 13.52 111.808 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' ' 192' ' ' ASN . 30.2 Cg_endo -66.24 -28.68 47.62 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.667 2.245 . . . . 14.9 111.064 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 8.2 p -89.89 86.35 6.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.659 -0.701 . . . . 17.54 110.446 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.57 -27.82 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.498 0.665 . . . . 18.06 109.248 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -76.69 85.04 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.938 -1.028 . . . . 21.28 109.852 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.57 104.5 7.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.831 -0.622 . . . . 21.53 109.521 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 21.9 t -84.1 75.95 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.133 0.492 . . . . 23.03 111.353 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.14 -31.13 61.96 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.938 -1.665 . . . . 24.72 108.938 167.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 58.9 t80 . . . . . 0 C--O 1.243 0.73 0 CA-C-N 113.928 -1.136 . . . . 27.31 108.625 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.826 0.346 . . . . 29.42 110.309 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -77.17 34.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.944 0.72 . . . . 26.59 112.944 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -109.67 -29.73 8.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.27 -0.641 . . . . 25.53 109.27 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 m -75.98 -50.09 15.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.26 -0.644 . . . . 23.29 109.26 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -109.01 132.06 54.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.236 -0.893 . . . . 21.2 109.711 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -86.79 -47.41 9.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.267 0.556 . . . . 20.05 109.737 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -95.46 178.61 5.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.409 -0.814 . . . . 16.73 110.359 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -124.39 132.39 53.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.613 -0.884 . . . . 16.22 108.613 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -100.34 123.33 44.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.13 -0.486 . . . . 13.24 111.579 -166.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 63.4 m-85 -122.31 150.3 42.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 10.33 110.048 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 10' ' ' TYR . 2.4 mptp? -123.52 169.9 10.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.792 -0.185 . . . . 14.9 110.751 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.659 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 17.5 p -46.43 112.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.939 0.774 . . . . 11.71 112.208 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.53 -8.27 5.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.745 -0.74 . . . . 9.66 112.327 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.11 172.06 8.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.767 0.318 . . . . 10.47 111.09 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' B' ' 189' ' ' ILE . 3.3 tm? -131.16 138.26 49.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 7.46 110.531 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.796 HG21 HD13 ' B' ' 163' ' ' LEU . 3.1 m -144.05 160.54 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.544 . . . . 6.87 110.647 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.61 102.98 15.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.979 -0.748 . . . . 6.78 108.979 171.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' B' ' 158' ' ' LEU . . . -84.52 136.05 33.98 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 6.21 111.503 -173.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.6 110.12 22.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.705 -0.679 . . . . 12.44 109.844 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 24.8 ttt -107.61 159.72 16.23 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.953 -0.758 . . . . 10.95 108.953 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 20.2 tptp -66.04 115.21 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.84 -0.744 . . . . 15.91 109.152 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.21 -8.48 62.76 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.796 -0.638 . . . . 14.09 112.338 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 89.2 m-85 -128.71 121.84 21.28 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 110.37 -0.233 . . . . 13.65 110.37 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 40.7 Cg_exo -56.25 -88.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.182 2.588 . . . . 12.38 114.005 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 96.4 m-70 -148.28 93.9 2.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.528 -0.545 . . . . 11.05 109.528 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.69 139.27 20.71 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.061 -0.518 . . . . 10.23 110.993 -173.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.17 101.95 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.084 1.856 . . . . 5.52 110.213 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -124.96 134.0 52.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.123 0.487 . . . . 3.98 110.415 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -84.46 129.72 34.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.642 -0.708 . . . . 11.28 110.249 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -74.17 139.22 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.28 0.562 . . . . 7.51 110.054 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' B' ' 146' ' ' GLN . 7.4 t70 -146.8 174.34 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.316 -0.856 . . . . 10.28 108.892 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 10.6 pt-20 -158.94 129.87 6.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 10.44 112.187 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.464 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 61.0 mtt -137.23 137.2 22.0 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.555 -0.748 . . . . 12.85 109.744 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 34.1 Cg_exo -60.17 134.78 58.03 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.271 2.647 . . . . 13.07 112.937 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 73.95 -47.16 0.64 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.288 1.035 . . . . 14.04 112.134 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.82 74.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 15.24 110.91 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 146' ' ' GLN . . . -126.22 -63.98 1.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.093 -0.503 . . . . 14.64 111.105 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' B' ' 142' ' ' ALA . 14.1 m -91.48 145.23 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.537 -0.301 . . . . 12.42 110.401 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -97.34 175.56 6.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.027 0.441 . . . . 10.84 110.513 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 t -129.82 80.99 1.99 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.712 -1.218 . . . . 9.63 107.712 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 157.12 45.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 9.56 110.935 -171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' B' ' 137' ' ' ALA . . . -120.92 -14.91 8.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.628 -0.715 . . . . 8.3 110.237 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 6.8 m-20 73.05 -53.17 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.071 0.857 . . . . 8.55 111.139 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 58' ' ' LEU . 28.9 tttp -134.44 123.91 24.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.612 -0.885 . . . . 7.5 108.612 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -95.07 -172.66 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.954 0.407 . . . . 6.01 110.635 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.91 128.9 45.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.381 -0.97 . . . . 6.99 108.381 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 58' ' ' LEU . 46.5 t -110.05 109.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.353 0.597 . . . . 4.6 109.993 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -92.63 110.68 22.11 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.082 -0.71 . . . . 5.62 109.082 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 23.1 m-85 -59.56 104.56 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.121 -0.491 . . . . 4.03 110.059 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 32.7 t80 -66.14 -49.14 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.906 -1.043 . . . . 4.15 110.776 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.3 30.05 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.711 -0.757 . . . . 5.0 112.852 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 -20.57 47.85 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.757 -0.26 . . . . 5.56 111.478 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.1 t60 66.08 42.25 3.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.451 0.644 . . . . 6.72 110.409 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.93 173.81 10.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.938 -0.574 . . . . 6.33 110.66 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -125.59 136.95 53.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 5.99 111.433 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.42 176.63 9.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.835 -0.62 . . . . 5.39 109.851 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.09 110.74 15.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.001 -0.37 . . . . 7.73 110.001 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 47' ' ' VAL . 88.9 mt -143.08 156.82 44.89 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.865 -0.42 . . . . 5.32 109.865 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.28 -173.48 21.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.971 -0.633 . . . . 5.57 111.685 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -62.31 -27.76 78.2 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.556 2.17 . . . . 6.06 112.063 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -80.29 -7.95 59.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.084 -0.507 . . . . 7.7 110.371 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 21.2 m-20 -106.6 9.81 31.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.822 -0.807 . . . . 5.82 108.822 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.7 tp -127.59 131.6 49.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.225 -0.898 . . . . 4.21 109.973 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.631 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.6 m-85 -126.29 150.37 69.82 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.796 0.295 . . . . 4.63 111.796 -171.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 32.0 Cg_exo -57.77 142.91 96.27 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.65 2.9 . . . . 4.58 113.816 -174.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.769 ' HD1' ' H ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -97.4 -14.03 21.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.56 . . . . 4.79 111.715 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -92.98 -42.34 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.322 0.582 . . . . 6.1 109.993 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -81.05 -54.47 5.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.477 -0.783 . . . . 6.71 110.731 -174.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.8 m -77.03 -18.41 58.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.216 -0.447 . . . . 5.49 111.814 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 29.1 ttpp -54.22 -43.08 70.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.204 0.526 . . . . 6.26 110.646 174.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.68 -18.29 59.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 7.73 110.002 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -79.6 -29.82 41.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.943 -1.026 . . . . 8.1 110.735 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 6.0 m-85 -102.53 -32.2 10.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.801 -0.444 . . . . 5.97 109.801 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 46.87 48.3 18.63 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.318 -0.855 . . . . 6.74 114.457 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 pttt -142.39 103.34 5.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 117.395 0.597 . . . . 8.38 111.185 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.718 ' HA ' ' HE2' ' A' ' 82' ' ' PHE . 67.5 Cg_endo -96.37 173.01 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.821 2.347 . . . . 7.75 112.157 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 42.2 m-80 66.29 -166.58 0.22 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.004 -0.544 . . . . 7.82 112.065 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 72.66 -40.48 0.48 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.98 0.912 . . . . 10.11 112.019 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 13.6 mmm180 -114.64 120.35 39.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.258 -0.645 . . . . 8.81 109.258 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG3' ' OE2' ' A' ' 84' ' ' GLU . 80.0 tttt -63.1 -48.17 79.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.623 0.231 . . . . 8.87 111.623 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 -22.78 69.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.405 -0.902 . . . . 5.87 112.311 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.718 ' HE2' ' HA ' ' A' ' 76' ' ' PRO . 63.9 t80 -81.01 -50.29 9.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.93 -0.396 . . . . 5.14 109.93 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 77' ' ' ASN . 14.6 m -63.42 -49.28 74.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 6.17 111.095 -176.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.656 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -69.49 -35.34 75.46 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.088 0.242 . . . . 6.87 110.701 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.92 -47.5 85.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.895 -1.145 . . . . 4.6 111.073 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 3.3 tm? -66.56 -38.27 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.345 -0.428 . . . . 5.05 109.999 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -62.76 -52.36 63.51 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.569 -0.287 . . . . 7.15 110.853 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.9 mt-10 -61.11 -38.13 85.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.968 0.729 . . . . 5.21 112.968 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG13 HD12 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -87.06 -17.06 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 118.767 -1.173 . . . . 4.46 111.196 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 4.2 tm-20 -62.65 -34.59 77.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.98 -0.378 . . . . 6.86 109.98 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -54.0 -31.41 50.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.854 -0.612 . . . . 6.04 110.304 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' OD1' ' HB ' ' A' ' 95' ' ' VAL . 3.5 t-20 59.72 81.12 0.25 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.979 . . . . 5.09 112.412 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 -57.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.628 2.219 . . . . 6.48 111.452 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.4 m -101.17 112.19 24.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.854 -0.612 . . . . 7.32 110.368 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' HB ' ' OD1' ' A' ' 92' ' ' ASN . 5.2 p -122.89 118.8 56.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.131 -0.486 . . . . 6.13 110.925 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 70.97 10.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.539 0.685 . . . . 9.68 110.134 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -165.2 139.81 5.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.295 -0.866 . . . . 8.54 109.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -114.03 18.41 17.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.332 0.586 . . . . 9.88 110.317 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.25 141.06 3.02 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.426 -0.807 . . . . 9.93 111.662 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 12.88 110.641 179.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.377 0.608 . . . . 13.85 110.797 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 57.2 p -133.65 -44.6 0.82 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 12.37 110.34 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -135.02 73.66 1.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.32 0.581 . . . . 12.02 110.157 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.7 t -100.16 -12.53 19.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 10.42 108.593 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -80.41 109.94 15.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.153 -0.931 . . . . 8.13 110.154 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.63 -39.27 24.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.764 -0.653 . . . . 10.78 111.02 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -87.37 113.84 23.45 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.909 -0.587 . . . . 8.36 111.395 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' B' ' 108' ' ' LYS . 20.9 ptmt -85.28 -17.47 36.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.413 -0.958 . . . . 8.99 108.413 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.83 172.42 8.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.522 -1.217 . . . . 8.32 109.507 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -100.51 162.71 12.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.518 0.199 . . . . 5.28 110.604 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.9 114.71 21.38 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.136 -1.061 . . . . 8.12 108.136 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.712 ' HB3' HD12 ' B' ' 130' ' ' ILE . 79.5 m 62.3 -50.27 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.997 0.81 . . . . 5.93 111.105 -168.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.478 ' HA3' HG13 ' B' ' 130' ' ' ILE . . . 164.88 -20.99 0.13 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.254 -0.738 . . . . 4.62 111.254 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' B' ' 115' ' ' LEU . 14.2 m-20 58.03 -152.82 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.123 0.487 . . . . 4.66 112.026 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.51 HD12 HG13 ' A' ' 89' ' ' ILE . 1.8 tm? -116.2 120.0 37.58 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.709 -0.848 . . . . 3.32 108.709 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -162.34 -170.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.189 0.305 . . . . 3.43 111.02 -172.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 76.5 m-85 -86.14 123.52 31.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.616 0.246 . . . . 3.93 110.598 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.13 149.76 22.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.126 -0.324 . . . . 3.3 110.126 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 87.7 tttt -116.32 95.9 5.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 5.76 111.123 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 25.0 ttt -110.49 161.47 15.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.096 -0.705 . . . . 6.08 109.096 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' B' ' 121' ' ' LYS . 38.2 tptt -69.86 117.23 11.18 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.103 -0.639 . . . . 8.78 109.322 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.0 -20.47 28.76 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.64 -0.984 . . . . 6.27 110.64 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' B' ' 126' ' ' TRP . 20.7 m-85 -134.47 86.33 35.29 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.86 -0.792 . . . . 7.06 108.86 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -51.21 11.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.117 2.544 . . . . 5.68 112.597 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -148.91 96.28 2.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.903 -0.777 . . . . 4.71 108.903 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.747 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.8 t-105 -124.03 131.42 24.22 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.843 -0.617 . . . . 6.03 110.15 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.99 115.24 2.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.939 2.426 . . . . 3.48 112.604 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -134.29 158.89 42.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.788 -0.642 . . . . 2.83 110.923 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -109.54 139.55 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.767 . . . . 5.33 109.766 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' B' ' 112' ' ' CYS . 0.0 OUTLIER -72.37 143.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.501 -0.555 . . . . 4.34 109.501 175.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.561 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.6 t70 -130.43 128.45 41.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.729 -0.471 . . . . 5.66 109.729 175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.67 88.79 2.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.758 -0.656 . . . . 7.05 110.374 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.5 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 23.6 mmt -111.84 147.49 36.96 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.165 -0.47 . . . . 9.64 110.469 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.97 138.57 83.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.974 2.449 . . . . 9.8 111.659 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 71.11 -18.43 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.492 0.717 . . . . 12.27 112.342 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.28 -63.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.562 . . . . 11.49 110.149 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.445 ' O ' ' HB1' ' A' ' 42' ' ' ALA . . . -86.9 -62.19 1.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.783 -0.821 . . . . 11.38 108.783 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.31 103.09 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 9.65 110.115 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -125.31 13.48 8.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.442 0.639 . . . . 11.11 110.163 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 23.8 t -161.49 -174.3 4.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.275 -1.009 . . . . 8.66 108.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 48.6 m -154.58 -69.28 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 9.44 110.087 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.561 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . . . -110.81 145.74 37.65 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.835 -0.62 . . . . 8.63 111.191 -175.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -105.73 -32.63 8.33 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.492 -0.929 . . . . 9.61 108.492 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -121.47 156.18 33.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.637 -1.165 . . . . 8.97 109.218 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.16 161.87 26.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.232 -0.44 . . . . 7.97 110.026 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.419 ' HB2' ' CB ' ' A' ' 37' ' ' ALA . 15.3 tt0 -88.38 122.67 32.14 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.062 -0.718 . . . . 9.5 109.062 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.6 110.3 30.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.496 -0.32 . . . . 6.03 110.4 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -80.2 114.99 19.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.472 -0.566 . . . . 10.78 109.472 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.405 ' HB3' ' OG1' ' B' ' 152' ' ' THR . 0.2 OUTLIER -92.96 111.67 23.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.591 -0.731 . . . . 8.4 111.062 -170.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -75.62 161.69 28.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 9.24 109.479 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.07 -53.25 4.61 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.535 -0.84 . . . . 10.64 112.765 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' B' ' 149' ' ' PHE . 42.6 p -83.82 -18.55 37.25 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.04 -0.355 . . . . 12.27 110.04 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.0 m80 64.98 40.42 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.318 -0.855 . . . . 13.51 111.176 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.74 177.04 8.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.646 -0.422 . . . . 12.96 111.212 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 24.2 m -114.67 122.03 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 10.75 110.818 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.92 166.28 11.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.857 -0.61 . . . . 8.03 110.927 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.27 105.1 8.12 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 9.95 109.574 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 91.8 mt -127.49 174.26 9.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.082 -0.508 . . . . 6.89 110.351 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.73 178.52 18.03 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.403 -0.904 . . . . 6.24 111.631 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.16 -31.83 94.26 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.541 2.16 . . . . 8.35 111.71 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.78 -26.61 67.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.772 -0.649 . . . . 12.73 110.991 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 41.9 m-20 -98.87 -5.3 31.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.005 -0.543 . . . . 9.49 110.835 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 16' ' ' VAL . 20.9 mt -103.58 122.78 45.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.17 -0.468 . . . . 7.88 110.492 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.489 ' HB3' ' OG ' ' B' ' 169' ' ' SER . 80.4 m-85 -112.49 107.37 55.23 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.891 -0.595 . . . . 10.48 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.61 ' HA ' HG12 ' A' ' 16' ' ' VAL . 12.2 Cg_endo -55.57 120.36 8.09 Favored 'Trans proline' 0 C--O 1.223 -0.232 0 C-N-CA 123.087 2.525 . . . . 10.82 112.735 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.47 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 0.1 OUTLIER -50.2 -40.64 47.74 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 123.348 0.659 . . . . 10.52 111.862 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.737 ' HA ' ' HE3' ' B' ' 170' ' ' LYS . 45.1 mm-40 -67.02 -16.78 64.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.054 0.39 . . . . 13.98 112.054 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' B' ' 171' ' ' GLU . 37.1 tt0 -112.7 -40.81 3.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.871 0.367 . . . . 15.72 111.269 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' B' ' 164' ' ' PHE . 13.3 m -89.36 -13.06 38.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.328 0.492 . . . . 11.91 112.328 -173.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' B' ' 167' ' ' GLU . 19.1 ptpt -48.05 -30.39 4.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.125 0.416 . . . . 12.55 112.125 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 168' ' ' GLU . 7.4 pt-20 -68.17 -20.87 64.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.253 0.464 . . . . 15.86 112.253 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' B' ' 171' ' ' GLU . 49.9 mttm -93.48 -58.88 2.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.924 0.392 . . . . 16.47 111.473 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -112.15 -15.91 13.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.446 -0.343 . . . . 11.15 111.645 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.0 -116.87 9.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.977 -0.63 . . . . 11.12 112.404 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.739 ' HD3' HD11 ' B' ' 186' ' ' LEU . 85.5 mttt -138.94 91.96 11.29 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.336 -0.616 . . . . 14.56 109.336 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.634 ' HD2' ' CZ ' ' B' ' 182' ' ' PHE . 35.3 Cg_endo -97.64 90.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 123.289 2.66 . . . . 11.81 111.375 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.718 ' HA ' ' CD1' ' B' ' 182' ' ' PHE . 43.1 m-80 -60.69 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 13.38 111.264 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 65.55 -59.91 0.28 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.53 0.519 . . . . 16.74 112.081 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -74.72 142.09 44.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.339 -0.391 . . . . 16.14 110.157 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -58.39 -41.15 84.23 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.261 0.553 . . . . 15.89 110.177 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.33 -31.02 66.34 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.237 -0.892 . . . . 11.57 112.635 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.718 ' CD1' ' HA ' ' B' ' 177' ' ' ASN . 17.4 t80 -70.96 -45.54 63.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.198 -0.668 . . . . 9.65 109.198 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' B' ' 177' ' ' ASN . 11.3 p -61.74 -28.09 69.18 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.299 -0.409 . . . . 10.46 110.744 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 30.8 tt0 -73.1 -55.83 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 12.15 110.528 176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.25 94.12 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.801 -0.714 . . . . 8.24 112.699 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.739 HD11 ' HD3' ' B' ' 175' ' ' LYS . 2.1 tm? -69.09 -38.72 79.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.597 -0.519 . . . . 7.89 109.597 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.98 -50.87 66.86 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.149 -0.478 . . . . 11.87 110.036 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' B' ' 191' ' ' ASN . 64.1 mm-40 -55.69 -32.76 63.56 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.783 0.677 . . . . 11.62 111.558 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.8 HG12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 tp -88.1 -26.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.704 0.631 . . . . 9.26 112.704 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.48 -35.09 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 11.04 111.121 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.483 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.8 p30 -79.2 -17.5 54.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.291 0.567 . . . . 12.59 109.88 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -126.9 74.1 76.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.0 -0.741 . . . . 13.52 109.0 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.0 88.85 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.11 2.54 . . . . 14.9 112.965 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.403 HG22 ' HE2' ' B' ' 196' ' ' LYS . 3.5 m 60.79 27.61 17.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.59 -0.732 . . . . 17.54 110.935 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.95 111.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 18.06 109.87 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . 0.403 ' HE2' HG22 ' B' ' 194' ' ' THR . 72.5 mmtt -74.05 102.2 4.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 21.28 109.952 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.4 115.92 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.029 -0.532 . . . . 21.53 110.99 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 56.6 m -156.09 -46.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.998 -0.546 . . . . 23.03 110.483 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.43 -96.72 0.35 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.04 -0.824 . . . . 24.72 111.04 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.409 -0.805 . . . . 27.31 109.072 173.296 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.669 0.271 . . . . 29.42 110.673 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -80.42 104.76 11.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.62 -0.511 . . . . 26.59 109.62 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -90.5 -48.92 6.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.714 -0.675 . . . . 25.53 110.312 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.6 t -109.47 116.37 31.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.871 -0.604 . . . . 23.29 110.013 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.37 169.18 13.15 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.922 -0.399 . . . . 21.2 109.922 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 57.27 -114.89 0.84 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.831 0.452 . . . . 20.05 111.517 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 4.0 pt20 -122.47 156.63 33.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.314 . . . . 16.73 110.909 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -103.57 -64.77 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.914 -0.772 . . . . 16.22 108.914 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 7' ' ' GLN . 7.5 mm-40 58.15 -160.89 0.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.952 -1.022 . . . . 13.24 112.35 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -119.93 112.06 18.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.675 -0.693 . . . . 10.33 109.207 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.91 136.97 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.001 -0.545 . . . . 14.9 110.987 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' ILE . 2.0 p -47.92 120.69 3.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.753 -0.658 . . . . 11.71 111.94 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.08 -10.14 15.33 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.418 -0.81 . . . . 9.66 111.978 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -90.81 170.82 9.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.153 0.502 . . . . 10.47 111.047 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' VAL . 3.4 tm? -120.03 140.85 50.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.491 -0.777 . . . . 7.46 108.978 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 HD21 ' B' ' 163' ' ' LEU . 0.4 OUTLIER -152.8 177.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.441 -0.345 . . . . 6.87 110.814 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' B' ' 166' ' ' TYR . 88.2 m-85 -95.79 114.94 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.939 -0.393 . . . . 6.78 109.939 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.72 149.02 26.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.699 0.285 . . . . 6.21 110.511 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' B' ' 162' ' ' ASP . 19.4 pttp -120.66 134.51 55.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.182 -0.303 . . . . 12.44 110.182 176.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.848 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 25.0 ttt -116.45 156.17 27.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.076 -0.712 . . . . 10.95 109.076 175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.15 115.84 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.137 -0.625 . . . . 15.91 109.332 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.9 81.03 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 14.09 112.175 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.848 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 92.2 m-85 -122.49 130.11 24.79 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.018 0.437 . . . . 13.65 110.863 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 27.1 Cg_exo -62.13 -174.89 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.27 2.647 . . . . 12.38 112.712 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -77.69 97.49 5.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.537 0.684 . . . . 11.05 109.606 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER -103.93 138.17 19.45 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.583 -1.19 . . . . 10.23 109.99 -171.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 12.3 Cg_endo -57.38 116.14 3.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.056 1.837 . . . . 5.52 111.429 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -134.38 146.69 50.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.077 -0.511 . . . . 3.98 110.832 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -92.33 146.48 23.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.015 -0.539 . . . . 11.28 110.993 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -98.88 137.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.597 -0.729 . . . . 7.51 111.251 -177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' B' ' 148' ' ' PHE . 38.7 t70 -156.04 148.89 24.11 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.349 -0.387 . . . . 10.28 110.309 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.03 147.94 9.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.847 -0.615 . . . . 10.44 109.356 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.421 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 55.7 ttp -140.83 107.65 6.4 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.379 -0.6 . . . . 12.85 109.379 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 19.6 Cg_endo -60.98 135.45 59.27 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.228 1.952 . . . . 13.07 110.776 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 11.9 mm-40 -53.12 -49.03 67.36 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.498 0.499 . . . . 14.04 110.503 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.76 92.29 0.94 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.571 -0.741 . . . . 15.24 109.593 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.72 -54.77 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.959 0.787 . . . . 14.64 110.606 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.24 155.59 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.261 -1.014 . . . . 12.42 108.261 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 43.6 tttp -84.34 79.32 9.59 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.275 -0.639 . . . . 10.84 109.275 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -89.15 115.66 26.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 9.63 111.483 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' B' ' 140' ' ' SER . 22.3 m -156.6 129.53 7.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.071 -0.513 . . . . 9.56 110.61 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' B' ' 139' ' ' LYS . . . -152.73 -85.64 0.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.594 . . . . 8.3 109.722 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.55 94.18 7.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.232 -1.025 . . . . 8.55 108.232 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 57' ' ' PHE . 38.6 ttpt -138.02 123.0 19.01 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.701 -0.8 . . . . 7.5 112.126 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CE2' ' HG3' ' A' ' 60' ' ' PRO . 44.5 m-85 -119.87 146.29 45.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.94 -1.027 . . . . 6.01 108.311 168.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 52.8 tt0 -81.84 105.22 12.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.421 -0.585 . . . . 6.99 109.421 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.593 HG21 ' HB2' ' A' ' 58' ' ' LEU . 80.5 t -97.36 104.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.004 -0.544 . . . . 4.6 109.87 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -89.52 98.19 11.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.882 -0.599 . . . . 5.62 109.508 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 2.3 m-85 -59.64 114.48 2.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 4.03 110.348 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -79.87 -25.11 40.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.681 -0.691 . . . . 4.15 110.077 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.761 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -80.07 -23.89 60.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.008 -0.615 . . . . 5.0 113.427 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 p -111.54 -13.64 13.8 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.701 -0.293 . . . . 5.56 111.002 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.1 t60 63.5 36.43 11.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.724 -0.671 . . . . 6.72 109.691 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.7 147.05 46.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.564 . . . . 6.33 110.663 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 m -97.79 119.33 36.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.99 0.424 . . . . 5.99 111.168 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.32 -179.74 4.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.888 -0.596 . . . . 5.39 110.307 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 40.0 p90 -130.81 133.34 45.87 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.052 -0.351 . . . . 7.73 110.052 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' HB2' HG21 ' A' ' 47' ' ' VAL . 90.7 mt -142.24 167.76 21.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 5.32 110.691 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.56 165.15 28.4 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.022 -0.608 . . . . 5.57 111.65 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 45' ' ' TYR . 32.4 Cg_exo -57.9 -39.8 83.56 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.822 2.348 . . . . 6.06 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -71.12 -12.3 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 7.7 111.687 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.5 5.55 31.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.264 0.554 . . . . 5.82 110.636 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HG ' HG21 ' B' ' 116' ' ' VAL . 19.0 tp -118.92 116.64 26.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.356 -0.979 . . . . 4.21 108.356 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.646 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 85.7 m-85 -107.49 119.09 51.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 111.662 0.245 . . . . 4.63 111.662 -170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' B' ' 116' ' ' VAL . 61.4 Cg_exo -52.96 129.78 34.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.381 2.721 . . . . 4.58 112.382 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.49 -21.97 55.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.504 -0.316 . . . . 4.79 110.891 -175.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.0 -11.57 59.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.292 0.567 . . . . 6.1 110.033 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -113.39 1.16 15.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 6.71 111.064 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 51.1 p -145.03 -37.28 0.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.163 1.172 . . . . 5.49 114.163 -170.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 21.6 pttp -62.94 -15.34 55.26 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.492 0.587 . . . . 6.26 112.319 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 3.9 pt-20 -64.5 -34.41 78.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.023 0.439 . . . . 7.73 110.128 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 37.9 mttm -99.56 -28.79 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.392 0.615 . . . . 8.1 110.006 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 3.4 m-30 -91.1 -8.81 47.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.399 -0.819 . . . . 5.97 110.43 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.44 95.06 0.76 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.897 -0.592 . . . . 6.74 112.214 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -149.99 96.28 3.54 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.397 -0.964 . . . . 8.38 108.397 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -64.4 100.79 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.176 1.918 . . . . 7.75 111.399 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ARG . 52.0 t30 -154.54 156.67 37.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.993 -1.003 . . . . 7.82 108.663 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 73.3 mmtt 72.88 -23.88 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.044 0.537 . . . . 10.11 111.691 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 14.7 mtp180 46.3 -125.5 1.4 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.618 0.767 . . . . 8.81 112.464 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 11.2 ttpp 50.85 -148.45 0.35 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.926 -1.138 . . . . 8.87 107.926 -168.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.1 3.9 49.75 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.647 -1.263 . . . . 5.87 113.258 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' HB2' ' CZ2' ' B' ' 126' ' ' TRP . 89.4 t80 -84.68 -60.17 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.84 0.82 . . . . 5.14 110.777 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.925 ' HB3' ' HA ' ' A' ' 79' ' ' ARG . 21.4 t -79.17 -40.25 31.35 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.527 -0.546 . . . . 6.17 109.527 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 36.4 tt0 -74.39 -31.02 62.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.647 -0.706 . . . . 6.87 109.098 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -69.17 -48.03 49.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.069 -1.062 . . . . 4.6 111.413 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.784 ' HG ' ' HG3' ' B' ' 127' ' ' PRO . 30.3 mt -60.14 -33.35 72.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.964 0.411 . . . . 5.05 111.2 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -71.91 -45.2 62.05 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.28 -0.418 . . . . 7.15 110.639 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 37.4 mt-10 -68.26 -26.05 65.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.115 0.413 . . . . 5.21 112.115 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -82.55 -46.15 19.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 4.46 111.107 178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.09 -24.86 37.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 6.86 111.645 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -122.3 30.89 6.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.86 0.362 . . . . 6.04 110.338 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.74 121.1 65.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.825 -0.625 . . . . 5.09 110.954 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 94' ' ' THR . 13.0 Cg_exo -69.71 110.44 2.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.844 2.363 . . . . 6.48 111.599 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 93' ' ' PRO . 98.2 m 71.56 91.72 0.09 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.742 0.651 . . . . 7.32 110.831 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.37 151.43 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 6.13 110.786 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.79 102.6 10.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 9.68 110.907 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.73 -70.74 0.67 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 8.54 109.527 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 m 70.18 -52.55 0.64 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.551 0.74 . . . . 9.88 112.381 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.6 -26.82 1.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.643 -0.583 . . . . 9.93 111.643 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 123.178 0.591 . . . . 12.88 111.333 176.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.935 0.397 . . . . 13.85 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -79.18 -9.4 59.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.056 0.455 . . . . 12.37 111.151 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 103' ' ' ARG . 25.7 ttp180 -143.32 102.16 3.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 12.02 110.34 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -87.82 126.93 35.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.837 -0.62 . . . . 10.42 110.017 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -93.4 136.47 33.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 8.13 110.596 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -89.26 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 10.78 109.698 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -76.86 111.14 12.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.186 0.517 . . . . 8.36 111.949 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.53 -32.32 22.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.471 -0.786 . . . . 8.99 109.162 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.57 147.89 27.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.426 -0.806 . . . . 8.32 110.432 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.431 ' HE1' ' HG3' ' A' ' 65' ' ' PRO . 35.7 m-85 -86.77 111.63 20.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.308 -0.627 . . . . 5.28 109.308 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.43 ' HD3' ' OE1' ' B' ' 132' ' ' GLU . 6.4 mmtm -85.41 141.98 29.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.186 -0.461 . . . . 8.12 110.386 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 50.5 t -50.37 112.67 0.72 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.708 0.63 . . . . 5.93 110.583 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.64 -24.71 2.88 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.655 -0.702 . . . . 4.62 111.53 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -63.33 102.88 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.135 0.493 . . . . 4.66 111.373 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.72 ' HG ' HG13 ' A' ' 89' ' ' ILE . 3.0 tm? -91.37 104.72 17.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.611 -1.255 . . . . 3.32 107.611 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 28.6 m -131.42 -172.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.798 -0.361 . . . . 3.43 110.809 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 82.8 m-85 -94.09 115.32 27.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.124 0.488 . . . . 3.93 110.611 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -94.19 146.4 24.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.613 -0.721 . . . . 3.3 110.535 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -112.48 101.39 9.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.115 -0.493 . . . . 5.76 109.836 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.48 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 1.2 tmm? -114.82 173.85 6.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.257 -0.429 . . . . 6.08 110.227 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.14 117.02 7.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.142 -0.688 . . . . 8.78 109.142 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.82 -1.45 80.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.943 -0.646 . . . . 6.27 112.212 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.48 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 79.5 m-85 -129.21 103.8 18.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 110.25 -0.278 . . . . 7.06 110.25 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.62 -62.79 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.717 2.278 . . . . 5.68 111.943 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -150.16 98.44 2.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.075 -0.713 . . . . 4.71 109.075 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.761 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.5 t-105 -122.08 132.67 24.21 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.904 -0.319 . . . . 6.03 110.764 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.784 ' HG3' ' HG ' ' A' ' 86' ' ' LEU . 1.3 Cg_endo -44.82 113.86 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.247 3.298 . . . . 3.48 113.103 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.06 143.78 38.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 2.83 110.108 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -90.96 138.38 31.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.405 -0.361 . . . . 5.33 110.248 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' B' ' 114' ' ' ASP . 0.2 OUTLIER -83.43 120.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.6 0.714 . . . . 4.34 110.025 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' GLN . 0.8 OUTLIER -102.9 115.4 30.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.501 -0.926 . . . . 5.66 108.501 169.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 111' ' ' LYS . 43.1 tt0 -69.31 113.19 6.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.749 -1.114 . . . . 7.05 112.073 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 78.3 mtp -110.89 111.39 56.51 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.757 -0.656 . . . . 9.64 109.289 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 126.14 13.22 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.711 2.274 . . . . 9.8 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' B' ' 138' ' ' VAL . 32.1 mt-10 -89.26 12.53 15.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 12.27 109.41 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' B' ' 137' ' ' ALA . . . -77.32 101.34 6.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.956 -1.02 . . . . 11.49 109.485 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' B' ' 136' ' ' ALA . . . 79.28 -40.07 0.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.268 0.98 . . . . 11.38 110.606 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' B' ' 135' ' ' GLU . 92.5 t -97.3 101.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.363 0.602 . . . . 9.65 110.991 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 20.6 pttp -156.71 33.55 0.31 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.137 -1.06 . . . . 11.11 108.137 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 41' ' ' THR . 6.7 p -167.23 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.245 -1.343 . . . . 8.66 110.203 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m 60.2 58.58 2.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.717 0.77 . . . . 9.44 110.558 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 143' ' ' ASN . . . -122.92 158.38 30.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.276 -0.875 . . . . 8.63 109.173 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 142' ' ' ALA . 28.2 t-20 78.32 -38.82 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.085 0.554 . . . . 9.61 111.362 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' B' ' 142' ' ' ALA . 2.7 mptp? -83.91 136.84 33.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.971 -0.751 . . . . 8.97 108.971 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.75 167.85 10.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.376 -0.375 . . . . 7.97 110.403 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -84.62 102.18 12.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.417 0.627 . . . . 9.5 110.149 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 158' ' ' LEU . 72.0 t -98.62 113.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.473 -0.785 . . . . 6.03 110.189 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 31' ' ' ASP . 92.6 m-85 -93.36 99.1 11.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.625 -0.716 . . . . 10.78 110.055 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -53.65 109.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.117 -0.492 . . . . 8.4 109.81 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.416 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 31.6 t80 -75.7 -33.75 60.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 9.24 110.703 -171.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.08 -53.37 30.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.864 -0.684 . . . . 10.64 112.754 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.2 p -87.84 -12.58 44.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.616 0.246 . . . . 12.27 111.515 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 67.77 35.37 3.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 13.51 110.842 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -109.44 179.15 4.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.597 . . . . 12.96 110.659 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 127.92 42.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.636 -0.256 . . . . 10.75 110.653 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.9 156.89 48.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.312 -0.404 . . . . 8.03 110.283 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.67 109.2 20.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.634 -0.506 . . . . 9.95 109.634 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.0 mt -125.68 156.79 38.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.313 -0.403 . . . . 6.89 110.479 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.83 179.01 28.78 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 6.24 111.394 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.35 -31.34 93.67 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.614 2.209 . . . . 8.35 112.093 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.14 -23.43 63.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.769 -0.65 . . . . 12.73 111.144 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.616 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 23.2 m-20 -93.12 1.93 56.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.39 . . . . 9.49 110.775 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 16' ' ' VAL . 10.3 tp -123.09 141.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.523 -0.308 . . . . 7.88 110.982 -172.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -136.95 133.15 18.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 10.48 110.694 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.618 ' HG2' ' HB3' ' B' ' 168' ' ' GLU . 74.2 Cg_endo -81.35 142.62 13.38 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.569 2.179 . . . . 10.82 112.88 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.446 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.2 OUTLIER -63.79 -37.17 86.37 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.32 -0.4 . . . . 10.52 111.925 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.446 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 43.8 tt0 -62.02 -18.11 59.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.236 0.541 . . . . 13.98 110.225 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' B' ' 165' ' ' PRO . 10.1 tp10 -103.14 -32.87 9.44 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.717 -0.674 . . . . 15.72 111.585 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' B' ' 173' ' ' PHE . 18.3 p -145.3 18.77 1.55 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.113 1.153 . . . . 11.91 114.113 -169.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -50.69 -42.55 57.01 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.133 0.42 . . . . 12.55 112.133 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 171' ' ' GLU . 0.9 OUTLIER -83.17 -19.7 36.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.818 0.342 . . . . 15.86 111.52 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.5 -23.25 53.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.093 0.473 . . . . 16.47 110.339 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' B' ' 169' ' ' SER . 22.1 m-85 -124.69 7.96 8.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.595 -0.729 . . . . 11.15 109.954 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' B' ' 175' ' ' LYS . . . -77.57 66.18 3.03 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.589 -0.732 . . . . 11.12 112.537 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' B' ' 174' ' ' GLY . 2.6 mptp? -142.13 95.49 6.77 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.896 -1.15 . . . . 14.56 107.896 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.25 91.19 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.3 2.0 . . . . 11.81 111.929 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -113.72 155.17 26.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.414 -0.812 . . . . 13.38 110.097 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 70.03 4.18 4.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.271 0.628 . . . . 16.74 110.821 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.615 ' HA ' ' HB3' ' B' ' 183' ' ' SER . 13.8 ptp180 38.86 -141.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.627 1.171 . . . . 16.14 114.16 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' B' ' 179' ' ' ARG . 35.3 mtmm 59.78 -136.2 0.76 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 115.736 -0.666 . . . . 15.89 110.179 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.67 -7.63 58.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.726 -0.75 . . . . 11.57 112.62 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -82.44 -56.03 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.71 -0.478 . . . . 9.65 109.71 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.615 ' HB3' ' HA ' ' B' ' 179' ' ' ARG . 62.3 p -64.94 -50.05 67.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 10.46 110.689 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 5.4 mm-40 -68.87 -29.75 68.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 12.15 109.873 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.79 -46.92 90.61 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.624 -0.798 . . . . 8.24 111.48 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.18 -38.25 89.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 7.89 110.754 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -68.74 -42.42 77.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.251 -0.432 . . . . 11.87 110.235 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.57 -39.9 95.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.88 -0.6 . . . . 11.62 111.355 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.488 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -79.59 -30.14 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.857 -0.337 . . . . 9.26 111.427 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . 0.488 ' N ' HD12 ' B' ' 189' ' ' ILE . 34.0 tt0 -80.69 -38.86 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.378 0.609 . . . . 11.04 110.879 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -113.82 82.41 1.69 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.587 -0.733 . . . . 12.59 110.284 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -64.18 124.27 84.96 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.503 -0.771 . . . . 13.52 110.839 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.79 -28.59 59.41 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 14.9 112.178 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 18.4 m -100.55 98.03 8.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 17.54 110.085 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.24 135.88 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.003 -0.544 . . . . 18.06 110.471 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -100.8 107.97 19.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 21.28 110.497 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -153.92 133.49 12.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 21.53 109.743 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 12.8 t -111.93 91.68 3.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 23.03 110.144 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.46 62.39 0.65 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.269 -0.733 . . . . 24.72 111.269 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.677 -0.678 . . . . 27.31 110.317 -175.172 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.583 0.23 . . . . 29.42 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -68.84 -58.96 3.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.865 0.364 . . . . 26.59 110.737 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -108.18 104.0 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.558 -0.534 . . . . 25.53 109.558 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -98.83 173.16 7.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.036 -0.529 . . . . 23.29 110.039 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.43 123.44 25.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 21.2 109.803 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.64 -6.69 59.38 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.838 -0.619 . . . . 20.05 110.644 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -94.76 100.28 12.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.494 -0.775 . . . . 16.73 110.515 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 35.3 mtpt -110.88 107.75 17.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.569 . . . . 16.22 110.858 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -136.69 146.26 45.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.234 -0.654 . . . . 13.24 109.234 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.31 119.68 27.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.481 -0.327 . . . . 10.33 110.694 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -108.81 149.07 29.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.359 . . . . 14.9 111.084 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 30' ' ' ILE . 8.6 m -40.44 113.66 0.38 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.552 -0.749 . . . . 11.71 111.768 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.4 -23.28 9.15 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.607 -0.806 . . . . 9.66 112.502 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -75.78 144.51 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 10.47 109.965 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 16' ' ' VAL . 5.0 tt -110.94 139.96 45.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.093 -1.077 . . . . 7.46 108.093 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -154.59 -176.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.624 0.25 . . . . 6.87 110.784 -175.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -97.42 118.04 33.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 6.78 110.587 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.84 150.52 24.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.381 -0.372 . . . . 6.21 111.409 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 58.5 pttt -115.71 123.3 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 12.44 110.848 175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.706 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 1.8 tmm? -129.28 -179.8 5.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.993 -0.743 . . . . 10.95 108.993 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -63.3 116.32 5.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.812 0.339 . . . . 15.91 110.488 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . 85.74 -17.19 36.97 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.816 -0.629 . . . . 14.09 112.43 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 77.8 m-85 -102.31 102.79 26.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.257 -0.275 . . . . 13.65 110.257 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 76.3 Cg_endo -91.3 95.25 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.213 2.608 . . . . 12.38 113.36 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.7 m80 60.85 62.23 1.5 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.401 0.62 . . . . 11.05 110.477 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 1.2 t-105 -96.89 126.84 41.22 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.179 -0.919 . . . . 10.23 109.723 -173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.43 109.76 0.4 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.192 2.595 . . . . 5.52 112.43 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -131.95 158.19 42.1 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.303 -0.408 . . . . 3.98 111.784 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.25 143.62 33.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.005 0.431 . . . . 11.28 111.275 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 12' ' ' CYS . 1.7 mm -92.27 132.89 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 7.51 111.972 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 37.7 t70 -148.42 110.89 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 10.28 109.887 169.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 9.3 tp10 -90.0 125.26 35.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.442 -0.577 . . . . 10.44 109.442 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.499 ' SD ' ' HD2' ' A' ' 34' ' ' PRO . 48.9 tpp -150.22 128.05 5.74 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.109 -0.496 . . . . 12.85 110.094 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 29.3 Cg_endo -62.57 167.07 12.15 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.685 2.257 . . . . 13.07 111.973 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -69.6 -31.57 69.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.398 0.618 . . . . 14.04 109.441 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.89 -59.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.961 -1.018 . . . . 15.24 108.907 172.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.92 -33.83 2.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.304 -0.862 . . . . 14.64 109.69 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.663 HG23 HG23 ' B' ' 141' ' ' THR . 10.7 p -122.49 157.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.758 -0.656 . . . . 12.42 109.478 175.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 34' ' ' PRO . 28.1 ttmt -102.56 -51.57 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.928 0.394 . . . . 10.84 110.316 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 p -137.69 145.76 42.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 9.63 110.891 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.515 HG22 ' HE3' ' B' ' 139' ' ' LYS . 2.8 p -118.51 89.23 3.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.56 0.695 . . . . 9.56 110.198 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' B' ' 140' ' ' SER . . . -95.09 121.6 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.564 -0.743 . . . . 8.3 111.643 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' B' ' 138' ' ' VAL . 43.4 t30 -177.42 -88.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.008 0.818 . . . . 8.55 109.568 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -146.98 161.03 41.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.559 . . . . 7.5 110.316 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -95.34 116.28 28.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.19 -0.67 . . . . 6.01 109.19 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.8 tp-100 -74.8 96.74 3.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.341 -0.985 . . . . 6.99 108.341 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 58' ' ' LEU . 92.7 t -84.21 104.06 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.827 -0.624 . . . . 4.6 110.805 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -87.8 99.03 11.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.318 -0.623 . . . . 5.62 109.318 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 29.7 m-85 -55.21 117.89 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 4.03 110.681 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.546 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 76.0 t80 -80.92 -39.56 26.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.55 -0.75 . . . . 4.15 109.521 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.77 -51.5 24.5 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.433 -0.889 . . . . 5.0 111.929 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -73.47 -21.3 60.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.6 0.238 . . . . 5.56 111.048 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.3 m80 63.67 36.04 11.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.443 0.639 . . . . 6.72 110.784 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -126.52 172.29 10.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.494 -0.776 . . . . 6.33 110.316 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -115.96 132.16 56.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.805 0.336 . . . . 5.99 111.742 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.23 -179.49 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.906 -0.405 . . . . 5.39 109.906 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -138.48 131.78 30.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 7.73 111.019 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' B' ' 120' ' ' MET . 88.6 mt -138.65 176.25 8.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.473 -0.785 . . . . 5.32 110.464 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.44 179.48 33.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.889 -0.672 . . . . 5.57 111.753 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.36 -42.4 41.94 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.729 2.286 . . . . 6.06 112.802 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -83.85 1.7 41.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 7.7 111.035 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.4 m-20 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.192 -0.67 . . . . 5.82 109.192 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.6 tp -119.01 131.07 55.97 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.413 -0.812 . . . . 4.21 109.848 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.749 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 93.1 m-85 -120.86 159.68 47.87 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 4.63 111.283 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.95 162.76 2.42 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.796 2.997 . . . . 4.58 114.601 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' B' ' 116' ' ' VAL . 85.3 t80 -98.42 -76.48 0.53 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.087 -0.96 . . . . 4.79 110.863 -172.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -90.82 -22.95 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.247 0.546 . . . . 6.1 110.142 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.1 mp0 -80.91 -10.16 59.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.848 -0.614 . . . . 6.71 110.4 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -143.43 -0.1 1.11 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.669 0.988 . . . . 5.49 113.669 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -55.76 -29.44 59.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.673 0.669 . . . . 6.26 111.417 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.12 -29.47 66.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 7.73 111.091 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -72.06 -27.7 62.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 8.1 109.267 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.96 8.36 36.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.126 -0.943 . . . . 5.97 109.633 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.86 67.19 2.37 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.65 -0.704 . . . . 6.74 112.229 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 96.92 14.05 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.352 -0.981 . . . . 8.38 108.352 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -82.49 102.57 1.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.53 2.153 . . . . 7.75 113.729 -167.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -83.34 162.54 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.242 -1.022 . . . . 7.82 108.242 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.98 64.21 7.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.99 0.9 . . . . 10.11 110.524 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 12.8 mmt180 -107.33 124.82 50.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.516 -1.22 . . . . 8.81 107.925 172.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -50.43 -65.56 0.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.432 0.457 . . . . 8.87 111.858 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.42 -35.61 92.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.92 -0.657 . . . . 5.87 112.921 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.729 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 28.4 t80 -61.23 -41.77 97.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.647 0.26 . . . . 5.14 110.505 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 m -65.76 -45.98 80.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 6.17 110.382 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.53 -51.21 70.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.106 -0.497 . . . . 6.87 110.615 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.57 -45.96 94.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.674 -0.694 . . . . 4.6 112.584 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.52 -42.57 95.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.856 0.36 . . . . 5.05 110.15 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -68.63 -48.24 64.56 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.972 -0.291 . . . . 7.15 110.645 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.585 ' HA ' HD21 ' A' ' 91' ' ' ASN . 4.3 tp10 -60.53 -26.95 67.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.567 . . . . 5.21 110.476 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.714 HG13 ' CE1' ' A' ' 66' ' ' TYR . 1.3 mp -82.28 -35.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.427 -0.806 . . . . 4.46 110.852 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -75.51 -46.01 34.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 6.86 111.133 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.585 HD21 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -87.77 10.3 18.85 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.72 -0.392 . . . . 6.04 111.739 -177.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.56 129.46 93.68 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 5.09 110.431 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.68 164.65 2.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.275 2.65 . . . . 6.48 112.855 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 94' ' ' THR . 9.3 t -65.4 105.72 1.22 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.861 0.838 . . . . 7.32 111.358 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 m -114.58 115.9 50.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.506 -0.77 . . . . 6.13 110.156 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.7 76.78 9.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.309 -0.405 . . . . 9.68 110.213 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 69.21 -59.1 0.49 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.713 0.805 . . . . 8.54 111.571 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 t -145.0 -40.78 0.24 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.537 -0.542 . . . . 9.88 109.537 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.82 -169.88 36.59 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.477 -0.649 . . . . 9.93 111.477 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.153 0.501 . . . . 12.88 110.123 -179.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.339 0.114 . . . . 13.85 110.715 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m 75.19 -59.24 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.453 0.701 . . . . 12.37 112.168 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.94 126.01 50.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.944 0.402 . . . . 12.02 111.02 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 40.5 m -145.71 111.88 5.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.828 -0.624 . . . . 10.42 110.119 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -76.75 109.77 10.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 8.13 110.255 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -90.74 -6.69 54.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.076 -0.511 . . . . 10.78 112.089 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -122.26 95.18 4.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.48 0.657 . . . . 8.36 111.387 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -100.35 78.17 2.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 8.99 109.988 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -169.29 129.1 1.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.929 -0.578 . . . . 8.32 109.817 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -89.12 136.47 33.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.655 -0.498 . . . . 5.28 109.655 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' B' ' 113' ' ' GLY . 74.5 mmtt -74.79 114.98 13.86 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.991 -0.744 . . . . 8.12 108.991 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 57.6 m 63.94 -51.59 0.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.138 -0.937 . . . . 5.93 110.756 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' B' ' 111' ' ' LYS . . . 133.11 -9.73 5.11 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.694 -1.363 . . . . 4.62 109.694 -172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 13.7 t70 34.2 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.497 1.119 . . . . 4.66 113.22 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' B' ' 129' ' ' ARG . 3.5 tt -150.31 123.01 8.6 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.085 -1.08 . . . . 3.32 108.085 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 66' ' ' TYR . 2.6 m -153.36 -170.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.646 0.591 . . . . 3.43 109.935 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -88.92 141.49 28.44 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.051 -0.406 . . . . 3.93 110.69 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.54 159.25 26.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.638 0.256 . . . . 3.3 111.613 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.579 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 33.6 ttpt -124.74 105.23 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 5.76 110.702 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 58' ' ' LEU . 14.4 tpt -113.47 156.84 22.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.19 -0.3 . . . . 6.08 110.19 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -62.29 115.84 4.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.673 -0.862 . . . . 8.78 108.673 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 -15.3 50.29 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.828 -0.701 . . . . 6.27 111.564 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 68.7 m-85 -131.48 100.53 16.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.8 -0.445 . . . . 7.06 109.8 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 7.7 Cg_endo -48.72 -72.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.431 2.754 . . . . 5.68 112.841 -175.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -142.38 104.96 4.5 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.686 -0.857 . . . . 4.71 108.686 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.3 t-105 -126.01 128.78 24.43 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.973 -0.558 . . . . 6.03 110.456 -169.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.89 124.71 16.32 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.927 2.418 . . . . 3.48 112.665 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.546 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -144.93 152.82 40.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.149 0.5 . . . . 2.83 112.126 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 15.5 ttm180 -100.3 146.58 26.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 5.33 109.734 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.46 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.0 OUTLIER -81.8 144.5 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.569 . . . . 4.34 110.933 -174.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 7.6 t70 -139.14 158.34 44.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.991 -1.115 . . . . 5.66 107.991 171.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -96.69 127.44 42.67 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.056 -0.258 . . . . 7.05 111.208 -172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.598 ' HB2' HE21 ' A' ' 46' ' ' GLN . 23.5 ttt -123.51 90.28 50.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.73 0.3 . . . . 9.64 111.117 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -101.53 -173.68 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.422 2.748 . . . . 9.8 112.156 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.47 ' OE2' ' HG2' ' B' ' 139' ' ' LYS . 24.2 mm-40 61.94 29.36 17.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 12.27 112.439 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.52 94.46 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.858 -0.337 . . . . 11.49 110.821 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 71.58 -58.81 0.57 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.93 0.769 . . . . 11.38 111.27 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 43' ' ' ASN . 32.6 t -107.86 146.77 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.519 -0.549 . . . . 9.65 109.519 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HE3' HG22 ' A' ' 41' ' ' THR . 19.6 tptm 177.59 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.516 . . . . 11.11 109.987 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.498 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 19.6 m -94.45 88.48 5.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.922 -0.581 . . . . 8.66 109.732 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 0.663 HG23 HG23 ' A' ' 38' ' ' VAL . 53.8 m -64.03 -32.73 74.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.84 -0.618 . . . . 9.44 110.789 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.13 165.57 12.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 8.63 109.475 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.481 ' OD1' ' HG3' ' B' ' 144' ' ' LYS . 28.8 t-20 -158.56 -68.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.83 0.348 . . . . 9.61 110.699 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' B' ' 143' ' ' ASN . 36.8 mtmm -123.1 130.35 52.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.291 -0.413 . . . . 8.97 110.149 177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.573 ' HD1' ' HB2' ' A' ' 32' ' ' GLU . 60.8 m-85 -75.78 164.07 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 7.97 110.554 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 35.4 tt0 -88.21 106.37 18.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.827 -0.805 . . . . 9.5 108.827 172.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' B' ' 158' ' ' LEU . 74.3 t -93.66 107.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.558 -0.746 . . . . 6.03 109.857 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.474 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 31.1 t80 -94.64 103.62 15.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.965 -0.561 . . . . 10.78 109.917 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.662 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 12.5 m-85 -57.0 108.76 0.55 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.75 -0.659 . . . . 8.4 110.641 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 30.8 t80 -64.79 -41.81 95.55 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.555 1.159 . . . . 9.24 110.841 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.03 -48.73 14.88 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.683 -0.77 . . . . 10.64 113.308 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.524 ' HB ' ' HG2' ' B' ' 154' ' ' GLU . 0.2 OUTLIER -92.77 -8.22 44.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.837 0.681 . . . . 12.27 112.837 -173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.3 m80 63.07 39.05 10.38 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.296 0.57 . . . . 13.51 110.395 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 13.1 mm-40 -101.38 118.55 37.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.577 -0.738 . . . . 12.96 110.499 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.474 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 8.0 m -96.41 103.45 15.35 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.494 -0.482 . . . . 10.75 110.312 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.71 178.35 5.5 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.198 -0.456 . . . . 8.03 110.824 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -122.82 123.01 40.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.925 -0.398 . . . . 9.95 109.925 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' B' ' 147' ' ' VAL . 97.0 mt -139.3 163.72 31.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.137 -0.483 . . . . 6.89 110.123 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.15 170.4 22.55 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.372 -0.918 . . . . 6.24 111.173 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.476 ' HD3' ' HE2' ' B' ' 145' ' ' TYR . 18.0 Cg_endo -60.96 -22.46 74.59 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.277 1.985 . . . . 8.35 111.076 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.33 -26.72 68.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.433 -0.803 . . . . 12.73 110.727 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.735 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 30.4 m-20 -98.26 5.56 48.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.878 -0.601 . . . . 9.49 110.418 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 16' ' ' VAL . 11.6 tp -117.93 132.54 56.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.878 -0.601 . . . . 7.88 110.501 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.71 155.2 54.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 112.087 0.403 . . . . 10.48 112.087 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' B' ' 168' ' ' GLU . 88.4 Cg_exo -49.01 135.19 29.63 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.168 3.245 . . . . 10.82 114.618 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.973 ' HE1' HG13 ' B' ' 189' ' ' ILE . 45.4 t80 -89.59 -65.45 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.461 -1.245 . . . . 10.52 111.492 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -83.31 -8.4 59.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.438 0.637 . . . . 13.98 109.73 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' B' ' 165' ' ' PRO . 27.6 mt-10 -98.35 -47.98 5.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.379 -0.828 . . . . 15.72 111.606 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.5 m -104.85 -4.0 22.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.627 0.603 . . . . 11.91 112.627 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 51.9 pttt -56.94 -18.44 13.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.61 -0.436 . . . . 12.55 111.793 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' B' ' 172' ' ' LYS . 8.4 pt-20 -61.4 -28.65 69.4 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.742 0.306 . . . . 15.86 111.516 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' B' ' 171' ' ' GLU . 14.6 mmmm -101.26 -11.55 19.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.954 0.353 . . . . 16.47 111.954 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -100.8 12.9 36.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 11.15 110.562 -176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -79.84 79.11 1.72 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.938 -0.649 . . . . 11.12 112.223 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.43 96.31 3.67 Favored Pre-proline 0 CA--C 1.51 -0.576 0 N-CA-C 108.449 -0.945 . . . . 14.56 108.449 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.35 104.2 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.206 1.938 . . . . 11.81 111.212 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.409 HD22 ' HE2' ' B' ' 182' ' ' PHE . 26.2 m-80 -75.72 -173.67 2.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.2 -0.909 . . . . 13.38 111.608 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -80.27 16.05 1.39 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 16.74 111.041 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -112.56 111.03 21.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.671 -0.863 . . . . 16.14 108.671 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.59 -31.06 71.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.461 0.171 . . . . 15.89 111.461 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.0 97.0 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.719 -0.753 . . . . 11.57 111.801 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 14.2 t80 -66.5 -46.63 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.034 -0.358 . . . . 9.65 110.034 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 32.1 t -63.89 -43.37 96.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 10.46 111.035 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.68 -51.38 69.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.015 0.436 . . . . 12.15 110.209 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.06 -45.81 95.32 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.573 -0.74 . . . . 8.24 112.099 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' B' ' 182' ' ' PHE . 20.8 mt -57.54 -44.99 85.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.556 0.206 . . . . 7.89 111.556 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -62.79 -52.77 61.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 121.104 -0.239 . . . . 11.87 110.591 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.678 ' HA ' HD21 ' B' ' 191' ' ' ASN . 6.2 mm-40 -58.49 -27.51 64.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 11.62 111.261 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.973 HG13 ' HE1' ' B' ' 166' ' ' TYR . 1.5 mp -86.21 -33.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.454 -0.794 . . . . 9.26 111.196 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.19 -43.24 67.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.434 -0.348 . . . . 11.04 111.526 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.678 HD21 ' HA ' ' B' ' 188' ' ' GLU . 9.2 p30 -73.65 -8.61 56.68 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.927 -0.309 . . . . 12.59 110.964 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.52 HD22 HG22 ' B' ' 195' ' ' VAL . 2.7 p-10 43.5 97.03 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.798 1.239 . . . . 13.52 114.066 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' B' ' 192' ' ' ASN . 42.0 Cg_endo -67.74 161.86 41.96 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 122.753 2.302 . . . . 14.9 111.674 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 41.9 m 70.66 -58.92 0.54 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.883 0.473 . . . . 17.54 111.633 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.52 HG22 HD22 ' B' ' 192' ' ' ASN . 22.5 t 66.04 86.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.116 0.567 . . . . 18.06 110.577 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -96.36 114.45 26.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.772 -0.649 . . . . 21.28 109.71 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 64.57 73.66 0.42 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.606 0.717 . . . . 21.53 110.98 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 2.2 p -76.01 93.59 3.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.568 -0.742 . . . . 23.03 111.28 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -159.88 28.46 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.045 -0.597 . . . . 24.72 111.928 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.715 -0.659 . . . . 27.31 110.137 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.766 -0.457 . . . . 29.42 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -86.47 -44.74 11.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 26.59 109.44 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 61.23 -172.27 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.574 -0.739 . . . . 25.53 112.408 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m 59.58 22.06 10.68 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.04 -0.982 . . . . 23.29 112.157 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.03 96.34 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.019 -0.734 . . . . 21.2 109.019 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -100.4 -23.6 14.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.34 -0.391 . . . . 20.05 111.092 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -78.13 94.66 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.481 . . . . 16.73 109.848 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -143.56 -49.61 0.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.19 -0.914 . . . . 16.22 109.391 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -94.18 161.11 14.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.235 -0.893 . . . . 13.24 110.082 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -117.29 155.15 30.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 10.33 109.885 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 13' ' ' GLY . 44.1 mmtm -91.68 113.54 25.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.916 -1.142 . . . . 14.9 107.916 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 30' ' ' ILE . 11.2 t 65.09 -48.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.948 0.78 . . . . 11.71 109.843 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.678 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 161.31 -20.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.55 -1.02 . . . . 9.66 110.55 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 64.24 -169.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.547 0.739 . . . . 10.47 112.217 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD11 ' HB ' ' B' ' 189' ' ' ILE . 3.2 tm? -102.56 121.8 43.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.117 -1.068 . . . . 7.46 108.117 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' B' ' 163' ' ' LEU . 2.9 m -152.0 -170.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.407 -0.36 . . . . 6.87 110.913 -170.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' B' ' 170' ' ' LYS . 67.6 m-85 -103.93 126.53 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.496 -0.557 . . . . 6.78 109.496 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.94 161.66 14.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.483 -0.326 . . . . 6.21 111.371 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -116.39 123.78 48.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.47 . . . . 12.44 110.45 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.657 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 2.6 tmm? -126.54 173.83 9.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.891 -0.781 . . . . 10.95 108.891 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.3 117.16 13.6 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.512 -0.551 . . . . 15.91 109.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.57 65.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.991 -0.623 . . . . 14.09 111.679 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 42.2 m-85 -121.92 96.17 47.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.763 -0.458 . . . . 13.65 109.763 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.3 -55.09 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.867 2.378 . . . . 12.38 112.664 -176.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -146.77 110.08 4.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.113 -0.699 . . . . 11.05 109.113 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.1 t-105 -136.4 134.43 19.84 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.957 -0.386 . . . . 10.23 109.957 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.84 120.75 8.85 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.978 2.452 . . . . 5.52 112.581 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -144.58 151.45 39.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 3.98 111.784 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.0 ttm180 -112.16 144.03 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 11.28 110.254 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.678 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.45 145.0 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.15 0.5 . . . . 7.51 111.788 -176.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.589 ' N ' HD13 ' A' ' 30' ' ' ILE . 13.4 t70 -145.16 146.56 31.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.535 -0.913 . . . . 10.28 108.535 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.99 123.34 37.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 10.44 111.881 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 47.1 tpp -140.87 101.03 6.47 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.929 -0.578 . . . . 12.85 110.28 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.802 ' CA ' ' HA ' ' B' ' 142' ' ' ALA . 47.8 Cg_exo -37.79 119.38 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 124.663 3.575 . . . . 13.07 115.161 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.858 ' HA ' ' HB ' ' B' ' 141' ' ' THR . 13.7 tt0 174.33 11.42 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.86 0.725 . . . . 14.04 112.166 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' B' ' 144' ' ' LYS . . . -86.84 -86.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.2 0.815 . . . . 15.24 113.2 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' B' ' 140' ' ' SER . . . -113.86 -53.18 2.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.295 0.48 . . . . 14.64 112.295 -171.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' B' ' 142' ' ' ALA . 12.0 p -122.21 143.38 35.1 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 N-CA-C 109.405 -0.591 . . . . 12.42 109.405 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.812 ' HD2' ' HB2' ' B' ' 142' ' ' ALA . 21.5 tptp -117.12 -22.95 8.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 10.84 110.181 170.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.703 ' HA ' ' HG2' ' B' ' 135' ' ' GLU . 22.1 m 64.75 19.73 11.92 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.651 -0.704 . . . . 9.63 110.518 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.73 148.14 30.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 9.56 109.99 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.8 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.521 -0.309 . . . . 8.3 110.486 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.54 20.29 11.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.102 0.477 . . . . 8.55 110.923 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 12.1 ptmm? -141.92 163.16 33.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.955 -0.566 . . . . 7.5 109.624 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CE2' ' HD2' ' B' ' 110' ' ' TYR . 24.4 m-85 -111.33 157.37 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 6.01 111.269 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -99.54 105.85 17.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.179 -1.045 . . . . 6.99 108.179 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 82.7 t -99.81 110.84 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.285 0.564 . . . . 4.6 111.112 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.02 104.68 16.71 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.924 -0.58 . . . . 5.62 109.447 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 10.7 m-85 -53.47 121.58 7.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.145 -0.48 . . . . 4.03 110.515 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' H ' ' HA ' ' B' ' 128' ' ' ALA . 60.7 t80 -84.81 -42.68 14.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.692 -0.685 . . . . 4.15 109.93 -173.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.61 -44.22 40.98 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.586 -0.816 . . . . 5.0 112.154 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -78.35 -21.81 48.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.708 0.289 . . . . 5.56 110.957 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 60.54 48.25 7.71 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.934 -0.575 . . . . 6.72 110.383 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -135.0 166.95 21.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 6.33 110.147 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.5 m -108.72 135.46 49.91 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.08 -0.248 . . . . 5.99 110.869 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.99 121.05 10.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 5.39 111.118 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -78.07 116.9 18.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.361 . . . . 7.73 110.521 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' B' ' 120' ' ' MET . 89.8 mt -132.96 175.15 9.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.425 -0.352 . . . . 5.32 111.211 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.73 172.06 19.74 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.894 -0.67 . . . . 5.57 111.551 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' A' ' 45' ' ' TYR . 11.6 Cg_endo -56.03 -39.41 91.39 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.062 2.508 . . . . 6.06 112.94 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -76.97 -7.7 56.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 7.7 111.244 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -95.46 3.45 54.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 5.82 110.48 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 13.6 tp -119.02 117.6 29.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.001 -0.545 . . . . 4.21 109.802 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 50.8 m-85 -114.81 123.66 31.67 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-O 120.46 0.172 . . . . 4.63 111.388 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HG11 ' B' ' 116' ' ' VAL . 32.5 Cg_endo -65.18 135.06 41.82 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.736 2.291 . . . . 4.58 112.541 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.673 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -67.11 -12.99 61.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.217 -0.447 . . . . 4.79 111.884 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 46.4 mt-10 -44.78 -44.17 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.053 0.541 . . . . 6.1 112.297 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.2 22.08 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 6.71 111.328 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 66' ' ' TYR . 53.5 p -127.6 -30.18 2.58 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.617 -0.433 . . . . 5.49 111.913 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 66' ' ' TYR . 20.4 pttm -56.44 -40.3 74.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.649 0.262 . . . . 6.26 111.285 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 70' ' ' LYS . 1.6 pm0 -84.0 -19.27 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.141 -0.349 . . . . 7.73 111.84 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -67.55 -52.07 43.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.017 0.436 . . . . 8.1 110.622 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 17.9 p90 -124.69 -28.93 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.182 -0.463 . . . . 5.97 110.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 -114.38 5.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.057 -0.592 . . . . 6.74 112.351 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.951 ' HB3' HD13 ' A' ' 86' ' ' LEU . 19.7 pttp -129.95 94.44 31.25 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 121.531 0.681 . . . . 8.38 110.408 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 82' ' ' PHE . 58.8 Cg_endo -88.63 -0.27 6.55 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.595 2.197 . . . . 7.75 112.348 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -125.45 126.05 44.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.211 -0.449 . . . . 7.82 110.385 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -101.52 30.18 4.42 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.355 0.597 . . . . 10.11 110.099 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -66.82 149.33 50.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.285 -0.871 . . . . 8.81 108.939 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -45.39 -56.35 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.692 0.62 . . . . 8.87 112.595 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.87 -15.95 80.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.337 -0.935 . . . . 5.87 113.599 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 75' ' ' LYS . 11.8 t80 -80.78 -55.68 4.66 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.348 -0.501 . . . . 5.14 110.31 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 p -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.51 . . . . 6.17 110.749 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 32.6 tt0 -70.47 -37.94 74.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.244 -0.435 . . . . 6.87 109.912 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' HD13 ' A' ' 89' ' ' ILE . . . -66.6 -45.08 87.89 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.677 -0.773 . . . . 4.6 111.993 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 75' ' ' LYS . 6.8 tt -68.01 -30.64 69.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.095 -0.335 . . . . 5.05 110.095 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -62.05 -48.85 78.4 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.858 -0.423 . . . . 7.15 109.858 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HA ' HD21 ' A' ' 91' ' ' ASN . 45.8 mt-10 -57.33 -25.19 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.712 0.633 . . . . 5.21 110.925 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 HD11 HD11 ' B' ' 115' ' ' LEU . 1.5 mp -78.65 -45.65 25.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.818 -0.628 . . . . 4.46 110.747 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.09 -33.8 74.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.013 -0.539 . . . . 6.86 111.509 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.753 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.2 p30 -93.65 0.96 56.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.554 -0.294 . . . . 6.04 111.102 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.1 t30 -70.15 113.07 15.03 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.472 -0.331 . . . . 5.09 111.022 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -84.44 -30.22 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.988 2.459 . . . . 6.48 112.893 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 t -85.19 94.62 8.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.889 0.852 . . . . 7.32 111.326 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.97 94.94 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.315 -0.857 . . . . 6.13 108.947 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.09 88.28 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 9.68 111.02 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.02 175.12 6.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.809 -0.632 . . . . 8.54 110.304 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -60.45 -29.33 68.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.138 0.494 . . . . 9.88 111.146 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.98 85.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.815 -0.707 . . . . 9.93 111.976 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.845 0.355 . . . . 12.88 110.058 179.099 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.686 0.279 . . . . 13.85 110.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -89.6 146.08 24.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.428 -0.582 . . . . 12.37 109.428 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 68.17 86.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.918 0.761 . . . . 12.02 110.284 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 69.8 p -93.86 120.58 34.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.634 -0.712 . . . . 10.42 110.203 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -74.38 91.42 2.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 8.13 110.215 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -121.63 -26.44 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.732 -0.667 . . . . 10.78 110.591 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.76 112.39 18.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 8.36 110.181 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -96.06 -71.91 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.334 0.588 . . . . 8.99 110.242 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -106.75 139.93 40.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 8.32 109.323 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.598 ' HB2' HD12 ' B' ' 130' ' ' ILE . 91.8 m-85 -78.89 130.76 35.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.406 -0.59 . . . . 5.28 109.406 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -92.03 144.18 25.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.098 -0.501 . . . . 8.12 110.345 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.46 ' HA ' HG23 ' B' ' 130' ' ' ILE . 51.4 t -48.59 127.83 14.08 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.426 0.454 . . . . 5.93 110.903 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.52 -18.35 17.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.964 -0.636 . . . . 4.62 112.016 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' B' ' 130' ' ' ILE . 31.3 t70 -58.27 145.79 36.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.95 0.405 . . . . 4.66 111.746 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.533 HD11 HD11 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -138.54 105.86 5.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.921 -0.77 . . . . 3.32 108.921 -178.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.595 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 28.5 m -142.49 -170.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.653 -0.249 . . . . 3.43 110.505 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -85.13 116.76 23.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 3.93 110.497 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.79 155.04 17.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.309 -0.405 . . . . 3.3 110.473 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' B' ' 119' ' ' LYS . 4.8 ttpm? -120.14 110.15 16.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 5.76 110.397 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.595 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 2.1 tmm? -118.68 -179.07 3.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.234 -0.654 . . . . 6.08 109.234 176.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -72.48 121.22 19.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.127 0.489 . . . . 8.78 109.71 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.67 -9.53 73.48 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.552 -0.749 . . . . 6.27 111.912 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 70.9 m-85 -118.93 101.2 50.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.726 -0.472 . . . . 7.06 109.726 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.52 -66.16 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.751 2.301 . . . . 5.68 112.09 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.41 97.1 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.891 -0.781 . . . . 4.71 108.891 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -120.36 132.49 24.11 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.174 -0.466 . . . . 6.03 110.073 -172.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.3 116.96 3.42 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.897 2.398 . . . . 3.48 112.641 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -137.45 155.08 49.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.757 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -108.33 145.15 34.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 5.33 110.778 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' B' ' 110' ' ' TYR . 3.4 tt -92.79 151.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.994 -0.548 . . . . 4.34 111.376 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.8 134.92 30.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 5.66 109.558 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.75 147.93 25.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 7.05 111.111 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 91.7 mtp -133.27 134.69 24.35 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.825 -0.625 . . . . 9.64 109.586 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 4.4 Cg_exo -78.47 -70.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.729 2.286 . . . . 9.8 111.998 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -165.14 -149.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 12.27 109.991 177.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' B' ' 135' ' ' GLU . . . 71.53 13.15 6.45 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.731 0.644 . . . . 11.49 111.701 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -178.51 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 11.38 109.87 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' B' ' 139' ' ' LYS . 4.3 p -91.22 117.89 35.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.13 -0.941 . . . . 9.65 110.757 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.42 ' HG2' HG22 ' B' ' 138' ' ' VAL . 31.8 mmmt 62.54 -78.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.575 -0.739 . . . . 11.11 111.211 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 54.2 m 54.8 47.59 22.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.215 0.531 . . . . 8.66 111.283 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 0.858 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 19.4 p -116.78 85.91 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.11 0.781 . . . . 9.44 113.11 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.812 ' HB2' ' HD2' ' A' ' 39' ' ' LYS . . . -148.1 166.68 27.1 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.144 -0.347 . . . . 8.63 111.262 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.466 ' N ' ' HA ' ' A' ' 34' ' ' PRO . 4.5 t30 63.95 37.4 9.44 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.825 0.85 . . . . 9.61 112.319 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.641 ' HD3' ' HB2' ' B' ' 157' ' ' PHE . 30.4 ttmt -89.61 147.08 24.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.383 -0.527 . . . . 8.97 109.644 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' B' ' 158' ' ' LEU . 13.5 m-85 -88.15 98.32 11.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.991 0.424 . . . . 7.97 110.456 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 33' ' ' MET . 28.2 tt0 -80.89 96.03 6.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.494 -0.928 . . . . 9.5 108.494 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.66 ' HB ' HD13 ' B' ' 158' ' ' LEU . 90.3 t -88.92 117.25 31.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.926 -0.579 . . . . 6.03 111.384 -172.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.79 106.8 17.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.515 -0.766 . . . . 10.78 109.728 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 20' ' ' MET . 4.9 m-85 -63.83 99.68 0.25 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.027 -0.533 . . . . 8.4 109.837 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.472 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 29.8 t80 -71.05 -19.73 62.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.322 -0.399 . . . . 9.24 110.504 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.737 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.84 -69.7 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.962 -0.637 . . . . 10.64 112.536 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.4 p -86.26 -3.4 58.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 12.27 111.669 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 66.49 35.51 5.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.701 -0.681 . . . . 13.51 111.176 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.27 179.52 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 12.96 110.827 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 15.8 m -138.29 135.84 35.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.543 0.211 . . . . 10.75 111.017 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.7 172.74 14.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 8.03 110.67 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.641 ' HB2' ' HD3' ' B' ' 144' ' ' LYS . 39.8 p90 -105.78 127.54 53.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.106 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' B' ' 147' ' ' VAL . 6.7 mp -139.34 175.54 9.47 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 121.581 0.705 . . . . 6.89 111.57 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.58 174.85 19.93 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.322 -1.308 . . . . 6.24 110.416 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.49 -27.5 85.13 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.088 2.525 . . . . 8.35 113.619 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.83 -27.24 68.74 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.052 0.39 . . . . 12.73 112.052 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -111.26 20.79 17.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.3 0.572 . . . . 9.49 110.569 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 16' ' ' VAL . 12.0 tp -113.47 125.1 53.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.332 -0.849 . . . . 7.88 108.897 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.618 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 83.1 m-85 -109.39 134.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 111.751 0.278 . . . . 10.48 111.751 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.19 133.77 59.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.008 3.139 . . . . 10.82 114.302 -172.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 86.5 t80 -63.85 -63.11 1.25 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.259 -0.882 . . . . 10.52 111.478 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -53.03 -29.03 27.25 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.02 0.748 . . . . 13.98 113.02 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.62 -36.9 7.75 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.544 -0.463 . . . . 15.72 112.209 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.526 ' HB3' ' HE2' ' B' ' 173' ' ' PHE . 60.7 m -91.28 -24.41 19.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.293 0.479 . . . . 11.91 112.293 -175.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 15.6 pttp -56.78 -30.95 64.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.494 -0.483 . . . . 12.55 111.235 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.31 -19.15 59.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.2 0.524 . . . . 15.86 110.61 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -88.08 -24.2 23.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 16.47 110.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' B' ' 169' ' ' SER . 43.6 m-85 -114.39 14.02 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 11.15 110.865 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -75.33 66.88 2.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.971 -0.633 . . . . 11.12 111.95 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -149.17 95.13 3.88 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 109.238 -0.653 . . . . 14.56 109.238 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.03 145.45 55.59 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.481 2.121 . . . . 11.81 112.023 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.41 -170.01 2.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.893 -0.594 . . . . 13.38 110.668 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -71.64 -25.66 62.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.344 -0.613 . . . . 16.74 109.344 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -55.3 124.05 15.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.168 -0.924 . . . . 16.14 110.933 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.53 -56.71 4.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.59 -0.732 . . . . 15.89 111.635 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.82 71.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.939 -0.648 . . . . 11.57 112.231 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.11 -55.89 5.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.927 -0.137 . . . . 9.65 110.72 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -65.61 -39.42 91.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.781 -0.19 . . . . 10.46 111.291 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 0.3 OUTLIER -65.51 -46.8 78.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.173 -0.211 . . . . 12.15 110.863 178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.737 ' HA3' ' HA2' ' B' ' 151' ' ' GLY . . . -67.2 -40.14 92.42 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.342 -0.933 . . . . 8.24 111.811 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.43 ' O ' HG13 ' B' ' 189' ' ' ILE . 5.7 tt -57.75 -49.46 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 7.89 110.058 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -67.07 -34.42 77.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.315 -0.402 . . . . 11.87 110.748 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 22.9 mm-40 -75.21 -28.49 59.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.078 0.399 . . . . 11.62 112.078 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' A' ' 15' ' ' LEU . 2.8 pp -85.13 -28.26 6.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.647 -0.421 . . . . 9.26 111.197 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . 0.514 ' N ' HD12 ' B' ' 189' ' ' ILE . 9.9 tp10 -86.76 -31.05 21.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.454 0.645 . . . . 11.04 110.028 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -124.85 83.76 2.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.539 -0.755 . . . . 12.59 110.517 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -82.03 126.2 75.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.428 -0.582 . . . . 13.52 109.428 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 100.83 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.698 2.265 . . . . 14.9 112.385 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 60.2 m 63.75 97.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.72 . . . . 17.54 111.805 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.85 87.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.03 0.919 . . . . 18.06 110.692 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -79.14 77.46 5.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.665 -0.698 . . . . 21.28 110.216 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -162.28 -36.37 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 21.53 111.004 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 15.7 m -83.79 5.7 24.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.137 -0.483 . . . . 23.03 111.521 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 81.1 -96.77 1.73 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.872 -0.68 . . . . 24.72 111.887 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.575 -0.726 . . . . 27.31 110.424 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.442 -0.207 . . . . 29.42 110.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 m -87.85 -45.05 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.414 -0.587 . . . . 26.59 109.414 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -141.99 -163.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 25.53 109.228 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m 70.26 91.9 0.09 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.58 0.705 . . . . 23.29 110.241 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.91 175.09 10.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.209 -0.905 . . . . 21.2 110.907 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 71.0 mtt180 -127.22 79.22 1.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.007 -0.542 . . . . 20.05 109.789 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -108.34 95.93 6.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.792 -0.64 . . . . 16.73 110.895 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.744 ' HB3' HG21 ' A' ' 38' ' ' VAL . 65.4 tttp -175.83 126.62 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 16.22 110.894 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -154.73 -67.75 0.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.57 -0.9 . . . . 13.24 108.57 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -72.66 151.52 42.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.111 -0.7 . . . . 10.33 109.111 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -79.62 131.28 35.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.419 -0.355 . . . . 14.9 111.098 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.909 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 7.9 p -49.43 133.73 19.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.381 0.61 . . . . 11.71 111.486 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.39 -16.41 26.9 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.579 -0.82 . . . . 9.66 111.548 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.02 118.18 8.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.969 -0.752 . . . . 10.47 108.969 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' B' ' 189' ' ' ILE . 43.8 tp -121.83 99.92 6.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 7.46 110.348 -171.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 33.6 m -140.07 -171.57 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.511 -0.313 . . . . 6.87 111.204 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' PRO . 77.7 m-85 -87.74 126.64 35.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.633 0.254 . . . . 6.78 111.276 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.89 147.45 33.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.373 -0.376 . . . . 6.21 110.019 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' PRO . 83.4 tttt -111.77 109.47 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.822 -0.351 . . . . 12.44 110.427 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.603 ' HB3' ' HD2' ' A' ' 23' ' ' TYR . 11.9 tpt -105.57 159.23 16.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.633 -0.506 . . . . 10.95 109.633 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.52 114.98 5.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.196 -0.668 . . . . 15.91 109.196 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.27 -12.34 55.1 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.526 -0.761 . . . . 14.09 111.972 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.603 ' HD2' ' HB3' ' A' ' 20' ' ' MET . 39.0 m-85 -128.89 103.29 18.91 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.765 -0.457 . . . . 13.65 109.765 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 65.7 Cg_exo -50.77 -62.35 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.537 2.825 . . . . 12.38 113.261 -173.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -146.11 92.54 2.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.127 0.489 . . . . 11.05 109.791 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.646 ' CH2' ' HA3' ' B' ' 185' ' ' GLY . 0.1 OUTLIER -105.14 114.14 63.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.255 -0.884 . . . . 10.23 109.709 -175.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.866 ' HB2' HG13 ' B' ' 189' ' ' ILE . 34.6 Cg_endo -64.39 114.63 2.77 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.709 2.273 . . . . 5.52 112.06 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.87 165.39 23.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.269 0.557 . . . . 3.98 111.595 -172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -94.44 136.45 34.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 11.28 110.971 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -77.51 133.66 30.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.655 -0.868 . . . . 7.51 108.655 171.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' N ' HD13 ' A' ' 30' ' ' ILE . 26.3 t70 -130.8 142.25 50.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.783 -0.451 . . . . 10.28 109.783 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HG2' ' HB3' ' A' ' 12' ' ' CYS . 7.6 pt-20 -129.87 160.02 34.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.97 0.414 . . . . 10.44 111.495 -173.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 61.0 mtt -97.77 151.79 37.78 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.473 -0.785 . . . . 12.85 109.189 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.35 162.23 15.04 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.64 2.227 . . . . 13.07 112.118 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.99 77.7 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 14.04 110.784 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.79 -48.2 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.19 -0.459 . . . . 15.24 110.658 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.11 -21.17 2.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.595 . . . . 14.64 110.793 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.781 HG22 ' HG2' ' A' ' 39' ' ' LYS . 14.4 p -67.19 134.91 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 12.42 111.099 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 38' ' ' VAL . 13.1 mmmm 70.2 -43.82 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.575 0.75 . . . . 10.84 111.224 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t 66.0 -154.83 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.524 0.73 . . . . 9.63 110.758 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -61.16 -20.76 63.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.672 0.389 . . . . 9.56 111.716 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 71.52 -53.36 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.465 0.706 . . . . 8.3 110.922 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -82.44 100.59 10.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.031 0.443 . . . . 8.55 110.376 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 32.1 mmtm -147.05 139.23 24.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 7.5 109.413 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' HE2' ' HD3' ' A' ' 60' ' ' PRO . 74.3 m-85 -84.48 138.76 32.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.129 -0.693 . . . . 6.01 109.129 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -82.08 97.6 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.25 -0.648 . . . . 6.99 109.25 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.2 t -92.62 106.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.147 0.498 . . . . 4.6 110.687 -175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.25 109.37 21.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 5.62 110.454 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 33.1 m-85 -68.69 123.27 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.046 -0.524 . . . . 4.03 110.235 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 13.8 m-85 -75.63 -49.86 17.18 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.192 0.308 . . . . 4.15 110.741 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -65.75 -48.29 68.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.831 -0.699 . . . . 5.0 112.596 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -18.36 59.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.133 0.492 . . . . 5.56 110.067 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.84 46.11 17.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.005 -0.998 . . . . 6.72 111.687 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.56 159.66 44.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 6.33 111.042 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -92.99 133.59 35.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.758 -0.655 . . . . 5.99 111.602 -172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.4 176.09 8.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.594 -0.73 . . . . 5.39 110.013 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 97.8 m-85 -131.44 120.14 22.6 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.139 -0.319 . . . . 7.73 110.139 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' VAL . 95.8 mt -134.06 174.34 10.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.438 -0.346 . . . . 5.32 110.76 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.38 176.16 18.76 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.217 -0.753 . . . . 5.57 111.217 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' A' ' 45' ' ' TYR . 20.2 Cg_endo -61.36 -35.21 85.0 Favored 'Trans proline' 0 CA--C 1.527 0.14 0 C-N-CA 122.385 2.057 . . . . 6.06 112.072 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -70.72 -11.53 61.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 7.7 111.12 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' B' ' 119' ' ' LYS . 24.4 m-20 -114.56 13.34 17.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.204 -0.453 . . . . 5.82 110.101 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG21 ' B' ' 116' ' ' VAL . 12.8 tp -133.81 128.26 34.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.074 -0.512 . . . . 4.21 109.63 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 83.0 m-85 -120.29 126.5 26.77 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 111.746 0.276 . . . . 4.63 111.746 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.612 ' HA ' HG12 ' B' ' 116' ' ' VAL . 46.9 Cg_exo -57.18 129.22 33.14 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.613 2.875 . . . . 4.58 112.291 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.587 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.8 p90 -78.94 -25.11 43.59 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 116.59 -0.277 . . . . 4.79 110.845 -172.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -70.94 -7.99 49.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.219 -0.592 . . . . 6.1 111.279 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' B' ' 108' ' ' LYS . 45.6 mt-10 -115.75 -30.52 6.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.015 -0.539 . . . . 6.71 110.344 175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.542 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 23.6 m -90.24 -21.64 22.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 5.49 111.924 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 37.0 ttmt -48.28 -43.03 32.34 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.098 0.407 . . . . 6.26 112.098 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.9 -18.38 62.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.805 0.298 . . . . 7.73 111.805 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.06 -49.74 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.963 -0.295 . . . . 8.1 111.023 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 21.8 m-85 -100.02 -1.84 35.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 5.97 111.182 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.55 84.14 0.99 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.186 -0.53 . . . . 6.74 112.161 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 56.1 pttt -150.36 115.22 3.34 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 108.109 -1.071 . . . . 8.38 108.109 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.1 Cg_endo -79.4 90.73 1.24 Allowed 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.789 1.659 . . . . 7.75 111.673 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' OD1' ' HG2' ' A' ' 79' ' ' ARG . 18.7 p30 -85.78 5.88 30.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.584 -1.189 . . . . 7.82 110.956 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 66.45 24.97 10.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.746 . . . . 10.11 112.395 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HG2' ' OD1' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -77.09 113.18 14.54 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.059 -1.089 . . . . 8.81 108.059 168.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -28.66 -70.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.429 1.27 . . . . 8.87 114.429 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -67.39 -33.38 81.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.685 -0.769 . . . . 5.87 113.107 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 79.5 t80 -70.1 -43.65 70.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.629 0.252 . . . . 5.14 110.738 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 p -71.85 -45.99 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 6.17 111.554 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' GLY . 4.9 pt-20 -68.27 -32.96 73.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.595 -0.442 . . . . 6.87 109.969 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 89' ' ' ILE . . . -66.31 -48.25 65.4 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.73 -0.748 . . . . 4.6 111.857 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -62.01 -40.04 94.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.05 0.452 . . . . 5.05 110.864 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.402 ' HA ' HD22 ' A' ' 91' ' ' ASN . 27.5 t-105 -66.59 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.557 . . . . 7.15 110.033 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.4 tp10 -60.98 -46.6 90.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 5.21 111.611 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.803 HG13 ' HG ' ' B' ' 115' ' ' LEU . 0.0 OUTLIER -74.1 -42.92 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 4.46 111.252 -176.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' N ' HD13 ' A' ' 89' ' ' ILE . 5.0 tp10 -76.6 -43.42 38.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 6.86 111.444 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 87' ' ' TRP . 10.6 m-80 -105.03 25.31 10.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.834 -0.621 . . . . 6.04 110.459 -170.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 88' ' ' GLU . 6.7 t30 -64.0 115.96 23.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 5.09 111.087 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -88.48 -18.31 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.726 2.284 . . . . 6.48 113.057 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.7 t -151.84 97.66 2.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.469 0.652 . . . . 7.32 111.225 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' N ' HD21 ' A' ' 92' ' ' ASN . 7.6 p -93.0 123.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.731 -0.668 . . . . 6.13 110.35 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 48.2 tptt -87.48 80.96 7.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.387 0.613 . . . . 9.68 110.328 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.84 115.33 1.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.193 -0.912 . . . . 8.54 110.074 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 p -80.87 55.55 2.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.142 0.496 . . . . 9.88 110.656 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.97 -168.07 21.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.625 -0.716 . . . . 9.93 112.82 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.618 0.723 . . . . 12.88 110.714 -176.132 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 13.85 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m 56.36 -168.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.647 0.592 . . . . 12.37 111.619 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -93.44 127.77 39.22 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.659 -0.497 . . . . 12.02 109.659 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.5 t -78.96 -27.6 43.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 10.42 110.194 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -79.05 110.8 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.32 0.581 . . . . 8.13 109.953 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -79.94 90.96 5.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.638 -0.71 . . . . 10.78 109.909 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -81.5 107.58 14.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 8.36 110.614 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.414 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -96.91 -62.72 1.22 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.692 -0.485 . . . . 8.99 109.692 175.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 58.17 96.78 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.142 -0.935 . . . . 8.32 111.124 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -61.3 116.7 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 5.28 110.587 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -129.64 134.16 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.213 -0.903 . . . . 8.12 109.932 -173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 29.3 m -45.51 106.41 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.924 0.765 . . . . 5.93 112.014 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.03 -16.06 7.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.834 -0.698 . . . . 4.62 112.252 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.32 131.66 49.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 4.66 110.611 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.803 ' HG ' HG13 ' A' ' 89' ' ' ILE . 2.6 tm? -98.53 139.27 34.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.417 -0.586 . . . . 3.32 109.417 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -149.98 163.88 3.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.026 -0.534 . . . . 3.43 111.31 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -92.06 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.993 -0.743 . . . . 3.93 108.993 171.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -82.76 135.64 34.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 3.3 111.171 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' B' ' 119' ' ' LYS . 23.3 ttpt -110.68 90.12 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.704 -0.68 . . . . 5.76 109.52 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.504 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 27.3 ttt -95.67 161.33 14.08 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.108 -0.701 . . . . 6.08 109.108 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -66.23 115.31 6.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.759 -0.83 . . . . 8.78 108.759 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.06 -7.49 62.53 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.816 -0.629 . . . . 6.27 112.08 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 73.7 m-85 -129.11 101.44 19.53 Favored Pre-proline 0 CA--C 1.529 0.157 0 N-CA-C 109.674 -0.491 . . . . 7.06 109.674 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.14 -72.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.451 2.768 . . . . 5.68 113.517 -174.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -146.16 94.68 2.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.758 -0.83 . . . . 4.71 108.758 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 t-105 -116.8 133.01 23.11 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.348 -0.387 . . . . 6.03 110.863 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 126' ' ' TRP . 10.4 Cg_endo -54.32 111.08 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.271 2.647 . . . . 3.48 112.532 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.453 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -140.95 150.55 43.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.891 -0.595 . . . . 2.83 110.153 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.604 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 8.9 ttp180 -98.57 143.12 29.32 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.989 -0.284 . . . . 5.33 110.403 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -73.58 129.69 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.385 -0.968 . . . . 4.34 108.385 172.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -131.64 163.86 27.18 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.481 0.658 . . . . 5.66 110.635 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.29 138.7 33.5 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.475 -1.239 . . . . 7.05 111.301 -169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 25.2 ptt? -105.3 139.94 20.64 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.703 -0.48 . . . . 9.64 109.703 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 2.9 Cg_exo -73.82 100.3 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.645 2.23 . . . . 9.8 111.787 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -86.39 29.55 0.76 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.258 -0.428 . . . . 12.27 111.298 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.56 -59.25 5.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 11.49 110.95 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.89 -45.22 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 11.38 110.296 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' B' ' 142' ' ' ALA . 5.5 p -96.08 163.06 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.914 -0.585 . . . . 9.65 109.903 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -112.83 -64.71 1.27 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.846 0.355 . . . . 11.11 110.399 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 32.9 p -103.85 -82.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 8.66 111.506 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.8 p -139.22 115.65 10.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.795 0.331 . . . . 9.44 110.979 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' B' ' 138' ' ' VAL . . . -168.52 81.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 8.63 109.895 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -114.78 -3.63 12.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.089 -0.505 . . . . 9.61 111.056 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.99 155.55 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.166 0.508 . . . . 8.97 111.506 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.42 172.06 14.52 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.241 -0.891 . . . . 7.97 109.158 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -91.33 139.86 30.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.248 0.547 . . . . 9.5 111.129 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.75 117.94 51.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.443 -0.798 . . . . 6.03 109.097 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.429 ' HD1' ' HG1' ' B' ' 155' ' ' THR . 32.4 t80 -101.03 114.52 28.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.047 0.451 . . . . 10.78 111.234 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -82.81 125.75 31.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.438 -0.801 . . . . 8.4 110.174 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.529 ' HE2' HD11 ' B' ' 189' ' ' ILE . 38.3 m-85 -69.24 -54.6 13.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 9.24 111.276 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.93 -55.16 28.3 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.603 -0.726 . . . . 10.64 113.343 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 21.6 p -78.66 -5.77 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.052 0.426 . . . . 12.27 111.235 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 58.52 32.52 22.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 13.51 110.375 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.31 118.47 33.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.552 -0.749 . . . . 12.96 111.845 -172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' B' ' 148' ' ' PHE . 55.9 m -94.83 93.72 7.64 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.897 -0.779 . . . . 10.75 108.897 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.44 -178.07 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 8.03 110.532 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -130.01 129.07 43.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.905 0.383 . . . . 9.95 110.361 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.07 174.98 9.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 6.89 110.599 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -112.66 171.64 14.11 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.299 -0.72 . . . . 6.24 111.299 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.79 -31.56 62.31 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.094 2.529 . . . . 8.35 112.938 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -61.52 -27.12 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 12.73 111.683 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -106.07 11.52 31.38 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.933 -0.307 . . . . 9.49 111.66 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 13.5 tp -124.95 124.17 41.45 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.489 -0.56 . . . . 7.88 109.489 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.702 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 50.4 m-85 -118.11 125.38 27.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 10.48 111.691 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.484 ' HA ' HG11 ' A' ' 16' ' ' VAL . 18.8 Cg_endo -58.06 129.18 31.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.329 2.686 . . . . 10.82 112.764 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -89.13 -30.0 18.93 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.076 -0.511 . . . . 10.52 111.75 -173.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -50.24 -40.4 47.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 13.98 111.594 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.46 -43.38 4.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.295 -0.411 . . . . 15.72 111.326 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 63.2 m -97.75 4.21 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.802 1.038 . . . . 11.91 113.802 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 22.0 pttp -57.16 -26.96 61.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.306 0.503 . . . . 12.55 111.163 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.76 -17.78 46.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.252 -0.431 . . . . 15.86 111.746 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -82.59 -38.98 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.126 0.489 . . . . 16.47 110.262 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.89 -1.46 45.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.49 . . . . 11.15 110.543 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -78.36 62.27 3.78 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.601 -0.727 . . . . 11.12 112.957 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' B' ' 175' ' ' LYS . 15.2 ptpt -142.1 103.65 5.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.694 -0.854 . . . . 14.56 108.694 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.657 ' HA ' ' HE1' ' B' ' 182' ' ' PHE . 18.6 Cg_endo -84.63 165.78 12.04 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.829 2.353 . . . . 11.81 113.569 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.15 162.52 16.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.942 -1.027 . . . . 13.38 108.936 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -77.59 63.73 2.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.814 0.816 . . . . 16.74 111.644 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 17.9 mmt180 -121.36 134.91 55.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.839 -1.171 . . . . 16.14 107.839 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -60.07 -58.32 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.878 0.325 . . . . 15.89 111.878 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.36 -39.09 97.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 11.57 112.367 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.657 ' HE1' ' HA ' ' B' ' 176' ' ' PRO . 44.3 t80 -61.63 -45.19 95.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 9.65 110.355 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -67.18 -44.97 78.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.812 -0.631 . . . . 10.46 110.357 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.99 -50.25 74.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.312 -0.404 . . . . 12.15 110.637 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.646 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -60.67 -43.73 98.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.89 -0.671 . . . . 8.24 112.906 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -67.24 -28.22 67.87 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.115 -0.328 . . . . 7.89 110.115 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -77.07 -44.77 29.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.557 -0.292 . . . . 11.87 110.719 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -57.7 -29.74 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.444 0.64 . . . . 11.62 109.669 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 27' ' ' PRO . 2.3 mm -87.64 -28.29 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.964 -1.016 . . . . 9.26 112.363 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.36 -34.15 72.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 11.04 110.848 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -90.04 -17.76 27.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.959 -0.564 . . . . 12.59 110.392 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 61.41 102.45 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.383 -0.826 . . . . 13.52 112.132 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.45 5.98 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.942 2.428 . . . . 14.9 113.666 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 27.4 m -139.41 108.35 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 17.54 110.917 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 14.2 m -110.69 132.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.19 0.519 . . . . 18.06 111.811 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -110.68 70.97 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.6 -0.727 . . . . 21.28 109.508 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -159.51 107.46 1.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 21.53 110.796 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m 71.05 163.93 0.27 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.043 0.839 . . . . 23.03 111.528 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.93 84.55 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.823 -0.626 . . . . 24.72 111.872 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.447 -0.787 . . . . 27.31 110.222 179.868 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' B' ' 168' ' ' GLU . 25.1 ptt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.851 0.358 . . . . 29.42 110.579 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -60.39 138.4 57.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.557 -0.747 . . . . 26.59 111.383 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -104.99 -43.24 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 25.53 110.492 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -116.93 111.17 19.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 23.29 110.145 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -83.83 90.92 7.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.34 0.591 . . . . 21.2 109.549 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -99.52 -8.35 24.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.284 -0.871 . . . . 20.05 110.837 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -88.98 104.75 17.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.806 -0.634 . . . . 16.73 110.625 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.37 15.94 23.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.508 . . . . 16.22 110.286 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' OH ' ' B' ' 145' ' ' TYR . 7.8 tp10 -143.21 104.01 4.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.396 -0.82 . . . . 13.24 109.406 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -96.93 119.39 35.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.955 0.407 . . . . 10.33 110.295 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.18 141.8 29.08 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.372 0.606 . . . . 14.9 111.914 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 49.4 t -51.51 134.56 29.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.1 -0.955 . . . . 11.71 110.057 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.93 -25.53 8.84 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.5 -0.857 . . . . 9.66 111.977 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.85 153.64 32.52 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.148 0.499 . . . . 10.47 111.05 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.02 134.01 55.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.921 -0.77 . . . . 7.46 108.921 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 165' ' ' PRO . 1.0 OUTLIER -144.53 166.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.239 0.542 . . . . 6.87 112.355 -166.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' B' ' 166' ' ' TYR . 20.5 m-85 -102.5 116.81 33.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.654 . . . . 6.78 109.561 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.71 156.56 16.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.114 -0.493 . . . . 6.21 111.014 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -135.75 110.16 8.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.078 -0.51 . . . . 12.44 110.172 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.9 ttp -117.88 159.15 23.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.08 -0.711 . . . . 10.95 109.08 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.89 115.82 3.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.086 -0.709 . . . . 15.91 109.086 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.49 -20.95 26.98 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.727 -0.67 . . . . 14.09 111.77 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.39 100.72 25.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.65 -0.5 . . . . 13.65 109.65 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.45 -47.96 20.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.504 2.803 . . . . 12.38 112.504 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.05 122.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.108 -0.701 . . . . 11.05 109.108 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.819 ' HE1' ' HA3' ' B' ' 151' ' ' GLY . 1.3 t-105 -140.68 131.02 13.5 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.04 -0.527 . . . . 10.23 109.825 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HD1' ' B' ' 182' ' ' PHE . 17.5 Cg_endo -58.2 124.4 15.83 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.707 2.271 . . . . 5.52 112.076 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.83 149.54 47.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 3.98 111.282 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -88.23 133.53 34.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 11.28 109.896 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -80.17 129.16 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.642 -0.503 . . . . 7.51 109.642 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -125.48 132.61 52.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.323 -0.621 . . . . 10.28 109.323 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.752 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 69.7 tt0 -115.3 125.86 53.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.778 -0.647 . . . . 10.44 110.794 -172.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.49 132.82 57.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.796 -0.638 . . . . 12.85 109.662 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -59.09 -36.14 96.72 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.415 2.076 . . . . 13.07 111.968 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 32.4 tt0 -154.33 -84.14 0.07 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.134 -0.485 . . . . 14.04 110.425 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.48 -87.65 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.495 0.497 . . . . 15.24 111.097 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.04 -1.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.364 . . . . 14.64 110.79 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 7.6 p -122.53 129.54 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 12.42 110.83 -175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 19.8 ptmt 64.17 -35.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.393 1.477 . . . . 10.84 113.497 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.758 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 23.0 p 49.21 47.38 22.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.469 0.708 . . . . 9.63 111.993 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 m 75.76 -59.18 0.53 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.631 -0.713 . . . . 9.56 110.331 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' OG ' ' B' ' 140' ' ' SER . . . -164.74 90.78 0.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.783 -0.644 . . . . 8.3 109.795 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' A' ' 44' ' ' LYS . 3.1 p-10 -81.94 5.09 20.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 8.55 110.909 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 72.1 mmtt -138.48 125.6 21.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 7.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.578 ' HA ' ' HB3' ' B' ' 133' ' ' MET . 21.1 m-85 -101.58 170.13 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.745 -0.835 . . . . 6.01 108.745 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' HG2' ' HD3' ' B' ' 134' ' ' PRO . 15.5 mm100 -86.34 124.17 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.193 -0.669 . . . . 6.99 109.193 177.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 ' HB2' ' A' ' 58' ' ' LEU . 76.5 t -116.86 118.09 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 4.6 111.056 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.94 113.16 24.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.453 -0.794 . . . . 5.62 109.293 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' CB ' ' HB2' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -81.87 103.57 11.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.425 -0.807 . . . . 4.03 111.424 -174.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -60.16 149.94 31.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.588 -1.187 . . . . 4.15 109.952 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.27 -63.35 2.93 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.011 -0.614 . . . . 5.0 112.649 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 53' ' ' HIS . 17.6 p -73.45 -13.22 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.06 0.393 . . . . 5.56 112.06 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 52' ' ' THR . 56.0 t-80 71.39 19.78 5.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.521 0.677 . . . . 6.72 110.608 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 49' ' ' PHE . 10.1 mm-40 -89.15 161.84 16.26 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.384 -0.526 . . . . 6.33 111.076 -173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 m -146.02 123.3 11.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.362 -0.607 . . . . 5.99 109.362 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -178.34 7.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.66 0.267 . . . . 5.39 111.047 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 21.9 p90 -112.6 117.3 31.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 7.73 110.521 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.729 ' HB2' HG21 ' A' ' 47' ' ' VAL . 96.1 mt -133.76 143.02 48.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.757 -0.656 . . . . 5.32 109.51 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.77 -172.41 30.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 5.57 112.391 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.63 -37.44 97.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 123.037 2.491 . . . . 6.06 112.517 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -85.62 4.27 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 7.7 111.328 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 46.3 m-20 -105.15 -1.35 25.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.721 -0.844 . . . . 5.82 108.721 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.46 138.28 53.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.369 -0.832 . . . . 4.21 110.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 57.3 m-85 -129.5 116.94 18.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.787 0.327 . . . . 4.63 110.964 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' HG11 ' B' ' 116' ' ' VAL . 20.8 Cg_exo -65.65 121.38 8.75 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.267 2.645 . . . . 4.58 112.632 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -63.99 -15.29 58.98 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.44 -0.345 . . . . 4.79 111.769 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 33.6 tt0 -57.24 -38.39 73.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 6.1 109.965 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -108.36 -18.23 13.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 6.71 111.306 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.9 m -95.41 -25.95 16.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.063 0.764 . . . . 5.49 113.063 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 20.1 pttm -65.53 -16.26 63.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.665 -0.414 . . . . 6.26 110.866 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.17 -54.23 40.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 7.73 111.581 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -100.29 -49.79 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.936 0.347 . . . . 8.1 111.936 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -118.65 35.04 4.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.019 0.438 . . . . 5.97 111.256 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 70' ' ' LYS . . . -63.79 -33.68 87.9 Favored Glycine 0 C--O 1.228 -0.238 0 CA-C-N 115.684 -0.689 . . . . 6.74 112.504 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -148.23 93.48 4.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.732 -0.47 . . . . 8.38 109.732 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 82' ' ' PHE . 55.9 Cg_endo -76.13 -32.46 4.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.516 2.144 . . . . 7.75 111.714 172.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 53.23 73.02 0.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.627 -0.715 . . . . 7.82 112.125 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.91 -21.6 11.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 10.11 110.951 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -137.56 156.39 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.507 -0.315 . . . . 8.81 110.443 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.02 -52.42 17.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 8.87 112.249 -167.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HZ2' ' B' ' 126' ' ' TRP . . . -55.95 -28.18 52.61 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.177 -0.535 . . . . 5.87 112.272 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.624 ' CE2' ' HD2' ' A' ' 76' ' ' PRO . 70.1 t80 -70.58 -55.11 9.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.088 -0.338 . . . . 5.14 110.088 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -62.68 -40.38 96.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.058 -0.519 . . . . 6.17 111.595 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.49 -33.48 48.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.631 -0.259 . . . . 6.87 110.962 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.619 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -73.43 -37.43 53.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.834 -1.174 . . . . 4.6 111.346 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 86' ' ' LEU . 3.9 tt -72.85 -25.49 61.13 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.37 -0.604 . . . . 5.05 109.37 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -62.17 -46.4 89.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.567 -0.531 . . . . 7.15 109.567 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.676 ' HA ' HD21 ' A' ' 91' ' ' ASN . 37.3 mt-10 -57.04 -26.85 61.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.816 -0.629 . . . . 5.21 110.281 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.2 mm -84.51 -35.32 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 4.46 112.026 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.94 -50.75 68.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.431 0.634 . . . . 6.86 110.267 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.676 HD21 ' HA ' ' A' ' 88' ' ' GLU . 3.6 p30 -78.5 -37.28 43.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 6.04 110.033 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 55.65 86.85 0.15 Allowed Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 115.412 -0.813 . . . . 5.09 112.184 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -92.27 7.3 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.953 2.435 . . . . 6.48 111.039 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -85.72 30.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.286 -0.87 . . . . 7.32 110.459 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 t -72.56 -26.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 6.13 109.884 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.3 80.12 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 9.68 110.809 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.77 -55.38 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.518 -0.765 . . . . 8.54 109.596 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -123.61 170.76 10.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.62 -0.718 . . . . 9.88 109.874 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.55 134.17 2.21 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.156 -0.778 . . . . 9.93 111.156 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 12.88 110.022 -179.3 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.896 0.379 . . . . 13.85 110.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 10.5 m -95.51 26.01 4.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 12.37 110.278 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -64.69 106.54 1.2 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.664 -0.698 . . . . 12.02 111.901 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 25.6 t -104.83 -8.29 18.83 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.28 -1.007 . . . . 10.42 108.28 169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -65.51 119.92 11.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.835 -1.075 . . . . 8.13 109.835 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 68.81 22.36 7.31 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.715 0.634 . . . . 10.78 111.094 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' B' ' 108' ' ' LYS . 16.1 mm100 -114.78 121.76 44.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.5 -0.556 . . . . 8.36 109.5 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' B' ' 107' ' ' GLN . 9.1 mtpm? 72.45 80.21 0.14 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.701 0.762 . . . . 8.99 109.62 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -58.92 142.0 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.358 -1.292 . . . . 8.32 111.554 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -92.43 131.73 37.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.668 -0.864 . . . . 5.28 108.668 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' B' ' 111' ' ' LYS . 63.1 mmtt -72.24 115.52 11.57 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 120.135 -0.626 . . . . 8.12 109.701 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 73.5 m 63.54 -52.4 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.458 -1.246 . . . . 5.93 111.113 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.436 ' N ' HG21 ' B' ' 130' ' ' ILE . . . 150.12 -12.2 0.93 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.986 -0.845 . . . . 4.62 110.986 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 65.35 -171.44 0.19 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.99 0.9 . . . . 4.66 112.877 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.64 105.1 15.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.257 -1.338 . . . . 3.32 108.051 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 65' ' ' PRO . 16.7 m -148.51 -171.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.39 0.138 . . . . 3.43 111.085 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' B' ' 125' ' ' HIS . 28.2 m-85 -82.12 121.38 26.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.6 0.238 . . . . 3.93 110.797 -175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.67 139.26 40.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.218 -0.289 . . . . 3.3 110.218 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -106.26 101.76 11.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.343 0.592 . . . . 5.76 110.295 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.441 ' HB3' ' HD2' ' B' ' 123' ' ' TYR . 11.2 tpt -106.69 166.64 10.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.269 -0.878 . . . . 6.08 109.373 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.28 117.78 7.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.394 0.616 . . . . 8.78 110.105 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.75 -2.84 80.69 Favored Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.621 -1.172 . . . . 6.27 112.775 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' B' ' 120' ' ' MET . 46.7 m-85 -131.68 109.94 14.61 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.006 -0.368 . . . . 7.06 110.006 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 50.4 Cg_exo -54.82 -76.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.481 2.787 . . . . 5.68 113.42 -173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 117' ' ' PHE . 87.0 m-70 -144.71 79.96 1.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.342 -0.614 . . . . 4.71 109.342 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.619 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -97.7 124.24 49.01 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.917 -0.583 . . . . 6.03 109.977 -175.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.463 ' HB2' HG13 ' A' ' 89' ' ' ILE . 11.8 Cg_endo -57.05 107.32 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.794 2.33 . . . . 3.48 112.504 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.59 159.55 28.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.697 -0.683 . . . . 2.83 110.348 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -97.37 132.77 42.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 5.33 110.47 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.641 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.1 OUTLIER -74.26 141.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.992 -0.744 . . . . 4.34 108.992 173.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.641 ' N ' HD13 ' B' ' 130' ' ' ILE . 6.4 t70 -132.1 145.8 51.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.606 -0.516 . . . . 5.66 109.606 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -49.16 122.17 5.68 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.841 0.713 . . . . 7.05 111.423 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.578 ' HB3' ' HA ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -67.26 156.04 89.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.788 -0.642 . . . . 9.64 111.083 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.577 ' HB2' ' O ' ' B' ' 138' ' ' VAL . 24.2 Cg_exo -63.25 152.17 81.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.782 2.321 . . . . 9.8 112.515 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.57 -6.3 12.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 12.27 109.979 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.62 133.44 25.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.845 -0.616 . . . . 11.49 110.784 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.38 -42.87 0.55 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.442 1.089 . . . . 11.38 112.542 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' B' ' 134' ' ' PRO . 55.3 t -121.52 133.26 68.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.543 0.211 . . . . 9.65 111.514 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -149.93 -51.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.064 -0.517 . . . . 11.11 110.418 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 42' ' ' ALA . 52.6 m -147.36 -156.11 0.69 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.036 -0.529 . . . . 8.66 110.819 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 m -137.58 92.88 2.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.545 -0.539 . . . . 9.44 109.545 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' B' ' 145' ' ' TYR . . . -82.64 112.2 19.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 8.63 110.835 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -72.62 -20.48 61.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.779 -0.646 . . . . 9.61 110.941 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -150.14 139.69 21.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.018 0.437 . . . . 8.97 110.144 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 142' ' ' ALA . 92.1 m-85 -114.7 158.2 22.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.62 -0.718 . . . . 7.97 109.408 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.3 99.76 11.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.871 -0.788 . . . . 9.5 108.871 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' B' ' 158' ' ' LEU . 91.0 t -91.43 104.58 15.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.193 -0.912 . . . . 6.03 109.602 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -86.85 98.8 11.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.055 -0.52 . . . . 10.78 109.814 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 10.5 m-85 -59.74 108.52 0.76 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.877 -0.601 . . . . 8.4 110.045 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -74.78 -20.47 59.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.804 -1.089 . . . . 9.24 110.279 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.819 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -84.77 -49.0 4.73 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.681 -0.771 . . . . 10.64 112.944 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 18.4 p -92.85 -0.62 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.645 -0.327 . . . . 12.27 111.846 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 2.6 t60 62.2 42.02 9.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.3 -0.409 . . . . 13.51 110.695 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.63 147.62 52.53 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 12.96 111.525 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 27.1 m -99.86 106.17 17.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.195 -0.457 . . . . 10.75 110.275 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.97 172.71 6.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.011 -0.541 . . . . 8.03 110.495 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -122.26 113.89 20.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.166 0.508 . . . . 9.95 110.228 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.62 ' HB2' HG21 ' B' ' 147' ' ' VAL . 8.1 mp -123.65 170.91 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 6.89 109.955 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.81 173.66 21.93 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.53 -0.843 . . . . 6.24 111.618 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.81 -33.67 97.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.651 2.234 . . . . 8.35 111.987 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.04 -9.32 44.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 12.73 111.474 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.3 8.12 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.49 110.542 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.65 HD21 HG21 ' A' ' 16' ' ' VAL . 14.9 tp -139.98 123.7 17.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.957 -0.297 . . . . 7.88 110.554 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 165' ' ' PRO . 91.2 m-85 -130.99 135.78 27.86 Favored Pre-proline 0 N--CA 1.462 0.174 0 N-CA-C 111.569 0.211 . . . . 10.48 111.569 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.702 ' HA ' HG12 ' A' ' 16' ' ' VAL . 34.4 Cg_exo -58.65 123.51 13.73 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.34 2.693 . . . . 10.82 112.183 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.476 ' HA ' ' OG ' ' B' ' 169' ' ' SER . 1.2 p90 -68.74 -27.76 66.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.405 -0.361 . . . . 10.52 111.674 -170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.99 -45.0 60.95 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.771 0.286 . . . . 13.98 111.771 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 1' ' ' MET . 48.0 mt-10 -117.17 18.21 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.719 -0.393 . . . . 15.72 111.834 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' B' ' 166' ' ' TYR . 84.4 p -118.03 -30.25 5.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.486 -0.486 . . . . 11.91 110.766 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -49.11 -22.22 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.089 0.774 . . . . 12.55 113.089 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.22 -45.69 93.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.373 . . . . 15.86 111.096 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -104.52 -26.14 12.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 16.47 110.788 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.464 ' N ' ' HD1' ' B' ' 173' ' ' PHE . 2.4 m-30 -89.5 -8.94 51.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 11.15 110.672 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.98 79.48 1.91 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.094 -0.574 . . . . 11.12 112.357 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 24.3 ttmm -143.88 100.34 5.04 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 108.952 -0.758 . . . . 14.56 108.952 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.613 ' HA ' ' CE2' ' B' ' 182' ' ' PHE . 6.3 Cg_endo -82.24 145.27 13.55 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.806 2.337 . . . . 11.81 113.125 -171.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.405 HD22 ' C ' ' B' ' 176' ' ' PRO . 1.0 OUTLIER -117.6 -176.9 3.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.103 -0.953 . . . . 13.38 109.094 175.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -79.5 76.39 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.567 0.699 . . . . 16.74 111.65 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' B' ' 182' ' ' PHE . 74.1 mmt-85 -141.23 125.45 17.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.149 . . . . 16.14 108.417 173.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' B' ' 184' ' ' GLU . 96.8 mttt -57.78 -61.23 2.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.445 0.466 . . . . 15.89 111.247 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.58 -18.49 63.71 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 121.075 -0.583 . . . . 11.57 113.03 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' B' ' 176' ' ' PRO . 13.7 t80 -80.73 -45.29 17.31 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.559 -0.377 . . . . 9.65 110.161 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.5 m -70.91 -51.73 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.406 -0.361 . . . . 10.46 110.778 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' B' ' 180' ' ' LYS . 12.0 pt-20 -78.87 -21.88 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.634 -0.426 . . . . 12.15 110.301 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.09 -43.13 73.76 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.426 -0.892 . . . . 8.24 111.093 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.97 -39.75 93.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.815 -0.809 . . . . 7.89 108.815 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -64.18 -43.49 94.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.514 -0.766 . . . . 11.87 110.123 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.09 -35.76 82.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.988 -0.551 . . . . 11.62 111.666 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 190' ' ' GLU . 2.9 pp -80.6 -21.82 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.776 -0.37 . . . . 9.26 111.199 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . 0.412 ' N ' HD12 ' B' ' 189' ' ' ILE . 37.3 tt0 -92.43 -35.33 13.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.451 0.643 . . . . 11.04 110.833 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -113.5 40.3 2.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.725 . . . . 12.59 109.862 -173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 4.7 p-10 -57.84 127.17 78.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.857 . . . . 13.52 111.224 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 23.1 Cg_exo -63.83 -45.5 10.65 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.049 2.499 . . . . 14.9 111.976 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 31.3 m -101.43 116.21 32.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.876 -0.602 . . . . 17.54 109.648 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.459 ' HA ' ' ND2' ' B' ' 192' ' ' ASN . 7.2 p -71.83 129.31 35.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.025 -0.361 . . . . 18.06 110.025 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.77 79.0 4.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 21.28 110.706 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.7 14.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.849 -0.614 . . . . 21.53 110.649 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 19.7 m -119.07 -18.17 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.29 0.567 . . . . 23.03 109.874 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -121.23 44.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.653 -0.703 . . . . 24.72 111.685 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 79.4 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.612 -0.708 . . . . 27.31 109.451 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.815 -0.069 . . . . 29.42 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m 67.68 -76.94 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.706 0.628 . . . . 26.59 110.63 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 41.4 ttp180 63.29 30.33 15.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 25.53 111.082 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -78.99 83.53 5.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.719 -0.845 . . . . 23.29 108.719 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -62.86 143.1 57.93 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.226 -0.897 . . . . 21.2 110.303 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -77.03 -179.88 5.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.152 -0.476 . . . . 20.05 111.042 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -98.08 133.73 42.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.921 -0.581 . . . . 16.73 111.782 -173.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -101.71 99.64 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.764 -1.199 . . . . 16.22 107.764 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.31 131.11 35.56 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.007 -0.542 . . . . 13.24 110.6 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.661 ' HB3' HG13 ' A' ' 30' ' ' ILE . 59.9 m-85 -88.99 110.49 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.856 -0.611 . . . . 10.33 110.089 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -144.96 171.98 13.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.473 -0.785 . . . . 14.9 110.237 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.1 t 65.54 -74.95 0.05 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 124.245 0.965 . . . . 11.71 111.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . -176.94 31.59 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.272 -0.731 . . . . 9.66 111.272 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 30' ' ' ILE . 22.4 t70 -57.81 125.92 25.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.789 -0.448 . . . . 10.47 109.789 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 HD11 ' B' ' 189' ' ' ILE . 69.5 tp -100.17 120.35 39.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 7.46 111.306 -172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' B' ' 164' ' ' PHE . 10.1 m -147.15 -169.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.366 . . . . 6.87 110.52 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -93.28 145.24 24.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.157 -0.312 . . . . 6.78 110.157 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.43 166.15 17.75 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.271 -0.27 . . . . 6.21 110.271 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' B' ' 162' ' ' ASP . 60.7 pttt -119.89 126.57 51.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.234 0.54 . . . . 12.44 111.037 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.672 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 27.0 ttt -118.61 160.4 21.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.543 -0.91 . . . . 10.95 108.543 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -68.08 115.75 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.816 -0.754 . . . . 15.91 109.514 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.72 67.71 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.74 -0.664 . . . . 14.09 111.489 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.672 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 41.2 m-85 -125.59 96.25 38.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.412 -0.588 . . . . 13.65 109.412 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.87 -66.56 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.67 2.913 . . . . 12.38 113.536 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -145.75 102.72 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.117 -0.697 . . . . 11.05 109.117 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.9 OUTLIER -125.09 132.09 24.23 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.672 -0.695 . . . . 10.23 109.972 -170.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.63 127.79 27.66 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.254 2.636 . . . . 5.52 113.287 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -145.95 146.88 31.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 3.98 111.166 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -99.88 139.87 34.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.13 -0.486 . . . . 11.28 110.507 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -81.81 145.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.098 -0.501 . . . . 7.51 110.226 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' HD13 ' A' ' 30' ' ' ILE . 20.7 t70 -145.97 140.34 26.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.093 0.473 . . . . 10.28 110.48 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.08 89.24 3.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.539 0.685 . . . . 10.44 110.595 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.3 ttt -101.56 133.03 21.07 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.646 -0.706 . . . . 12.85 110.681 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 1.008 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 46.0 Cg_exo -57.8 149.51 68.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.89 2.394 . . . . 13.07 111.695 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 74.17 -36.37 0.33 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.493 0.717 . . . . 14.04 111.381 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.91 -61.82 1.69 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 15.24 110.37 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' B' ' 145' ' ' TYR . . . -99.55 -39.62 8.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.63 -0.713 . . . . 14.64 109.941 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.008 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 89.7 t -80.09 102.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.418 -0.81 . . . . 12.42 110.258 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -131.69 121.49 24.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.934 -0.765 . . . . 10.84 108.934 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -103.36 94.35 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.452 0.538 . . . . 9.63 112.452 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.038 ' HB ' HG21 ' B' ' 141' ' ' THR . 19.7 m -134.21 86.11 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.677 . . . . 9.56 109.171 171.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.68 101.29 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.94 -0.573 . . . . 8.3 111.068 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.69 0.72 56.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.141 -0.481 . . . . 8.55 110.319 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -96.59 124.52 40.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.655 -0.702 . . . . 7.5 109.895 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.475 ' HE2' ' HG3' ' A' ' 60' ' ' PRO . 60.1 m-85 -103.46 137.57 41.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.75 -0.463 . . . . 6.01 109.75 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.57 97.73 9.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.331 0.586 . . . . 6.99 109.723 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.9 t -91.05 107.69 18.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 4.6 110.147 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.18 98.59 11.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.736 -0.665 . . . . 5.62 110.006 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 5.8 m-85 -52.21 116.49 2.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.503 . . . . 4.03 109.811 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' HE2' ' HB2' ' A' ' 88' ' ' GLU . 32.8 t80 -83.11 -22.87 33.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.841 -0.618 . . . . 4.15 110.509 -170.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.774 ' HA3' ' HE1' ' B' ' 126' ' ' TRP . . . -77.85 -56.98 3.63 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 5.0 112.524 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -86.22 -7.37 58.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.02 0.438 . . . . 5.56 111.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 58.39 48.3 12.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.272 -0.876 . . . . 6.72 110.914 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -122.01 179.69 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.543 . . . . 6.33 110.008 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -123.62 131.87 53.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.767 0.318 . . . . 5.99 111.241 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.57 51.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 5.39 110.211 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -103.59 109.16 20.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.833 -0.432 . . . . 7.73 109.833 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' B' ' 120' ' ' MET . 89.6 mt -131.42 174.8 9.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.281 -0.418 . . . . 5.32 111.1 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.78 -174.55 20.89 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.943 -0.646 . . . . 5.57 111.577 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HG3' ' HE2' ' A' ' 45' ' ' TYR . 21.3 Cg_exo -64.56 -30.56 61.03 Favored 'Trans proline' 0 C--N 1.34 0.1 0 C-N-CA 122.778 2.318 . . . . 6.06 112.16 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -73.69 -21.59 60.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.604 -0.725 . . . . 7.7 111.297 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 10.3 m-20 -88.41 1.89 53.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 5.82 110.281 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 10.5 tp -122.24 116.87 24.87 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.11 -0.496 . . . . 4.21 109.799 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 52.8 m-85 -112.82 123.24 34.2 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 111.685 0.254 . . . . 4.63 111.685 -172.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' B' ' 116' ' ' VAL . 9.5 Cg_endo -51.11 115.98 2.37 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.968 3.112 . . . . 4.58 113.869 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -78.42 -14.21 59.49 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.444 -0.798 . . . . 4.79 110.477 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -70.69 -36.64 73.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.327 0.584 . . . . 6.1 109.715 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.69 -45.16 4.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.857 0.688 . . . . 6.71 112.857 -173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -112.0 8.33 20.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.112 0.782 . . . . 5.49 113.112 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -48.68 -40.76 29.33 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.56 0.948 . . . . 6.26 113.56 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.04 -19.22 61.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.968 0.359 . . . . 7.73 111.968 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -76.71 -14.42 59.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.088 0.471 . . . . 8.1 110.309 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -122.11 16.08 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.861 -0.608 . . . . 5.97 109.589 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.62 81.35 1.48 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.633 -0.712 . . . . 6.74 112.738 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -138.14 96.1 10.3 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.309 -0.626 . . . . 8.38 109.309 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 42.8 Cg_endo -82.27 -177.17 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.739 2.292 . . . . 7.75 112.057 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER 69.52 17.09 8.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.434 0.635 . . . . 7.82 109.748 -176.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -85.33 54.45 3.11 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.074 -1.084 . . . . 10.11 108.074 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 75.98 162.01 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.842 -1.072 . . . . 8.81 110.889 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.24 -23.8 51.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.147 0.425 . . . . 8.87 112.147 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.7 77.39 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.238 -0.982 . . . . 5.87 111.271 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 76' ' ' PRO . 44.1 t80 -62.21 -43.68 98.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.946 0.403 . . . . 5.14 110.476 175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 m -65.72 -38.52 89.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.715 . . . . 6.17 111.36 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.84 -46.55 87.39 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 110.21 -0.293 . . . . 6.87 110.21 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.88 -46.4 93.65 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.792 -0.718 . . . . 4.6 111.963 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.01 -40.14 95.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.687 -0.486 . . . . 5.05 109.687 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -61.39 -51.71 67.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.993 -0.549 . . . . 7.15 111.071 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 91' ' ' ASN . 6.3 mm-40 -57.85 -29.54 65.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 5.21 111.181 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 115' ' ' LEU . 1.5 mp -82.06 -29.65 9.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.604 -0.725 . . . . 4.46 110.653 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.16 -32.23 68.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 6.86 110.707 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.0 p30 -109.98 22.3 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 6.04 110.58 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.666 HD21 HG22 ' A' ' 95' ' ' VAL . 24.3 p-10 -50.08 122.5 14.67 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.539 -0.755 . . . . 5.09 112.18 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.09 10.52 3.62 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.916 2.411 . . . . 6.48 112.134 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.9 m -145.94 112.1 5.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 7.32 110.591 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 92' ' ' ASN . 29.7 t -112.96 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.803 . . . . 6.13 109.26 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -99.31 92.28 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.958 0.409 . . . . 9.68 111.25 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.66 -51.41 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.439 -0.578 . . . . 8.54 109.439 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -115.24 47.86 1.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.872 -0.788 . . . . 9.88 108.872 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.89 105.03 2.38 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.461 -0.79 . . . . 9.93 112.544 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.812 0.339 . . . . 12.88 110.163 176.708 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.029 0.442 . . . . 13.85 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -159.54 110.26 1.97 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 12.37 110.174 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' B' ' 103' ' ' ARG . 9.1 ptp85 -86.42 -18.2 32.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 12.02 110.172 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m -67.52 -25.93 66.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 10.42 110.797 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -89.82 124.39 34.62 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.265 -0.643 . . . . 8.13 109.265 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.25 160.25 22.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.101 0.477 . . . . 10.78 111.771 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -82.33 96.03 7.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.606 -0.725 . . . . 8.36 109.314 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -152.22 -44.23 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 8.99 108.686 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.477 ' HB2' ' HE2' ' B' ' 111' ' ' LYS . 42.0 mt-10 -82.81 129.89 35.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.329 -0.989 . . . . 8.32 108.329 168.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' B' ' 130' ' ' ILE . 77.2 m-85 -80.56 110.83 16.41 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.8 -0.36 . . . . 5.28 110.04 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' B' ' 109' ' ' GLU . 5.0 mptp? -90.8 144.78 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 8.12 111.132 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 49.5 t -43.09 114.05 0.56 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.03 0.831 . . . . 5.93 111.084 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -28.88 4.88 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 4.62 111.765 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.18 152.51 41.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.731 -0.47 . . . . 4.66 109.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -151.97 146.98 26.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.926 -0.398 . . . . 3.32 109.926 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.832 ' CG2' ' HG ' ' A' ' 63' ' ' LEU . 33.7 m -150.83 -169.97 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 3.43 109.725 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.558 ' HB3' ' CD2' ' B' ' 125' ' ' HIS . 44.6 m-85 -85.84 103.82 14.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.889 -0.412 . . . . 3.93 109.889 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 63' ' ' LEU . . . -89.65 162.61 15.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 3.3 110.877 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . 63.3 tttm -139.68 110.97 7.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.525 -0.761 . . . . 5.76 109.586 176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.589 ' HG3' HD21 ' A' ' 58' ' ' LEU . 29.8 ttp -104.24 159.08 16.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.009 -0.737 . . . . 6.08 109.009 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.7 mptt -65.84 115.0 5.49 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 8.78 108.386 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.62 31.76 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.833 -0.622 . . . . 6.27 112.082 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.433 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 79.4 m-85 -117.91 105.77 46.83 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 122.837 -0.214 . . . . 7.06 110.682 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 123' ' ' TYR . 6.4 Cg_endo -48.45 -46.8 22.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.172 3.248 . . . . 5.68 112.997 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . 0.558 ' CD2' ' HB3' ' B' ' 117' ' ' PHE . 0.2 OUTLIER -177.18 126.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.357 -0.609 . . . . 4.71 109.357 174.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.774 ' HE1' ' HA3' ' A' ' 51' ' ' GLY . 1.6 t-105 -151.48 136.01 10.04 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 109.923 -0.399 . . . . 6.03 109.923 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 33.6 Cg_exo -58.51 126.18 20.59 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.875 2.383 . . . . 3.48 112.409 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 50' ' ' PHE . . . -141.83 150.91 42.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.83 110.825 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.668 ' HG3' ' HB3' ' B' ' 115' ' ' LEU . 52.7 ttt180 -105.95 151.86 24.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 5.33 110.553 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' B' ' 110' ' ' TYR . 0.4 OUTLIER -98.43 142.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.687 -0.688 . . . . 4.34 110.972 -176.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -143.55 109.37 5.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 5.66 109.796 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' B' ' 132' ' ' GLU . 5.7 pt-20 -96.83 91.23 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.505 0.669 . . . . 7.05 110.64 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 92.5 mmm -119.91 97.37 49.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 9.64 110.854 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.39 158.75 36.66 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.326 2.018 . . . . 9.8 111.343 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.55 16.78 10.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.802 -0.635 . . . . 12.27 111.162 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.07 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 11.49 110.328 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -155.76 -79.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 11.38 110.784 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.99 147.02 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.271 -0.422 . . . . 9.65 110.727 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 139' ' ' LYS . 0.4 OUTLIER -114.48 -30.18 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.411 -0.358 . . . . 11.11 110.108 177.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m 74.64 -42.41 0.5 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.412 0.893 . . . . 8.66 113.412 173.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 1.038 HG21 ' HB ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -66.41 -20.18 66.0 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.0 0.741 . . . . 9.44 113.0 -175.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.92 110.64 10.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.36 . . . . 8.63 110.309 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' B' ' 160' ' ' PRO . 26.8 t-20 -132.36 -58.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.511 . . . . 9.61 110.756 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' B' ' 159' ' ' GLY . 21.2 mtpp -90.4 140.49 29.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.722 -0.473 . . . . 8.97 109.722 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 95.7 m-85 -112.31 176.91 4.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.307 -0.406 . . . . 7.97 110.763 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -89.43 109.39 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.985 -0.746 . . . . 9.5 108.985 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' B' ' 158' ' ' LEU . 97.8 t -102.91 127.74 56.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.132 0.492 . . . . 6.03 111.224 -174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.57 111.4 23.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.883 -0.598 . . . . 10.78 109.953 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.671 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 3.3 m-85 -69.2 103.69 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.809 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.473 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 71.5 t80 -65.52 -40.67 93.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.602 -0.726 . . . . 9.24 110.408 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.56 -50.67 11.06 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.849 -0.691 . . . . 10.64 112.915 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -84.53 -8.11 59.04 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.803 -0.233 . . . . 12.27 111.462 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m170 64.64 29.31 13.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.374 0.607 . . . . 13.51 110.131 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -109.18 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.664 -0.698 . . . . 12.96 111.591 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 31.4 m -138.4 128.95 26.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.79 -0.641 . . . . 10.75 109.652 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.53 172.83 13.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.324 -0.25 . . . . 8.03 110.324 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -112.89 121.84 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.094 0.473 . . . . 9.95 109.824 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.674 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.1 mt -136.18 154.35 50.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.16 -0.473 . . . . 6.89 110.056 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 144' ' ' LYS . . . -99.29 -175.93 31.55 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.427 -0.892 . . . . 6.24 111.54 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' B' ' 143' ' ' ASN . 28.5 Cg_exo -62.3 -31.97 81.8 Favored 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.559 2.173 . . . . 8.35 112.069 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -83.02 -7.09 59.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 12.73 110.81 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.891 ' HA ' ' HE2' ' A' ' 19' ' ' LYS . 33.0 m-20 -103.66 3.67 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.468 -0.787 . . . . 9.49 108.963 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.26 139.36 53.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.205 -0.907 . . . . 7.88 109.306 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.58 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.7 m-85 -132.0 128.3 21.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.05 0.453 . . . . 10.48 111.123 -172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.515 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 59.5 Cg_endo -77.46 116.27 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.769 2.313 . . . . 10.82 114.284 -172.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.7 -25.56 67.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.851 -0.796 . . . . 10.52 108.851 172.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.36 -19.65 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.112 -1.404 . . . . 13.98 111.613 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' B' ' 169' ' ' SER . 3.5 pt-20 -127.1 -45.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 15.72 111.568 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 168' ' ' GLU . 69.6 m -114.84 25.49 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.099 0.777 . . . . 11.91 113.099 -170.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' B' ' 198' ' ' SER . 18.5 ptpt -48.92 -38.64 23.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.871 0.367 . . . . 12.55 111.434 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -66.74 -22.17 66.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.112 -0.494 . . . . 15.86 111.93 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -88.09 -9.62 52.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.906 0.384 . . . . 16.47 110.965 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -113.5 -8.04 13.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.006 0.431 . . . . 11.15 110.248 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.667 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -77.84 83.98 1.13 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.653 . . . . 11.12 111.874 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.45 ' HB2' ' NZ ' ' B' ' 175' ' ' LYS . 0.0 OUTLIER -150.01 95.93 3.58 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 108.203 -1.036 . . . . 14.56 108.203 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.35 120.71 8.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.485 2.123 . . . . 11.81 112.462 -171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -98.05 15.68 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 13.38 111.196 -171.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp 68.65 23.39 7.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.023 -0.535 . . . . 16.74 111.755 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -118.91 137.9 53.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.596 -0.274 . . . . 16.14 110.74 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -55.59 -60.72 3.03 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 123.641 0.588 . . . . 15.89 112.544 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.81 -27.16 67.99 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 11.57 112.264 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 68.6 t80 -72.67 -48.44 39.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.29 . . . . 9.65 110.482 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 7.7 p -65.45 -42.78 91.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.478 -0.328 . . . . 10.46 111.648 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.52 -39.09 85.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.487 -0.485 . . . . 12.15 110.46 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.492 ' O ' HD13 ' B' ' 189' ' ' ILE . . . -69.39 -46.74 55.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.36 -0.924 . . . . 8.24 111.916 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.667 HD11 ' HA2' ' B' ' 174' ' ' GLY . 4.2 tt -60.96 -45.03 96.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.823 -0.436 . . . . 7.89 109.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -60.1 -53.12 61.58 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.349 -0.387 . . . . 11.87 110.708 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.673 ' HA ' HD21 ' B' ' 191' ' ' ASN . 5.5 mm-40 -60.77 -25.81 66.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 11.62 111.314 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 15' ' ' LEU . 1.5 mp -81.71 -36.66 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.526 -0.761 . . . . 9.26 110.619 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -76.45 -41.01 48.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.21 -0.45 . . . . 11.04 111.927 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.673 HD21 ' HA ' ' B' ' 188' ' ' GLU . 3.6 p30 -84.51 27.19 0.73 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.02 0.438 . . . . 12.59 110.929 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 193' ' ' PRO . 0.3 OUTLIER -47.44 137.02 9.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 115.581 -0.736 . . . . 13.52 112.076 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 192' ' ' ASN . 32.3 Cg_exo -58.03 120.15 7.86 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.945 2.43 . . . . 14.9 111.921 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.405 HG22 ' HG3' ' B' ' 196' ' ' LYS . 57.4 m 71.91 86.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.549 -0.75 . . . . 17.54 110.42 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.65 101.4 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.431 -0.804 . . . . 18.06 110.472 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . 0.405 ' HG3' HG22 ' B' ' 194' ' ' THR . 63.2 mttm -98.87 98.29 9.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.24 -0.436 . . . . 21.28 111.2 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 53.84 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 124.175 0.922 . . . . 21.53 112.761 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' B' ' 170' ' ' LYS . 35.1 m -137.08 104.24 5.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.221 -0.445 . . . . 23.03 110.513 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 172.15 -143.32 7.38 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.948 -0.644 . . . . 24.72 111.949 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.357 -0.83 . . . . 27.31 110.83 -178.009 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.026 0.441 . . . . 29.42 110.389 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -77.62 -40.0 43.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.276 -0.42 . . . . 26.59 111.934 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 62.37 17.0 9.04 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.542 0.526 . . . . 25.53 111.093 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -84.59 -45.3 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 23.29 110.351 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -88.94 97.85 11.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 21.2 110.092 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -118.26 -14.61 9.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 20.05 110.53 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.44 132.57 34.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.124 -0.489 . . . . 16.73 110.836 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 8' ' ' LYS . 3.4 mppt? -109.65 5.78 23.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 16.22 109.798 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -97.68 107.64 20.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 13.24 109.974 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -81.65 143.1 32.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.161 -0.311 . . . . 10.33 110.161 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 64.0 mmtt -121.57 153.98 37.32 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.567 0.699 . . . . 14.9 112.807 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 26.3 p -44.35 126.21 5.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.13 -1.396 . . . . 11.71 113.434 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.83 7.18 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.4 -0.818 . . . . 9.66 112.892 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.3 141.78 48.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 10.47 111.891 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 29' ' ' ARG . 3.5 tm? -94.73 138.09 33.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.95 -1.023 . . . . 7.46 109.392 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -148.73 -173.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.533 -0.303 . . . . 6.87 110.4 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.6 123.32 49.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.864 0.364 . . . . 6.78 110.599 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.0 158.02 15.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.856 -0.611 . . . . 6.21 111.229 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -128.04 100.23 5.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 12.44 109.724 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ttt -113.3 155.21 25.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.044 -0.525 . . . . 10.95 109.65 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -66.08 115.59 6.27 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.387 -0.598 . . . . 15.91 109.387 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -18.43 30.4 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.913 -0.875 . . . . 14.09 110.913 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . 60.4 m-85 -133.47 95.32 18.13 Favored Pre-proline 0 C--N 1.332 -0.158 0 N-CA-C 109.783 -0.451 . . . . 13.65 109.783 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 5.7 Cg_endo -46.79 -65.4 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.561 2.841 . . . . 12.38 112.789 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -145.37 113.46 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.824 -0.806 . . . . 11.05 108.824 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' B' ' 182' ' ' PHE . 0.8 OUTLIER -132.65 130.59 21.75 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 116.182 -0.463 . . . . 10.23 110.313 -170.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.05 120.89 9.03 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.768 2.312 . . . . 5.52 112.576 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.38 144.55 42.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 3.98 111.089 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.738 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.9 mtp180 -95.77 154.02 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.967 -0.56 . . . . 11.28 110.73 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 12' ' ' CYS . 6.4 mm -82.99 116.95 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.119 -0.491 . . . . 7.51 111.187 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' B' ' 146' ' ' GLN . 33.5 t70 -102.8 94.51 5.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.743 -0.836 . . . . 10.28 108.743 168.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.964 ' HB3' ' HB3' ' A' ' 12' ' ' CYS . 52.1 tt0 -101.97 118.43 36.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.218 -0.901 . . . . 10.44 109.922 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.4 mmt -120.88 148.6 48.95 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.865 -0.42 . . . . 12.85 109.865 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' ALA . 50.8 Cg_exo -56.11 150.2 49.36 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.922 2.415 . . . . 13.07 112.092 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.87 35.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.87 -0.605 . . . . 14.04 111.846 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -82.8 -29.48 29.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.136 0.494 . . . . 15.24 110.358 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.12 -5.68 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.801 -0.636 . . . . 14.64 111.12 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.29 116.43 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 12.42 110.502 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 58.1 27.54 15.11 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.066 -0.516 . . . . 10.84 110.773 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.0 t -61.65 106.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.745 . . . . 9.63 110.002 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 m -100.12 81.11 2.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 9.56 111.038 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.57 109.18 11.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.368 -0.833 . . . . 8.3 110.137 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 30.8 t30 -136.13 -54.23 0.75 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.924 -0.58 . . . . 8.55 109.744 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -97.28 123.85 41.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -103.05 149.55 24.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.63 -0.507 . . . . 6.01 109.63 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 7.2 tp-100 -83.53 119.63 24.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.56 -0.533 . . . . 6.99 109.56 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 58' ' ' LEU . 91.6 t -108.42 124.58 64.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.145 0.497 . . . . 4.6 110.781 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -108.52 111.34 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.721 . . . . 5.62 110.417 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.62 114.29 18.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.047 -0.524 . . . . 4.03 110.344 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -68.71 -50.66 49.04 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.284 0.365 . . . . 4.15 110.913 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -70.05 -50.44 28.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 5.0 112.757 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 m -70.43 -19.47 62.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 5.56 111.206 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.5 t60 62.01 38.51 14.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.73 -0.668 . . . . 6.72 110.293 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -122.12 164.24 18.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 6.33 111.152 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 134.1 42.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.331 -0.395 . . . . 5.99 110.79 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.18 14.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.47 . . . . 5.39 109.926 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -90.78 116.62 28.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.392 0.615 . . . . 7.73 110.369 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 62' ' ' ASP . 10.1 mp -110.21 173.87 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.59 -0.732 . . . . 5.32 109.512 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.26 169.35 26.32 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.346 -0.93 . . . . 5.57 111.084 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 23.3 Cg_endo -62.25 -27.3 78.1 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.568 2.179 . . . . 6.06 111.181 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.265 -0.88 . . . . 7.7 110.473 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.525 ' HB3' HD23 ' A' ' 58' ' ' LEU . 45.6 m-20 -99.13 -6.04 29.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.52 . . . . 5.82 109.988 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' B' ' 116' ' ' VAL . 12.8 tp -115.94 124.09 49.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.023 -0.535 . . . . 4.21 110.297 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.75 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 75.9 m-85 -115.64 139.48 24.82 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.563 -0.289 . . . . 4.63 110.772 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 69' ' ' SER . 51.5 Cg_exo -54.48 158.89 9.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.599 2.866 . . . . 4.58 114.05 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' B' ' 116' ' ' VAL . 10.1 t80 -98.59 -60.35 1.56 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.378 -0.828 . . . . 4.79 109.794 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -51.29 -54.35 26.92 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.715 0.635 . . . . 6.1 112.715 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -90.5 -44.66 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.953 0.353 . . . . 6.71 111.953 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 34.2 m -71.97 -16.34 62.08 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.082 0.401 . . . . 5.49 112.082 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.91 -30.09 13.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.035 0.384 . . . . 6.26 112.035 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.83 -39.52 94.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 7.73 111.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.15 -17.35 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.888 0.375 . . . . 8.1 111.192 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -108.09 15.37 24.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.392 0.615 . . . . 5.97 109.402 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.05 84.6 0.49 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.015 -0.993 . . . . 6.74 113.35 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 8.3 mmmm -140.65 95.51 7.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.485 -0.932 . . . . 8.38 108.485 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.23 104.13 1.85 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.699 2.266 . . . . 7.75 111.767 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -123.48 128.95 50.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.277 -0.874 . . . . 7.82 109.621 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 41.8 mtpt -80.13 24.23 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.559 -0.291 . . . . 10.11 111.604 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.71 127.94 32.41 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.593 -0.892 . . . . 8.81 108.593 171.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 99.1 mttt -42.85 -55.27 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.431 0.901 . . . . 8.87 113.431 -167.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . -64.72 -33.3 86.87 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.4 -0.905 . . . . 5.87 113.06 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 86' ' ' LEU . 49.9 t80 -80.96 -36.56 30.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.468 0.652 . . . . 5.14 109.833 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.31 -45.06 77.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.157 -0.929 . . . . 6.17 110.856 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 43.4 mm-40 -59.81 -34.36 72.96 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.827 0.346 . . . . 6.87 110.227 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.11 -45.63 61.4 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.725 -0.75 . . . . 4.6 112.255 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 82' ' ' PHE . 87.2 mt -66.33 -41.71 89.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 5.05 110.273 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -58.67 -51.64 69.05 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.999 -0.546 . . . . 7.15 110.158 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.764 ' HA ' HD21 ' A' ' 91' ' ' ASN . 7.5 tp10 -57.37 -27.03 61.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 5.21 111.141 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' B' ' 115' ' ' LEU . 2.0 tp -87.22 -27.16 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.469 0.544 . . . . 4.46 112.469 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.79 -27.82 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 6.86 110.479 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.764 HD21 ' HA ' ' A' ' 88' ' ' GLU . 2.7 p30 -99.45 4.81 46.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 6.04 110.367 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -64.48 120.95 69.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 5.09 111.247 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -83.5 -33.82 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.367 2.045 . . . . 6.48 112.112 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 m -88.19 70.49 9.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.352 0.596 . . . . 7.32 110.905 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.46 -36.94 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.666 -0.864 . . . . 6.13 108.666 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -87.13 87.1 7.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.162 -0.926 . . . . 9.68 109.687 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.09 -66.67 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.449 -0.796 . . . . 8.54 110.437 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m -103.49 -44.55 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.501 -0.555 . . . . 9.88 109.501 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.46 -75.5 1.39 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.826 -0.624 . . . . 9.93 112.962 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 12.88 112.247 -173.595 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.192 0.52 . . . . 13.85 109.981 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.7 m -91.29 30.34 1.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.029 -0.532 . . . . 12.37 110.302 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -67.94 -62.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 12.02 110.266 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 9.6 p -109.99 -36.25 5.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 10.42 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.99 118.92 20.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.574 -0.528 . . . . 8.13 109.574 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.83 145.08 29.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 10.78 111.22 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.8 96.7 7.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.873 -0.603 . . . . 8.36 110.16 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -107.25 5.28 27.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.807 -0.633 . . . . 8.99 110.03 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -103.55 139.94 38.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.455 -0.793 . . . . 8.32 110.048 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -102.4 170.47 8.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 5.28 110.331 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.409 ' HG3' ' OD2' ' B' ' 114' ' ' ASP . 13.4 pttp -152.24 153.95 34.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 8.12 111.153 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.3 m -56.52 134.49 54.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.815 -0.629 . . . . 5.93 111.119 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.2 -5.97 55.95 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.635 -0.793 . . . . 4.62 112.514 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' B' ' 111' ' ' LYS . 1.3 m-20 -71.31 106.03 3.71 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.393 0.616 . . . . 4.66 111.388 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 89' ' ' ILE . 3.3 tm? -93.72 113.85 26.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.885 -1.154 . . . . 3.32 107.885 171.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.75 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 15.5 m -141.0 -170.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.212 -0.449 . . . . 3.43 110.89 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.31 107.18 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.929 0.395 . . . . 3.93 110.619 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.93 136.62 32.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.15 -0.477 . . . . 3.3 110.659 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 50.0 tttm -108.33 101.98 11.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.962 0.411 . . . . 5.76 110.41 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 36.8 ttp -105.52 157.62 17.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.237 -1.023 . . . . 6.08 108.237 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -60.07 116.55 4.26 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.498 -0.556 . . . . 8.78 109.498 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.48 -19.49 47.81 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.777 -0.647 . . . . 6.27 112.14 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.41 87.07 22.62 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.008 0.433 . . . . 7.06 110.514 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 1.3 Cg_endo -84.79 110.75 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.424 2.75 . . . . 5.68 113.057 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 32.7 m80 69.1 73.2 0.26 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.613 -0.721 . . . . 4.71 110.059 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -120.07 138.09 26.63 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.414 -0.812 . . . . 6.03 109.816 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.77 102.04 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.993 2.462 . . . . 3.48 112.241 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.25 144.77 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.09 -0.504 . . . . 2.83 110.954 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.64 HH21 ' HB2' ' B' ' 131' ' ' ASP . 28.8 ttp180 -94.53 142.04 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 5.33 110.813 -175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.441 HG12 ' N ' ' B' ' 131' ' ' ASP . 4.4 tt -77.3 157.8 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 4.34 110.258 175.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 12.7 t70 -152.78 138.35 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.345 -0.388 . . . . 5.66 110.033 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.79 45.65 2.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 7.05 110.546 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 45.5 ttp -62.42 130.2 93.1 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 116.339 -0.392 . . . . 9.64 110.557 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.26 141.15 95.22 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.351 2.701 . . . . 9.8 112.775 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 68.18 8.72 6.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.428 -0.806 . . . . 12.27 110.827 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.44 -57.65 1.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.013 -0.54 . . . . 11.49 109.871 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.6 -56.29 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.891 -0.595 . . . . 11.38 109.691 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 86.5 t -93.24 128.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.718 -0.674 . . . . 9.65 110.521 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.19 168.28 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.851 -0.425 . . . . 11.11 109.851 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 38.3 t -125.45 116.71 22.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.25 -0.432 . . . . 8.66 109.969 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.9 p -110.61 27.01 10.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.279 0.561 . . . . 9.44 110.78 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.11 25.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.723 -0.671 . . . . 8.63 110.939 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -134.02 9.05 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 9.61 110.632 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.51 156.17 46.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 8.97 110.783 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.689 ' HE1' ' HD3' ' B' ' 160' ' ' PRO . 31.8 m-85 -114.12 162.47 16.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.872 -1.158 . . . . 7.97 107.872 170.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -85.85 92.82 8.75 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.637 -0.875 . . . . 9.5 108.637 165.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' B' ' 158' ' ' LEU . 70.9 t -74.45 102.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 108.113 -1.069 . . . . 6.03 108.113 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -91.91 97.34 10.91 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.539 -0.755 . . . . 10.78 109.865 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -50.84 111.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 8.4 109.857 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' B' ' 188' ' ' GLU . 86.1 t80 -72.31 -37.71 68.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 9.24 109.971 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.58 -47.47 15.71 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.54 -0.755 . . . . 10.64 112.903 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -10.81 54.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.565 -0.373 . . . . 12.27 111.549 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 62.26 38.28 13.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.95 -0.568 . . . . 13.51 110.836 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.47 155.4 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.885 -0.598 . . . . 12.96 110.858 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.4 m -112.91 103.77 11.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.574 -0.528 . . . . 10.75 109.574 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.94 137.03 48.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.609 -0.269 . . . . 8.03 111.132 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -85.91 95.98 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 9.95 110.209 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 98.6 mt -128.0 170.5 12.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 6.89 110.156 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.02 -172.52 16.79 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.366 -0.921 . . . . 6.24 112.047 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.689 ' HD3' ' HE1' ' B' ' 145' ' ' TYR . 28.9 Cg_endo -64.09 -26.73 65.43 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.435 2.09 . . . . 8.35 111.694 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -68.45 -18.97 64.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 12.73 110.528 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 12.1 m-20 -106.81 9.58 30.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.972 -0.558 . . . . 9.49 110.221 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 16' ' ' VAL . 14.1 tp -139.73 128.41 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.435 -0.348 . . . . 7.88 111.136 -170.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -122.4 141.09 33.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.42 -0.354 . . . . 10.48 111.102 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 16' ' ' VAL . 26.4 Cg_endo -62.81 128.3 22.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.319 2.679 . . . . 10.82 113.021 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' B' ' 170' ' ' LYS . 0.0 OUTLIER -71.88 -37.6 70.15 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.06 -0.518 . . . . 10.52 111.516 -177.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' B' ' 166' ' ' TYR . 43.4 mt-10 -58.13 -25.23 61.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.257 0.551 . . . . 13.98 110.47 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -88.07 -54.57 4.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 15.72 110.873 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -122.86 5.16 9.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.228 1.566 . . . . 11.91 115.228 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 18.9 pttp -58.32 -38.09 76.42 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.493 1.042 . . . . 12.55 111.043 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.95 -19.24 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 15.86 111.086 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.023 -0.535 . . . . 16.47 109.989 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -118.81 16.76 13.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 11.15 109.613 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.6 71.05 1.34 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.674 -0.694 . . . . 11.12 113.085 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -148.95 107.22 3.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.207 -0.664 . . . . 14.56 109.207 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.34 109.64 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.481 2.12 . . . . 11.81 112.52 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.64 -173.11 4.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.705 -0.68 . . . . 13.38 110.818 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -83.67 1.2 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.147 0.499 . . . . 16.74 110.961 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -71.04 103.24 2.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.721 -0.844 . . . . 16.14 108.721 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.53 -39.0 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.215 0.45 . . . . 15.89 112.215 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -62.63 -34.25 89.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.441 -0.885 . . . . 11.57 112.07 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . 43.4 t80 -76.27 -45.79 30.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.437 -0.208 . . . . 9.65 110.437 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 33.6 p -63.83 -39.8 95.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 10.46 110.672 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.28 -54.6 38.3 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.471 -0.331 . . . . 12.15 110.173 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.45 98.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.572 -0.823 . . . . 8.24 112.317 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.19 -50.83 62.54 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.431 -0.211 . . . . 7.89 110.431 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.74 -43.15 76.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.442 -0.503 . . . . 11.87 110.63 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.791 ' HA ' HD21 ' B' ' 191' ' ' ASN . 1.8 tp10 -60.47 -27.03 67.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 123.522 0.513 . . . . 11.62 109.857 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' B' ' 192' ' ' ASN . 1.0 OUTLIER -83.88 -30.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 9.26 111.539 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -68.17 -28.67 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.518 -0.31 . . . . 11.04 110.999 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.791 HD21 ' HA ' ' B' ' 188' ' ' GLU . 5.6 p30 -105.6 -14.38 15.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.779 0.324 . . . . 12.59 110.651 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' B' ' 189' ' ' ILE . 25.6 t30 -151.15 109.07 3.01 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 13.52 110.016 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -53.06 -34.22 66.86 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.02 2.48 . . . . 14.9 113.206 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.4 t -170.2 -48.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.075 -0.511 . . . . 17.54 109.882 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 3.5 p -173.74 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.668 0.747 . . . . 18.06 111.051 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.89 80.32 1.68 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.654 -0.703 . . . . 21.28 109.357 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.06 -40.92 11.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.646 -0.706 . . . . 21.53 110.621 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 29.9 m -76.37 125.08 28.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.083 -0.508 . . . . 23.03 110.456 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.5 -166.83 22.74 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.789 -0.72 . . . . 24.72 112.563 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.662 -0.685 . . . . 27.31 110.385 -179.331 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.631 0.253 . . . . 29.42 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -90.62 -12.78 35.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.432 0.634 . . . . 26.59 109.959 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.3 158.41 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 25.53 109.593 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -88.03 145.77 25.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.986 0.422 . . . . 23.29 110.056 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 122.98 36.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.211 -0.449 . . . . 21.2 110.048 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -70.18 115.13 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.318 -0.623 . . . . 20.05 109.318 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.83 137.95 31.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 16.73 111.001 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 26.5 tptp -77.16 119.43 20.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.67 -0.695 . . . . 16.22 109.336 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 48.9 mt-10 73.36 169.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.047 0.842 . . . . 13.24 111.234 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 75.9 m-85 -121.67 168.82 11.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.204 -0.453 . . . . 10.33 110.616 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 2.2 mppt? -111.96 139.67 47.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.872 -0.788 . . . . 14.9 108.872 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 54.0 t -38.15 109.01 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.029 0.83 . . . . 11.71 111.862 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 197' ' ' ALA . . . 123.1 -22.46 7.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.993 -0.622 . . . . 9.66 112.749 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 8.0 m-20 -60.74 138.37 58.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.156 0.503 . . . . 10.47 111.365 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.671 HD23 ' HE2' ' B' ' 150' ' ' PHE . 3.3 tm? -94.81 136.83 34.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.539 -0.755 . . . . 7.46 109.494 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.591 HG11 HD21 ' B' ' 163' ' ' LEU . 2.4 p -157.46 152.18 7.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.902 -0.59 . . . . 6.87 109.418 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.747 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 13.6 m-30 -83.23 122.09 27.96 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.079 0.466 . . . . 6.78 110.786 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -102.96 165.81 10.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.776 -0.647 . . . . 6.21 111.336 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -131.88 132.16 43.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.721 -0.672 . . . . 12.44 109.944 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.811 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 26.2 ttt -111.56 160.92 16.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.226 -0.657 . . . . 10.95 109.226 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -66.81 116.16 7.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.492 -0.558 . . . . 15.91 109.492 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.74 -6.3 79.76 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.773 -0.649 . . . . 14.09 112.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 96.9 m-85 -125.48 122.04 24.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.226 -0.287 . . . . 13.65 110.226 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' TYR . 47.2 Cg_exo -54.83 -83.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.292 2.662 . . . . 12.38 113.783 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 24' ' ' PRO . 94.9 m-70 -150.88 137.73 19.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 110.205 -0.295 . . . . 11.05 110.205 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.622 ' HB2' ' CE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -142.46 147.78 44.49 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 116.041 -0.527 . . . . 10.23 111.091 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' HD1' ' A' ' 26' ' ' TRP . 37.0 Cg_endo -64.83 114.23 2.68 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.409 2.073 . . . . 5.52 110.377 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.54 49.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.005 0.431 . . . . 3.98 111.68 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 13.0 ttm180 -87.56 132.35 34.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.712 -0.676 . . . . 11.28 109.967 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -81.35 135.41 25.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.71 -0.478 . . . . 7.51 109.71 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD13 ' A' ' 30' ' ' ILE . 45.1 t0 -135.5 124.74 24.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.41 -0.589 . . . . 10.28 109.41 175.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 15.7 pt-20 -111.64 154.07 25.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.112 -0.494 . . . . 10.44 111.511 -171.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.454 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 2.0 mpt? -94.17 132.15 29.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.635 -0.711 . . . . 12.85 109.468 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 23.8 Cg_exo -65.56 -23.86 56.74 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.083 2.522 . . . . 13.07 112.594 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.944 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . 35.3 tt0 69.76 94.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.788 0.68 . . . . 14.04 111.337 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.82 -17.4 19.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.635 . . . . 15.24 109.284 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.57 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.59 -1.186 . . . . 14.64 109.773 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.58 150.9 24.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.794 -0.639 . . . . 12.42 110.577 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 12.4 mmtp -93.66 -92.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.332 -0.147 . . . . 10.84 110.959 175.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 p -176.89 29.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.432 -0.349 . . . . 9.63 111.143 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.641 HG21 ' H ' ' B' ' 143' ' ' ASN . 15.2 t -151.5 149.21 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.1 -0.64 . . . . 9.56 112.408 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.64 80.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 8.3 113.682 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 11.98 11.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.235 0.541 . . . . 8.55 110.289 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -88.74 149.57 23.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 7.5 109.801 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -111.97 174.45 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.748 0.309 . . . . 6.01 110.759 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' B' ' 131' ' ' ASP . 8.5 tt0 -86.61 130.11 34.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.306 -0.628 . . . . 6.99 109.306 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.11 113.84 34.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.24 -0.436 . . . . 4.6 110.053 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -98.78 116.76 31.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.969 0.414 . . . . 5.62 110.954 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.896 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 31.4 m-85 -79.28 109.6 13.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.828 -0.623 . . . . 4.03 110.476 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' B' ' 129' ' ' ARG . 81.6 m-85 -70.73 -51.42 27.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.337 . . . . 4.15 110.569 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 84' ' ' GLU . . . -63.67 -42.59 98.66 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.811 -0.632 . . . . 5.0 112.86 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.972 0.415 . . . . 5.56 110.538 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 63.13 24.07 14.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.613 -0.721 . . . . 6.72 111.427 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -110.28 147.32 34.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.097 -0.501 . . . . 6.33 110.91 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -110.7 121.19 44.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.781 -0.451 . . . . 5.99 109.781 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.95 -178.01 5.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.39 111.165 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -129.91 135.6 48.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.288 -0.634 . . . . 7.73 109.288 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' B' ' 120' ' ' MET . 86.0 mt -140.2 161.24 38.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 5.32 110.757 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.5 174.93 27.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.824 -0.703 . . . . 5.57 111.853 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.48 -37.96 89.9 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.963 2.442 . . . . 6.06 112.719 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -70.11 -14.84 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 7.7 110.712 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -109.72 12.17 24.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.045 -0.525 . . . . 5.82 110.376 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD21 HG21 ' B' ' 116' ' ' VAL . 13.9 tp -138.93 118.35 12.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.45 -0.5 . . . . 4.21 111.047 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 62.1 m-85 -111.03 123.72 34.62 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 4.63 110.289 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.824 ' HA ' HG12 ' B' ' 116' ' ' VAL . 36.1 Cg_exo -57.92 146.84 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.058 2.506 . . . . 4.58 113.588 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HA ' ' CE2' ' B' ' 117' ' ' PHE . 43.6 t80 -62.89 -65.2 0.72 Allowed 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.45 -0.796 . . . . 4.79 110.035 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -59.08 -20.25 51.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.038 0.447 . . . . 6.1 111.653 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 11.2 tp10 -86.49 -46.36 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 6.71 111.149 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -106.68 -20.09 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.978 0.733 . . . . 5.49 112.978 -168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.794 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 64.4 pttt -48.81 -32.66 9.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.153 0.797 . . . . 6.26 113.153 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HG3' ' A' ' 72' ' ' LYS . 14.4 pt-20 -72.65 -39.0 67.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.076 0.399 . . . . 7.73 112.076 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.698 ' HG3' ' HG3' ' A' ' 71' ' ' GLU . 97.7 mttt -98.21 -64.25 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.84 0.353 . . . . 8.1 111.805 -174.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -118.92 26.8 9.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.245 0.545 . . . . 5.97 110.807 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 70' ' ' LYS . . . -75.79 -14.76 81.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.644 -0.788 . . . . 6.74 112.091 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -116.08 94.06 40.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.405 -0.961 . . . . 8.38 108.405 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.615 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 55.7 Cg_endo -90.25 -16.47 1.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.809 2.339 . . . . 7.75 113.439 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 36.9 t-20 57.21 83.3 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.363 0.601 . . . . 7.82 111.537 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 76' ' ' PRO . 5.3 mptp? -117.71 43.74 2.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.822 -0.626 . . . . 10.11 110.051 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 79' ' ' ARG . 36.4 mtp-105 67.72 -148.18 0.15 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.288 -0.869 . . . . 8.81 111.474 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 26.1 ttpp -54.19 -45.82 72.25 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.243 0.461 . . . . 8.87 112.243 -173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' HZ2' ' B' ' 126' ' ' TRP . . . -59.12 -31.7 69.61 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.081 -0.581 . . . . 5.87 112.512 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 16.5 t80 -71.8 -44.27 64.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.806 -0.197 . . . . 5.14 110.682 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.3 m -62.45 -52.83 61.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.302 -0.408 . . . . 6.17 110.729 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 pt-20 -69.4 -30.05 67.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.471 . . . . 6.87 110.347 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 89' ' ' ILE . . . -70.24 -46.73 48.4 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.017 -0.611 . . . . 4.6 112.153 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 89' ' ' ILE . 6.5 tt -63.16 -41.8 99.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.236 0.541 . . . . 5.05 109.574 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.39 -51.85 68.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.949 -0.568 . . . . 7.15 109.63 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 7.3 tp10 -57.43 -45.19 84.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.585 -0.734 . . . . 5.21 112.578 -172.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.593 HG22 ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -86.25 -14.83 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.908 -0.717 . . . . 4.46 111.534 -175.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.67 -26.09 44.99 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.377 -0.529 . . . . 6.86 110.751 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 88' ' ' GLU . 10.1 p30 -91.21 16.52 9.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.701 -0.227 . . . . 6.04 110.491 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -54.42 115.94 9.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.086 -0.506 . . . . 5.09 111.374 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.41 -15.11 8.96 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.732 2.288 . . . . 6.48 112.99 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.5 m -85.09 86.14 7.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 7.32 110.629 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.24 126.17 57.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.15 0.5 . . . . 6.13 110.141 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -84.75 70.4 10.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.468 0.651 . . . . 9.68 110.143 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.17 -7.68 9.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.157 -0.929 . . . . 8.54 109.769 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 p -87.23 139.6 30.39 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.163 -0.926 . . . . 9.88 110.503 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 151.15 125.84 1.26 Allowed Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.667 -0.777 . . . . 9.93 111.888 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 12.88 110.117 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.231 -0.285 . . . . 13.85 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.4 m -89.32 171.21 9.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 12.37 110.06 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' B' ' 103' ' ' ARG . 5.8 tpp180 -67.0 -49.85 64.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.836 0.35 . . . . 12.02 111.212 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -92.71 141.49 28.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.439 . . . . 10.42 111.467 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.36 126.97 31.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.805 -0.634 . . . . 8.13 109.31 172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -92.91 121.92 34.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.981 0.42 . . . . 10.78 111.31 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -81.89 155.41 25.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.783 -0.644 . . . . 8.36 109.893 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 81.03 4.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.935 -0.765 . . . . 8.99 108.935 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.05 -45.45 67.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.878 -1.056 . . . . 8.32 111.119 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.18 131.13 45.43 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.151 -0.685 . . . . 5.28 109.151 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -128.44 139.39 52.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.817 0.341 . . . . 8.12 111.315 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' B' ' 132' ' ' GLU . 34.6 m -45.88 134.29 7.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 5.93 111.939 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.3 3.56 90.01 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.762 -0.732 . . . . 4.62 113.714 173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.99 169.62 17.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.148 0.474 . . . . 4.66 110.421 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 115' ' ' LEU . 0.3 OUTLIER -116.84 144.98 43.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.015 -0.539 . . . . 3.32 110.076 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -151.82 166.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.405 -0.816 . . . . 3.43 111.268 -171.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 66' ' ' TYR . 60.6 m-85 -108.13 114.16 27.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.382 -0.97 . . . . 3.93 108.382 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -91.66 146.1 24.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.891 -0.595 . . . . 3.3 111.671 -171.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 49.6 tttm -117.1 94.55 4.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.309 -0.86 . . . . 5.76 109.553 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.521 ' HG2' HD21 ' A' ' 58' ' ' LEU . 3.6 tmm? -97.95 171.38 8.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.644 -0.873 . . . . 6.08 108.644 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 121' ' ' LYS . 22.4 pttm -70.82 118.05 13.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.805 -0.758 . . . . 8.78 109.523 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.01 -14.1 65.09 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.402 -0.817 . . . . 6.27 112.07 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.47 87.56 49.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.561 -0.533 . . . . 7.06 109.561 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 34.0 Cg_endo -65.04 -29.15 57.04 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.726 2.284 . . . . 5.68 113.619 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -151.97 106.61 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.334 -0.247 . . . . 4.71 110.334 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.896 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -148.13 124.05 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.961 -0.385 . . . . 6.03 109.961 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.82 131.06 43.22 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.018 2.479 . . . . 3.48 112.986 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -149.83 164.06 36.34 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.058 0.456 . . . . 2.83 111.581 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 16.6 tpp180 -84.42 143.21 29.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 5.33 111.118 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.536 HG12 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -92.27 134.1 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.816 -0.809 . . . . 4.34 108.816 170.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 46' ' ' GLN . 27.2 t70 -132.76 103.74 6.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.486 -0.561 . . . . 5.66 109.486 171.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.648 ' HB3' ' SG ' ' B' ' 112' ' ' CYS . 61.6 tt0 -83.16 116.72 22.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.55 -0.75 . . . . 7.05 109.889 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 75.0 mtp -88.23 129.85 48.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 9.64 110.208 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.32 -55.61 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.747 2.298 . . . . 9.8 112.559 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.1 124.54 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 12.27 110.677 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -170.01 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.657 -0.701 . . . . 11.49 109.501 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -111.84 -13.6 13.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.01 -0.737 . . . . 11.38 109.01 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' B' ' 139' ' ' LYS . 12.3 p -79.96 149.88 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.739 -1.118 . . . . 9.65 109.776 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.542 ' HG2' HG22 ' B' ' 138' ' ' VAL . 67.3 mmtt 64.13 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.804 0.69 . . . . 11.11 110.012 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 59.4 m 61.62 -172.89 0.14 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.938 -1.028 . . . . 8.66 112.191 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 0.632 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.9 p -85.84 -61.17 1.82 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 9.44 110.368 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -167.29 125.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.379 -0.373 . . . . 8.63 110.437 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.641 ' H ' HG21 ' A' ' 41' ' ' THR . 13.0 m120 -118.42 -28.12 5.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.317 -0.401 . . . . 9.61 110.348 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -141.14 135.81 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 8.97 109.702 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -131.32 -169.82 2.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 7.97 110.383 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -92.28 129.88 38.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.219 0.533 . . . . 9.5 110.613 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' B' ' 158' ' ' LEU . 80.6 t -126.94 118.58 50.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 6.03 110.382 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 57.3 t80 -93.24 112.06 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.982 0.42 . . . . 10.78 110.713 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -78.22 114.98 17.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.016 -0.538 . . . . 8.4 110.417 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.671 ' HE2' HD23 ' A' ' 15' ' ' LEU . 33.7 m-85 -71.06 -46.98 60.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.72 0.295 . . . . 9.24 111.119 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 26' ' ' TRP . . . -61.4 -50.54 65.66 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.943 -0.572 . . . . 10.64 113.534 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 35.4 p -84.2 -11.29 56.77 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.558 -0.378 . . . . 12.27 111.175 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 62.95 38.95 10.8 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.385 0.612 . . . . 13.51 110.535 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.68 147.87 50.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 12.96 111.181 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.9 m -96.79 117.48 31.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 10.75 110.333 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.74 -177.54 3.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.467 -0.333 . . . . 8.03 110.908 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -126.94 126.19 42.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.896 0.379 . . . . 9.95 110.226 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.66 ' HB2' HG21 ' B' ' 147' ' ' VAL . 98.2 mt -143.2 166.05 25.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 6.89 109.989 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.66 -177.56 17.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.568 -0.825 . . . . 6.24 111.614 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.55 -28.35 86.48 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.848 2.365 . . . . 8.35 111.71 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -73.71 -19.49 60.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 12.73 110.573 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' B' ' 158' ' ' LEU . 9.9 m-20 -102.75 3.64 37.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.511 -0.768 . . . . 9.49 109.231 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 16' ' ' VAL . 9.4 tp -123.9 137.14 54.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.524 -0.762 . . . . 7.88 110.663 -172.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -123.82 116.49 27.65 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 116.482 -0.326 . . . . 10.48 111.053 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' B' ' 168' ' ' GLU . 32.1 Cg_exo -56.38 118.68 5.53 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.069 2.513 . . . . 10.82 112.214 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.472 ' O ' ' HD2' ' B' ' 170' ' ' LYS . 2.5 p90 -78.24 -27.72 47.68 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.511 -0.313 . . . . 10.52 111.21 -173.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.99 -16.08 58.52 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.802 -0.561 . . . . 13.98 111.515 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' B' ' 165' ' ' PRO . 7.6 pt-20 -119.58 -0.19 10.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.593 -0.276 . . . . 15.72 111.464 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -145.34 0.3 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.592 0.96 . . . . 11.91 113.592 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -57.22 -22.33 40.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.053 -0.404 . . . . 12.55 111.52 177.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -77.16 -24.76 51.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.727 0.298 . . . . 15.86 111.15 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.92 -49.74 11.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.629 . . . . 16.47 110.48 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -89.82 -9.48 49.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.704 -0.68 . . . . 11.15 110.517 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 186' ' ' LEU . . . -76.89 75.38 1.71 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.805 -0.634 . . . . 11.12 112.437 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.02 93.38 3.67 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.23 -1.026 . . . . 14.56 108.23 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.23 117.22 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.82 2.347 . . . . 11.81 112.519 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -86.24 173.42 9.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.156 -0.929 . . . . 13.38 109.774 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -62.61 -20.32 64.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.658 0.266 . . . . 16.74 111.311 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -67.07 114.12 5.59 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.096 -0.335 . . . . 16.14 110.096 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -56.89 -42.39 79.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 15.89 112.357 -174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.53 -29.39 75.07 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.552 -0.832 . . . . 11.57 112.249 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.416 ' HA ' ' NE1' ' A' ' 26' ' ' TRP . 38.8 t80 -78.42 -49.2 13.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.107 0.479 . . . . 9.65 109.742 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -63.6 -45.48 90.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.594 -0.73 . . . . 10.46 111.062 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.16 -41.1 90.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.564 -0.289 . . . . 12.15 110.634 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.04 92.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.344 -0.931 . . . . 8.24 111.883 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 174' ' ' GLY . 1.2 tt -66.7 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.443 -0.577 . . . . 7.89 109.443 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -58.6 -52.48 65.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.401 -0.363 . . . . 11.87 110.688 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' B' ' 193' ' ' PRO . 28.6 mt-10 -56.82 -34.43 67.71 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.732 0.645 . . . . 11.62 111.222 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.533 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -87.51 -31.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.605 -0.838 . . . . 9.26 112.548 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.65 -41.68 97.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 11.04 111.154 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -82.51 -29.12 30.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 12.59 111.109 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 59.13 90.73 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 123.551 0.532 . . . . 13.52 110.938 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' B' ' 188' ' ' GLU . 24.1 Cg_exo -64.84 -55.66 0.49 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.398 2.065 . . . . 14.9 110.931 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 62.5 m -157.03 -47.75 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 17.54 109.866 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 41.0 t 58.02 68.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.877 0.846 . . . . 18.06 109.911 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -84.38 97.05 9.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.346 -0.843 . . . . 21.28 111.115 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 13' ' ' GLY . . . -86.67 -49.93 7.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 21.53 109.916 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 23.2 m -135.99 99.02 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 23.03 110.09 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.4 -49.23 5.58 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.281 -1.128 . . . . 24.72 110.281 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.512 -0.756 . . . . 27.31 109.179 172.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.838 0.351 . . . . 29.42 110.652 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t -135.79 3.96 3.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.338 -0.392 . . . . 26.59 111.24 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 25.53 111.255 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 t -130.41 113.41 14.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.363 -0.606 . . . . 23.29 109.363 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.84 121.65 15.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 21.2 110.892 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -85.38 171.68 11.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 20.05 110.477 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.54 171.5 8.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.093 0.473 . . . . 16.73 111.201 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -100.01 98.09 8.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.657 -0.701 . . . . 16.22 109.907 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.25 146.52 26.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.594 -0.73 . . . . 13.24 110.212 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 160' ' ' PRO . 64.9 m-85 -70.62 144.65 51.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.9 0.381 . . . . 10.33 111.284 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -120.62 118.02 29.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.929 -0.578 . . . . 14.9 110.868 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -44.35 108.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 11.71 110.426 171.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.85 -23.78 3.91 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.704 -0.76 . . . . 9.66 111.906 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -60.46 138.64 57.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 110.153 -0.314 . . . . 10.47 110.153 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 16' ' ' VAL . 2.1 tm? -104.97 143.09 33.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.992 -0.744 . . . . 7.46 108.992 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' B' ' 163' ' ' LEU . 7.5 p -160.73 157.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.499 -0.319 . . . . 6.87 110.87 -168.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.35 114.75 22.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.067 -0.346 . . . . 6.78 110.067 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HA ' HD23 ' B' ' 163' ' ' LEU . . . -92.91 130.17 38.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.017 0.437 . . . . 6.21 110.97 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -101.81 93.4 5.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.191 -0.459 . . . . 12.44 110.892 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.1 ttt -107.09 146.21 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.676 -0.861 . . . . 10.95 108.676 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.72 116.25 5.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.614 -0.884 . . . . 15.91 108.614 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.34 -20.4 28.05 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.595 -0.729 . . . . 14.09 111.42 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -129.49 88.86 48.92 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 109.535 -0.543 . . . . 13.65 109.535 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.25 89.78 0.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.734 2.289 . . . . 12.38 113.025 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.5 m80 64.17 64.55 0.72 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.528 -0.76 . . . . 11.05 110.019 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -100.24 131.69 23.73 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.278 -0.874 . . . . 10.23 109.78 -174.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 26' ' ' TRP . 10.4 Cg_endo -54.41 114.5 1.85 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.005 2.47 . . . . 5.52 112.698 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 15' ' ' LEU . . . -139.74 150.92 45.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 3.98 110.255 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' B' ' 150' ' ' PHE . 58.3 ttp180 -97.13 142.38 29.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 11.28 111.386 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.78 137.62 21.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.586 -0.734 . . . . 7.51 110.479 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' B' ' 146' ' ' GLN . 30.8 t70 -141.74 152.11 43.51 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.166 -0.679 . . . . 10.28 109.166 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.61 137.06 21.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.732 0.301 . . . . 10.44 111.383 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.5 ttm -141.55 100.33 6.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.852 -0.613 . . . . 12.85 109.87 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.34 169.41 22.56 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.067 2.512 . . . . 13.07 111.8 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -80.76 -53.54 6.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.683 -0.488 . . . . 14.04 109.683 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.03 82.66 0.37 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.733 -0.667 . . . . 15.24 109.275 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.83 0.48 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.936 0.773 . . . . 14.64 110.116 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.43 158.36 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.81 -0.811 . . . . 12.42 108.81 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' B' ' 141' ' ' THR . 75.1 mttt -108.35 96.57 6.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.627 -0.508 . . . . 10.84 109.627 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -133.12 176.61 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.032 -0.531 . . . . 9.63 109.952 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.667 HG23 ' HE2' ' A' ' 44' ' ' LYS . 16.4 m 73.88 3.63 4.49 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.366 0.416 . . . . 9.56 111.298 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' B' ' 139' ' ' LYS . . . -56.37 -49.23 75.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.948 0.404 . . . . 8.3 111.773 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -94.87 20.04 9.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.19 -0.459 . . . . 8.55 111.251 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.667 ' HE2' HG23 ' A' ' 41' ' ' THR . 38.7 ttpt -114.37 136.1 53.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.745 -0.465 . . . . 7.5 109.745 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' B' ' 131' ' ' ASP . 60.4 m-85 -114.15 179.5 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 6.01 110.391 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 8.0 tt0 -99.66 120.25 39.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.351 -0.611 . . . . 6.99 109.351 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 58' ' ' LEU . 79.4 t -107.61 115.96 50.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.999 -0.546 . . . . 4.6 109.872 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 53.5 t80 -101.23 120.4 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.988 0.423 . . . . 5.62 110.975 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -85.85 116.24 23.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.578 -0.737 . . . . 4.03 110.023 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.655 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 65.5 m-85 -66.74 -55.56 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.348 0.405 . . . . 4.15 111.315 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.83 9.78 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.0 113.518 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.535 HG21 ' CE1' ' B' ' 123' ' ' TYR . 24.2 p -71.32 -10.56 59.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.071 0.436 . . . . 5.56 111.546 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 64.73 25.4 12.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.593 0.711 . . . . 6.72 110.125 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -102.45 128.67 48.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 6.33 111.426 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 48' ' ' PHE . 4.3 m -101.94 122.29 43.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.661 -0.699 . . . . 5.99 109.783 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -128.7 165.28 21.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 5.39 111.405 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.42 103.52 11.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.036 -0.728 . . . . 7.73 109.036 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 47' ' ' VAL . 84.9 mt -129.86 174.13 10.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.345 0.593 . . . . 5.32 111.458 -172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 -164.69 11.02 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.384 -1.087 . . . . 5.57 110.384 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.15 -28.68 62.42 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 122.878 2.385 . . . . 6.06 112.133 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -48.88 -40.65 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.257 -0.883 . . . . 7.7 112.049 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.97 20.38 9.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.355 -0.384 . . . . 5.82 110.906 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.512 HD11 HG23 ' B' ' 116' ' ' VAL . 17.0 tp -133.58 132.86 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.554 -0.293 . . . . 4.21 110.417 -175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 58.9 m-85 -128.26 154.07 78.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.477 -0.329 . . . . 4.63 110.707 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' SER . 38.9 Cg_exo -58.05 157.88 23.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.947 2.431 . . . . 4.58 112.928 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' HA ' ' CD1' ' B' ' 117' ' ' PHE . 12.6 t80 -98.59 -58.66 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 4.79 109.763 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.41 -18.71 65.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 6.1 112.382 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.36 -49.06 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.046 -0.261 . . . . 6.71 111.512 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 35.0 m -79.54 -0.37 33.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.657 0.265 . . . . 5.49 111.676 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 66' ' ' TYR . 59.5 pttt -48.0 -32.48 6.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.914 0.388 . . . . 6.26 112.033 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -77.86 -19.74 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.53 -0.305 . . . . 7.73 111.734 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -97.8 -32.81 11.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 8.1 111.306 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 32.6 m-85 -113.47 6.45 17.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 5.97 111.136 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.07 78.78 1.97 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.848 -0.692 . . . . 6.74 112.261 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.0 pttt -148.19 116.58 4.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.873 -0.788 . . . . 8.38 108.873 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.7 Cg_endo -90.07 124.36 1.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.585 2.19 . . . . 7.75 113.434 -171.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.95 136.52 52.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 7.82 108.883 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.63 83.36 2.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.41 0.624 . . . . 10.11 112.02 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 86.9 mtt180 -124.57 141.81 51.82 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.452 -1.314 . . . . 8.81 107.452 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -51.9 -56.52 13.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.689 0.255 . . . . 8.87 111.689 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' HG22 ' A' ' 52' ' ' THR . . . -68.37 -37.64 86.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.49 -0.862 . . . . 5.87 112.492 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 6.2 t80 -60.65 -50.15 74.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.542 0.687 . . . . 5.14 110.751 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -70.73 -44.86 65.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.712 -1.131 . . . . 6.17 110.465 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.03 -30.42 70.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 6.87 110.315 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA3' ' CZ3' ' B' ' 126' ' ' TRP . . . -69.93 -47.5 46.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.274 -0.965 . . . . 4.6 112.681 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 86' ' ' LEU . 4.5 tt -70.96 -34.21 71.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.292 -0.633 . . . . 5.05 109.292 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -66.42 -45.69 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.572 -0.286 . . . . 7.15 110.731 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 50' ' ' PHE . 6.7 tp10 -57.01 -29.6 63.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 5.21 109.661 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 89' ' ' ILE . 0.4 OUTLIER -86.88 -28.17 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.552 -0.749 . . . . 4.46 112.403 177.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -58.53 -37.03 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 6.86 110.013 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' A' ' 88' ' ' GLU . 4.9 p30 -94.47 -34.17 12.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 6.04 109.96 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 t30 68.39 113.34 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.406 -0.815 . . . . 5.09 112.513 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.38 -59.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.843 2.362 . . . . 6.48 112.922 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.3 m -92.74 110.03 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.794 0.33 . . . . 7.32 110.812 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.81 141.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.065 -0.516 . . . . 6.13 110.587 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -84.62 98.63 10.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.333 0.587 . . . . 9.68 110.469 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.87 -39.97 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.278 -0.874 . . . . 8.54 110.267 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.2 t 69.52 90.22 0.1 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.502 -0.772 . . . . 9.88 110.48 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.4 -141.39 9.59 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.413 -0.812 . . . . 9.93 112.634 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.506 0.67 . . . . 12.88 111.898 -175.203 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 41.3 tpp . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.344 0.592 . . . . 13.85 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -92.59 47.44 1.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 12.37 110.955 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -140.56 129.99 23.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.88 -0.785 . . . . 12.02 108.88 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.1 t -76.9 146.46 37.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.825 0.345 . . . . 10.42 111.114 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -96.97 122.88 40.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 8.13 109.963 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -97.24 145.53 25.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 10.78 110.882 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -115.1 135.24 54.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.052 -0.721 . . . . 8.36 109.052 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -89.24 -18.7 26.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 8.99 110.512 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.87 173.94 7.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.918 -0.583 . . . . 8.32 110.658 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -68.58 124.35 23.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 5.28 110.483 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -102.45 151.51 22.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.515 -0.311 . . . . 8.12 110.48 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 51.4 t -39.74 126.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.836 0.854 . . . . 5.93 113.024 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.84 67.71 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.693 -0.685 . . . . 4.62 113.251 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' B' ' 129' ' ' ARG . 4.6 t70 -83.16 174.8 10.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.049 0.424 . . . . 4.66 110.878 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.462 HD22 ' O ' ' B' ' 128' ' ' ALA . 3.0 tm? -137.42 121.29 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.782 -0.451 . . . . 3.32 109.782 -172.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -146.55 179.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.698 -0.228 . . . . 3.43 111.526 -176.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 52.7 m-85 -83.25 123.9 30.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.622 0.248 . . . . 3.93 110.771 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.22 158.67 22.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.801 0.334 . . . . 3.3 110.887 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -142.7 147.0 34.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.959 -0.564 . . . . 5.76 110.28 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.459 ' HB3' ' CD2' ' B' ' 123' ' ' TYR . 38.2 ttm -129.94 164.32 24.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.277 -0.638 . . . . 6.08 109.277 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -59.75 115.31 3.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.872 -0.788 . . . . 8.78 108.872 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.6 58.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.109 -0.567 . . . . 6.27 112.312 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.535 ' CE1' HG21 ' A' ' 52' ' ' THR . 91.4 m-85 -114.12 109.0 49.8 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 7.06 110.068 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.432 ' HG2' ' CD2' ' A' ' 82' ' ' PHE . 5.0 Cg_endo -47.84 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.856 3.037 . . . . 5.68 114.153 -173.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -160.01 116.58 2.49 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.156 -0.34 . . . . 4.71 110.714 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.786 ' NE1' ' HA ' ' A' ' 82' ' ' PHE . 59.5 p-90 -164.42 156.05 13.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.531 0.567 . . . . 6.03 112.531 164.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' B' ' 116' ' ' VAL . 78.7 Cg_exo -48.59 128.33 17.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.625 3.55 . . . . 3.48 115.534 -175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.462 ' O ' HD22 ' B' ' 115' ' ' LEU . . . -133.25 162.63 31.28 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.158 -0.928 . . . . 2.83 109.943 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.649 ' HE ' ' HZ ' ' A' ' 50' ' ' PHE . 16.2 tpp180 -87.97 147.18 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 5.33 110.96 -174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.414 HD13 ' H ' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -103.47 143.0 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.154 -0.475 . . . . 4.34 112.004 -173.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.718 ' HA ' ' HB3' ' A' ' 45' ' ' TYR . 14.5 t70 79.47 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.027 -0.988 . . . . 5.66 112.411 166.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 47.89 25.62 0.78 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.79 0.682 . . . . 7.05 112.197 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 46.4 tpp -166.7 102.94 0.66 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 9.64 109.814 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.04 177.71 8.4 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.821 2.348 . . . . 9.8 113.154 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' B' ' 135' ' ' GLU . 0.0 OUTLIER -101.97 29.25 5.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.737 -0.665 . . . . 12.27 110.109 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.44 85.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.538 -0.755 . . . . 11.49 112.159 -174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.54 10.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 11.38 111.641 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.434 HG23 ' HE2' ' B' ' 139' ' ' LYS . 34.4 m -120.61 136.97 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.966 -0.383 . . . . 9.65 109.966 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 13.3 mtmt 55.61 20.98 4.17 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.436 0.46 . . . . 11.11 110.703 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -74.88 -60.35 2.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 8.66 111.75 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 39' ' ' LYS . 42.8 p -100.78 104.75 16.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.745 0.307 . . . . 9.44 111.589 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.68 -77.2 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 8.63 109.857 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.1 -45.05 20.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.192 0.52 . . . . 9.61 110.136 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -91.62 142.06 28.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.627 -0.715 . . . . 8.97 110.49 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' B' ' 157' ' ' PHE . 16.6 m-85 -97.66 164.28 12.48 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.558 -0.746 . . . . 7.97 110.208 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 23.8 tt0 -89.57 104.62 17.16 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' B' ' 158' ' ' LEU . 98.4 t -101.14 127.78 54.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.052 -0.522 . . . . 6.03 110.826 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -99.49 110.64 23.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.914 -0.585 . . . . 10.78 110.99 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 7.2 m-85 -78.53 107.64 11.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.716 -0.675 . . . . 8.4 110.105 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 36.4 m-85 -69.15 -24.34 64.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 9.24 110.983 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.48 -69.04 1.4 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.054 -0.593 . . . . 10.64 112.553 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 2.2 p -89.05 1.79 55.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.771 0.319 . . . . 12.27 111.453 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.36 30.99 17.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.935 -0.575 . . . . 13.51 111.595 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -113.26 170.28 8.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.495 -0.32 . . . . 12.96 110.357 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.6 m -119.69 137.25 54.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.498 -0.319 . . . . 10.75 110.195 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.17 155.01 44.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.273 -0.422 . . . . 8.03 110.362 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 145' ' ' TYR . 99.0 m-85 -99.92 105.72 17.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.743 0.306 . . . . 9.95 110.442 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG21 ' B' ' 147' ' ' VAL . 3.2 mm? -121.34 170.05 10.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.071 -0.513 . . . . 6.89 109.892 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.27 170.99 13.48 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.498 -0.858 . . . . 6.24 111.133 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 10' ' ' TYR . 32.5 Cg_exo -58.9 -27.9 85.81 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.688 2.259 . . . . 8.35 111.834 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -74.63 -15.99 60.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.615 -0.721 . . . . 12.73 110.519 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -103.86 5.95 36.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.029 -0.532 . . . . 9.49 110.119 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.822 ' HB3' HG21 ' A' ' 16' ' ' VAL . 43.8 mt -118.98 123.73 45.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.388 -0.824 . . . . 7.88 110.427 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -105.7 110.37 64.13 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 10.48 110.078 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.57 132.67 36.34 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.706 2.937 . . . . 10.82 113.366 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' B' ' 170' ' ' LYS . 4.8 t80 -67.54 -62.6 1.34 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.702 -0.681 . . . . 10.52 110.171 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 167' ' ' GLU . 13.2 mp0 -53.96 -23.56 13.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.328 0.492 . . . . 13.98 112.328 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -103.75 -57.17 2.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.834 -0.346 . . . . 15.72 111.415 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 t -91.9 2.1 56.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.193 0.442 . . . . 11.91 112.193 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' B' ' 166' ' ' TYR . 0.0 OUTLIER -56.6 -17.32 8.21 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.744 0.306 . . . . 12.55 111.404 172.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 170' ' ' LYS . 42.7 mt-10 -77.18 -18.66 57.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.452 -0.34 . . . . 15.86 111.236 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -98.79 -18.99 17.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 16.47 110.205 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -124.4 20.78 8.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 11.15 111.038 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.28 55.51 4.83 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.925 -0.655 . . . . 11.12 111.561 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -139.84 94.92 8.88 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 107.636 -1.246 . . . . 14.56 107.636 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.557 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 4.5 Cg_exo -74.83 145.47 32.2 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.529 2.152 . . . . 11.81 112.452 -170.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -111.65 149.07 32.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.435 -0.802 . . . . 13.38 109.395 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.5 72.38 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.861 0.839 . . . . 16.74 110.921 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' B' ' 182' ' ' PHE . 1.3 mmp_? -128.63 142.54 51.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 16.14 108.695 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -59.7 -55.72 30.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.607 0.242 . . . . 15.89 111.082 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.62 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 11.57 112.659 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.557 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 30.3 t80 -77.1 -49.62 14.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.023 0.439 . . . . 9.65 110.159 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 16.0 m -68.88 -41.71 77.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.739 -0.664 . . . . 10.46 110.428 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.85 -37.64 82.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 12.15 109.787 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.441 ' O ' HG23 ' B' ' 189' ' ' ILE . . . -64.69 -47.11 87.04 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.654 . . . . 8.24 111.945 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' B' ' 189' ' ' ILE . 63.3 mt -63.09 -33.77 76.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.206 0.527 . . . . 7.89 110.597 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . 0.434 ' HA ' HD22 ' B' ' 191' ' ' ASN . 30.1 t-105 -68.79 -47.97 64.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.999 -0.546 . . . . 11.87 110.435 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.17 -38.32 90.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.975 0.732 . . . . 11.62 112.975 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 186' ' ' LEU . 0.2 OUTLIER -86.5 -25.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 119.319 -0.952 . . . . 9.26 111.716 -176.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.89 -19.7 18.66 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.328 -0.549 . . . . 11.04 110.756 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' B' ' 187' ' ' TRP . 15.7 m-80 -125.0 72.06 1.21 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.542 -0.91 . . . . 12.59 108.542 176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -61.76 154.82 64.86 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.441 -0.799 . . . . 13.52 111.425 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.95 169.12 10.89 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.636 2.224 . . . . 14.9 111.386 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 7.8 p -58.26 105.62 0.3 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 17.54 111.179 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.99 94.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.792 -0.448 . . . . 18.06 109.792 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . 0.646 ' HE3' ' HA3' ' B' ' 199' ' ' GLY . 64.2 tttp -127.66 93.21 3.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 21.28 110.522 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -95.4 -15.34 23.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.532 -0.758 . . . . 21.53 109.536 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 35.4 p -63.43 -37.83 88.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.33 -0.85 . . . . 23.03 110.518 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . 0.646 ' HA3' ' HE3' ' B' ' 196' ' ' LYS . . . -123.06 72.88 0.4 Allowed Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.376 -0.829 . . . . 24.72 111.29 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 26.4 t80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.594 -0.717 . . . . 27.31 109.38 -178.657 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.785 0.326 . . . . 29.42 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -98.44 -52.66 3.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.779 -0.191 . . . . 26.59 111.376 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 61.55 19.39 10.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.991 0.516 . . . . 25.53 111.866 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -126.48 150.81 48.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.509 -0.552 . . . . 23.29 109.509 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -79.34 148.83 31.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.807 0.337 . . . . 21.2 110.548 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -75.89 123.16 25.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.469 -0.937 . . . . 20.05 108.469 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -70.38 137.99 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.06 0.457 . . . . 16.73 111.069 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -80.31 95.24 6.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.522 0.677 . . . . 16.22 109.837 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.08 147.46 31.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.087 -0.96 . . . . 13.24 110.202 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -75.07 144.71 42.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 10.33 110.467 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.92 131.29 35.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.849 -0.426 . . . . 14.9 109.849 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 t -60.76 111.08 1.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 11.71 109.493 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 30' ' ' ILE . . . 120.05 -9.51 11.23 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.072 -0.585 . . . . 9.66 112.624 -173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -75.43 158.14 33.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 10.47 111.483 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -110.27 131.63 54.89 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.267 -0.642 . . . . 7.46 109.267 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' B' ' 166' ' ' TYR . 3.0 m -145.02 -176.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.514 -0.312 . . . . 6.87 111.076 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.651 ' HE2' ' HA ' ' B' ' 170' ' ' LYS . 56.1 m-85 -98.64 121.81 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.198 -0.297 . . . . 6.78 110.198 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' B' ' 163' ' ' LEU . . . -98.91 145.41 27.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.826 0.346 . . . . 6.21 111.328 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -114.1 104.02 11.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.146 -0.479 . . . . 12.44 109.986 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ttt -118.32 157.05 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.297 -0.631 . . . . 10.95 109.297 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -62.11 116.85 5.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.051 -0.66 . . . . 15.91 109.293 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.84 -20.34 39.03 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.966 -0.635 . . . . 14.09 111.856 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -124.3 95.51 43.33 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-O 120.975 0.417 . . . . 13.65 110.276 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.02 86.15 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.726 2.284 . . . . 12.38 112.947 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.2 m80 70.8 80.4 0.17 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.712 -0.676 . . . . 11.05 109.716 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.51 ' HB3' ' CE2' ' B' ' 149' ' ' PHE . 1.5 t-105 -121.38 131.34 24.48 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.133 -0.94 . . . . 10.23 109.329 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.16 122.21 10.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.837 2.358 . . . . 5.52 112.65 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -142.06 152.12 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 3.98 112.072 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 15' ' ' LEU . 30.0 ttt180 -91.0 139.01 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.381 -0.827 . . . . 11.28 110.474 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -86.79 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.613 -0.514 . . . . 7.51 109.613 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 30' ' ' ILE . 15.3 t70 -160.08 170.4 21.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.551 -0.537 . . . . 10.28 109.551 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 11.2 pt-20 -165.42 153.06 10.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.186 -0.301 . . . . 10.44 110.186 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.48 101.68 36.98 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.93 0.395 . . . . 12.85 111.139 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 32' ' ' GLU . 2.0 Cg_endo -83.15 113.85 2.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.957 2.438 . . . . 13.07 110.986 175.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.81 -50.44 70.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.92 0.39 . . . . 14.04 110.814 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.69 83.41 1.93 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.969 -0.56 . . . . 15.24 110.235 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.63 -65.08 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.543 0.737 . . . . 14.64 111.394 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.71 HG22 ' H ' ' A' ' 40' ' ' SER . 8.9 p -121.54 147.57 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.633 -0.506 . . . . 12.42 109.633 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.21 8.8 10.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.33 0.586 . . . . 10.84 110.567 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.71 ' H ' HG22 ' A' ' 38' ' ' VAL . 22.4 m -104.85 120.31 41.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 9.63 110.442 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.3 m -152.3 102.05 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 9.56 110.734 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.66 133.61 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 8.3 110.068 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -168.88 20.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 8.55 111.51 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -137.79 137.32 38.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.646 -0.421 . . . . 7.5 111.198 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.57 170.2 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.989 -0.745 . . . . 6.01 108.989 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' B' ' 131' ' ' ASP . 24.4 mt-30 -89.86 95.37 10.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.248 0.547 . . . . 6.99 109.564 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 58' ' ' LEU . 57.0 t -85.02 106.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.663 -0.699 . . . . 4.6 109.479 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -90.33 105.05 17.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.672 -0.695 . . . . 5.62 109.729 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' B' ' 126' ' ' TRP . 6.9 m-85 -62.96 105.05 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.091 -0.337 . . . . 4.03 110.091 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -72.12 -25.17 61.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.874 -0.603 . . . . 4.15 110.532 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.86 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.926 -0.654 . . . . 5.0 112.653 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -92.26 0.09 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.982 0.364 . . . . 5.56 111.982 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 65.0 m170 64.85 30.17 12.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.118 -0.492 . . . . 6.72 111.422 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.19 145.06 37.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.76 -0.2 . . . . 6.33 111.122 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 m -97.84 126.02 43.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.018 -0.364 . . . . 5.99 110.018 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.4 169.05 15.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.388 -0.369 . . . . 5.39 110.73 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.85 109.25 14.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 7.73 109.927 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.0 mp -124.74 163.49 21.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 5.32 110.436 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.71 176.81 31.33 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.622 -0.799 . . . . 5.57 111.562 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.57 -35.57 89.48 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.693 2.262 . . . . 6.06 112.422 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -74.89 -10.16 59.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.162 -0.472 . . . . 7.7 111.745 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.454 ' HB3' HD23 ' A' ' 58' ' ' LEU . 28.4 m-20 -104.03 4.06 34.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.171 0.51 . . . . 5.82 110.214 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 HG21 ' B' ' 116' ' ' VAL . 14.4 tp -123.65 139.13 54.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.601 -0.727 . . . . 4.21 109.442 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 62.8 m-85 -126.39 142.5 43.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.504 -0.316 . . . . 4.63 110.674 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' SER . 1.5 Cg_endo -46.84 152.4 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.638 2.892 . . . . 4.58 114.021 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 85.5 t80 -84.74 -57.82 2.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.587 -1.188 . . . . 4.79 110.744 -172.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.05 -31.29 68.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 6.1 111.569 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.04 -61.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.494 -0.321 . . . . 6.71 111.522 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.712 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 73.7 m -68.82 -18.26 64.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.482 0.549 . . . . 5.49 112.482 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 39.4 ttpt -53.71 -33.15 54.63 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.499 -0.48 . . . . 6.26 110.431 172.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.81 -34.03 64.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 7.73 111.054 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.712 ' HD3' ' HA ' ' A' ' 69' ' ' SER . 4.1 mptp? -76.59 -26.23 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 8.1 111.013 -173.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -113.61 25.97 10.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.328 0.585 . . . . 5.97 109.44 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.93 75.47 1.1 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.133 -0.94 . . . . 6.74 112.733 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 27.5 ttpt -132.65 95.41 20.06 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 107.678 -1.23 . . . . 8.38 107.678 174.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 5.1 Cg_endo -84.43 158.91 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.323 2.682 . . . . 7.75 115.223 -160.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.703 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 m120 52.38 70.23 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 113.93 -1.487 . . . . 7.82 112.688 174.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -97.01 -33.7 11.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.141 0.496 . . . . 10.11 109.9 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -162.09 164.66 27.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 8.81 109.839 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.86 -51.09 70.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.314 0.857 . . . . 8.87 113.314 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.94 -23.12 72.62 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.007 -1.092 . . . . 5.87 112.181 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -80.84 -50.59 9.61 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.652 -0.274 . . . . 5.14 110.658 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 5.3 p -67.71 -46.67 71.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.945 0.402 . . . . 6.17 111.327 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -80.02 -21.27 43.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 6.87 109.906 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.27 -41.12 27.03 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.723 -0.751 . . . . 4.6 111.633 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 HD11 ' A' ' 89' ' ' ILE . 3.2 tm? -62.02 -41.82 98.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 5.05 109.856 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -66.6 -41.07 89.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 7.15 110.188 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 7.5 tp10 -57.74 -37.96 74.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.415 -0.811 . . . . 5.21 111.495 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 90' ' ' GLU . 2.9 pp -86.61 -30.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.591 . . . . 4.46 112.597 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 89' ' ' ILE . 10.1 tp10 -60.24 -39.27 86.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.94 0.4 . . . . 6.86 111.591 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.31 -38.88 68.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 6.04 110.642 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -172.19 108.41 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 5.09 110.336 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.18 -25.71 72.58 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.234 2.622 . . . . 6.48 112.685 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -121.37 79.95 1.6 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.169 0.509 . . . . 7.32 110.701 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 p -78.3 125.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 6.13 109.84 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 22.6 ttmm -122.93 78.92 1.6 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.304 -0.407 . . . . 9.68 110.212 -177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 68.89 -85.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.963 -1.017 . . . . 8.54 111.574 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 73.5 m -143.01 140.92 31.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.493 -0.321 . . . . 9.88 110.199 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.08 55.61 5.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.663 -0.779 . . . . 9.93 113.147 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 98' ' ' SER . 52.2 p90 . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 110.245 -0.279 . . . . 12.88 110.245 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.234 0.26 0 N-CA-C 110.14 -0.319 . . . . 13.85 110.14 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 9.4 t -149.2 -170.92 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.732 -0.47 . . . . 12.37 109.732 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -128.59 120.23 26.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.963 0.411 . . . . 12.02 110.48 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -113.89 -26.97 7.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 10.42 111.347 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -113.98 168.92 9.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 8.13 111.364 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -148.91 168.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.03 -0.532 . . . . 10.78 109.619 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.47 123.01 47.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 8.36 110.404 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -94.37 -9.24 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.921 0.341 . . . . 8.99 111.921 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -91.77 141.32 28.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.875 0.369 . . . . 8.32 110.894 -174.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -86.67 111.37 20.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 5.28 109.891 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.706 ' HA ' HG21 ' B' ' 130' ' ' ILE . 15.5 ptmt -172.49 -167.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 8.12 110.972 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.5 m 68.06 15.08 9.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.318 -0.855 . . . . 5.93 111.917 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' B' ' 130' ' ' ILE . . . 69.54 26.77 74.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.847 -0.692 . . . . 4.62 112.489 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.04 144.42 33.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.146 -0.316 . . . . 4.66 110.146 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.617 HD23 ' N ' ' B' ' 116' ' ' VAL . 4.0 tt -95.75 144.05 26.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.715 -0.476 . . . . 3.32 109.715 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.617 ' N ' HD23 ' B' ' 115' ' ' LEU . 1.3 m -154.32 -170.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 123.617 0.573 . . . . 3.43 110.569 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 7.1 m-85 -104.14 132.87 49.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.56 0.219 . . . . 3.93 110.595 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.86 161.73 20.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.756 0.312 . . . . 3.3 111.671 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.1 tttt -127.5 116.78 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.96 -0.564 . . . . 5.76 110.373 172.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.12 169.42 10.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.056 -0.72 . . . . 6.08 109.056 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.16 127.05 31.7 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.876 -0.73 . . . . 8.78 109.187 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.78 -14.6 64.67 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.556 -0.747 . . . . 6.27 111.615 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' B' ' 124' ' ' PRO . 50.6 m-85 -130.31 90.94 40.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 109.839 -0.43 . . . . 7.06 109.839 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 7.1 Cg_endo -47.7 -66.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.69 2.927 . . . . 5.68 113.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -147.65 112.9 5.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.702 -0.851 . . . . 4.71 108.702 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.481 ' CZ3' ' HD1' ' B' ' 123' ' ' TYR . 0.1 OUTLIER -137.62 134.76 18.53 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 116.22 -0.445 . . . . 6.03 110.81 -169.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' B' ' 126' ' ' TRP . 20.8 Cg_endo -62.91 122.03 10.15 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.462 2.108 . . . . 3.48 112.33 175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.48 153.75 50.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.839 -0.619 . . . . 2.83 110.14 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' B' ' 115' ' ' LEU . 34.7 ttm180 -104.15 145.84 29.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.001 0.429 . . . . 5.33 110.727 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.706 HG21 ' HA ' ' B' ' 111' ' ' LYS . 1.2 mm -73.03 126.39 33.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 4.34 110.683 173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -118.87 114.07 22.04 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.637 -0.875 . . . . 5.66 108.637 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 132' ' ' GLU . 0.0 OUTLIER -90.24 106.65 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.244 -0.889 . . . . 7.05 111.249 -172.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 17.0 tpt -79.59 126.92 79.74 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 9.64 109.355 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 24.4 Cg_exo -65.27 -165.93 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.137 2.558 . . . . 9.8 112.202 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.454 ' O ' HG12 ' B' ' 138' ' ' VAL . 5.6 pt-20 -102.86 -67.16 0.89 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.331 -0.395 . . . . 12.27 111.566 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' B' ' 135' ' ' GLU . . . 61.43 -67.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.029 0.532 . . . . 11.49 110.894 -172.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -133.21 -39.12 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.177 -0.465 . . . . 11.38 110.25 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 135' ' ' GLU . 12.5 p -69.03 134.52 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.298 -0.41 . . . . 9.65 110.658 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 pttm 50.77 13.86 0.15 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.264 1.026 . . . . 11.11 113.153 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.618 ' O ' ' HE2' ' B' ' 144' ' ' LYS . 25.7 t -71.26 -42.66 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 8.66 110.714 -173.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.7 p -82.33 -1.77 50.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 9.44 111.759 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.11 -65.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 8.63 111.46 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' B' ' 144' ' ' LYS . 50.3 t-20 -90.82 84.21 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.659 -0.246 . . . . 9.61 110.98 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.618 ' HE2' ' O ' ' B' ' 140' ' ' SER . 0.1 OUTLIER 172.16 166.5 0.11 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.454 -0.794 . . . . 8.97 109.999 170.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.464 ' HE2' ' HG3' ' B' ' 160' ' ' PRO . 94.9 m-85 -126.18 150.68 48.15 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.742 -0.663 . . . . 7.97 109.551 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -80.94 101.15 9.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.853 -0.795 . . . . 9.5 108.853 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' B' ' 158' ' ' LEU . 71.0 t -90.83 104.26 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 115.449 -0.796 . . . . 6.03 109.903 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -84.58 94.64 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.703 -0.681 . . . . 10.78 109.388 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 5.2 m-85 -52.9 116.4 2.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.046 -0.525 . . . . 8.4 110.227 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 3.2 t80 -81.85 -31.33 31.65 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.96 -0.564 . . . . 9.24 110.038 -172.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.487 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -65.23 -54.9 24.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 10.64 112.531 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.0 p -90.61 -8.56 49.79 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.511 -0.405 . . . . 12.27 111.497 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 42.1 m80 64.37 37.99 8.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.011 -0.54 . . . . 13.51 110.694 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -108.19 139.6 42.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 12.96 110.783 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 39.6 m -90.52 116.77 28.69 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.054 -0.35 . . . . 10.75 110.054 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.01 -177.53 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 8.03 110.491 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -135.68 128.26 30.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.128 0.49 . . . . 9.95 110.731 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' B' ' 147' ' ' VAL . 95.5 mt -136.76 169.7 17.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 6.89 109.942 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.32 170.56 25.92 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.476 -0.869 . . . . 6.24 111.818 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.464 ' HG3' ' HE2' ' B' ' 145' ' ' TYR . 31.7 Cg_exo -59.13 -36.4 95.97 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.763 2.309 . . . . 8.35 111.99 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -70.33 -12.42 61.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.595 . . . . 12.73 111.061 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.44 8.97 29.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 9.49 110.167 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' ALA . 13.5 tp -128.26 117.6 21.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.19 -0.459 . . . . 7.88 110.381 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 79.6 m-85 -105.75 133.34 20.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.932 -0.576 . . . . 10.48 110.809 -175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.594 ' HB2' ' HB2' ' B' ' 168' ' ' GLU . 39.9 Cg_exo -57.26 137.95 84.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.101 2.534 . . . . 10.82 112.624 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.661 ' HB2' ' HA ' ' A' ' 16' ' ' VAL . 2.6 t80 -79.14 -59.4 2.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.756 -0.831 . . . . 10.52 108.756 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.03 -26.32 36.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.25 -0.432 . . . . 13.98 112.102 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' B' ' 165' ' ' PRO . 46.4 mt-10 -93.64 -38.9 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.1 0.407 . . . . 15.72 112.1 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.537 ' HB3' ' CE2' ' B' ' 173' ' ' PHE . 45.9 m -117.72 4.36 12.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.715 1.006 . . . . 11.91 113.715 -170.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -52.31 -21.28 3.36 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.906 0.706 . . . . 12.55 112.906 173.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.0 -39.06 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.075 -0.391 . . . . 15.86 111.387 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -76.39 -32.47 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.148 0.499 . . . . 16.47 110.729 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' B' ' 169' ' ' SER . 54.4 m-85 -102.53 13.45 34.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 11.15 110.401 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.68 82.03 0.73 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.724 -0.671 . . . . 11.12 111.565 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -148.38 98.0 3.75 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.534 -0.913 . . . . 14.56 108.534 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' B' ' 182' ' ' PHE . 2.0 Cg_endo -77.32 108.11 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.794 2.33 . . . . 11.81 112.536 -171.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.13 137.33 37.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.276 -0.875 . . . . 13.38 109.58 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -75.89 76.66 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.168 0.509 . . . . 16.74 111.233 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -140.14 141.46 36.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.186 -0.915 . . . . 16.14 108.883 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -58.47 -47.22 84.76 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.47 0.482 . . . . 15.89 112.187 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.08 -36.64 90.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.876 -0.678 . . . . 11.57 112.243 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' B' ' 176' ' ' PRO . 37.0 t80 -65.93 -47.07 75.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.816 0.341 . . . . 9.65 110.355 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -68.04 -34.79 77.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.06 -0.518 . . . . 10.46 110.337 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -65.6 -53.22 44.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 12.15 110.054 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.84 83.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.002 -0.618 . . . . 8.24 112.128 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.92 -41.74 95.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.516 -0.55 . . . . 7.89 109.516 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -68.6 -42.71 77.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.393 -0.367 . . . . 11.87 110.909 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.736 ' HA ' HD21 ' B' ' 191' ' ' ASN . 41.3 mt-10 -59.81 -26.92 66.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 11.62 110.667 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -81.71 -33.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.866 -0.606 . . . . 9.26 110.513 173.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.94 -44.37 97.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 11.04 110.103 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.736 HD21 ' HA ' ' B' ' 188' ' ' GLU . 0.1 OUTLIER -93.19 -99.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.332 -0.547 . . . . 12.59 110.666 172.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.523 ' H ' ' ND2' ' B' ' 191' ' ' ASN . 3.7 p-10 -173.49 148.13 1.48 Allowed Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 13.52 109.5 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.98 115.85 3.35 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.581 2.187 . . . . 14.9 111.662 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 88.8 m 67.94 95.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.581 . . . . 17.54 110.658 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' B' ' 192' ' ' ASN . 34.7 m -92.68 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 18.06 110.786 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -101.0 71.23 1.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.111 0.481 . . . . 21.28 110.412 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -94.5 -49.51 5.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.861 -0.609 . . . . 21.53 110.001 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 44.9 m -102.33 126.51 49.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.72 -0.673 . . . . 23.03 110.237 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . -95.38 94.87 1.78 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.824 -0.703 . . . . 24.72 111.846 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.719 -0.658 . . . . 27.31 109.803 -179.701 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.189 -0.3 . . . . 29.42 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -60.6 134.33 56.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.292 0.567 . . . . 26.59 112.188 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -133.19 -29.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.807 -0.633 . . . . 25.53 110.851 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.4 p 56.86 -166.6 0.13 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.081 0.952 . . . . 23.29 111.114 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -76.67 131.98 39.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.467 -0.333 . . . . 21.2 110.555 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -78.86 102.66 8.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.189 -0.459 . . . . 20.05 110.69 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.518 ' HB2' ' OD2' ' A' ' 14' ' ' ASP . 3.6 pt20 -81.35 141.97 33.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.975 -0.557 . . . . 16.73 110.341 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' HG3' ' HG2' ' A' ' 9' ' ' GLU . 16.4 ptpt -158.61 0.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.253 -0.43 . . . . 16.22 111.231 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 7.9 pt-20 -166.04 18.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.115 0.483 . . . . 13.24 110.532 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.624 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.9 m-85 -122.24 175.76 6.21 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.042 -0.526 . . . . 10.33 110.531 -173.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 50.0 pttt -61.65 -149.24 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.375 0.88 . . . . 14.9 113.375 -171.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t 74.92 -61.43 0.49 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.686 -0.688 . . . . 11.71 110.867 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' ILE . . . 175.03 25.18 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.62 -0.8 . . . . 9.66 112.446 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 28.8 m-20 -62.2 123.61 18.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.231 -0.587 . . . . 10.47 111.982 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 16' ' ' VAL . 2.7 tt -96.45 124.89 40.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.765 -0.828 . . . . 7.46 108.765 173.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' B' ' 165' ' ' PRO . 0.3 OUTLIER -160.95 -170.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.457 0.473 . . . . 6.87 110.346 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' B' ' 166' ' ' TYR . 99.0 m-85 -94.12 112.8 24.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 6.78 110.467 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.64 159.97 16.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 6.21 111.076 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 18.0 ttpt -126.27 105.2 8.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.533 . . . . 12.44 110.002 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.614 ' HB2' ' HZ ' ' B' ' 149' ' ' PHE . 1.7 tmm? -114.95 170.35 8.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.69 -0.485 . . . . 10.95 109.69 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.98 117.62 7.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.688 -0.486 . . . . 15.91 109.688 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.47 -6.88 82.67 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.964 -0.636 . . . . 14.09 112.055 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -127.06 84.69 62.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 13.65 110.223 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.19 101.1 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.614 2.209 . . . . 12.38 112.578 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 69.47 82.63 0.16 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.67 -0.695 . . . . 11.05 109.539 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 1.6 t-105 -130.34 128.71 22.72 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.483 -0.78 . . . . 10.23 109.701 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 43.1 Cg_exo -56.98 114.47 1.94 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.891 2.394 . . . . 5.52 112.526 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -139.18 150.74 45.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.066 -0.516 . . . . 3.98 111.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 12.1 ttm180 -103.32 121.91 43.73 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.56 -0.533 . . . . 11.28 109.56 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.141 HD11 ' HB3' ' B' ' 145' ' ' TYR . 0.5 OUTLIER -73.43 145.91 11.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.328 -0.851 . . . . 7.51 109.897 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' H ' HD13 ' A' ' 30' ' ' ILE . 1.9 t70 -145.39 -178.03 5.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.627 -0.509 . . . . 10.28 109.627 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.86 156.88 27.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.334 0.588 . . . . 10.44 111.713 -173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.639 ' HG3' ' HB ' ' A' ' 38' ' ' VAL . 83.9 mmm -86.76 135.94 35.13 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.32 -0.993 . . . . 12.85 108.32 168.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 13.0 Cg_exo -71.24 37.86 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.067 2.511 . . . . 13.07 112.865 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 59.86 95.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.84 0.856 . . . . 14.04 111.911 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.74 -77.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.158 -0.928 . . . . 15.24 109.405 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.42 -6.99 9.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.345 0.593 . . . . 14.64 109.505 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 33' ' ' MET . 39.1 t -121.28 129.25 75.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.336 -0.847 . . . . 12.42 110.473 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 143' ' ' ASN . 0.0 OUTLIER -139.13 -175.22 4.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.683 -0.858 . . . . 10.84 108.683 172.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 p -84.99 -168.29 2.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.673 -0.491 . . . . 9.63 109.673 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -82.5 127.22 33.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 9.56 111.0 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' B' ' 140' ' ' SER . . . -136.25 21.77 3.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.457 -0.792 . . . . 8.3 109.657 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -127.58 28.18 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.43 -0.804 . . . . 8.55 109.117 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -124.64 151.95 44.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 7.5 110.681 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -104.48 147.58 27.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.747 -0.66 . . . . 6.01 109.264 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' B' ' 131' ' ' ASP . 53.2 tt0 -80.69 99.19 8.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.388 -0.968 . . . . 6.99 108.388 174.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' B' ' 128' ' ' ALA . 81.4 t -101.74 120.04 50.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.416 -0.811 . . . . 4.6 111.102 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.89 ' HB2' ' HB2' ' B' ' 129' ' ' ARG . 50.8 m-85 -82.72 114.54 21.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.157 -0.683 . . . . 5.62 109.157 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 95.85 2.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.252 -0.647 . . . . 4.03 109.252 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE2' ' HG3' ' A' ' 88' ' ' GLU . 7.6 t80 -70.59 -16.32 62.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 4.15 110.77 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA3' ' CD1' ' B' ' 126' ' ' TRP . . . -79.23 -66.16 1.72 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.975 -0.631 . . . . 5.0 112.876 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -81.38 -1.78 46.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.017 0.408 . . . . 5.56 111.685 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 67.88 32.68 5.08 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.33 0.586 . . . . 6.72 110.553 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.13 -179.34 3.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.711 -0.677 . . . . 6.33 111.103 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.8 m -133.69 117.22 16.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 5.99 109.84 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.45 -178.8 5.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 5.39 110.935 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -123.76 114.78 20.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.544 -0.539 . . . . 7.73 109.544 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 7.0 mp -120.01 150.48 40.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.584 -0.28 . . . . 5.32 110.712 -177.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.01 35.93 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.808 -0.917 . . . . 5.57 110.808 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HA ' ' HE2' ' B' ' 110' ' ' TYR . 53.1 Cg_exo -55.1 -39.84 88.87 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.311 2.007 . . . . 6.06 111.943 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -73.69 -5.72 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.189 0.44 . . . . 7.7 112.189 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 15.0 m-20 -109.16 -12.28 14.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.161 0.505 . . . . 5.82 110.158 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD21 HG21 ' B' ' 116' ' ' VAL . 20.1 tp -117.22 146.46 43.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 4.21 110.012 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.94 154.25 81.67 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.676 -0.238 . . . . 4.63 110.544 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.12 153.63 77.36 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.972 2.448 . . . . 4.58 113.086 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.667 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 50.9 t80 -100.13 -68.96 0.79 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.605 -0.725 . . . . 4.79 110.434 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -52.35 -39.3 60.55 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.111 0.782 . . . . 6.1 113.111 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -92.63 -56.48 3.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.84 0.352 . . . . 6.71 111.539 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -86.28 4.79 37.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 5.49 113.043 -171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 26.7 ttpp -50.25 -19.24 0.75 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.293 0.479 . . . . 6.26 112.293 173.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.95 -45.07 94.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 7.73 111.344 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -71.48 -32.16 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.203 0.525 . . . . 8.1 111.16 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -100.68 5.04 43.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.923 -0.58 . . . . 5.97 110.224 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 71.5 2.69 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.362 -0.836 . . . . 6.74 112.525 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -148.41 95.18 4.08 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.761 -0.829 . . . . 8.38 108.761 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 86' ' ' LEU . 36.9 Cg_endo -71.27 104.02 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.479 2.12 . . . . 7.75 111.577 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -69.88 148.82 48.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.461 -0.79 . . . . 7.82 110.349 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 40.9 pttt -73.21 6.18 2.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.998 -0.546 . . . . 10.11 112.01 -176.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -75.83 125.68 29.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.298 -1.001 . . . . 8.81 108.298 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 58.2 mtmt -59.27 -43.94 92.47 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.372 0.508 . . . . 8.87 112.372 -169.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.34 -33.92 86.31 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.745 -0.741 . . . . 5.87 112.261 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' NE1' ' B' ' 126' ' ' TRP . 4.4 t80 -71.44 -49.49 41.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.685 -0.487 . . . . 5.14 109.685 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 t -62.2 -41.23 98.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.768 -0.651 . . . . 6.17 110.666 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 60.7 mm-40 -58.33 -52.83 63.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.537 -0.301 . . . . 6.87 111.271 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.541 ' HA3' ' HA2' ' A' ' 51' ' ' GLY . . . -62.41 -44.05 98.18 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.424 -0.893 . . . . 4.6 112.188 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 76' ' ' PRO . 2.7 tm? -69.75 -39.09 76.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.567 -0.317 . . . . 5.05 110.6 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -65.84 -49.08 69.47 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 110.027 -0.36 . . . . 7.15 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 9.3 tp10 -56.63 -32.14 65.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.863 0.727 . . . . 5.21 111.254 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 HD21 ' B' ' 115' ' ' LEU . 7.5 tp -88.19 -35.63 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.472 -0.491 . . . . 4.46 112.013 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -71.64 -39.37 70.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 6.86 110.703 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.36 -2.13 48.07 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.457 -0.338 . . . . 6.04 111.704 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -156.37 93.8 2.42 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 5.09 111.481 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.52 -30.62 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.792 2.328 . . . . 6.48 111.282 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.2 p -86.61 75.5 9.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.807 -0.633 . . . . 7.32 111.137 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.87 2.32 5.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.035 -0.53 . . . . 6.13 111.607 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.43 70.44 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.557 0.694 . . . . 9.68 110.685 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.82 -31.68 0.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.816 -1.084 . . . . 8.54 109.196 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 t -71.85 99.97 2.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.329 -0.85 . . . . 9.88 109.427 173.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.27 -159.51 28.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.647 -0.787 . . . . 9.93 111.794 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 109.847 -0.427 . . . . 12.88 109.847 -176.623 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' B' ' 102' ' ' SER . 55.5 ttp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.527 -0.546 . . . . 13.85 109.527 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 101' ' ' MET . 45.8 t 71.24 104.4 0.06 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.88 0.737 . . . . 12.37 110.729 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -64.88 107.35 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.699 . . . . 12.02 110.432 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -80.97 -9.58 59.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.186 0.517 . . . . 10.42 110.912 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -95.96 166.96 11.53 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.699 -0.682 . . . . 8.13 110.193 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -111.4 128.86 56.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.441 -0.345 . . . . 10.78 110.08 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.55 124.58 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.48 . . . . 8.36 110.359 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -114.2 -38.32 4.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 8.99 109.731 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' B' ' 109' ' ' GLU . 0.0 OUTLIER -86.25 165.03 16.8 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.08 -0.963 . . . . 8.32 110.732 -177.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 60' ' ' PRO . 76.5 m-85 -82.76 164.56 20.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 5.28 110.313 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -62.54 116.3 5.01 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 122.01 0.91 . . . . 8.12 113.074 -162.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.21 108.24 0.66 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.26 -1.336 . . . . 5.93 107.912 167.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 114' ' ' ASP . . . 154.69 -11.5 0.45 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 109.749 -1.341 . . . . 4.62 109.749 -168.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . 1.1 m-20 84.23 21.1 0.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.525 0.779 . . . . 4.66 112.285 166.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -136.62 130.57 32.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.687 -0.805 . . . . 3.32 113.057 -176.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.884 HG21 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -162.71 -171.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 114.599 -1.182 . . . . 3.43 109.357 174.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.5 m-85 -116.92 134.64 54.51 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 122.19 -0.319 . . . . 3.93 110.561 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.78 32.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.887 0.375 . . . . 3.3 111.909 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' B' ' 124' ' ' PRO . 59.3 tttm -140.75 119.82 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.892 -0.595 . . . . 5.76 110.006 173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.544 ' HB2' ' HD2' ' B' ' 123' ' ' TYR . 87.3 mtp -123.18 -170.1 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 6.08 111.335 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -69.04 119.3 13.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.251 -0.431 . . . . 8.78 109.908 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.26 -7.65 60.08 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.775 -0.648 . . . . 6.27 112.229 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' B' ' 120' ' ' MET . 20.5 m-30 -108.83 101.44 44.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.909 -0.404 . . . . 7.06 109.909 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' B' ' 119' ' ' LYS . 19.1 Cg_endo -60.11 -69.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.308 2.672 . . . . 5.68 112.967 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -152.1 111.69 3.96 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.753 0.311 . . . . 4.71 110.207 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.705 ' CD1' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -132.4 139.37 34.6 Favored Pre-proline 0 N--CA 1.441 -0.925 0 CA-C-O 120.938 0.399 . . . . 6.03 111.258 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.53 129.31 31.92 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.983 2.455 . . . . 3.48 111.133 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -117.57 151.96 36.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.061 0.458 . . . . 2.83 112.045 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.9 mtp180 -106.69 148.84 27.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.646 -0.706 . . . . 5.33 111.032 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' B' ' 114' ' ' ASP . 0.1 OUTLIER -98.5 136.06 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.688 -0.687 . . . . 4.34 111.293 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' GLN . 37.2 t70 -147.29 120.76 9.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.324 -0.621 . . . . 5.66 109.324 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 69.91 124.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.826 0.822 . . . . 7.05 111.5 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . . . . . . . . . 13.3 ptm -133.22 99.09 14.96 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 9.64 111.278 -171.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.41 102.87 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.488 2.792 . . . . 9.8 112.207 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.773 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 20.1 tp10 -140.21 -25.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 12.27 110.603 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.36 123.41 47.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.336 -0.393 . . . . 11.49 110.85 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . 69.84 -45.91 0.58 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.993 0.808 . . . . 11.38 112.578 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.498 ' CG1' ' HB1' ' A' ' 42' ' ' ALA . 96.9 t -90.8 129.2 41.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.79 0.329 . . . . 9.65 111.255 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' B' ' 135' ' ' GLU . 28.0 mmtp -163.09 120.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.573 -0.899 . . . . 11.11 108.573 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . 0.555 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 23.1 t -140.97 104.8 4.74 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.093 -0.643 . . . . 8.66 110.611 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -91.51 -29.73 16.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.088 -0.505 . . . . 9.44 110.528 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.65 82.86 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 8.63 110.513 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 5.1 p30 -103.68 96.69 6.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.736 0.779 . . . . 9.61 110.77 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -129.57 145.86 51.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.347 -0.842 . . . . 8.97 109.809 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 1.141 ' HB3' HD11 ' A' ' 30' ' ' ILE . 12.5 m-30 -102.48 136.52 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.371 -0.377 . . . . 7.97 110.497 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.04 94.83 9.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.671 -0.492 . . . . 9.5 109.671 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.08 104.0 12.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.185 0.517 . . . . 6.03 109.947 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -91.06 107.51 19.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.021 -0.733 . . . . 10.78 109.021 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' B' ' 154' ' ' GLU . 42.2 m-85 -63.59 100.57 0.28 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.008 -0.542 . . . . 8.4 110.283 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.484 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 37.6 t80 -61.11 -32.46 72.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.503 -1.226 . . . . 9.24 111.001 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 181' ' ' GLY . . . -87.86 -50.66 3.44 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.505 -0.855 . . . . 10.64 113.001 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.47 -5.73 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.323 0.49 . . . . 12.27 112.323 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 63.91 31.73 13.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.266 0.555 . . . . 13.51 109.762 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' B' ' 149' ' ' PHE . 5.9 mm-40 -104.67 158.43 16.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.661 . . . . 12.96 110.998 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.7 m -127.27 109.52 11.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.837 -0.431 . . . . 10.75 109.837 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.06 165.56 20.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.884 0.373 . . . . 8.03 111.616 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.98 120.08 37.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.068 -0.514 . . . . 9.95 109.949 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 20' ' ' MET . 96.2 mt -132.77 174.88 9.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 6.89 110.741 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.57 170.54 19.36 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.906 -0.664 . . . . 6.24 111.667 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.06 -36.34 96.54 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.481 2.121 . . . . 8.35 112.22 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 33.1 tptt -82.31 0.79 40.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.087 0.47 . . . . 12.73 110.908 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.34 7.53 42.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.397 0.618 . . . . 9.49 109.354 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.497 HD11 HG23 ' A' ' 16' ' ' VAL . 14.9 tp -117.47 138.64 51.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.224 -0.898 . . . . 7.88 109.778 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.513 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 89.2 m-85 -123.88 122.89 26.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 10.48 111.296 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.555 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 4.7 Cg_exo -77.49 132.83 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.306 2.671 . . . . 10.82 112.949 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.541 ' HB3' ' HE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -70.49 -24.21 62.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.299 -0.409 . . . . 10.52 111.169 178.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.563 ' HA ' ' OE1' ' B' ' 167' ' ' GLU . 4.0 mm-40 -52.41 -37.57 56.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.243 0.46 . . . . 13.98 112.243 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -109.33 -17.32 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.141 0.423 . . . . 15.72 112.141 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 49.0 m -117.85 5.51 12.21 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.735 1.013 . . . . 11.91 113.735 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' B' ' 166' ' ' TYR . 9.9 ptpp? -56.78 -20.35 21.91 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.908 0.336 . . . . 12.55 111.908 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.02 -58.39 8.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.097 0.475 . . . . 15.86 111.273 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -90.87 -36.2 14.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 16.47 110.944 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' B' ' 173' ' ' PHE . 6.4 m-30 -83.61 -24.19 31.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.32 -0.4 . . . . 11.15 110.755 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.57 61.2 4.79 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.321 -0.711 . . . . 11.12 111.321 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' B' ' 175' ' ' LYS . 2.8 tppt? -137.88 95.46 10.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.076 -0.713 . . . . 14.56 109.076 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.29 72.0 6.75 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.251 1.967 . . . . 11.81 112.813 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 178' ' ' LYS . 3.0 t-20 -126.66 100.85 6.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 13.38 110.163 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' B' ' 182' ' ' PHE . 41.5 ttmt 164.46 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.428 1.091 . . . . 16.74 108.328 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' B' ' 182' ' ' PHE . 4.3 ttt180 69.02 -150.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.439 -1.255 . . . . 16.14 111.442 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.93 -149.1 0.46 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.499 -0.556 . . . . 15.89 109.499 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 151' ' ' GLY . . . -71.87 2.23 26.45 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.438 -0.887 . . . . 11.57 112.652 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' B' ' 178' ' ' LYS . 82.1 t80 -81.68 -57.2 3.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.401 0.6 . . . . 9.65 109.885 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' B' ' 179' ' ' ARG . 67.0 m -71.06 -38.56 72.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.04 -0.356 . . . . 10.46 110.04 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' B' ' 188' ' ' GLU . 35.0 tt0 -63.0 -50.64 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 12.15 110.44 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.623 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -64.59 -45.35 93.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.647 -0.787 . . . . 8.24 111.946 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.21 -36.74 82.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 7.89 110.467 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -69.52 -38.52 77.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.837 -0.345 . . . . 11.87 110.422 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' B' ' 184' ' ' GLU . 7.2 mm-40 -68.37 -30.34 69.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 11.62 111.623 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -82.67 -47.97 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.812 0.339 . . . . 9.26 110.328 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . 0.496 ' N ' HD13 ' B' ' 189' ' ' ILE . 27.4 tt0 -66.29 -29.67 69.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 11.04 110.172 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -130.96 74.5 1.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.266 -0.879 . . . . 12.59 108.885 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.77 HD22 HG22 ' B' ' 195' ' ' VAL . 9.8 t30 -56.99 120.28 37.26 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.397 -0.819 . . . . 13.52 111.65 -173.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.67 167.07 23.01 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.959 2.44 . . . . 14.9 112.528 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 25.5 m 71.44 -73.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 17.54 111.192 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.77 HG22 HD22 ' B' ' 192' ' ' ASN . 22.7 t 53.8 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.087 0.555 . . . . 18.06 111.277 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -85.37 99.13 10.96 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.041 -0.355 . . . . 21.28 110.041 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -97.32 -67.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 21.53 109.347 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 48.5 m -108.27 152.39 24.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.957 -0.565 . . . . 23.03 109.926 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 155.89 -62.17 0.34 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.454 -0.658 . . . . 24.72 111.454 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 52.9 t80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.111 -0.947 . . . . 27.31 109.712 176.546 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.883 -0.414 . . . . 29.42 109.883 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -145.88 132.99 20.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 26.59 110.53 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.24 109.96 22.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 25.53 109.471 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 m -66.28 -29.53 69.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.015 0.436 . . . . 23.29 110.801 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.91 158.28 20.62 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.504 -0.554 . . . . 21.2 109.504 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 5.1 mmp_? -104.44 116.43 32.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.96 0.41 . . . . 20.05 111.463 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -75.89 146.68 39.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.336 -0.616 . . . . 16.73 109.336 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -110.5 175.47 5.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.482 0.182 . . . . 16.22 110.555 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.19 157.81 35.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 13.24 110.486 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.77 122.7 48.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 10.33 110.118 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.7 ' O ' HG21 ' A' ' 30' ' ' ILE . 39.8 ttmt -61.84 137.02 58.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.671 -0.492 . . . . 14.9 109.671 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.0 m -64.31 3.21 0.48 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.755 1.021 . . . . 11.71 113.755 -172.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.09 31.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.427 -0.892 . . . . 9.66 112.503 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.591 ' HB2' ' HB3' ' A' ' 11' ' ' LYS . 1.1 t70 -98.0 -174.33 2.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.721 0.296 . . . . 10.47 111.379 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 16' ' ' VAL . 4.1 tt -140.64 136.51 32.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.541 -0.54 . . . . 7.46 109.541 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' B' ' 163' ' ' LEU . 16.5 m -146.14 -176.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.756 -0.202 . . . . 6.87 110.482 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -88.51 130.77 35.15 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.923 -0.399 . . . . 6.78 109.923 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.55 134.86 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 6.21 111.034 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -105.61 101.92 11.41 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 12.44 109.77 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . 12.9 tpt -100.31 157.28 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.357 -0.609 . . . . 10.95 109.357 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -66.03 114.5 5.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.219 -1.03 . . . . 15.91 108.219 176.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.12 -13.01 57.42 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.746 -0.661 . . . . 14.09 112.25 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 64.8 m-85 -127.43 114.8 21.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 110.28 -0.267 . . . . 13.65 110.28 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 9.9 Cg_endo -52.29 -80.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.592 2.862 . . . . 12.38 113.659 -173.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -144.24 88.42 1.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.436 -0.579 . . . . 11.05 109.436 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.97 134.28 20.43 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.787 -0.642 . . . . 10.23 110.515 -172.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.9 126.43 20.36 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.487 2.125 . . . . 5.52 111.623 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' H ' ' B' ' 150' ' ' PHE . . . -143.35 148.96 37.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.342 -0.39 . . . . 3.98 111.282 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HG2' ' HG ' ' A' ' 15' ' ' LEU . 25.2 mtm180 -92.74 162.41 14.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.069 -0.514 . . . . 11.28 110.37 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.7 HG21 ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -100.52 151.23 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.491 -0.777 . . . . 7.51 109.977 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' B' ' 146' ' ' GLN . 33.0 t70 -145.44 121.95 11.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.462 -0.57 . . . . 10.28 109.462 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -114.65 128.9 56.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 10.44 110.697 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.473 ' CE ' ' HB2' ' B' ' 146' ' ' GLN . 2.1 mpt? -82.22 153.57 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 12.85 109.874 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' MET . 3.0 Cg_exo -76.51 175.76 10.94 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.683 2.255 . . . . 13.07 110.879 172.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.92 83.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.249 0.547 . . . . 14.04 110.594 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.65 -48.02 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.864 . . . . 15.24 109.35 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.75 -28.69 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.715 -0.675 . . . . 14.64 110.14 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG22 ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -121.99 145.77 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 12.42 109.677 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' HG2' HG22 ' A' ' 38' ' ' VAL . 29.6 mmmt 54.65 25.47 6.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.174 0.511 . . . . 10.84 110.79 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -60.76 -38.76 86.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.21 -0.905 . . . . 9.63 111.784 -171.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -152.02 155.2 37.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.907 -0.405 . . . . 9.56 109.907 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.66 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.685 -0.234 . . . . 8.3 111.203 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -91.37 71.93 6.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 8.55 110.484 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -142.28 143.74 32.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.477 -0.935 . . . . 7.5 108.477 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -113.65 172.08 7.19 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.533 -0.543 . . . . 6.01 109.533 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -95.54 111.29 23.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 6.99 110.065 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 58' ' ' LEU . 75.0 t -100.71 123.69 53.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.249 0.547 . . . . 4.6 110.548 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -94.62 117.64 30.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.381 -0.827 . . . . 5.62 110.521 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -86.93 125.76 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.147 -0.933 . . . . 4.03 110.652 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -77.13 -168.43 1.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.701 -0.851 . . . . 4.15 108.701 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' HH2' ' B' ' 126' ' ' TRP . . . 63.33 -87.68 0.06 OUTLIER Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.721 -0.752 . . . . 5.0 112.516 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.0 p -68.84 -17.0 63.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.797 0.332 . . . . 5.56 110.532 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 13.6 t-80 58.72 54.33 5.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.853 0.835 . . . . 6.72 110.443 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.66 176.71 5.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.947 -1.024 . . . . 6.33 111.164 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 m -147.3 115.27 6.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.179 -0.464 . . . . 5.99 110.005 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.02 -178.54 5.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 5.39 110.487 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -111.83 117.68 33.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 7.73 110.546 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.668 ' HB2' HG21 ' A' ' 47' ' ' VAL . 6.7 mp -128.98 166.34 19.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.156 -0.475 . . . . 5.32 109.883 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.27 176.0 19.57 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.779 -0.724 . . . . 5.57 111.762 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.81 -38.44 94.45 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.779 2.32 . . . . 6.06 112.228 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -57.07 -36.08 70.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 7.7 111.254 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.5 21.03 14.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.911 -0.586 . . . . 5.82 111.336 -175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD21 HG21 ' B' ' 116' ' ' VAL . 20.6 tp -129.82 117.26 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 4.21 109.536 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 66.3 m-85 -107.61 123.33 38.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.723 0.297 . . . . 4.63 111.529 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 1.032 ' HA ' HG12 ' B' ' 116' ' ' VAL . 31.1 Cg_exo -59.45 119.92 7.44 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.214 2.609 . . . . 4.58 112.573 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.752 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -68.54 -13.94 62.67 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 120.848 0.356 . . . . 4.79 110.918 -177.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 26.3 tt0 -62.2 -23.79 66.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.678 -0.692 . . . . 6.1 110.184 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -127.3 -28.88 2.78 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.073 0.397 . . . . 6.71 112.073 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.781 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 81.8 p -64.82 -29.22 70.18 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.738 -0.385 . . . . 5.49 110.432 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 67' ' ' GLU . 65.3 pttt -53.29 -34.71 58.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.006 -0.543 . . . . 6.26 111.052 172.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.68 -29.21 30.08 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.822 0.344 . . . . 7.73 110.955 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -80.81 -51.9 8.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.323 -0.399 . . . . 8.1 111.638 -168.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.781 ' CE1' ' HB2' ' A' ' 69' ' ' SER . 41.8 p90 -124.63 -21.27 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.0 -0.28 . . . . 5.97 110.903 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.27 -123.49 14.44 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.818 -0.706 . . . . 6.74 113.149 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.866 ' HD2' HD11 ' A' ' 86' ' ' LEU . 18.4 pttp -150.43 96.21 3.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.132 0.491 . . . . 8.38 110.526 -173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 2.1 Cg_endo -81.32 -22.53 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.587 2.191 . . . . 7.75 113.064 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.579 ' HA ' ' HD2' ' A' ' 82' ' ' PHE . 2.3 m-20 55.07 28.83 11.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.142 -0.481 . . . . 7.82 112.157 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mtpp -68.67 -25.6 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 10.11 110.692 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -110.99 127.33 55.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.929 -0.767 . . . . 8.81 108.929 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -61.17 -31.6 71.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.947 0.351 . . . . 8.87 111.947 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.3 98.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 5.87 111.252 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD2' ' HA ' ' A' ' 77' ' ' ASN . 72.0 t80 -66.42 -34.8 78.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 5.14 110.315 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.3 t -64.83 -42.37 94.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.074 -0.512 . . . . 6.17 109.997 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.56 -40.1 76.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 6.87 110.002 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.585 ' HA3' ' CH2' ' B' ' 126' ' ' TRP . . . -64.64 -33.47 87.33 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.628 -0.796 . . . . 4.6 111.98 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.866 HD11 ' HD2' ' A' ' 75' ' ' LYS . 1.3 tt -61.7 -43.43 98.87 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.132 -0.692 . . . . 5.05 109.132 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -60.75 -46.73 89.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.392 -0.367 . . . . 7.15 110.705 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.01 -34.25 65.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.746 0.654 . . . . 5.21 110.74 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -88.49 -23.67 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.672 0.619 . . . . 4.46 112.672 177.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.43 -40.64 97.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.998 0.428 . . . . 6.86 110.937 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -76.51 -24.25 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.507 -0.553 . . . . 6.04 109.507 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 t30 58.64 89.65 0.1 Allowed Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 114.797 -1.092 . . . . 5.09 111.467 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.79 -49.05 3.32 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.783 2.322 . . . . 6.48 112.578 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 m -96.88 102.58 14.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 7.32 111.246 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.2 m -98.09 129.37 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.173 -0.467 . . . . 6.13 110.732 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -146.98 71.11 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.283 0.563 . . . . 9.68 110.812 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.59 -55.96 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.54 110.208 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -101.45 -52.96 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 9.88 110.119 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.86 -81.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.821 -0.627 . . . . 9.93 112.393 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.746 0.308 . . . . 12.88 110.308 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.934 0.397 . . . . 13.85 111.128 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 45.6 m -157.25 156.88 33.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.29 -0.868 . . . . 12.37 109.193 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -95.81 147.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.753 -0.379 . . . . 12.02 110.159 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -141.15 161.48 37.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.274 -0.421 . . . . 10.42 110.283 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -69.94 138.29 52.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.86 -0.609 . . . . 8.13 110.459 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 106' ' ' ARG . 18.5 mtm180 -79.26 -39.2 33.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.106 0.479 . . . . 10.78 110.141 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 128.28 47.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 8.36 110.392 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -107.24 93.64 4.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.092 0.473 . . . . 8.99 110.736 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -89.58 -30.08 18.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 8.32 110.304 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -99.82 111.63 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 5.28 110.215 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -115.26 143.79 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.352 -0.61 . . . . 8.12 109.352 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -43.13 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.637 0.586 . . . . 5.93 111.078 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.9 -22.52 5.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.064 -0.589 . . . . 4.62 112.548 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.26 160.75 32.25 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.022 0.439 . . . . 4.66 111.391 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 ' HA ' ' B' ' 129' ' ' ARG . 25.9 mt -125.76 143.51 51.02 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.783 -0.644 . . . . 3.32 111.678 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 1.032 HG12 ' HA ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -159.47 -179.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.584 -0.735 . . . . 3.43 111.86 -169.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -104.71 110.01 22.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 3.93 109.581 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -87.9 161.13 17.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.307 -0.406 . . . . 3.3 110.801 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 37.6 ttpt -128.08 93.83 3.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.779 -0.452 . . . . 5.76 109.779 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 12.9 tpt -101.08 158.0 16.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.807 -0.633 . . . . 6.08 109.364 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' B' ' 121' ' ' LYS . 13.3 tmtt? -60.61 115.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.72 -0.845 . . . . 8.78 108.72 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.22 -19.96 36.35 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.458 -0.792 . . . . 6.27 112.048 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.09 86.85 14.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.04 0.448 . . . . 7.06 110.727 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' B' ' 119' ' ' LYS . 2.5 Cg_endo -82.03 113.38 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.171 2.581 . . . . 5.68 112.0 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 40.9 m80 74.29 76.34 0.12 Allowed 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 123.802 0.688 . . . . 4.71 109.804 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.585 ' CH2' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -130.81 124.86 21.05 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.986 -1.006 . . . . 6.03 109.628 -175.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' CE1' ' A' ' 82' ' ' PHE . 27.4 Cg_exo -61.7 112.28 1.43 Allowed 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.037 2.492 . . . . 3.48 112.57 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.61 163.55 29.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.82 0.343 . . . . 2.83 111.752 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.771 ' HA ' HD23 ' B' ' 115' ' ' LEU . 70.7 ttp85 -101.95 139.92 36.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.8 -0.636 . . . . 5.33 110.908 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 136.5 23.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.006 -0.543 . . . . 4.34 110.696 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -140.14 148.87 42.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.624 -0.88 . . . . 5.66 108.624 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.38 110.83 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.197 0.522 . . . . 7.05 112.228 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 134' ' ' PRO . 74.1 mtm -124.4 104.64 31.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.725 -0.843 . . . . 9.64 108.725 170.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 133' ' ' MET . 10.5 Cg_exo -71.87 -18.99 27.66 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.153 2.569 . . . . 9.8 113.53 -173.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 136' ' ' ALA . 46.2 mt-10 -140.37 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.536 0.208 . . . . 12.27 110.96 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' B' ' 135' ' ' GLU . . . 73.07 -71.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.049 0.843 . . . . 11.49 111.85 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.26 -20.94 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.071 0.462 . . . . 11.38 110.909 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' B' ' 139' ' ' LYS . 7.3 p -121.95 162.77 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.634 . . . . 9.65 109.807 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' B' ' 138' ' ' VAL . 7.6 mmmm 51.77 -94.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.701 0.625 . . . . 11.11 111.91 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 33.4 m 60.57 -90.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.045 -0.98 . . . . 8.66 111.783 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -125.91 103.07 7.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.928 0.395 . . . . 9.44 110.306 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.04 7.53 46.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.002 -0.545 . . . . 8.63 110.972 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -87.63 97.6 10.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.085 -0.507 . . . . 9.61 109.83 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -163.04 125.93 2.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.171 0.51 . . . . 8.97 111.581 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.34 147.72 45.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.561 -0.745 . . . . 7.97 109.353 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.662 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 6.1 tp60 -83.82 119.06 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.171 -0.677 . . . . 9.5 109.171 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' B' ' 158' ' ' LEU . 73.8 t -113.86 113.9 45.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 6.03 111.012 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.5 101.03 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.59 -0.732 . . . . 10.78 110.027 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 153' ' ' HIS . 3.3 m-85 -52.5 119.0 3.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.557 . . . . 8.4 110.547 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.442 ' H ' ' HA ' ' A' ' 28' ' ' ALA . 86.6 t80 -84.8 -35.39 22.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.225 -0.443 . . . . 9.24 110.147 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.468 ' HA2' ' HA3' ' B' ' 185' ' ' GLY . . . -66.37 -55.88 16.25 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.612 -0.722 . . . . 10.64 112.885 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 25.8 p -93.34 -3.78 52.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.626 0.25 . . . . 12.27 111.648 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' B' ' 149' ' ' PHE . 7.1 t-80 58.86 47.87 11.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.538 0.685 . . . . 13.51 110.595 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.76 -179.66 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.507 -0.77 . . . . 12.96 110.911 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 19.5 m -137.74 125.78 22.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.794 0.33 . . . . 10.75 111.032 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.54 178.07 8.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 8.03 109.928 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.453 ' C ' HD12 ' B' ' 158' ' ' LEU . 24.8 p90 -118.42 121.16 39.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.458 0.647 . . . . 9.95 110.658 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' B' ' 147' ' ' VAL . 7.1 mp -129.6 175.09 9.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.575 -0.738 . . . . 6.89 109.489 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.58 -179.73 18.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.781 . . . . 6.24 111.497 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.01 -37.09 95.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.619 2.213 . . . . 8.35 112.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.41 -17.95 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 12.73 111.494 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.537 ' HB3' HD23 ' B' ' 158' ' ' LEU . 15.1 m-20 -87.92 -10.68 49.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.271 0.558 . . . . 9.49 110.086 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 16' ' ' VAL . 25.7 mt -106.73 140.2 39.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.32 -0.854 . . . . 7.88 110.233 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' B' ' 165' ' ' PRO . 57.0 m-85 -129.24 115.65 18.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 10.48 110.797 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.564 ' HA ' HG12 ' A' ' 16' ' ' VAL . 14.6 Cg_endo -57.7 114.9 2.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.92 2.413 . . . . 10.82 112.124 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.533 ' HD1' ' N ' ' B' ' 167' ' ' GLU . 0.1 OUTLIER -55.12 -25.34 31.02 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.265 0.469 . . . . 10.52 112.265 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' B' ' 166' ' ' TYR . 27.5 mt-10 -46.69 -35.66 6.29 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.602 0.564 . . . . 13.98 111.175 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -117.48 -33.03 4.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 15.72 110.732 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.67 ' HB2' ' CD2' ' B' ' 173' ' ' PHE . 93.7 p -82.48 -25.02 33.9 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.323 0.86 . . . . 11.91 113.323 -168.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.75 -27.21 39.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.829 0.677 . . . . 12.55 112.829 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.67 -35.61 52.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.801 -0.36 . . . . 15.86 111.83 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -87.47 -28.57 21.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.797 0.332 . . . . 16.47 111.453 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' B' ' 169' ' ' SER . 28.1 m-85 -108.43 0.91 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.194 0.521 . . . . 11.15 110.225 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -76.12 83.73 0.95 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.486 -0.779 . . . . 11.12 111.743 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -137.72 95.45 11.11 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.077 -1.083 . . . . 14.56 108.077 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.734 ' HA ' ' HE2' ' B' ' 182' ' ' PHE . 2.3 Cg_endo -76.99 108.57 2.67 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.662 2.242 . . . . 11.81 112.769 -168.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . 0.489 ' N ' HD22 ' B' ' 177' ' ' ASN . 0.8 OUTLIER -79.49 165.57 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.11 -0.95 . . . . 13.38 108.921 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -84.59 -1.5 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.906 0.384 . . . . 16.74 110.989 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -66.94 126.65 29.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.522 -0.548 . . . . 16.14 109.522 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' OG ' ' B' ' 183' ' ' SER . 23.7 mtpp -64.42 -39.37 93.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.856 0.687 . . . . 15.89 112.856 -167.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.52 71.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.989 -1.101 . . . . 11.57 112.077 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.734 ' HE2' ' HA ' ' B' ' 176' ' ' PRO . 64.8 t80 -81.84 -48.19 11.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.833 0.349 . . . . 9.65 110.424 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' B' ' 180' ' ' LYS . 34.3 p -64.46 -44.68 90.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.985 -0.552 . . . . 10.46 111.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -40.11 69.73 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.597 -0.441 . . . . 12.15 110.095 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 189' ' ' ILE . . . -59.16 -47.21 91.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.612 -0.804 . . . . 8.24 112.607 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.8 -37.08 81.55 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.341 0.591 . . . . 7.89 109.839 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -65.17 -50.85 64.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.754 -0.657 . . . . 11.87 110.984 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.93 -27.35 69.09 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.642 0.608 . . . . 11.62 112.642 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.622 HG22 ' O ' ' B' ' 185' ' ' GLY . 0.0 OUTLIER -80.97 -45.85 20.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.274 -0.57 . . . . 9.26 110.37 178.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -19.54 58.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 11.04 111.534 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -137.16 42.04 2.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.947 -0.57 . . . . 12.59 109.951 -172.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . 0.531 ' O ' HG13 ' B' ' 195' ' ' VAL . 0.3 OUTLIER -52.68 141.86 34.35 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.818 -0.628 . . . . 13.52 111.781 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -35.26 86.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.336 2.691 . . . . 14.9 113.226 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 9.5 m -82.97 88.7 6.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.079 0.466 . . . . 17.54 110.641 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 192' ' ' ASN . 6.2 m -119.02 147.23 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.493 0.663 . . . . 18.06 112.004 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -102.51 97.29 7.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.027 -0.988 . . . . 21.28 108.766 171.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . 59.57 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.883 -0.599 . . . . 21.53 110.927 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -131.67 14.59 4.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 23.03 109.998 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.46 -35.51 2.16 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.979 -0.849 . . . . 24.72 110.979 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.842 -0.599 . . . . 27.31 109.557 178.387 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.061 0.458 . . . . 29.42 110.303 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -71.77 -36.83 70.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 26.59 110.474 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 59.45 30.4 20.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.617 0.722 . . . . 25.53 109.998 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -63.99 126.02 26.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.231 -0.895 . . . . 23.29 110.673 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -75.73 92.42 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.156 0.503 . . . . 21.2 110.31 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -86.01 114.45 22.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.827 -0.624 . . . . 20.05 109.691 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -62.21 110.66 1.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 16.73 111.66 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -135.66 83.9 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.726 . . . . 16.22 109.737 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.52 -24.46 17.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 13.24 109.82 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -114.93 120.6 40.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.328 -0.851 . . . . 10.33 109.783 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' GLY . 88.9 tttt -85.08 114.35 22.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.814 -1.18 . . . . 14.9 107.814 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m 65.64 -45.23 0.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.862 0.726 . . . . 11.71 110.372 -167.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.626 ' HA3' HG13 ' A' ' 30' ' ' ILE . . . 160.7 -20.64 0.22 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.796 -0.921 . . . . 9.66 110.796 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.93 -163.47 0.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.206 0.526 . . . . 10.47 111.925 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.75 120.25 35.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.541 -0.911 . . . . 7.46 108.541 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HD2' ' B' ' 166' ' ' TYR . 3.8 m -155.61 -170.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 O-C-N 123.191 0.307 . . . . 6.87 110.627 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' B' ' 166' ' ' TYR . 15.1 m-85 -89.38 121.76 31.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 6.78 110.075 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.73 154.43 20.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 6.21 110.932 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.23 105.73 16.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.534 -0.757 . . . . 12.44 109.568 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.728 ' HB2' ' CZ ' ' B' ' 149' ' ' PHE . 27.8 ttt -96.0 155.5 16.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.541 -0.54 . . . . 10.95 109.541 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.04 115.68 5.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.749 -0.834 . . . . 15.91 108.749 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.19 -18.77 55.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.789 -0.72 . . . . 14.09 112.535 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' MET . 86.1 m-85 -128.98 105.86 18.18 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.98 0.39 . . . . 13.65 110.376 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 23' ' ' TYR . 10.5 Cg_endo -53.59 -51.11 11.62 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.229 2.619 . . . . 12.38 113.194 -175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -145.11 118.64 9.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.687 0.28 . . . . 11.05 110.37 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.751 ' HB3' ' HE2' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -141.83 135.31 14.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.888 -0.597 . . . . 10.23 109.899 -177.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' TRP . 25.6 Cg_exo -63.17 116.14 3.41 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.011 2.474 . . . . 5.52 112.518 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.86 155.98 49.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.97 0.414 . . . . 3.98 111.934 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.675 ' HB2' ' CZ ' ' B' ' 150' ' ' PHE . 24.6 ttp180 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.851 -0.613 . . . . 11.28 109.991 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG13 ' HA3' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.9 138.44 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.187 0.518 . . . . 7.51 110.296 176.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 146' ' ' GLN . 25.2 t0 -126.17 142.45 51.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.84 -0.8 . . . . 10.28 108.84 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.58 139.05 40.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 10.44 111.949 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.38 114.77 2.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.95 -1.023 . . . . 12.85 109.187 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 1.04 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 42.4 Cg_exo -57.93 151.49 56.94 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.436 2.09 . . . . 13.07 111.212 175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 34' ' ' PRO . 43.3 tt0 76.77 -33.61 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.388 0.675 . . . . 14.04 111.66 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.25 -64.85 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.74 0.305 . . . . 15.24 110.495 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' B' ' 145' ' ' TYR . . . -95.14 -42.76 8.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.179 0.514 . . . . 14.64 110.178 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.04 ' HB ' ' HA ' ' A' ' 34' ' ' PRO . 66.2 t -81.64 102.85 7.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 12.42 109.853 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -109.66 11.63 24.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 10.84 110.54 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 t -100.88 4.23 42.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 9.63 110.883 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.83 1.84 48.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.435 . . . . 9.56 111.74 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.11 106.77 18.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.187 0.518 . . . . 8.3 110.982 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.28 95.4 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 8.55 109.756 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.31 124.25 17.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.248 -0.649 . . . . 7.5 109.248 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HA ' ' HB1' ' B' ' 137' ' ' ALA . 90.3 m-85 -82.57 165.95 19.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.544 0.687 . . . . 6.01 112.362 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.17 104.06 16.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.446 -0.797 . . . . 6.99 109.623 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -92.89 116.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.922 -0.399 . . . . 4.6 109.922 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -91.66 116.04 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.028 0.442 . . . . 5.62 110.946 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' B' ' 126' ' ' TRP . 11.5 m-85 -87.86 125.46 34.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.667 -0.697 . . . . 4.03 111.68 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' B' ' 115' ' ' LEU . 22.7 m-85 -69.86 -42.1 73.97 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.658 0.599 . . . . 4.15 110.238 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.33 -55.92 26.46 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 5.0 113.468 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -82.5 -13.12 57.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.618 0.247 . . . . 5.56 111.491 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.4 m80 60.47 38.64 19.04 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.069 -0.514 . . . . 6.72 109.93 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.27 153.74 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 6.33 111.298 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.3 m -92.96 126.55 38.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.519 . . . . 5.99 110.172 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.3 132.38 55.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.025 -0.534 . . . . 5.39 110.792 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.88 97.69 8.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.113 0.482 . . . . 7.73 110.348 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 89.2 mt -120.09 163.72 17.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.944 -0.571 . . . . 5.32 110.301 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.03 172.4 28.08 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.498 -0.858 . . . . 5.57 111.269 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.4 -27.77 85.49 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.592 2.195 . . . . 6.06 111.99 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -79.61 -15.05 58.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 7.7 111.345 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 38.6 m-20 -86.36 -2.88 58.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 5.82 109.548 175.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' B' ' 116' ' ' VAL . 11.4 tp -108.34 118.33 36.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.409 -0.814 . . . . 4.21 109.702 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' B' ' 116' ' ' VAL . 56.3 m-85 -114.4 124.6 30.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.515 0.198 . . . . 4.63 111.167 -174.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.63 116.36 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.405 2.737 . . . . 4.58 113.122 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.847 ' HB3' ' HA ' ' B' ' 116' ' ' VAL . 0.8 OUTLIER -67.05 -20.56 65.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.94 -0.573 . . . . 4.79 110.719 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 -29.0 68.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.91 0.386 . . . . 6.1 109.979 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.51 -39.09 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 6.71 110.287 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 49.9 m -65.41 -43.57 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 5.49 112.045 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 1.8 tmmt? -59.16 -18.99 41.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.747 0.308 . . . . 6.26 111.365 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.2 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 7.73 110.926 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -83.85 -19.58 34.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 8.1 111.388 -170.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 12.2 m-85 -106.63 10.41 31.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.286 0.565 . . . . 5.97 110.002 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.13 71.58 2.75 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.625 -0.716 . . . . 6.74 111.949 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -148.09 93.85 4.38 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.044 -1.095 . . . . 8.38 108.044 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.59 126.71 18.92 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.82 2.347 . . . . 7.75 112.595 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.61 -172.04 3.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 7.82 110.417 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -100.33 9.88 42.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 10.11 110.051 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.16 123.05 39.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 8.81 110.022 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 51.5 tptt -58.22 -39.01 77.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.825 . . . . 8.87 111.783 -168.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.39 99.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.404 -0.903 . . . . 5.87 112.422 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -69.65 -41.42 75.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.89 -0.411 . . . . 5.14 109.89 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -59.16 -48.08 82.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.642 -0.708 . . . . 6.17 110.84 178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 80' ' ' LYS . 14.0 mm-40 -56.88 -47.52 80.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.747 0.308 . . . . 6.87 110.803 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.9 93.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.768 -0.729 . . . . 4.6 112.62 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.79 73.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.849 0.356 . . . . 5.05 110.413 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -64.42 -52.93 55.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.244 -0.435 . . . . 7.15 110.291 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.643 ' HA ' HD21 ' A' ' 91' ' ' ASN . 5.4 tp10 -58.48 -26.59 63.58 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.886 0.741 . . . . 5.21 110.328 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.74 HD11 ' HG ' ' B' ' 115' ' ' LEU . 0.7 OUTLIER -85.58 -33.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.995 -0.548 . . . . 4.46 111.979 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -74.3 -43.66 55.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 6.86 110.402 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -86.71 5.55 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.903 0.382 . . . . 6.04 111.364 -179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 88' ' ' GLU . 2.1 t-20 -157.71 82.7 2.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.252 -0.431 . . . . 5.09 110.704 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.83 -78.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.797 2.331 . . . . 6.48 111.354 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.9 m -126.09 76.23 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.478 0.656 . . . . 7.32 110.711 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.9 133.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.587 -0.894 . . . . 6.13 108.587 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -92.67 95.4 9.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.053 -0.351 . . . . 9.68 110.053 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.09 -77.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.026 0.829 . . . . 8.54 111.46 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 t -150.39 147.54 27.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.746 -0.835 . . . . 9.88 108.746 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.48 88.16 0.47 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.224 -0.988 . . . . 9.93 113.276 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.193 0.521 . . . . 12.88 109.967 174.174 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.99 0.424 . . . . 13.85 110.528 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -116.53 95.34 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.451 . . . . 12.37 109.908 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.0 31.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.004 0.43 . . . . 12.02 110.984 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 41.3 m 68.39 86.25 0.13 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.202 -0.908 . . . . 10.42 112.494 175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -83.28 119.66 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.674 -0.861 . . . . 8.13 108.674 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -77.21 93.32 3.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.42 0.628 . . . . 10.78 111.164 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -86.47 110.08 19.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 8.36 110.263 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -96.75 0.13 49.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.916 -0.584 . . . . 8.99 110.473 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.86 156.88 16.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 8.32 110.981 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -80.6 124.85 29.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.731 -0.84 . . . . 5.28 108.731 170.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' B' ' 111' ' ' LYS . 0.1 OUTLIER -71.16 137.47 48.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.89 -0.596 . . . . 8.12 110.758 -172.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.41 104.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.286 0.565 . . . . 5.93 110.589 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.11 11.1 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.424 -0.67 . . . . 4.62 111.424 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.16 148.08 41.92 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.827 0.346 . . . . 4.66 110.225 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.74 ' HG ' HD11 ' A' ' 89' ' ' ILE . 28.2 tp -141.3 103.93 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.35 . . . . 3.32 110.708 -171.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.847 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 35.2 m -144.34 -170.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.344 -0.389 . . . . 3.43 111.139 -172.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.94 125.27 35.72 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.829 -0.434 . . . . 3.93 109.829 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.84 156.58 19.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.619 -0.264 . . . . 3.3 110.703 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.55 ' HB2' ' HE2' ' A' ' 64' ' ' PHE . 65.2 tttp -107.86 118.6 37.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.104 0.478 . . . . 5.76 110.657 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.691 ' HB3' ' HB2' ' B' ' 123' ' ' TYR . 23.1 ttt -106.04 162.99 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.443 -0.947 . . . . 6.08 108.443 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 3.7 mptp? -73.36 115.8 13.16 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.706 -0.798 . . . . 8.78 109.086 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.71 -3.24 67.79 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.592 -0.731 . . . . 6.27 111.859 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' TYR . . . . . 0.691 ' HB2' ' HB3' ' B' ' 120' ' ' MET . 91.3 m-85 -129.26 113.83 18.39 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 110.0 -0.371 . . . . 7.06 110.0 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 123' ' ' TYR . 32.0 Cg_exo -57.07 -74.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.318 2.678 . . . . 5.68 113.506 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -140.73 107.68 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.208 -0.664 . . . . 4.71 109.208 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.73 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -126.9 125.77 24.3 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.89 -0.596 . . . . 6.03 109.703 -172.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 126' ' ' TRP . 52.9 Cg_exo -55.44 124.33 16.02 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.838 2.359 . . . . 3.48 112.563 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.77 37.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.215 0.531 . . . . 2.83 111.339 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -103.85 141.41 36.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.452 -0.794 . . . . 5.33 111.037 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.509 HD13 ' N ' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -81.05 132.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.434 -0.95 . . . . 4.34 108.434 172.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' HD13 ' B' ' 130' ' ' ILE . 18.3 t0 -132.36 129.55 39.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 5.66 110.192 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.08 149.71 27.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.634 -0.712 . . . . 7.05 110.888 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' MET . . . . . 0.588 ' HB3' ' HB3' ' B' ' 136' ' ' ALA . 43.8 tpp -160.74 109.51 1.31 Allowed Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.324 -0.991 . . . . 9.64 108.324 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.35 -6.24 8.12 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.64 2.893 . . . . 9.8 113.892 -171.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -128.94 17.19 6.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.934 0.397 . . . . 12.27 110.635 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' B' ' 133' ' ' MET . . . -143.95 -54.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.41 . . . . 11.49 111.159 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 45' ' ' TYR . . . -77.85 -75.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 11.38 109.417 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 72.2 t -78.7 111.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.163 -0.68 . . . . 9.65 109.163 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -79.67 116.74 20.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.063 0.458 . . . . 11.11 111.187 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' SER . . . . . . . . . . . . . 20.9 p -121.22 17.56 11.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.833 0.825 . . . . 8.66 109.066 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 11.9 m -77.0 102.51 6.48 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.734 -1.121 . . . . 9.44 111.23 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.82 110.32 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.014 -0.539 . . . . 8.63 109.556 174.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.55 -55.14 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.956 0.407 . . . . 9.61 110.996 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -136.88 158.58 44.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.986 -0.552 . . . . 8.97 110.762 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 74.5 m-85 -115.08 170.45 8.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 7.97 109.886 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 31' ' ' ASP . 41.8 tt0 -90.21 84.99 6.13 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.563 0.697 . . . . 9.5 109.289 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' B' ' 158' ' ' LEU . 89.8 t -78.18 124.19 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 6.03 110.548 -175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -106.17 125.7 51.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.216 0.531 . . . . 10.78 110.348 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.751 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 11.9 m-85 -89.37 125.09 34.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.389 -0.823 . . . . 8.4 110.78 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 39.8 m-85 -65.43 -75.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 124.099 0.874 . . . . 9.24 111.209 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLY . . . . . 0.434 ' H ' ' HH2' ' A' ' 26' ' ' TRP . . . -63.63 -47.06 90.26 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.614 -0.721 . . . . 10.64 113.145 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -27.56 66.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.122 0.487 . . . . 12.27 110.202 174.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' HIS . . . . . . . . . . . . . 1.9 t60 56.54 48.61 16.31 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.986 -1.006 . . . . 13.51 110.513 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -134.81 150.02 50.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.615 -0.721 . . . . 12.96 111.039 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 85.3 m -101.58 127.24 48.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 10.75 109.934 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.85 137.44 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.27 -0.423 . . . . 8.03 110.764 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -89.47 104.63 17.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.81 -0.441 . . . . 9.95 109.81 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' B' ' 147' ' ' VAL . 96.2 mt -119.72 146.79 45.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 6.89 110.839 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.01 174.85 33.15 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.876 -0.602 . . . . 6.24 112.315 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.6 -32.86 96.66 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.061 2.507 . . . . 8.35 112.91 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 pptp? -80.6 -2.46 46.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 12.73 111.698 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -112.19 5.11 18.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.226 0.536 . . . . 9.49 109.752 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 16' ' ' VAL . 12.3 tp -115.89 117.32 29.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 7.88 109.649 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' PHE . . . . . 0.684 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 38.4 m-85 -116.16 133.74 22.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 10.48 111.399 -172.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' PRO . . . . . 0.542 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 15.7 Cg_exo -67.53 126.9 15.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.092 2.528 . . . . 10.82 112.422 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' TYR . . . . . 0.792 ' HD2' ' HA ' ' A' ' 16' ' ' VAL . 11.9 p90 -85.53 -27.13 25.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.845 -0.342 . . . . 10.52 110.431 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.49 -35.6 60.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.66 0.266 . . . . 13.98 110.905 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -117.39 18.78 14.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.321 -0.399 . . . . 15.72 112.015 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 66.7 m -150.63 -9.27 0.26 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.713 0.634 . . . . 11.91 112.713 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -48.35 -34.09 10.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.368 0.507 . . . . 12.55 112.368 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.75 -23.51 65.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.949 0.352 . . . . 15.86 111.949 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -94.35 -10.54 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 16.47 110.39 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -109.85 -21.02 12.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.094 -0.503 . . . . 11.15 110.53 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.51 0.42 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.748 -0.66 . . . . 11.12 112.144 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.11 99.93 3.05 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 106.993 -1.484 . . . . 14.56 106.993 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -65.1 93.11 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.161 1.907 . . . . 11.81 112.228 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -68.09 160.17 29.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.714 -1.13 . . . . 13.38 109.901 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -83.0 20.99 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.981 0.419 . . . . 16.74 111.619 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 179' ' ' ARG . 2.4 mmp_? -102.99 99.66 9.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 16.14 108.972 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -49.75 -34.63 19.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.011 0.819 . . . . 15.89 113.196 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.9 93.53 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.438 -0.887 . . . . 11.57 111.854 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.0 -39.33 63.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 9.65 110.283 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -60.07 -44.68 94.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.092 -0.504 . . . . 10.46 111.13 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.61 -37.9 65.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.247 -0.433 . . . . 12.15 110.217 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.54 ' HA3' ' CH2' ' A' ' 26' ' ' TRP . . . -64.9 -40.61 97.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.194 -1.003 . . . . 8.24 111.792 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' LEU . . . . . 0.424 ' O ' HD23 ' B' ' 186' ' ' LEU . 5.9 tt -62.34 -40.95 98.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.957 -0.757 . . . . 7.89 108.957 175.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -61.14 -42.09 97.92 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.64 -0.255 . . . . 11.87 110.797 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -57.27 -31.05 65.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.21 0.319 . . . . 11.62 110.909 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' B' ' 189' ' ' ILE . 0.2 OUTLIER -87.05 -31.57 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.922 -0.311 . . . . 9.26 111.301 173.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.6 -60.04 4.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.215 0.531 . . . . 11.04 110.778 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' ASN . . . . . 0.459 HD22 ' N ' ' B' ' 191' ' ' ASN . 0.1 OUTLIER -70.36 -18.48 63.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 12.59 111.1 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.7 135.77 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.908 0.755 . . . . 13.52 110.813 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.66 147.08 18.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.723 2.282 . . . . 14.9 112.258 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . . . . . . . . . 23.8 m -49.88 106.43 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.506 0.504 . . . . 17.54 111.509 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.67 111.22 19.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 18.06 110.781 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -149.61 88.56 1.56 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.62 -0.718 . . . . 21.28 109.25 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' ALA . . . . . . . . . . . . . . . -83.76 -71.1 0.52 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.015 -0.539 . . . . 21.53 110.313 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' SER . . . . . . . . . . . . . 6.6 p -136.79 57.84 1.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.878 -0.601 . . . . 23.03 109.815 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.92 60.25 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.48 -1.048 . . . . 24.72 110.48 -171.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 108.709 -0.849 . . . . 27.31 108.709 -177.239 . . . . . . . . 0 0 . 1 stop_ save_